Presentation number CoIOP01

ECCO'20 Conflict of Interest indications

Colombel, Jean-Frédéric:|:|Research grants from AbbVie, Janssen Pharmaceuticals, and Takeda; payment for lectures from AbbVie, Allergan, Inc., Amgen, Ferring Pharmaceuticals, Shire, and Takeda; consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, and Viela Bio; holds stock options in Genfit and Intestinal Biotech Development.|Julian Panés: Financial support for research: AbbVie and MSD; lecture fee(s): AbbVie, Ferring, Janssen, MSD, Pfizer, Shire Pharmaceuticals, Takeda, and Theravance; consultancy: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Ferring, Genentech, GlaxoSmithKline, GoodGut, Janssen, MSD, Nestle, Oppilan, Pfizer, Progenity, Robarts, Roche, Takeda, Theravance, TiGenix, and Topivert.||Panés, Julian:|:|Financial support for research: AbbVie and MSD; lecture fee(s): AbbVie, Ferring, Janssen, MSD, Pfizer, Shire Pharmaceuticals, Takeda, and Theravance; consultancy: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Ferring, Genentech, GlaxoSmithKline, GoodGut, Janssen, MSD, Nestle, Oppilan, Pfizer, Progenity, Robarts, Roche, Takeda, Theravance, TiGenix, and Topivert.||D'Haens, Geert:|:|Consulting and/or lecture fees from AbbVie, ActoGeniX, AIM, Boehringer Ingelheim GmbH, Centocor, Chemo Centryx, Cosmo Technologies, Dr Falk Pharma, Elan Pharmaceuticals, enGene, Ferring, Galapagos, Giuliani SpA, Given Imaging, GlaxoSmithKline, Janssen Biologics, MSD, Neovacs, Novo Nordisk, Otsuka, PDL BioPharma, Pfizer, Receptos, Salix, Schering-Plough, SetPoint, Shire Pharmaceuticals, Takeda, Tillotts Pharma, UCB Pharma, Versant, and Vifor Pharma; research grants from AbbVie, Dr Falk Pharma, Given Imaging, Janssen, MSD, and PhotoPill; speaking honoraria from AbbVie, Ferring, MSD, Norgine, Shire, Tillotts, Tramedico, and UCB Pharma.|Stefan Schreiber: Consultancy: AbbVie, Falk Pharma, Ferring, Genentech, GlaxoSmithKline, MSD, Pfizer, Shire, and Takeda.||Schreiber, Stefan:|:|Consultancy: AbbVie, Falk Pharma, Ferring, Genentech, GlaxoSmithKline, MSD, Pfizer, Shire, and Takeda.||Panaccione, Remo:|:|Consultant and/or lecture fees from AI4GI, AbbVie, Arena Pharmaceuticals Amgen, Atlantic Healthcare, BioBalance, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Coronado Biosciences, Cosmo Technologies, Eagle, Eisai Medical Research, Elan, Eli Lilly, EnGene, Ferring, Genentech, Gilead, Given Imaging, GlaxoSmithKline, Janssen, Lycera, Meda, Merck & Co., Merck Research Laboratories, Merck Serono, Novo Nordisk, PDL Biopharma, Pfizer, Prometheus Laboratories, Protagonist, Receptos, Robarts Clinical Trials, Salix, Sandoz, Sanofi Genzyme, Shire Pharmaceuticals, Sigmoid Pharma, Sublimity, Takeda, and Theravance.||Peyrin-Biroulet, Laurent:|:|Personal fees from AbbVie, Allergan, Alma, Amgen, Arena, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Ferring, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, MSD, Nestle, Pfizer, Pharmacosmos, Roche, Takeda, Tillotts, Samsung Bioepis, Sandoz, Sterna; grants from AbbVie, MSD, and Takeda; stock options: CTMA.|Edward V. Loftus Jr: Consultancy: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB; research support: AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Gilead, Janssen, Medimmune, Pfizer, Receptos, Robarts Clinical Trials, Takeda, and UCB. ||Loftus Jr, Edward V:|:|Consultancy: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Janssen, Pfizer, Takeda, and UCB; research support: AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Gilead, Janssen, Medimmune, Pfizer, Receptos, Robarts Clinical Trials, Takeda, and UCB. ||Danese, Silvio:|:|Financial support for research: AbbVie, Amgen, Genentech, Gilead, Janssen, Medimmune, Pfizer, Receptos, Robarts Clinical Trials, Seres Therapeutics, Takeda, and UCB; consultancy: AbbVie, Allergan, Amgen, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Janssen, Pfizer, Takeda, and UCB.||Louis, Edouard:|:|: Research grant: Janssen, Pfizer, and Takeda; educational grant: AbbVie, Janssen, MSD, and Takeda; speaker fees: AbbVie, Falk, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda; advisory board: AbbVie, Celgene, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda; consultancy: AbbVie.||Armuzzi, Alessandro:|:|Consultant or advisory member for AbbVie, Allergan, Amgen, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Hospira, Janssen, Lilly, MSD, Mundipharma, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, Sofar, and Takeda; lecture fees from AbbVie, Amgen, AstraZeneca, Chiesi, Ferring, Hospira, Janssen, Medtronic, Mitsubishi Tanabe, MSD, Mundipharma, Nikkiso, Otsuka, Pfizer, Samsung Bioepis, Takeda, Tigenix, and Zambon; research funding from MSD, Pfizer, and Takeda.||Ferrante, Marc:|:|Research grant: Janssen, Pfizer, and Takeda; consultancy: AbbVie, Boehringer-Ingelheim, Ferring, Janssen, Mitsubishi Tanabe, MSD, Pfizer, and Takeda; speakers fee: AbbVie, Boehringer Ingelheim, Chiesi, Ferring, Janssen, Lamepro, Mitsubishi Tanabe, MSD, Pfizer, Takeda, Tillotts, Tramedico, and Zeria. ||Vogelsang, Harald:|:|Consultant and/or lecture fee from AbbVie, Amgen, Astro, Bristol-Myers Squibb, Falk, Ferring, Gilead, Janssen, MSD, Pfizer, and Takeda.||Lefebvre, Jessica:|:|AbbVie employees, and may own AbbVie stock and/or options.||Doan, Thao:|:|AbbVie employees, and may own AbbVie stock and/or options.||Xie, Wangang:|:|AbbVie employees, and may own AbbVie stock and/or options.||Huang, Bidan:|:|AbbVie employees, and may own AbbVie stock and/or options.||Petersson, Joel:|:|AbbVie employees, and may own AbbVie stock and/or options.||Kalabic, Jasmina:|:|AbbVie employees, and may own AbbVie stock and/or

Page 1 of 135

OP02 Dr. LEY, Delphine: No conflict of intereset||Dr. Leroyer, Ariane: No conflict of intereset||Dr. Dupont, Claire: No conflict of intereset||Ms. Sarter, Hélène: No conflict of intereset||Dr. Bertrand, Valérie: No conflict of intereset||Dr. Spyckerelle, Claire: No conflict of intereset||Dr. Guillon, Nathalie: No conflict of intereset||Prof. Pariente, Benjamin: No conflict of intereset||Prof. Savoye, Guillaume: No conflict of intereset||Prof. Turck, Dominique: No conflict of intereset||Dr. Gower-Rousseau, Corinne: No conflict of intereset||Prof. Fumery, Mathurin: No conflict of intereset

OP03 Mr. Stevens, Toer: No conflict of intereset||Ms. Haasnoot, Laura: No conflict of intereset||Prof. Dr. D'Haens, Geert:|:|has served as advisor for Abbvie, Ablynx, Amakem, AM Pharma, Avaxia, Biogen, Bristol Meiers Squibb, Boerhinger Ingelheim, Celgene, Celltrion, Cosmo, Covidien, Ferring, DrFALK Pharma, Engene, Galapagos, Gilead, Glaxo Smith Kline, Hospira, Immunic, Johnson and Johnson, Lycera, Medicmetrics, Millenium/Takeda, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Novonordis, Pfizer, Prometheus laboratories/Nestle, Protagonist, Receptos, Robarts Clinical Trials, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor and received speaker fees from Abbvie, Ferring, Johnson and Johnson, Merck Sharp & Dohme, Mundipharma, Norgine, Pfizer, Shire, Millenium/Takeda, Tillotts and Vifor. ||Dr. Buskens, Christianne: No conflict of intereset||Dr. de Groof, E. Joline: No conflict of intereset||Dr. Eshuis, Emma: No conflict of intereset||Dr. Gardenbroef, Tjibbe: No conflict of intereset||Ms. Mol, Bregje: No conflict of intereset||Dr. Stokkers, Pieter: No conflict of intereset||Prof. Dr. Bemelman, Willem: No conflict of intereset||Prof. Dr. Ponsioen, Cyriel:|:|declares a grant from Takeda, Dr Falk Pharma and Abbvies, advisory board fees from Takeda and GSK as well as speaker’s fees from Takeda, Abbvie, Ferring, MSD and Dr. Falk Pharma.

OP04 Dr. Hammoudi, Nassim: No conflict of intereset||Dr. Auzolle, Claire: No conflict of intereset||Dr. Tran Minh, My-Linh: No conflict of intereset||Dr. Boschetti, Gilles:|:|GB received honoraria from Abbvie, MSD and Takeda, MB declares no competing interest||Ms. Bezault, Madeleine: No conflict of intereset||Dr. Buisson, Anthony:|:|AB received honoraria from MSD, Abbvie, Ferring, Takeda, Vifor Pharma, Sanofi-Aventis, Hospira, and Janssen||Dr. Pariente, Benjamin:|:|BP received honoraria from AbbVie, MSD, Takeda, Janssen, Bioagaran, and Ferring||Prof. Treton, Xavier:|:|XT received honoraria from Abbvie, MSD, Takeda, Ferring, Norgine, and Janssen.||Prof. Seksik, Philippe:|:|PS received honoraria from Takeda, MSD, Biocodex, Ferring and Abbvie and financial support from Takeda||Dr. Fumery, Mathurin:|:|MF received honoraria from Abbvie, MSD, Ferring, Takeda, Boehringer, Pfizer, Celgene, Gilead, and Janssen. ||Dr. Le Bourhis, Lionel: No conflict of intereset||Prof. Nancey, Stéphane:|:|SN received honoraria from MSD, Abbvie, Takeda, Janssen, HAC Pharma, Tillots, Ferring, and Novartis||Prof. Allez, Matthieu:|:|MA received honoraria from Abbvie, MSD, Janssen, Takeda, Pfizer, Novartis, Ferring, Tillots, Celgene, and Genentech/Roche

options.||Robinson, Anne:|:|AbbVie employees, and may own AbbVie stock and/or options.||Sandborn, William J:|:|Research grants from AbbVie, Amgen, Atlantic Healthcare Limited, Celgene/Receptos Genentech, Gilead Sciences, Janssen, Lilly, and Takeda; consulting fees from AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen, Kyowa Kirin Pharmaceutical Research, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pfizer, Precision IBD, Progenity, Prometheus Laboratories, Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust, HART), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna Biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts Pharma, UCB Pharma, Ventyx Biosciences, Vimalan Biosciences, and Vivelix Pharmaceuticals; and stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan Pharma, Precision IBD, Progenity, Ritter Pharmaceuticals, Ventyx Biosciences, and Vimalan Biosciences.

Page 2 of 135

OP05 Prof. Pariente, Benjamin: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset||Prof. Burisch, Johan: No conflict of intereset||Prof. Arebi, Naila: No conflict of intereset||Dr. Barberio, Brigida: No conflict of intereset||Dr. Duricova, Dana: No conflict of intereset||Dr. Ellul, Pierre: No conflict of intereset||Dr. Goldis, Adrian: No conflict of intereset||Dr. Kaimakliotis, ioannis: No conflict of intereset||Dr. Katsanos, Konstantinos: No conflict of intereset||Dr. Krznaric, zeljko: No conflict of intereset||Dr. Mc Namara , Deirdre: No conflict of intereset||Dr. Pedersen, Natalia: No conflict of intereset||Prof. Sebastian, Shaji: No conflict of intereset||Dr. Weimars, Petra: No conflict of intereset||Dr. Lung, Philip: No conflict of intereset||Dr. Lacognata, carmelo: No conflict of intereset||Dr. Horak, Martin: No conflict of intereset||Dr. Domislovic, Viktor: No conflict of intereset||Dr. Murphy, Ian: No conflict of intereset||Dr. Ungaro, Ryan: No conflict of intereset||Prof. Colombel , Jean Frederic: No conflict of intereset||Dr. Mary, Jean Yves: No conflict of intereset

OP06 Dr. Haberman Ziv, Yael: No conflict of intereset||Loberman-Nachum, Nurit: No conflict of intereset||Katya, Sosnovski: No conflict of intereset||Di Segni, Ayelet: No conflict of intereset||Efroni, Gilat: No conflict of intereset||Braun, Tzipi: No conflict of intereset||BenShoshan, Marina: No conflict of intereset||Shouval, Dror: No conflict of intereset||Denson, Lee A: No conflict of intereset||Amir, Amnon: No conflict of intereset||Unger, Ron: No conflict of intereset||Weiss, Batia: No conflict of intereset

OP07 Dr. Agrawal, Manasi: No conflict of intereset||Shrestha, Sarita: No conflict of intereset||Corn, Giulia: No conflict of intereset||Nielsen, Nete Munk: No conflict of intereset||Frisch, Morten: No conflict of intereset||Prof. Dr. Colombel, Jean-Frederic:|:|Dr. Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, |Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.|||Prof. Jess, Tine: No conflict of intereset

OP08 Dr. Axelrad, Jordan: No conflict of intereset||Dr. Olen, Ola: No conflict of intereset||Dr. Sachs, Michael: No conflict of intereset||Dr. Erichsen , Rune: No conflict of intereset||Prof. Pedersen, Lars: No conflict of intereset||Prof. Dr. Halfvarson, Jonas: No conflict of intereset||Prof. Dr. Askling, Johan: No conflict of intereset||Prof. Dr. Ekbom, Anders: No conflict of intereset||Prof. Dr. Sørensen , Henrik Toft: No conflict of intereset||Prof. Dr. Ludvigsson , Jonas: No conflict of intereset

OP09 Dr. Quraishi, Mohammed Nabil: No conflict of intereset||Dr. Oo, Ye H: No conflict of intereset||Dr. Beggs, Andrew: No conflict of intereset||Dr. Withers, David: No conflict of intereset||Dr. Acharjee, Animesh: No conflict of intereset||Dr. Sharma, Naveen: No conflict of intereset||Dr. Manzoor, Susan: No conflict of intereset||Prof. Hart, Ailsa L: No conflict of intereset||Dr. Gaya, Daniel R: No conflict of intereset||Prof. Loman, Nicholas J: No conflict of intereset||Prof. Hawkey, Peter M: No conflict of intereset||Dr. Gerasimidis, Konstantinos: No conflict of intereset||Dr. Hansen, Richard: No conflict of intereset||Prof. Gkoutous, Georgios: No conflict of intereset||Prof. Iqbal, Tariq H: No conflict of intereset

OP10 Mr. Brand, Eelco:|:|ECB is supported by the Alexandre Suerman program for MD and PhD candidates of the University Medical Centre Utrecht, Netherlands, and is co-applicant on an unrestricted Investigator Initiated research grant of Pfizer.||Mr. Laenen, Yaro: No conflict of intereset||Dr. van Wijk, Femke:|:|FvW is co-applicant on an unrestricted Investigator Initiated research grant of Pfizer||Dr. de Zoete, Marcel:|:|MdZ is supported by a VIDI grant from the Netherlands Organization for Scientific Research (NWO, grant 91715377) and the Utrecht Exposome Hub, and co-founder and consultant of Artizan Biosciences.||Prof. Dr. Oldenburg, Bas:|:|Unrestricted grants: Abbvie, Janssen, Pfizer, Ferring, dr. Falk, Takeda; advisory board: Janssen, Pfizer, Takeda, Cablon.

Page 3 of 135

OP11 Ms. Arnauts, Kaline: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.||Prof. Dr. Vermeire, Severine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Prof. Dr. Verfaillie, Catherine: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda

OP12 Mr. WEWER, Mads Damsgaard: No conflict of intereset||Mrs. Zhao, Mirabella: No conflict of intereset||Mr. Nordholm-Carstensen , Andreas: No conflict of intereset||Prof. Seidelin, Jakob Benedict: No conflict of intereset||Mr. Burisch, Johan: No conflict of intereset

OP13 Dr. Dias, Ana: No conflict of intereset||Ms. Gomes, Eduarda: No conflict of intereset||Ms. Silva, Mariana: No conflict of intereset||Dr. Fernandes, Ângela: No conflict of intereset||Dr. Garrido, Mónica: No conflict of intereset||Prof. Dr. Marcos-Pinto, Ricardo: No conflict of intereset||Dr. Lago, Paula: No conflict of intereset||Prof. Dr. Pinho, Salomé: No conflict of intereset

OP14 Dr. Olen, Ola:|:|Dr. Olén has been PI on projects at Karolinska Institutet partly financed by investigator-initiated grants from Janssen and Ferring, and also report a grant from Pfizer in the context of a national safety monitoring programme. None of those studies have any relation to the present study. Karolinska Institutet has received fees for lectures held by Olén and participation by Olén on advisory boards from Janssen, Ferring, Takeda, and Pfizer regarding topics not related to the present study.||Dr. Erichsen, Rune:|:|The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. None of these studies have any relation to the present study.||Dr. Sachs, Michael C: No conflict of intereset||Prof. Pedersen, Lars:|:|The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. None of these studies have any relation to the present study.||Prof. Dr. Halfvarson, Jonas:|:|Dr Halfvarson has served as speaker and/or advisory board member for AbbVie, Celgene, Celltrion, Ferring, Hospira, Janssen, MEDA, Medivir, MSD, Olink Proteomics, Pfizer, Prometheus Laboratories, Sandoz/Novartis, Shire, Takeda, Tillotts Pharma, Vifor Pharma, and UCB. He has received grant support from Janssen, MSD, and Takeda.||Prof. Dr. Askling, Johan:|:|Dr. Askling reports grants from AbbVie, Bristol-Myers Squibb, Lilly, Merck, Pfizer, Roche, Samsung Bioepis, and UCB, mainly in the context of a national safety monitoring programme for immunomoduators in rheumatology (ARTIS).||Prof. Dr. Ekbom, Anders: No conflict of intereset||Prof. Dr. Sørensen, Henrik Toft:|:|The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. None of these studies have any relation to the present study.||Prof. Dr. Ludvigsson, Jonas f:|:|Dr Ludvigsson coordinates a study unrelated to the present study on behalf of the Swedish IBD Quality Register (SWIBREG). That study has received funding from Janssen.

OP15 Dr. Sudhakar, Padhmanand: No conflict of intereset||Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Cremer, Jonathan: No conflict of intereset||Dr. Verstockt, Sare: No conflict of intereset||Dr. Korcsmaros, Tamas: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Prof. Dr. Vermeire, Severine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

Page 4 of 135

OP16 Guedelha Sabino, João: No conflict of intereset||Tarassishin, Leonid: No conflict of intereset||Eisele, Caroline: No conflict of intereset||Barré, Amélie: No conflict of intereset||Dr. Dubinsky, Marla: No conflict of intereset||Dr. Stone, Joanne: No conflict of intereset||Nair, Nilendra: No conflict of intereset||Debebe, Anketse: No conflict of intereset||Hawkins, Kelly: No conflict of intereset||Rendon, Alexa: No conflict of intereset||Hu, Jianzhong: No conflict of intereset||Dr. Colombel, Jean-frederic: No conflict of intereset||Prof. Inga, Peter: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset

OP17 Dr. Dong, Catherine: No conflict of intereset||Mr. Mahamat-Saleh, Yahya: No conflict of intereset||Dr. Racine , Antoine: No conflict of intereset||Dr. Jantchou, Prevost: No conflict of intereset||Prof. Dr. Hart, Andrew: No conflict of intereset||Prof. Dr. Carbonnel, Franck: No conflict of intereset||Dr. Boutron-Ruault, Marie-Christine: No conflict of intereset

OP18 Luglio, Gaetano: No conflict of intereset||Dr. Rispo, Antonio: No conflict of intereset||Dr. Imperatore, Nicola: No conflict of intereset||Dr. Amendola, Alfonso: No conflict of intereset||Dr. Tropeano, Francesca Paola: No conflict of intereset||Dr. Peltrini, Roberto: No conflict of intereset||Prof. Castiglione, Fabiana: No conflict of intereset||Prof. De Palma, Giovanni Domenico: No conflict of intereset||Prof. Bucci, Luigi: No conflict of intereset

OP19 Dr. Burgess, Christopher:|:|This work was supported by an Edinburgh Children’s Hospital Charity Research Fellowship award to CB and by funding from Crohn’s and Colitis UK (Edinburgh branch).||Dr. Schnier, Christian: No conflict of intereset||Dr. Chalmers, Iain: No conflict of intereset||Prof. Russell, Richard K:|:|RKR is supported by an NHS Research Scotland Senior Research Fellowship. RKR has received speaker’s fees, travel support, and/orparticipated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson,|Nutricia & 4D Pharma.||Hansen, Richard:|:|RH is supported by an NHS Research Scotland Senior Research Fellowship. RH has received speaker’s fees, travel support, and/or participated in medical board meetings with MSD Immunology, Dr Falk, Nutricia & 4D Pharma.||Dr. Henderson, Paul: No conflict of intereset||Dr. Wood, Rachael: No conflict of intereset||Prof. Wilson, David C:|:|DCW has received speaker’s fees, travel support and/or participated in medical board meetings with AbbVie, Takeda, Roche, Ferring, Predictimmune, Dr Falk, Napp, and 4D Pharma.

OP20 Dr. Caenepeel, Clara: No conflict of intereset||Ms. Viera-Silva, Sara: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Ms. Machiels, Kathleen: No conflict of intereset||Mrs. Davani, Nooshin Ardeshir: No conflict of intereset||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Raes, Jeroen: No conflict of intereset||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

OP21 Ms. Nice, Rachel: No conflict of intereset||Dr. Chanchlani, Neil:|:|Clinical research fellowship funded by Crohn's and Colitis UK.||Dr. Green, Harry: No conflict of intereset||Ms. Bewshea, Claire: No conflict of intereset||Dr. Kennedy, Nicholas:|:|Consulted for Falk and received honoraria from Falk, Allergan, Pharmacosmos and Takeda for unrelated topics and is a deputy editor of Alimentary Pharmacology & Therapeutics Journal||Dr. Ahmad, Tariq:|:|Received unrestricted research grants, advisory board fees, speaker honorariums and support to attend international meetings from AbbVie, Merck, Janssen, Takeda, Ferring, Tillotts, Ferring, Pfizer, NAPP, Celltrion, Hospira for unrelated topics.||Dr. Goodhand, James:|:|Received honoraria from Falk, Abbvie and Shield therapeutics for unrelated topics.||Dr. McDonald, Timothy: No conflict of intereset||Dr. Perry, Mandy: No conflict of intereset

OP22 Dr. Van Limbergen, Johan: No conflict of intereset||Dr. Dunn, Katherine: No conflict of intereset||Dr. Wine, Eytan: No conflict of intereset||Mrs. Sigall Boneh, Rotem: No conflict of intereset||Bielawski, Joseph: No conflict of intereset||Prof. Dr. Levine, Arie: No conflict of intereset

Page 5 of 135

OP23

OP24 Prof. Dr. Ben-Horin, Shomron:|:|receives consultancy/advisory board fees from Janssen, Takeda, Celltrion Inc., Abbvie, Ferring, Pfizer, GSK and research support from Takeda, Abbvie, Celltrion, Pfizer and Janssen.||Prof. Dr. Leszczyszyn, Jaroslaw: No conflict of intereset||Prof. Dr. Dudkowiak, Robert: No conflict of intereset||Prof. Dr. Lahat, Adi: No conflict of intereset||Prof. Dr. Gawdis-Wojnarska, Beata: No conflict of intereset||Prof. Dr. Pukitis, Aldis: No conflict of intereset||Prof. Dr. Horynski, Marek: No conflict of intereset||Prof. Dr. Farkas, Katalin: No conflict of intereset||Prof. Dr. Kierkus, Jaroslaw: No conflict of intereset||Prof. Dr. Kowalski, Maciej: No conflict of intereset||Prof. Dr. Ye, Byong Duk:|:|a research grant from Celltrion; consulting fees from Abbvie Korea, Celltrion, Daewoong Pharma., Ferring Korea, Janssen Korea, Kangstem Biotech, Kuhnil Pharm., Medtronic Korea, Shire Korea, Takeda Korea, IQVIA, Cornerstones Health, Robarts Clinical Trials Inc. and Takeda; and speaking fees from Abbvie Korea, Celltrion, Ferring Korea, Janssen Korea, Shire Korea, Takeda Korea, and IQVIA. ||Prof. Dr. Reinisch, Walter:|:|•

OP25 Dr. Holubar, Stefan: No conflict of intereset||Dr. Jai, Xue: No conflict of intereset||Prof. Hull, Tracy: No conflict of intereset||Prof. Hyman, Neil: No conflict of intereset||Prof. Ramamoorthy , Sonia: No conflict of intereset||Dr. Einsenstein, Samuel: No conflict of intereset

Dr. Vermeire, Séverine:|:|Lecture and consultancy fees: AbbVie, Chiesi, Ipsen, MSD, Roche; Consultancy: AbbVie, Celgene, Falk, Ferring, Janssen, Mundipharma, MSD, Pfizer, Takeda, Vifor||Dr. Sandborn, William:|:|Lecture fees: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim; Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim||Dr. Baert, Filip:|:|Lecture and consultancy fees: AbbVie, Chiesi, Ipsen, MSD, Roche; Consultancy: AbbVie, Celgene, Falk, Ferring, Janssen, Mundipharma, MSD, Pfizer, Takeda, Vifor||Dr. Danese, Silvio:|:|Lecture fees: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim; Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim||Dr. Kobayashi, Taku:|:|Financial support for: AbbVie GK, EA Pharma Co. Ltd, Otsuka Holdings Co. Ltd, ZERIA, Kyorin Pharmaceutical Co. Ltd, Mochida Pharmaceutical, EA Pharma Co. Ltd, Thermo Fisher Scientific, Alfresa Pharma, Nippon Kyaku, Asahi Kasei medical; Consultancy: AbbVie GK, Alfresa Pharma, Covidien, Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co. Ltd, Mochida Pharmaceutical, Nippon Kyaku, Pfizer, Takeda Pharmaceutical, Thermo Scientific; Lecture fees: AbbVie GK, Ajinomoto Pharma, Asahi Kasei Medical, Astellas, Alfresa Pharma, Celltrion, EA Pharma Co. Ltd, Kyorin Pharmaceutical Co. Ltd, Nippon Kyaku, Mochida Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, ZERIA, Eisai Co. Ltd, Gilead Sciences, Janssen, JIMRO Co, Ltd||Dr. Loftus Jr. , Edward V.:|:|Financial support for research: AbbVie, Takeda, Janssen, UCB, Amgen, Pfizer, Genentech, Celgene, Receptos, Gilead, MedImmune, Seres Therapeutics, Robarts Clinical Trials; Consultancy: AbbVie, Takeda, Janssen, UCB, Amgen, Pfizer, Eli Lilly, Celltrion Healthcare, Allergan, Bristol-Myers Squibb, Celgene, Gilead, Genentech, Boehringer Ingelheim||Dr. Bhatia, Siddharth:|:|Employee of Takeda||Dr. Kisfalvi, Krisztina:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Rosario, Maria:|:|Employee of Takeda at the time this research was conducted; has granted patents and pending patent applications relating to the clinical pharmacology of vedolizumab||Dr. Zhang, Wenwen:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. D’Haens, Geert:|:|Financial support for research: AbbVie, Bühlmann Laboratories, Ferring, DrFALK Pharma, Johnson and Johnson, GlaxoSmithKline, Medtronics, Millennium/Takeda, MSD, PhotoPill, Prometheus Laboratories, Robarts Clinical Trials, Setpoint; Lecture fees: AbbVie, Biogen, Ferring, DrFALK Pharma, Johnson and Johnson, Giuliani, Millennium/Takeda, MSD, Norgine, Otsuka, Shire, Tillotts, UCB, Vifor; Consultancy: AbbVie, Ablynx, Actogenix, Amakem, Amgen, AM Pharma, AstraZeneca, Biogen, Bristol-Myers Squibb, Boehringer Ingelheim, Cosmo, Elan, Ferring, Celgene/Receptos, Celltrion, Johnson and Johnson, Engene, Galapagos, Gilead, GlaxoSmithKline, Immunic Therapeutics, Lycera, Medimetrics, Medtronics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Novo Nordisk, Otsuka, Hospira/Pfizer, PDL, Prometheus Laboratories, Protagonist, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, TEVA, Tigenix, Tillotts, Topivert, UCB, Versant, Vifor; Directorship(s): Robarts Clinical Trials

Page 6 of 135

OP26 Iacucci, Marietta: No conflict of intereset||Dr. Smith, Samuel CL: No conflict of intereset||Dr. Bazarova , Alina: No conflict of intereset||Dr. Shivaji, Uday N: No conflict of intereset||Prof. Bhandari, Pradeep: No conflict of intereset||Dr. Cannatelli, Rosanna: No conflict of intereset||Dr. Daperno, Marco: No conflict of intereset||Dr. Ferraz, Jose G: No conflict of intereset||Dr. Goetz, Martin: No conflict of intereset||Dr. Gui, Xiang: No conflict of intereset||Dr. Hayee, Bu: No conflict of intereset||Dr. De Hertogh, Gert: No conflict of intereset||Prof. Lazarev, Mark: No conflict of intereset||Dr. Li, Jim: No conflict of intereset||Dr. Nardone, Olga M: No conflict of intereset||Dr. Occhipinti, Vincenzo: No conflict of intereset||Prof. Panaccione, Remo: No conflict of intereset||Dr. Parra-Blanco, Adolfo: No conflict of intereset||Dr. Pastorelli, Luca: No conflict of intereset||Prof. Rath, Timo: No conflict of intereset||Dr. Tontini, Gianeugenio: No conflict of intereset||Prof. Vieth, Michael: No conflict of intereset||Prof. Villanacci, Vincenzo: No conflict of intereset||Dr. Zardo, Davide: No conflict of intereset||Prof. Kiesslich, Ralf: No conflict of intereset||Prof. Bisschops, Raf: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset

OP27 Prof. Dr. Ferrante, Marc: No conflict of intereset||Feagan, Brian G:|:|Consultant for Abbott/AbbVie, ActoGeniX, Akros, Albireo Pharma, Amgen, AstraZeneca, Avaxia Biologics Inc., Avir Pharma, Axcan, Baxter Healthcare Corp., Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Elan/Biogen, enGene, Ferring Pharma, gICare Pharma, Gilead, Given Imaging Inc., GSK, Ironwood Pharma, Janssen Biotech (Centocor), JnJ/Janssen, Kyowa Hakko Kirin Co Ltd, Lexicon, Lilly, Lycera BioTech, Merck, Mesoblast Pharma, Millennium, Nektar, Nestle, Novartis, Novo Nordisk, Pfizer, Prometheus Therapeutics and Diagnostics, Protagonist, Receptos, Roche/Genentech, Salix Pharma, Serono, Shire, Sigmoid Pharma, Synergy Pharma Inc., Takeda, Teva Pharma, TiGenix, Tillotts, UCB Pharma, Vertex Pharma, VHsquared Ltd, Warner Chilcott, Wyeth, Zealand, and Zyngenia; has received grant and research support from Abbott/AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen Biotech (Centocor), JnJ/Janssen, Millennium, Pfizer, Receptos, Roche/Genentech, Sanofi, Santarus, Tillotts, and UCB Pharma; and is on the board of directors for Robarts Clinical Trials Inc. ||Panés, Julian:|:|Consulting fees from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Ferring, Genentech, GoodGut, Janssen, MSD, Oppilan, Pfizer, Progenity, Robarts, Roche, Takeda, Theravance, and TiGenix; speakers’ fees from AbbVie, Janssen, MSD, Shire, and Takeda; and research funding from AbbVie and MSD. ||Baert, Filip:|:|Research grants from AbbVie, Chiesi, Ipsen, MSD, and Roche; speaker and consultancy fees from AbbVie, Falk, Ferring, Janssen, Mundipharma, MSD, Pfizer, Takeda, and Vifor. ||Louis, Edouard:|:|Research grants from Janssen, Pfizer, and Takeda; educational grants from AbbVie, Janssen, MSD, and Takeda; speakers’ fees from AbbVie, Falk, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda; advisory boards with AbbVie, Celgene, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda; and consultancy for AbbVie. ||Dewit, Olivier:|:|Speakers’ or consultancy fees from AbbVie, Ferring, Janssen, MSD, Mylan, Pfizer, Sandoz, and Takeda. ||Kaser, Arthur:|:|Consulting fees from Applied Molecular Transport, Boehringer Ingelheim, Galapagos, Gilead Sciences, GSK, Hospira, Janssen, Pfizer, Roche, and VHsquared. ||Duan, Weijiang Rachel:|:|AbbVie employee, and may own AbbVie stock and/or options.||Gustafson, Dawn:|:|AbbVie employee, and may own AbbVie stock and/or options||Liao, Xiaomei:|:|AbbVie employee, and may own AbbVie stock and/or options||Wallace, Kori:|:|AbbVie employee, and may own AbbVie stock and/or options||Kalabic, Jasmina:|:|AbbVie employee and may own AbbVie stock and/or options||D'Haens, Geert R.:|:|Consulting and/or lecture fees from AbbVie, ActoGeniX, AIM, Allergan, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim GmbH, Celgene/Receptos, Celltrion, Cosmo Technologies, Dr Falk Pharma, Elan Pharmaceuticals, Eli Lilly, enGene, Ferring, Galapagos, Genentech, Gilead Sciences, Giuliani SpA, Given Imaging, Gossamer Bio, GSK, Janssen Biologics, MSD, Neovacs, Novo Nordisk, Otsuka, PDL BioPharma, Pfizer, Progenity, Prometheus Laboratories, Robarts Clinical Trials, Salix, Schering-Plough, Seres/Nestlé, SetPoint, Shire, Takeda, Tillotts Pharma, UCB Pharma, Versant, and Vifor Pharma; research grants from AbbVie, Dr Falk Pharma, Given Imaging, Janssen, MSD, and PhotoPill; speaking honoraria from AbbVie, Ferring, MSD, Norgine, Shire, Tillotts, Tramedico, and UCB Pharma.

Page 7 of 135

OP28 Dr. Steere, Boyd: No conflict of intereset||Dr. GOTTLIEB, Klaus: No conflict of intereset||Dr. Schmitz, Jochen: No conflict of intereset||Dr. Higgs, Richard: No conflict of intereset||Dr. Jia, Bochao: No conflict of intereset||Dr. Milch, Catherine: No conflict of intereset||Dr. Tuttle, Jay: No conflict of intereset||Dr. Krishnan, Venkatesh: No conflict of intereset||Dr. Belin, Ruth: No conflict of intereset||Prof. Dr. Reinisch, Walter:|:|•"Walter Reinisch has served |•as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult, |•as a consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC, |•as an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC, and |•has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, MSD"

OP29 Dr. Chaparro, Maria: No conflict of intereset||Mrs. Garre, Ana: No conflict of intereset||Dr. Mesonero, Francisco: No conflict of intereset||Dr. Rodríguez, Cristina: No conflict of intereset||Dr. Barreiro-de Acosta, Manu: No conflict of intereset||Dr. Martínez-Cadilla, Jesús: No conflict of intereset||Dr. Arroyo, María Teresa: No conflict of intereset||Dr. Manceñido, Noemí: No conflict of intereset||Dr. Sierra-Ausín, Mónica: No conflict of intereset||Dr. Vera-Mendoza, Isabel: No conflict of intereset||Dr. Casanova, María José: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. González-Muñoza, Carlos: No conflict of intereset||Dr. Martínez, Teresa: No conflict of intereset||Dr. Boscá-Watts, Maia: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. Calafat, Margalida: No conflict of intereset||Dr. Girona, Eva: No conflict of intereset||Dr. Llaó, Jordina: No conflict of intereset||Dr. Martín-Arranz, María Dolores: No conflict of intereset||Dr. Piqueras, Marta: No conflict of intereset||Dr. Ramos, Laura: No conflict of intereset||Dr. Suis, Gerard: No conflict of intereset||Dr. Bermejo, Fernando: No conflict of intereset||Dr. Carbajo, Ana Y: No conflict of intereset||Dr. Casas-Deza, Diego: No conflict of intereset||Dr. Fernández-Clotet, Agnes: No conflict of intereset||Dr. García, María J.: No conflict of intereset||Dr. Ginard, Daniel: No conflict of intereset||Dr. Gutiérrez-Casbas, Ana: No conflict of intereset||Dr. Hernández-Villalba, Luis: No conflict of intereset||Dr. Lucendo, Alfredo J.: No conflict of intereset||Dr. Márquez, Lucía: No conflict of intereset||Dr. Merino-Ochoa, Olga: No conflict of intereset||Dr. Rancel, Francisco J: No conflict of intereset||Dr. Taxonera, Carlos: No conflict of intereset||Dr. López Sanromán, Antonio: No conflict of intereset||Dr. Rubio, Saioa: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Gisbert, Javier P: No conflict of intereset

OP30 Mrs. Seyed Tabib, Nasim Sadat: No conflict of intereset||Dr. Caenepeel, Clara: No conflict of intereset||Dr. Machiels, Kathleen: No conflict of intereset||Dr. Verstockt, Sare: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Lecture fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm, and Takeda|||Mrs. Ardeshir Davani, Nooshin: No conflict of intereset||Dr. Sabino, João:|:|Lecture fee: Abbvie and Nestle Health Sciences.||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Lecture fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Prof. Dr. Vermeire, Séverine:|:|Research grant: from MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Lecture fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

Page 8 of 135

OP31 Mr. Mills, Robert: No conflict of intereset||Dr. Dulai, Parambir: No conflict of intereset||Mr. Vázquez-Baeza, Yoshiki: No conflict of intereset||Mr. Zhu, Qiyun: No conflict of intereset||Humphrey, Greg: No conflict of intereset||DeRight Goldasich, Lindsay: No conflict of intereset||Quinn, Robert: No conflict of intereset||Gewirtz, Andrew: No conflict of intereset||Chassaing, Benoit: No conflict of intereset||Chu, Hiutung: No conflict of intereset||Sandborn, William: No conflict of intereset||Dorrestein, Pieter: No conflict of intereset||Knight, Rob: No conflict of intereset||Gonzalez, David: No conflict of intereset

OP32 Dr. GONG, Wenbin: No conflict of intereset||Dr. Guo, Kun: No conflict of intereset||Prof. Dr. Ren, Jianan: No conflict of intereset

OP33 Mrs. MAIMON, Naama: No conflict of intereset||Dr. Gerassy-Vainberg, Shiran: No conflict of intereset||Dr. Bar-Yosef, Haggai: No conflict of intereset||Mrs. Alpert, Ayelet: No conflict of intereset||Dr. Starosvetsky, Elina: No conflict of intereset||Dr. Abu-Arisha, Muhammad: No conflict of intereset||Mrs. Shvedov, Tamara: No conflict of intereset||Prof. Shen-Orr, Shai:|:| CytoReason equity and advisory fees and Takeda grant support.|||Prof. Dr. Chowers, Yehuda:|:|Abbvie grant support, advisory and lecture fees, Janssen advisory and lecture fees, Takeda grant support and advisory and lecture fees, Pfizer advisory and lecture fees and Protalix Advisory fees

OP34 Dr. Kalla, Rahul: No conflict of intereset||Dr. Adams, Alex: No conflict of intereset||Dr. White, Ruby: No conflict of intereset||Dr. Clarke, Carolyn: No conflict of intereset||Dr. Ivens, Al: No conflict of intereset||Mr. Ventham, Nicholas: No conflict of intereset||Dr. Kennedy, Nicholas: No conflict of intereset||Dr. McTaggart, Seanna: No conflict of intereset||Mr. IBD Character Consortium, i: No conflict of intereset||Dr. Ho, Gwo-Tzer: No conflict of intereset||Dr. Buck, Amy: No conflict of intereset||Prof. Satsangi, Jack: No conflict of intereset

OP35 Zhao, Mirabella:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Lördal, Mikael:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Langholz, Ebbe:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Knudsen, Torben:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Voutilainen, Markku:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Dr. Høivik, Marte Lie:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Moum, Bjørn:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Ms. Saebo, Borghild:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Dr. Haiko, Paula:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Ms. Malmgren, Carolina:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Dr. Coskun, Mehmet:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Melberg, Hans Olav:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.||Prof. Burisch, Johan:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Melissa Bauer for medical writing support.

OP36 Ms. Giri, Rabina: No conflict of intereset||Mrs. Shamsunnahar, Khushi: No conflict of intereset||Dr. Salim, Angela: No conflict of intereset||Prof. Capon, Rob: No conflict of intereset||Prof. Morrison, Mark: No conflict of intereset||Dr. O Cuiv, Paraic: No conflict of intereset||Dr. Begun, Jakob: No conflict of intereset

Page 9 of 135

OP37 Mr. Creyns, Brecht: No conflict of intereset||Mr. Cremer, Jonathan: No conflict of intereset||Prof. Dr. De Hertogh, Gert:|:|Consulting fees from Glaxo Smith Kline, Shire Pharmaceuticals, Teva Pharma, Galapagos, Genentech, Novartis Pharma, Fast Forward Pharmaceuticals, Takeda and Janssen R&D.||Dr. Boon, Louis: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Mrs. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Van Assche, Gert:|:|Grants from Abbott and Ferring Pharmaceuticals; lecture fees from Janssen, MSD and Abbott; consultancy fees from PDL BioPharma, UCB Pharma, Sanofi-Aventis, Abbott, Abbvie, Ferring, Novartis, Biogen Idec, Janssen Biologics, NovoNordisk, Zealand Pharma A/S, Millenium/Takeda, Novartis and Bristol Mayer Squibb.||Prof. Dr. Ceuppens, Jan: No conflict of intereset||Prof. Dr. Breynaert, Christine:|:|Consultancy fee from Ablynx.

OP38 Ms. Jongsma, Myrthe: No conflict of intereset||Ms. Aardoom, Martine: No conflict of intereset||Mr. Cozijnsen, Maarten: No conflict of intereset||Mrs. van Pieterson, Merel: No conflict of intereset||Dr. de Meij, Tim: No conflict of intereset||Mr. Norbruis, Obbe: No conflict of intereset||Dr. Groeneweg, Michael: No conflict of intereset||Dr. Wolters, Victorien: No conflict of intereset||Dr. van Wering , Herbert: No conflict of intereset||Dr. Hojsak, Iva: No conflict of intereset||Prof. Kolho, kaija-Leena: No conflict of intereset||Dr. Hummel, Thalia: No conflict of intereset||Dr. Stapelbroek, Janneke: No conflict of intereset||Mrs. van der Feen, Cathelijne: No conflict of intereset||Dr. Rheenen, Patrick: No conflict of intereset||Dr. van Wijk, Michiel: No conflict of intereset||Dr. Teklenburg-Roord, Sarah: No conflict of intereset||Prof. Escher, Johanna: No conflict of intereset||Dr. Samsom, Janneke: No conflict of intereset||Dr. Ridder, Lissy:|:|Investigator initiated study, financial support by Pfizer|Participation in clinical studies sponsored by Abbott, Janssen Biologics, Shire, Abbvie and Hospira as an investigator|Consultant of Janssen Biologics, MSD, Abbvie and Shire

OP39 Mrsny, Randall: No conflict of intereset||Kanwar, Bittoo: No conflict of intereset||Mahmood, Tahir: No conflict of intereset

OP40 Dr. Gogokhia, Lasha: No conflict of intereset||Dr. Lima, Svetlana: No conflict of intereset||Dr. Viladomiu, Monica: No conflict of intereset||Dr. Gerardin, Ylaine: No conflict of intereset||Dr. Crawford, Carl: No conflict of intereset||Dr. Jacob, Vinita: No conflict of intereset||Dr. Scherl, Ellen: No conflict of intereset||Dr. Rosenthal, Melissa: No conflict of intereset||Dr. Brown, Su-Ellen: No conflict of intereset||Dr. Hambor, John: No conflict of intereset||Dr. LONGMAN, Randy: No conflict of intereset

DOP01 Dr. Shukla, Dheeraj: No conflict of intereset||PURCELL, Liz: No conflict of intereset||Dr. Palmer, Michelle: No conflict of intereset||Dr. pillai, leshni: No conflict of intereset

DOP02 Mr. Svolos, Vaios: No conflict of intereset||Mr. Gkikas, Konstantinos: No conflict of intereset||Ms. Rizou, Valentini: No conflict of intereset||Ms. Christina, Edelyn: No conflict of intereset||Mr. Kapranos, Panagiotis: No conflict of intereset||Ms. Kleingunnewiek, Jennifer: No conflict of intereset||Dr. Seenan, John Paul: No conflict of intereset||Dr. Macdonald, Jonathan: No conflict of intereset||Dr. Gaya, Daniel R: No conflict of intereset||Dr. Hansen, Richard: No conflict of intereset||Dr. Russell, Richard K: No conflict of intereset||Dr. Gerasimidis, Konstantinos: No conflict of intereset

DOP03 Dr. Miyoshi, Jun: No conflict of intereset||Dr. Saito, Daisuke: No conflict of intereset||Dr. Nakamura, Mio: No conflict of intereset||Dr. Miura, Miki: No conflict of intereset||Dr. Mitsui, Tatsuya: No conflict of intereset||Dr. Kudo, Toru: No conflict of intereset||Dr. Murakami, Shinnosuke: No conflict of intereset||Dr. Matsuura, Minoru: No conflict of intereset||Prof. Hisamatsu, Tadakazu:|:|The present research was supported by EA Pharma Co., Ltd. T. Hisamatsu provided lectures to EA Pharma Co., Ltd. and received honorarium.

DOP04 Dr. Ishikawa, Dai: No conflict of intereset||Dr. Okahara, Koki: No conflict of intereset||Dr. Takahashi, Masahito: No conflict of intereset||Dr. Haga, Keiichi: No conflict of intereset||Dr. Nomura, Kei: No conflict of intereset||Dr. Shibuya, Tomoyoshi: No conflict of intereset||Prof. Dr. Nagahara, Akihito: No conflict of intereset

Page 10 of 135

DOP05

DOP06 Dr. Buisson, Anthony: No conflict of intereset||Mrs. Vazeille, Emilie: No conflict of intereset||Prof. Dr. Hébuterne, Xavier: No conflict of intereset||Prof. Dr. Fumery, Mathurin: No conflict of intereset||Prof. Dr. Pariente, Benjamin: No conflict of intereset||Prof. Dr. Nancey, Stéphane: No conflict of intereset||Prof. Dr. Seksik, Philippe: No conflict of intereset||Prof. Dr. Peyrin-Biroulet, Laurent: No conflict of intereset||Prof. Dr. Allez, Matthieu: No conflict of intereset||Mrs. Ballet, Nathalie: No conflict of intereset||Mrs. Billard, Elisabeth: No conflict of intereset||Mrs. Rodriguez, Stéphanie: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Prof. Barnich, Nicolas: No conflict of intereset

DOP07 Prof. Dr. Uygun, Ahmet: No conflict of intereset||Dr. Karakaya, Muhammed Fatih: No conflict of intereset||Dr. Erdal, Harun: No conflict of intereset||Dr. CELEBI, Gurkan: No conflict of intereset||Dr. Sakin, Yusuf Serdar: No conflict of intereset||Dr. Artuk, Cumhur: No conflict of intereset||Dr. Ozturk, Kadir: No conflict of intereset||Prof. Dr. Gulsen, Mustafa: No conflict of intereset

DOP08 Dr. TAYLOR, Henry: No conflict of intereset||Dr. McDonald, Julie: No conflict of intereset||Dr. Serrano Contreras, Jose Ivan: No conflict of intereset||Dr. Li, Jia: No conflict of intereset||Prof. Marchesi, Julian: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset

DOP09 Dr. Costes, Léa: No conflict of intereset||Dr. Tindemans, Irma: No conflict of intereset||Dr. Joosse, Maria E.: No conflict of intereset||Ms. Aardoom, Martine A.: No conflict of intereset||Ms. Jongsma, Myrthe M.E.: No conflict of intereset||Ms. Raatgeep, Rolien H.C.: No conflict of intereset||Ms. van Haaften, Daniëlle H.: No conflict of intereset||Dr. Alexander, Katie L.: No conflict of intereset||Mr. Duck, Lennard W.: No conflict of intereset||Dr. Heikema, Astrid P.: No conflict of intereset||Mr. Kemos, Polychronis: No conflict of intereset||Prof. Dr. Escher, Johanna C.: No conflict of intereset||Dr. Ruemmele, Frank M.: No conflict of intereset||Dr. Croft, Nick M.: No conflict of intereset||Dr. Elson, Charles O.: No conflict of intereset||Dr. de Ridder, Lissy: No conflict of intereset||Dr. Samsom, Janneke N.: No conflict of intereset

Prof. Dr. Adamina, Michel: No conflict of intereset||Gerasimidis, Konstantinos:|:|Dr. Gerasimidis reports grants and personal fees from Nutricia, grants and personal fees from Nestle, personal fees from DrFalk, other from ECCO, outside the submitted work; ||Sigall-Boneh, Rotem:|:|Dr. Sigall Boneh reports personal fees from Invited speaker by Nestle Health Science, personal fees from Consulting to Nestle Health Science, personal fees from Invited speaker by Takeda, outside the submitted work||Zmora, Oded:|:|Dr. Zmora reports personal fees from consultancy by Lifebond, Sealantis, Takeda – Advisory Board, Takeda – Inspire Study Steering Committee; Payment for lectures including service on speakers bureaus by Novadac and Takeda; Travel/accommodation/meeting expenses from E-101 trial-travel expenses for investigators’ meeting and Novadac Imagine group consensus meeting; Other fees by Novadac KOL dinner, LifeBond- travel expenses for investigators' meeting, Johnson & Johnson.||de Buck van Overstraeten, Anthony: No conflict of intereset||Campmans-Kuijpers, Marjo:|:|Dr. Campmans-Kuijpers reports personal fees from Baxter, outside the submitted work||Ellul, Pierre: No conflict of intereset||Katsanos, Konstantinos:|:|Dr. Katsanos reports other from MSD, other from Abbvie, other from Takeda, other from AENORASIS, other from SHIRE, other from GRIFOLS, other from JANSSEN, other from FERRING, other from GENESIS, during the conduct of the study||Kotze, Paulo:|:|Dr. Kotze reports personal fees and other from Abbvie, personal fees and other from Janssen, personal fees and other from Ferring, personal fees and other from Pfizer, personal fees and other from Takeda, outside the submitted work; ||Noor, Nurulamin: No conflict of intereset||Schäfli-Thurnherr, Judit: No conflict of intereset||Vavricka, Stephan:|:|Dr. Vavricka reports grants and personal fees from MSD, grants and personal fees from Abbvie, personal fees from UCB, personal fees from Tillots, grants and personal fees from Vifor, personal fees from Ferring, grants and personal fees from Takeda, personal fees from Falk, personal fees from Pfizer, during the conduct of the study||Wall, Catherine:|:|Dr. Wall reports grants from Crohn's and Colitis UK, grants from Broad Institute, outside the submitted work||Wierdsma, Nicolette:|:|Dr. Wierdsma reports In addition, Dr. Wierdsma has a patent copyright with royalties paid||Yassin, Nuha: No conflict of intereset||Lomer, Miranda:|:|Dr. Lomer reports other from FoodMaestro FODMAP app, grants from Crohn's and Colitis UK, grants from Classado, personal fees from Abbvie, outside the submitted work.

Page 11 of 135

DOP10 Kucharzik, Torsten:|:|T Kucharzik reports personal fees from Janssen, during the conduct of the study personal fees from Janssen, outside the submitted work.||Wilkens, Rune:|:|R Wilkens reports personal fees from Janssen-Cilag, during the conduct of the study grants and personal fees from Takeda Denmark, grants and personal fees from AbbVie Denmark, outside the submitted work.||Maconi, Giovanni:|:|G Maconi reports advisory board fees from Abbvie, Janssen-Cilag and Roche speaker fees from Alfa Sigma.||D'Agostino, Maria Antonietta:|:|MA D'Agostino reports consultancy fees from Janssen. ||Le Bars, Manuela:|:|M Le Bars is an employee of Janssen-Cilag SARL and reports restricted stocks.||Nazar, Maciej:|:|M Nazar is an employee of Janssen-Cilag Sp. Z o.o and reports restricted stocks.||Sloan, Sheldon:|:|At the time of the interim data collection and analysis of the study, S Sloan was an employee of Janssen Scientific Affairs LLC and he continues to have restricted stocks.||Lahaye, Marjolein:|:|M Lahaye is an employee of Janssen-Cilag and reports restricted stocks.||Ni, Lioudmila:|:|L Ni is an employee of Janssen-Cilag and reports restricted stocks.||Ercole, Elena: No conflict of intereset||Alloca, Mariangela:|:|M Allocca reports personal fees from Nikkiso Europe, Janssen and Pfizer, outside the submitted work.||Machková, Naděžda:|:|M Naděžda reports personal fees from Abbvie s.r.o., Pfizer PFE s.r.o., Takeda Pharmaceuticals s.r.o. and Janssen-Cilag s.r.o., outside the submitted work.||Maaser, Christian:|:|C Maaser reports personal fees from Abbvie, MSD, Falk Foundation, Ferring, Takeda, Janssen, Celgene and Vifor Pharma.

DOP11 Dr. PLEVRIS, Nikolas:|:|NP has received consultancy fees from Takeda and speaker fees and travel support from AbbVie,Takeda, Norgine and Janssen.||Dr. Fulforth, James: No conflict of intereset||Mr. Jenkinson, Philip: No conflict of intereset||Dr. Lyons, Mathew: No conflict of intereset||Dr. Chuah, Cher: No conflict of intereset||Dr. Siakavellas, Spyros: No conflict of intereset||Ms. Pattenden, Rebecca: No conflict of intereset||Dr. Arnott, Ian:|:|IDA has received consultancy fees from Vifor and travel support from Takeda and Dr Falk.||Dr. Jones, Gareth: No conflict of intereset||Dr. Lees, Charlie:|:|CWL is funded by a UK Research and Innovation Future Leaders Fellowship. CWL has also received research support from Gilead, Oshi Health and AbbVie, consultancy fees from AbbVie, Pfizer, Dr. Falk, Hospira, MSD, Gilead, Pharmacosmos, Takeda and Vifor, and speaker fees and travel support from AbbVie, Pfizer, Ferring, Hospira and Takeda.

DOP12 Dr. Panaccione, Remo:|:|Investigator and Advisor for Janssen.||Dr. Sandborn, William J.:|:|Investigator and advisor for Janssen. ||Dr. Sands, Bruce E.:|:|Investigator and advisor for Janssen. ||Dr. Marano, Colleen:|:|Salaried employee for Janssen. ||Dr. O'Brien, Christopher D.:|:|Salaried employee for Janssen. ||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen. ||Dr. Johanns, Jewel:|:|Salaried employee for Janssen. ||Dr. Zhou, Yiying:|:|Salaried employee for Janssen. ||Dr. Peyrin-Biroulet, Laurent:|:|Investigator and advisor to Janssen. ||Dr. Hisamatsu, Tadakazu:|:|Investigator and advisor to Janssen.||Dr. Danese, Silvio:|:|Investigator and adviser to Janssen.

Page 12 of 135

DOP13 Danese, Silvio:|:|S Danese reports consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc. and Vifor.||Vermeire, Séverine:|:|S Vermieire reports grants/research support from MSD, Abbvie, Takeda, Janssen and Pfizer honoraria/consulting fees from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen participation in a company sponsored speakers bureau with AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots. ||D'Haens, Geert:|:|G D’Haens has served as advisor for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, DSM Pharma Echo Pharmaceuticals, Eli Lilly, Engene, Exeliom Biosciences, Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, ProciseDx, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor reports speaker fees from Abbvie, Biogen, Ferring, Johnson & Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor.||Panés, Julián:|:|J Panes reports grants from MSD, Abbvie and Pfizer consulting fees/honorarium from Abbvie, Boehringer Ingelheim, Celgene, Genentech - Roche, GSK, Janssen, MSD, Oppilan, Takeda, Theravance, TiGenix, Arena, Neste, Pfizer and Progenity support for travel to meetings from Abbvie and Takeda, during the conduct of the study payment for lectures including service on speakers bureaus from Abbott, MSD, Takeda, Janssen and Pfizer payment for development of educational presentations from Abbott, MSD, Roche, Pfizer and Janssen, outside the submitted work.||Dignass, Axel:|:|A Dignass reports support for travel to meetings for the study or other purposes from ECCO fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like from Falk, during the conduct of the study consultancy fees from Abbvie, MSD, Ferring, Roche/Genentech, Takeda, Vifor, Falk, Janssen, Pfizer, Sandoz/Hexal, Celgene Tillotts, Amgene and Fresenius Kabi grants from Insitut fur Gemeinwohl payment from lectures including service on speakers bureaus from Falk Foundation, Ferring, MSD, Abbvie, Vifor, Janssen-Cilag, Med Update GmbH, Pfizer, Tillotts payment for manuscript preparation from Falk Foundation, Thieme, Takeda and UniMed Verlag payment for development of educational presentations from Tillots and Ferring, outside the submitted work.||Magro, Fernando:|:|M Fernando reports fees from lectures to Ferring, OmPharma, MSD, Abbvie, Lab Vitoria, Vifor, Falk, Takeda, Hospira, PharmaKern and Schering.||Nazar, Maciej:|:|M Nazar is an employee of Janssen-Cilag Sp. z o.o and reports restricted stocks.||Le Bars, Manuela:|:|M Le Bars is an employee of Janssen-Cilag SARL and reports restricted stocks.||Sloan, Sheldon:|:|At the time of the interim data collection and analysis of the study, S Sloan was an employee of Janssen Scientific Affairs LLC and he continues to have restricted stocks.||Lahaye, Marjolein:|:|M Lahaye is an employee of Janssen-Cilag and reports restricted stocks.||Ni, Lioudmila:|:|L Ni is an employee of Janssen-Cilag and reports restricted stocks.||Daperno, Marco:|:|M Daperno reports personal fees from Janssen, outside the submitted work.||Lukáš, Milan: No conflict of intereset||Armuzzi, Alessandro:|:|A Armuzzi is a consultant for AbbVie, Allergan, Amgen, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, MSD, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, Sofar and Takeda reports lecture fees from AbbVie, Amgen, Biogen, Bristol-Myers Squibb, Chiesi, Ferring, Hospira, Janssen, MSD, Mitsubishi Tanabe, Nikkiso, Pfizer, Samsung Bioepis, Sandoz, Takeda and Tigenix research grants from MSD, Takeda and Pfizer. ||Löwenberg, Mark: No conflict of intereset||Gaya, Daniel R:|:|DR Gaya reports personal fees from Janssen, Takeda and Abbvie other from Vifor, outside the submitted work.||Peyrin-Biroulet, Laurent:|:|L Peyrin-Biroulet reports personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boehringer Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine, Mylan, Lilly, Fresenius, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics and Enthera grants from AbbVie, MSD and Takeda stock options from CTMA, outside the submitted work.

Page 13 of 135

DOP14

DOP15 Dr. Rimola, Jordi:|:|Consultancy fees from Robarts Clinical Trials, Takeda,|and TiGenix; grant/research support from AbbVie and Genentech; and speaker/honoraria fees from AbbVie, MSD, Janssen, and Takeda.|||Dr. Colombel, Jean-Frédéric:|:|Consultancy/advisory board membership: AbbVie, Amgen, Boehringer-Ingelheim, Celgene Corporation, Celltrion, Enterome, Ferring, Genentech, Janssen Pharmaceuticals, Medimmune, Merck & Co., Pfizer, Protagonist, Second Genome, Seres, Takeda, Theradiag; Speaker: AbbVie, Ferring, Takeda, Shire; Research support: AbbVie, Genentech, Takeda; Stock options: Intestinal Biotech Development, Genfit||Dr. Bressler, Brian:|:|Advisor/Speaker: Ferring, Janssen, AbbVie, Takeda, Pfizer, Novartis, Merck. Advisor: Robarts Clinical Trials, Celgene, Microbiome Insights, Merck, Amgen, Pendopharm, Genentech, BMS, Allergan, Protagonist. Research support: Janssen, AbbVie, GSK, BMS, Amgen, Genentech, Merck, BI, Qu Biologic, Celgene, Alvine. Stock Options: Qu Biologic||Dr. Adsul, Shashi:|:|Employees of Takeda; holds Takeda stock or stock options||Dr. Siegelman, Jenifer:|:|Employees of Takeda; holds Takeda stock or stock options||Dr. Cole, Patricia E.:|:|Employee of Takeda at the time this research was conducted||Dr. Lindner, Dirk:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Danese, Silvio:|:|Lecture fee(s): AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim; Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim

Dr. Dreesen, Erwin:|:|ED is a postdoctoral research fellow of the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) and received consultancy fees from argenx and Janssen (all honoraria/fees paid to the department).||Mrs. Berends, Sophie: No conflict of intereset||Prof. Dr. Laharie, David:|:|DL received board and lecture fees from AbbVie, Biogaran, Biogen, Ferring Pharmaceuticals, HAC pharma, Janssen Pharmaceutica, Merck Sharp & Dohme, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag, Tillots Pharma AG.||Prof. Dr. D'Haens, Geert:|:|GD served as advisor for AbbVie, Ablynx, Allergan, Amakem, Amgen, AM Pharma, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Ferring Pharmaceuticals, Dr. Falk Pharma, Eli Lilly, Engene, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Pfizer, Immunic AG, Johnson and Johnson, Lycera, Medimetrics, Millenium Pharmaceuticals, Takeda, Mitsubishi Pharma, Merck Sharp & Dohme, Mundipharma, Nextbiotics, Novo Nordisk, Otsuka, Pfizer, Hospira, Photopill, Prometheus laboratories/Nestle, Progenity, Protagonist, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, TiGenix, Tillotts, Topivert, Versant and Vifor Pharma; received speaker fees from AbbVie, Biogen, Ferring Pharmaceuticals, Johnson and Johnson, Merck Sharp & Dohme, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium Pharmaceuticals, Takeda, Tillotts and Vifor Pharma.||Prof. Dr. Vermeire, Séverine:|:|SV is a senior clinical researcher of the Research Foundation Flanders (FWO). SV received grant support from Merck Sharp & Dohme, AbbVie, Pfizer, Johnson and Johnson and Takeda, lecture fees from AbbVie, Merck Sharp & Dohme, Ferring Pharmaceuticals, Takeda, Hospira and consultancy fees from AbbVie, Takeda, Pfizer, Ferring Pharmaceuticals, Shire, Merck Sharp & Dohme, Hospira, Mundipharma, Celgene, Galapagos, Genentech/Roche.||Prof. Dr. Gils, Ann:|:|AG served as a speaker for Merck Sharp & Dohme, Janssen Biologicals, Pfizer, Takeda, Novartis, and AbbVie, and received Investigator-Initiated Research Grants from Pfizer and a national grant from Takeda. KU Leuven licensed antibodies for the infliximab, adalimumab, vedolizumab, golimumab, and ustekinumab ELISA to apDia and infliximab and adalimumab lateral flow assays to R-Biopharm.||Prof. Dr. Mathôt, Ron:|:|RM has served as advisor for Bayer, CSL Behring, Merck Sharp & Dohme, Shire, Zeria (all honoraria/fees paid to the department) and has received research grants from Bayer, CSL Behring, Shire and ZonMW.

Page 14 of 135

DOP16 Chen, Chunlin:|:|Employee of Takeda; holds stock or stock options||Dr. Rosario, Maria:|:|Employee of Takeda at the time this research was conducted; has granted patents and pending patent applications relating to the clinical pharmacology of vedolizumab||Dr. Polhamus, Daniel:|:|Employee of Metrum Research Group, which received funding from Takeda||Dr. Dirks, Nathanael:|:|Employee of Metrum Research Group, which received funding from Takeda||Ms. Zhang, Wenwen:|:|Employee of Takeda; holds stock or stock options||Mr. Sun, Wan:|:|Employee of Takeda and owns Takeda stock||Dr. Kisfalvi, Krisztina:|:|Employee of Takeda; holds stock or stock options||Dr. Feagan, Brian:|:|Consultancy: Abbott/AbbVie, ActoGeniX, Akros, Albireo Pharma, Amgen, Astra Zeneca, Avaxia Biologics Inc., Avir Pharma, Axcan, Baxter Healthcare Corp., Biogen Idec, Boehringer-Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Elan/Biogen, enGene, Ferring Pharma, Roche/Genentech, gICare Pharma, Gilead, Given Imaging Inc., GSK, Ironwood Pharma, Janssen Biotech (Centocor), Johnson & Johnson/Janssen, Kyowa Hakko Kirin Co Ltd., Lexicon, Lilly, Lycera BioTech, Merck, Mesoblast Pharma, Millennium, Nektar, Nestles, Novartis, Novo Nordisk, Pfizer, Prometheus Therapeutics and Diagnostics, Protagonist, Receptos, Salix Pharma, Serono, Shire, Sigmoid Pharma, Synergy Pharma Inc., Takeda, Teva Pharma, TiGenix, Tillotts, UCB Pharma, Vertex Pharma, VHsquared Ltd., Warner Chilcott, Wyeth, Zealand, Zyngenia; Grant/research support: Abbott/AbbVie, Amgen, Astra Zeneca, Bristol-Myers Squibb (BMS), Janssen Biotech (Centocor), Johnson & Johnson/Janssen, Roche/Genentech, Millennium, Pfizer, Receptos, Santarus, Sanofi, Tillotts, UCB Pharma; Membership (board of directors): Robarts Clinical Trials Inc.||Dr. Sandborn, William:|:|Healthcare Limited, Amgen, Genentech, Gilead Sciences, Abbvie, Janssen, Takeda, Lilly, Celgene/Receptos, Pfizer, Prometheus Laboratories (now Prometheus Biosciences); consulting fees from Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen, Kyowa Kirin Pharmaceutical Research, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust, HART), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna Biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts Pharma, UCB Pharma, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals; and stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Progenity, Ritter Pharmaceuticals, Ventyx Biosciences, Vimalan Biosciences. Spouse: Opthotech – consultant, stock options; Progenity – consultant, stock; Oppilan Pharma – employee, stock options; Escalier Biosciences – employee, stock options; Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories) – employee, stock options; Ventyx Biosciences – employee, stock options; Vimalan Biosciences – employee, stock options.||Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, Takeda, Pfizer, Johnson & Johnson; Lecture fee(s): Merck Sharp & Dohme Corp., AbbVie, Takeda, Ferring, Centocor, Hospira, Pfizer, Johnson & Johnson, Genentech/Roche, Tillotts; Consultancy: Merck Sharp & Dohme Corp., AbbVie, Takeda, Ferring, Centocor, Hospira, Pfizer, Johnson & Johnson, Genentech/Roche, Celgene, Mundipharma, Celltrion, SecondGenome, Prometheus, Gilead, Galapagos, ProDigest, Abivax, GSK, Tillotts.||Dr. D’Haens, Geert:|:|Financial support for research: AbbVie, Bühlmann Laboratories, Ferring, DrFALK Pharma, Johnson and Johnson, GlaxoSmithKline, Medtronics, Millennium/Takeda, MSD, Photopill, Prometheus Laboratories, Robarts Clinical Trials, Setpoint; Lecture fee(s): AbbVie, Biogen, Ferring, DrFALK Pharma, Johnson and Johnson, Giuliani, Millennium/Takeda, MSD, Norgine, Otsuka, Shire, Tillotts, UCB, Vifor; Consultancy: AbbVie, Ablynx, Actogenix, Amakem, Amgen, AM Pharma, AstraZeneca, Biogen, Bristol-Myers Squibb, Boehringer Ingelheim, Cosmo, Elan, Ferring, Celgene/Receptos, Celltrion, Johnson and Johnson, Engene, Galapagos, Gilead, GlaxoSmithKline, Immunic Therapeutics, Lycera, Medimetrics, Medtronics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Novo Nordisk, Otsuka, Hospira/Pfizer, PDL, Prometheus laboratories, Protagonist, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, TEVA, Tigenix, Tillotts, Topivert, UCB, Versant, Vifor; Directorship(s): Robarts Clinical Trials.

Page 15 of 135

DOP17 Prof. Dr. Vermeire, Séverine:|:|Received grant support from AbbVie, MSD, Pfizer, J&J, and Takeda; lecture fees from AbbVie, Ferring Pharmaceuticals, Hospira, MSD, and Takeda; consultancy fees from AbbVie, Celgene, Ferring Pharmaceuticals, Galapagos, Genentech/Roche, Hospira, MSD, Mundipharma, Pfizer, Shire Pharmaceuticals Group, Abivax, Prodigest, J&J, and Takeda.||Dr. Guay, Heath:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer, lecture fees from AbbVie, Ferring Pharmaceuticals, Janssen, R-Biopharm, and Takeda; consultancy fees from Janssen and Sandoz.||Dr. Fann, James:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Cheng, Jie:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Hong, Feng:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Lee, Wan-Ju:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Lacerda, Ana:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Zhou, Wen:|:|AbbVie employee and may own AbbVie stock and/or options.||Dr. Danese, Silvio:|:|Served as speaker, consultant, and advisory board member for AbbVie, Allergan, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Mundipharma, Pfizer, Sandoz, Takeda, TiGenix, UCB Pharma, and Vifor Pharma.

DOP18 Prof. Dr. Park, Jae Jun: No conflict of intereset||Mrs. Koo, Heejo: No conflict of intereset||Prof. Park, Yehyun: No conflict of intereset||Prof. Dr. Park, Soo Jung: No conflict of intereset||Prof. Dr. Kim, Tae Il: No conflict of intereset||Prof. Dr. Kim, Won Ho: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset||Prof. Han, Euna Han: No conflict of intereset

DOP19 Dr. Cohen, Benjamin:|:|Consulting Abbvie, Allergan, Celltrion, Janssen, Sublimity Therapeutics||Ms. Chang, Helena: No conflict of intereset||Mr. Jason Rogers, Jason Rogers:|:|Grant from Takeda||Mr. Garg, Shashank:|:|Grant from Takeda||Ms. Lawrence, Debra:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Ms. Fasihuddin, Farah:|:|Grant from Takeda||Dr. Lissoos, Trevor:|:|Employee Eli Lilly & Company||Dr. Atreja, Ashish: No conflict of intereset

DOP20 Mr. Lalisang, Robbert C A:|:|Research Intern at Pacmed||Ms. Adriaans, Greetje: No conflict of intereset||Dr. de Jong, Marin: No conflict of intereset||Dr. van der Meulen-de Jong, Andrea: No conflict of intereset||Dr. Romberg-Camps, Marielle: No conflict of intereset||Mr. Mahmmod, Nofel: No conflict of intereset||Mrs. Markus-de Kwaadsteniet, Tineke: No conflict of intereset||Prof. Dr. Dijkstra, Gerard:|:|will follow||Dr. Haans, Jeoffrey:|:|Personal fees, Consulting Takeda, Janssen-Cilag, Lamepro||Ms. Stamm, Christina:|:|Data Scientist at Pacmed||Dr. Vanwersch, Rob: No conflict of intereset||Prof. Jonkers, Daisy:|:|Part of research is funded by the public-private partnership 'Carbokinetics (www.cccresearch.nl), Grant Top Knowledge Institute (TKI)/ Well on Wheat (www.um-eatwell.nl/wow/) and H2020848228/DISCOvERY||Dr. Almeida, Rui Jorge: No conflict of intereset||Dr. Pierik, Marieke J:|:|will follow, can also be found in the ECCO profile of Dr. M.J. Pierik (conflicts are updated)

DOP21 Høivik, Marte:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Lördal, Mikael:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Burisch, Johan:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Langholz, Ebbe:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Knudsen, Torben:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Voutilainen, Markku:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Moum, Bjørn:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Dr. Anisdahl, Karoline:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Ms. Saebo, Borghild:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Dr. Haiko, Paula:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Ms. Malmgren , Carolina:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Dr. Coskun, Mehmet:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Melberg, Hans Olav:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.

Page 16 of 135

DOP22 Dr. Barreiro-de Acosta, Manuel: No conflict of intereset||Dr. Gutierrez, Ana: No conflict of intereset||Dr. Zabana, Yamile: No conflict of intereset||Dr. Beltran, Belen: No conflict of intereset||Prof. Dr. Calvet, Xavier: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Esteve, María: No conflict of intereset||Dr. Panés, Julián: No conflict of intereset||Prof. Gisbert, Javier. P.: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset

DOP23 Dr. GUO, Zhen: No conflict of intereset||Dr. Zhu, Yipeng: No conflict of intereset||Dr. Cao, Lei: No conflict of intereset||Dr. Li, Yi: No conflict of intereset||Prof. Wang, Zhiming: No conflict of intereset||Prof. Zhu, Weiming: No conflict of intereset

DOP24 Dr. Loftus, Jr, Edward V.:|:|Financial support for research: AbbVie, Takeda, Janssen, UCB, Amgen, Pfizer, Genentech, Celgene, Receptos, Gilead, MedImmune, Seres Therapeutics, and Robarts Clinical Trials; Consultancy: AbbVie, Takeda, Janssen, UCB, Amgen, Pfizer, Eli Lilly, Celltrion Healthcare, Allergan, Bristol-Myers Squibb, Celgene, Gilead, Genentech, Boehringer Ingelheim||Schreiber, Stefan Wolfgang:|:|Consultancy fees from AbbVie, Celltrion, Janssen, Merck, Pfizer, Roche, Takeda||Dr. Danese, Silvio:|:|Lecture fee(s): AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim; Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim||Dr. Peyrin-Biroulet, Laurent:|:|Consultancy: AbbVie, Janssen, Genentech, Ferring, Tillotts, Pharmacosmos, Celltrion, Takeda, Boehringer Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen ; Grants: AbbVie, MSD, Takeda; Stock options: CT-SCOUT||Dr. Colombel, Jean-Frédéric:|:|Consultancy/advisory board membership: AbbVie, Amgen, Boehringer Ingelheim, Celgene Corporation, Celltrion, Enterome, Ferring, Genentech, Janssen Pharmaceuticals, Medimmune, Merck & Co., Pfizer, Protagonist, Second Genome, Seres, Takeda, Theradiag; Lecture fees: AbbVie, Ferring, Takeda, Shire; Research support: AbbVie, Genentech, Takeda; Stock options: Intestinal Biotech Development, Genfit||Dr. Sands, Bruce E.:|:|Consultancy: 4D Pharma, AbbVie, Allergan, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Capella Bioscience, Celgene, Celltrion Healthcare, Eli Lilly and Company, EnGene, F. Hoffmann-La Roche, Ferring, Gilead Sciences, Ironwood Pharmaceuticals, Janssen, Lyndra, MedImmune, Oppilan Pharma, Otsuka America Pharmaceutical, Palatin Technologies, Pfizer, Progenity, Prometheus Laboratories, Protagonist Therapeutics, Rheos Medicines, Seres Therapeutics, Shire, Sienna Biopharmaceuticals, Synergy Pharmaceuticals, Takeda, Target PharmaSolutions, Theravance Biopharma, TiGenix, UCB, Valeant Pharmaceuticals North America, Vivelix Pharmaceuticals; Research support: Takeda, Janssen, Theravance Biopharma, Pfizer||Dr. Wang, Song:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Chen, Jingjing:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Lirio, Richard A.:|:|Employee of Takeda; holds Takeda stock or stock options

Page 17 of 135

DOP25 Dr. Barnes, Edward:|:|Consultant for AbbVie and TARGET PharmaSolutions||Dr. Hanson, John:|:|Pfizer and AbbVie: Speakers Bureau|BMS: Advisory board at AIBD||Dr. Regueiro, Miguel:|:|Research Support: AbbVie, Janson, Takeda|Unrestricted Educational Grants: AbbVie, Janssen, UCB, Pfizer, Takeda, Salix, Shire|Advisory Boards and Consultant: AbbVie, Janssen, UCB, Takeda, Pfizer, miraca Labs, Amgen, Celgene, Seres, Allergan, Genentech, Gilead, Salix, Prometheus, TARGET PharmaSolutions|Royalties: Wolters Kluwer Health as Author/Editor of UpToDate||Dr. Saha, Sumona: No conflict of intereset||Dr. Sands, Bruce E: No conflict of intereset||Dr. Rubin, David:|:|Abbvie Consultant and Grant Support|Abgenomics Consultant and Stock options|Allergan, Inc. Consultant|American College of Gastroenterology Board of Trustees|Biomica Consultant and Stock Options|Boehringer Ingelheim, Ltd. Consultant|Bristol-Myers Squibb Consultant|Celgene Corp/Syneos Consultant|Check-cap Consultant|Cornerstones Health, Inc. (non- profit) Co-Founder, CFO|Dizal Pharmaceuticals Consultant|GalenPharma/Atlantica Consultant|Genentech/Roche Consultant and Grant Support|Gilead Sciences Consultant|Glenmark Pharmaceuticals Consultant |GoDuRn, LLC Co-Founder|GSK (GlaxoSmithKline Services) Consultant|Janssen Pharmaceuticals Consultant and Grant Support|Lilly Consultant|Mahana Therapeutics Consultant|Narrow River Mgmt Consultant|Pfizer Consultant|Prometheus Laboratories Consultant and grant support |Reistone Consultant|Seres Therapeutics Consultant|Shire Consultant and Grant Support|Takeda Consultant and Grant Support|Target PharmaSolutions, Inc. Consultant|Techlab, Inc Consultant|||Dr. Dubinsky, Marla:|:|Consultant: Pfizer, Janssen, AbbVie, Celgene, Salix, AbbVie, Takeda, Prometheus labs, Arena, Genentech, Lilly|Research Support: Pfizer, AbbVie, Janssen||Dr. Siegel, Corey:|:|Consultant/Advisory Board||Abbvie, Amgen, BMS, Celgene, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Sebela, Takeda||Speaker for CME activities||Abbvie, Celgene, Janssen, Pfizer, Takeda||Grant support||Crohn’s and Colitis Foundation, AHRQ (1R01HS021747-01)||Broad Medical Research Program||Abbvie, Janssen, Pfizer, Takeda||Intellectual property||MiTest Health, LLC has a patent pending for a “System and Method of Communicating Predicted Medical Outcomes”, filed 3/24/10. Dr. Corey Siegel and Dr. Lori Siegel are inventors.||ColonaryConcepts, LLC has Unites States Patents on “Dietary Purgatives” and “Foods, Systems, Methods, and Kits for Providing Electrolyte Replacement.” Dr. Corey Siegel is an inventor||Equity Interest||Dr. Corey Siegel and Dr. Lori Siegel are co-founders of MiTest Health, LLC||Gazis, Derek:|:|Employee of TARGET PharmaSolutions||Dr. Crawford, Julie:|:|Employee of TARGET PharmaSolutions||Dr. Long, Millie:|:|Consulting/Advisory boards for Takeda, Pfizer, AbbVie, UCB, Janssen, Prometheus, Salix, Valeant, Target Pharmasolutions. Grant support: Takeda, Pfizer

Page 18 of 135

DOP26

DOP27 Ms. Van Praag, Elise: No conflict of intereset||Dr. Hompes, Roel: No conflict of intereset||Dr. Buskens, Christianne: No conflict of intereset||Prof. Dr. Tanis, Pieter: No conflict of intereset||Dr. Duijvestein, Marjolijn: No conflict of intereset||Prof. Dr. Bemelman, Wilhelmus: No conflict of intereset

DOP28 Dr. Lin, Simeng:|:|Dr Simeng Lin has received support for travel by Ferring.||Dr. Chanchlani, Neil:|:|Dr Neil Chanchlani is funded by Crohn’s and Colitis UK for a clinical research fellowship||Dr. Invergo, Brandon M.: No conflict of intereset||Dr. Anderson, Matthew W.: No conflict of intereset||Dr. Guay, Heath M.:|:|Heath Guay is an employee of AbbVie and may own stock in the company.||Dr. Reppell, Mark:|:|Mark Reppell is an employee of AbbVie and may own stock in the company||Dr. Butler, James W.:|:|James Butler is an employee of AbbVie and may own stock in the company| ||Dr. Goodhand, James R.:|:|James Goodhand has received honoraria from Falk, Abbvie and Shield therapeutics for unrelated topics.||Dr. Ahmad, Tariq:|:|Tariq Ahmad has received unrestricted research grants, advisory board fees, speaker honorariums and support to attend international meetings from AbbVie, Merck, Janssen, Takeda, Ferring, Tillotts, Ferring, Pfizer, NAPP, Celltrion, Hospira for unrelated topics, no financial relationships with any organizations that might have an interest in the submitted work in the previous three years||Dr. Kennedy, Nicholas A.:|:|Nicholas Kennedy has consulted for Falk and received honoraria from Falk, Allergan, Pharmacosmos and Takeda for unrelated topics and is a deputy editor of Alimentary Pharmacology & Therapeutics Journal.

DOP29 Dr. GONSKY, Rivkah: No conflict of intereset||Dr. Fleshner, Phillip: No conflict of intereset||Botwin, Gregory.: No conflict of intereset||Biener-Ramanujan, Eva: No conflict of intereset||Dr. McGovern, Dermot:|:|Grants: Second Genome|Consulting: Bridge Therapeutics, Prometheus Biosciences, Qu Biologics, Gilead, Merck, Janssen, Palatin|Shareholder: Prometheus Biosciences|||Dr. Targan, Stephan:|:||Seaver Foundation for Autism |(Non-Profit Organization)

DOP30 Mrs. Borren, Nynke: No conflict of intereset||Dr. Plichta, Damian: No conflict of intereset||Dr. joshi, Amit: No conflict of intereset||Dr. Bonilla, Gracia: No conflict of intereset||Dr. Sadreyev, Ruslan: No conflict of intereset||Dr. Vlamakis, Hera: No conflict of intereset||Prof. Dr. Xavier, Ramnik:|:|Dr. Xavier has served as a consultant to Novartis and Nestle. He is supported by the Helmsley Trust (SHARE project), Center for Microbiome Informatics and Therapeutics (CMIT), and the NIH Center for the Study of Inflammatory Bowel Disease (P30 DK 043351).||Dr. Ananthakrishnan, Ashwin:|:|Dr. Ananthakrishnan has served on advisory boards for Abbvie, Takeda, and Merck. He is supported by research funding from the Crohn’s and Colitis Foundation, National Institutes of Health, Chleck Family Foundation, and Pfizer.

af Björkesten, Clas-Göran:|:|C.G. af Björkesten has received consultant fees from Abbvie, MSD, Mylan, Ferring, Janssen-Cilag, Pfizer, Takeda, has received lecture fees from: Abbvie, MSD, Pfizer, Ratiopharm, has received congress fees from AbbVie, Ferring, Meda, MSD, Mylan, Tillotts.||Ilus, Tuire:|:|lecture fees from Tillotts Pharma.||Hallinen, Taru:|:| T. Hallinen is an employe and shareholders of ESiOR Oy, the company commissioned by Janssen-Cilag Oy to help perform this study. T. Hallinen declare no personal conflict of interest.||Soini, Erkki:|:|E.S. is an employe and shareholders of ESiOR Oy, the company commissioned by Janssen-Cilag Oy to help perform this study. E.S. declare no personal conflict of interest.||Eberl, Anja:|:|A. Eberl has received research support from Janssen-Cilag and consulting fees from MSD, Pfizer, Takeda and Janssen-Cilag||Hakala, Kalle: No conflict of intereset||Heikura, Mikko: No conflict of intereset||Hirsi, Eija: No conflict of intereset||Jussila, Airi:|:|A.Jussila has received speaker fees and travel support from Abbvie, Ferring, Janssen-Cilag, MSD, MEDA, Mylan, Pfizer, Takeda and Tillotts Pharma; has received consulting fees from Abbive, Janssen-Cilag, Pfizer, Takeda, Pfeizer, Tillotts Pharma and MSD. ||Kellokumpu , Mikko:|:|have received lecture fee from Pfizer. ||Koskela, Ritva:|:|Consulting fee from MSD, Pfizer; lecture fee Ferring, MSD, Tillotts||Koskinen, Inka:|:|Lecture fees from Tillots Pharma, MSD||Moilanen, Veikko: No conflict of intereset||Nielsen, Christian: No conflict of intereset||Nieminen, Urpo: No conflict of intereset||Nuutinen , Heikki:|:|H. Nuutinen has received lecture fees from Pfizer, Janssen-Cilag, Sanofi, Ferring, MSD, Abbvie, Takeda. ||Heikkinen , Markku: No conflict of intereset||Suhonen , Ulla-Maija: No conflict of intereset||Tillonen , Jyrki: No conflict of intereset||Utriainen, Karri:|:|K. Utriainen has received lecture fees from Abbvie, Takeda.||Vihriälä, Ilkka: No conflict of intereset||Dr. Wennerström, Christina:|:|Is an employe of Janssen-Cilag||Borsi, Andras:|:|Is an employe of Janssen-Cilag||Nissinen , Riikka:|:|Is an employe of Janssen-Cilag||Koivunen , Minni:|:|Is an employe of Janssen-Cilag||Sipponen, Taina:|:|T. Sipponen has received speaker fees from Abbvie, Ferring, Janssen-Cilag, MSD, Pfizer, Takeda and Tillotts Pharma; has received consulting fees from Hospira, Janssen-Cilag, Pfizer, Takeda and MSD; and has received a research grant from Janssen-Cilag and Takeda.

Page 19 of 135

DOP31 Ms. Verstockt, Sare: No conflict of intereset||Ms. Verplaetse, Nora: No conflict of intereset||Mr. Raimondi, Daniele: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Mrs. Glorieus, Elien: No conflict of intereset||Mrs. De Decker, Muriel: No conflict of intereset||Dr. Hannes, Laurens: No conflict of intereset||Mrs. Ballet, Vera: No conflict of intereset||Ms. Vandeput, Eline: No conflict of intereset||Prof. Moreau, Yves: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Laukens, Debby: No conflict of intereset||Prof. Dr. Mana, Fazia: No conflict of intereset||Prof. Dr. De Vos, Martine: No conflict of intereset||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Prof. Cleynen, Isabelle: No conflict of intereset

DOP32 Dr. Li, Katherine:|:|Salaried employee for Janssen||Dr. Yang, Feifei:|:|Salaried employee for Janssen||Dr. Hayden, Karen:|:|Salaried employee of Janssen||Dr. Strawn, David:|:|Salaried employee for Janssen||Dr. Wadman, Eric:|:|Salaried employee of Janssen||Dr. Bhagat, Sunita:|:|Salaried employee of Janssen||Dr. Marano, Colleen:|:|Salaried employee of Janssen||Dr. Friednman, Joshua R:|:|Salaried employee for Janssen

DOP33 Dr. Gropp, Roswitha: No conflict of intereset||Dr. Jodeleit, Henrika: No conflict of intereset||Ms. Caesar, Janina: No conflict of intereset||Ms. Villarroel Aguilera , Christina: No conflict of intereset||Dr. Sterz, Sebastian: No conflict of intereset||Prof. Dr. Holdt, Lesca: No conflict of intereset||Dr. Beigel, Florian: No conflict of intereset||Mrs. Breiteneicher, Simone: No conflict of intereset||Dr. Stallhofer, Johannes: No conflict of intereset||Dr. Siebeck, Matthias: No conflict of intereset

DOP34DOP35 Dr. Hammoudi, Nassim: No conflict of intereset||Mr. Perez, Kevin: No conflict of intereset||Dr.

Hassid, Deborah: No conflict of intereset||Dr. Tran Minh, My-Linh: No conflict of intereset||Dr. Gornet, Jean-Marc: No conflict of intereset||Dr. Baudry, Clotilde: No conflict of intereset||Dr. Lourenco, Nelson: No conflict of intereset||Mr. Gergaud, Brice: No conflict of intereset||Mr. Chardiny, Victor: No conflict of intereset||Dr. Bonnet, Joelle: No conflict of intereset||Dr. Le Bourhis, Lionel: No conflict of intereset||Prof. Allez, Matthieu: No conflict of intereset

DOP36 Dr. SHIN, Ga Young: No conflict of intereset||Dr. Park, Yoo Min: No conflict of intereset||Ms. Ha, Eunji: No conflict of intereset||Ms. Gu, Ki-Nam: No conflict of intereset||Prof. Kim, Kwangwoo: No conflict of intereset||Prof. Dr. Lee, Chang Kyun: No conflict of intereset||Prof. Dr. Kim, Hyo Jong: No conflict of intereset

DOP37 Dr. Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie||Dr. Demetter, Pieter: No conflict of intereset||Dr. De Vos, Martine: No conflict of intereset||Dr. Rahier, Jean-François:|:|Research Grants: Takeda, Abbvie|Personal Fees|- Consultancy fees: Abbvie, Takeda, Hospira, Mundipharma, MSD, Pfizer, GlaxoSk, Janssen|- Speaker fees : Abbvie, Takeda, Pfizer, Ferring, Falk||Dr. Baert, Filip:|:|Receipt of grants/research supports: Abbvie, Amgen, Takeda, Janssen. |Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen. |Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen, |||Dr. Moreels, Tom: No conflict of intereset||Dr. Macken, Elisabeth: No conflict of intereset||Dr. Louis, Edouard:|:|Research Grant: Takeda, Pfizer, Janssen|Educational Grant: Abbvie, MSD, Takeda, Janssen|Speaker Fees: Abbvie, Ferring, MSD, Falk, Takeda, Hospira, Janssen, Pfizer|Advisory Board: Abbvie, Ferring, MSD, Takeda, Celgene, Hospira, Janssen, Pfizer |Consultant: Abbvie|||Dr. Vermeire, Séverine:|:|Receipt of grants/research supports: MSD, Abbvie, Takeda, Janssen, Pfizer|Receipt of honoraria or consultation fees: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, Gilead and Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Dr. Franchimont, Denis:|:|Educational grants from Abbvie, Takeda, MSD.|Honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira.

Page 20 of 135

DOP38 Dr. Liefferinckx, Claire:|:|Consultancy fees: Takeda|Speaker fees: Sandoz, Janssen, Abbvie|||El hamdi, Mohamed: No conflict of intereset||Fassin, Manon: No conflict of intereset||Cremer , Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie|||Minsart , Charlotte: No conflict of intereset||Amininejad, Leila: No conflict of intereset||Wambacq, Valérie: No conflict of intereset||Van Gossum, André: No conflict of intereset||Franchimont , Denis:|:|Denis Franchimont received educational grants from Abbvie, Takeda, MSD, and received honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira

DOP39 Prof. Dr. Kobayashi, Taku:|:|Consultancy fees from Abbvie GK, Alfresa Pharma, CovidienÐ Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, Nippon Kyaku, Pfizer, Takeda Pharmaceutical, Thermo Scientific, lecture fees from Abbvie GK, Ajinomoto Pharma, Asahi Kasei Medical, Astellas, Alfresa Pharma, Celltrion, EA Pharma Co.,Ltd, Kyorin Pharmaceutical Co.,Ltd, Nippon Kyaku, Mochida Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma , ZERIA, Eisai Co.,Ltd, Gilead Sciences, Janssen, JIMRO Co.,Ltd, research funding from Abbvie GK, EA Pharma Co.,Ltd, Otsuka Holdings Co.,Ltd, ZERIA, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, EA Pharma Co.,Ltd, Thermo Fisher Scientific, Alfresa Pharma, Nippon Kyaku, Asahi Kasei medical||Dr. Motoya, Satoshi:|:|Grant support from EA pharma Co. Ltd., AbbVie GK, Takeda Pharmaceutical Co. Ltd., Janssen Pharmaceutical K.K.,Pfizer Inc., Mochida Pharmaceutical Co., Ltd. and lecture fee from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd.||Prof. Dr. Nakamura, Shiro:|:|Grants: Astellas Pharma Inc.; EA Pharma Co., Ltd.; AbbVie Japan Co., Ltd.; Asahi Kasei Medical Co., Ltd. ; Otsuka Pharmaceutical Factory, Inc.; JIMRO Co., Ltd.; KYORIN Pharmaceutical Co.,Ltd. ; Mitsubishi Tanabe Pharma Corporation; Zeria Pharmaceutical Co., Ltd.; Mochida Pharmaceutical Co., Ltd.|Personal Fees：Mitsubishi Tanabe Pharma Corporation; Zeria Pharmaceutical Co., Ltd.; Janssen Pharmaceutical K.K; Mochida Pharmaceutical Co., Ltd.; AbbVie Japan Co., Ltd.; EA Pharma Co., Ltd.; Nippon Kayaku Co.,Ltd. ; Takeda Pharmaceutical Co.; JIMRO Co., Ltd.; Pfizer Inc.; Kissei Pharmaceutical Co., Ltd.; TAIHO Phamaceutical Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Chugai Pharmaceutical Co.,Ltd.; Aspen Japan K.K.;Shire Japan K.K.; Ferring Pharmaceuticals Co.,Ltd.; Celltorion Healthcare Japan K.K.; KYORIN Pharmaceutical Co.,Ltd.; Daiichi Sankyo Co.,Ltd.; AstraZeneca plc|Support for travel for meetings to support study：Mitsubishi Tanabe Pharma Corporation; Zeria Pharmaceutical Co., Ltd.; Janssen Pharmaceutical K.K; Mochida Pharmaceutical Co., Ltd.; AbbVie Japan Co., Ltd.; EA Pharma Co., Ltd.; Takeda Pharmaceutical Co.; JIMRO Co., Ltd.; Pfizer Inc.; Kissei Pharmaceutical Co., Ltd.; Aspen Japan K.K.;KYORIN Pharmaceutical Co.,Ltd.||Dr. Yamamoto, Takayuki: No conflict of intereset||Dr. Nagahori, Masakazu:|:|Honoraria for consultancy by Kissei Pharma and Takeda, for lectures including service on speakers bureaus by Kyorin Pharma, Mochida Pharma, AbbVie, Mitsubishi-Tanabe Pharma, Nippon Kayaku, Kissei Pharma, Asashi Kasei, Zeria Pharma, Astellas Pharma, Nichi-Iko Pharma and Janssen Pharma, for manuscript preparation by Mitsubishi-Tanabe Pharma, and for development of educational presentations by Janssen Pharma and Takeda.||Prof. Dr. Tanaka, Shinji:|:|Grants from Mitsubishi-Tanabe and Nippon Kayaku||Prof Dr Hisamatsu Tadakazu:|:|Grant support: Mitsubishi Tanabe Pharma Corporation EA DOP40 Dr. Pittet, Valérie: No conflict of intereset

DOP41 Dr. Kabir, Misha: No conflict of intereset||Dr. Curtius, Kit: No conflict of intereset||Dr. Al-Bakir, Ibrahim: No conflict of intereset||Dr. Hartono, Juanda: No conflict of intereset||Mr. Johnson, Michael: No conflict of intereset||Prof. East, James E: No conflict of intereset||Prof. Lindsay, James O: No conflict of intereset||Dr. Vega, Roser: No conflict of intereset||Dr. Thomas-Gibson, Siwan: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Prof. Dr. Graham, Trevor: No conflict of intereset||Dr. Wilson, Ana: No conflict of intereset

DOP42 Ms. Bohn Thomsen, Sandra:|:|S. Bohn Thomsen has received conference fees from takeda, Janssen and Tillotts Pharma||Dr. Ungaro , Ryan:|:|R. Ungaro has served as an advisory board member or consultant for Janssen, Pfizer and takeda; research grant from abbVie||Dr. Allin, Kristine: No conflict of intereset||Mrs. Poulsen, Gry: No conflict of intereset||Mr. Mikael, Andersson: No conflict of intereset||Prof. Dr. Colombel, Jean-Frederic:|:|J.F. Colombel has served as an advisory board member or consultant for abbVie, amgen, Boehringer- ingelheim, arena Pharmaceuticals, celgene, celltrion, enterome, eli lilly, Ferring Pharmaceuticals, genentech, Janssen and Janssen, Medimmune, Merck & co, nextbiotix, novartis Pharmaceuticals, Otsuka Pharmaceutical Development & commercialization, Pfizer, Protagonist, Second genome, gilead, Seres therapeutics, Shire, takeda, theradiag; speaker for abbVie, Ferring, takeda, celgene; stock options: intestinal Biotech Development, genefit; research grants: abbVie, takeda, Janssen and Janssen. ||Prof. Dr. Jess, Tine: No conflict of intereset

DOP43 Mr. Lo, Bobby Zhao Sheng: No conflict of intereset||Ms. Zhao, Mirabella: No conflict of intereset||Ms. Vind, Ida: No conflict of intereset||Mr. Burisch, Johan: No conflict of intereset

DOP44 Ms. Midjord, Jóngerð Maria Miné: No conflict of intereset||Mrs. Vang, Amanda Gratton: No conflict of intereset||Ms. Hammer, Turid: No conflict of intereset||Mr. Burisch, Johan: No conflict of intereset||Mr. Nielsen, Kári Rubek: No conflict of intereset

Page 21 of 135

DOP45 Dr. Verdon, Christine: No conflict of intereset||Dr. Reinglas, Jason: No conflict of intereset||Dr. Filliter, Christopher: No conflict of intereset||Dr. Coulombe, Janie: No conflict of intereset||Dr. Gonczi, Lorant: No conflict of intereset||Dr. Afif, Waqqas: No conflict of intereset||Dr. Wild, Gary: No conflict of intereset||Dr. Seidman, Ernest: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Bessissow, Talat: No conflict of intereset||Dr. Brassard, Paul: No conflict of intereset||Prof. Dr. Lakatos, Péter Laszlo: No conflict of intereset

DOP46 Prof. Dr. Lee, Ho-Su: No conflict of intereset||Mr. Hannes, Laurens: No conflict of intereset||Dr. Vancamelbeke, Maaike: No conflict of intereset||Ms. Ballet, Vera: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Cleynen, Isabelle: No conflict of intereset

DOP47 Dr. CRETIN, Thibaut: No conflict of intereset||Mrs. Sarter, Helene: No conflict of intereset||Prof. Dr. Savoye, Guillaume: No conflict of intereset||Prof. Dr. Fumery, Mathurin: No conflict of intereset||Dr. Leroyer, Ariane: No conflict of intereset||Dr. Dauchet, Luc: No conflict of intereset||Prof. Dr. Pariente, Benjamin: No conflict of intereset||Dr. Gower-Rousseau, Corinne: No conflict of intereset

DOP48 Ms. Sæterstad, Siri: No conflict of intereset||Dr. Østvik, Ann Elisabet: No conflict of intereset||Prof. Dr. Sandvik, Arne Kristian: No conflict of intereset||Dr. Granlund Van Beelen, Atle: No conflict of intereset

DOP49 Ms. DOUADI, Clara: No conflict of intereset||Dr. Vazeille, Emilie: No conflict of intereset||Mr. Chambon, Christophe: No conflict of intereset||Dr. Hébraud, Michel: No conflict of intereset||Ms. Dodel, Marie: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Coban, Dilek: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset||Prof. Barnich, Nicolas: No conflict of intereset

DOP50 Mr. Olafsson, Sigurgeir: No conflict of intereset||Dr. McIntyre, Rebecca E.: No conflict of intereset||Coorens, Tim: No conflict of intereset||Butler, Timothy: No conflict of intereset||Robinson, Philip: No conflict of intereset||Lee-Six, Henry: No conflict of intereset||Sanders, Mathijs: No conflict of intereset||Arestang, Kenneth: No conflict of intereset||Dawson, Claire: No conflict of intereset||Tripathi, Monika: No conflict of intereset||Strongili, Konstantina: No conflict of intereset||Hooks, Yvette: No conflict of intereset||Stratton, Michael R.: No conflict of intereset||Parkes, Miles: No conflict of intereset||Martincorena, Inigo: No conflict of intereset||Raine, Tim: No conflict of intereset||Campbell, Peter J.: No conflict of intereset||Anderson, Carl A.: No conflict of intereset

DOP51DOP52 Ms. Unterweger, Anna: No conflict of intereset||Mrs. Caesar, Janina: No conflict of intereset||Mrs.

Winkelmann, Paula: No conflict of intereset||Mrs. Rüscher, Alena: No conflict of intereset||Mrs. Seuß, Marietta: No conflict of intereset||Mrs. Breiteneicher, Simone: No conflict of intereset||Dr. Stallhofer, Johannes: No conflict of intereset||Dr. Beigel, Florian: No conflict of intereset||Prof. Dr. Siebeck, Matthias: No conflict of intereset||Dr. Gropp, Roswitha: No conflict of intereset

DOP53DOP54 Dr. Modos, Dezso:|:|Consultant at the company IOTA and HEALX||Dr. Brooks, Johanne: No conflict of

intereset||Dr. Sudhakar, Padhmanand: No conflict of intereset||Dr. Verstockt, Bram: No conflict of intereset||Mr. Alexander-Dann, Benjamin: No conflict of intereset||Dr. Zoufir, Azedine:|:|Currently works full time at the company HEALX.||Mr. Fazekas, David: No conflict of intereset||Prof. Dr. Vermeire, Séverine: No conflict of intereset||Dr. Korcsmaros, Tamas: No conflict of intereset||Dr. Bender, Andreas: No conflict of intereset

Page 22 of 135

DOP55 Mantzaris, Gerassimos:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd. ||Dr. Bressler, Brian:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd. ||Dr. Kopylov, Uri:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd. ||Ms. Bassel, Marielle:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd. ||Dr. Brett, Neil:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd. ||Dr. Colby, Chris:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd. ||Dr. Lopez, Claudia:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Saha, Sumit:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Ms. Kifnidi, Christina:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Agboton, Christian:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Adsul, Shashi:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Demuth, Dirk:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Luo, Michelle:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Wang, Song:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Yarur, Andres:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.

DOP56 Dr. Sandborn, William J.:|:|Investigator and Advisor for Janssen||Dr. Rowbotham, David S.:|:|Investigator and Advisor for Janssen||Dr. Leong, Rupert W.L.:|:|Investigator and Advisor for Janssen||Dr. Han, Chenglong:|:|Salaried employee for Janssen||Dr. Zhou, Yiying:|:|Salaried employee for Janssen||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen||Dr. Johanns, Jewel:|:|Salaried employee for Janssen||Dr. Marano, Colleen:|:|Salaried employee for Janssen||Dr. Danese, Silvio:|:|Investigator and Advisor for Janssen

DOP57 Dr. Cohen, Nathaniel Aviv: No conflict of intereset||Dr. Plevris, Nikolas:|:|NP has received consultancy fees from Takeda and speaker fees and travel support from AbbVie, Takeda, Norgine and Janssen||Prof. Kopylov, Uri: No conflict of intereset||Dr. Grinman, Ana: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Dr. Yanai, Henit: No conflict of intereset||Dr. Leibovitzh, Haim: No conflict of intereset||Dr. Fliss, Naomi: No conflict of intereset||Dr. Hirsch, Ayal: No conflict of intereset||Dr. Ritter, Einat: No conflict of intereset||Dr. Ron, Yulia: No conflict of intereset||Dr. Bar-Gil Shitrit, Ariella: No conflict of intereset||Prof. Goldin, Eran: No conflict of intereset||Prof. Dotan, Iris: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Dr. Lees, Charlie:|:|CWL is funded by a UK Research and Innovation Future Leaders Fellowship. CWL has also received research support from Gilead, Oshi Health and AbbVie, consultancy fees from AbbVie, Pfizer, Dr. Falk, Hospira, MSD, Gilead, Pharmacosmos, Takeda and Vifor, and speaker fees and travel support from AbbVie, Pfizer, Ferring, Hospira and Takeda||Dr. Maharshak, Nitsan: No conflict of intereset

DOP58 Mr. Biemans, Vince BC: No conflict of intereset||Sleutjes, Jasmijn: No conflict of intereset||Dr. de Vries, Annemarie C: No conflict of intereset||Dr. Bodelier, Alexander GL: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Prof. Dr. Oldenburg, Bas: No conflict of intereset||Dr. Löwenberg, Mark: No conflict of intereset||Dr. van Bodegraven, Ad A: No conflict of intereset||Dr. van der Meulen-de Jong, Andrea E: No conflict of intereset||Dr. de Boer, Nanne K: No conflict of intereset||Dr. Srivastava, Nidhi: No conflict of intereset||Dr. West, Rachel L: No conflict of intereset||Dr. Römkens, Tessa: No conflict of intereset||Dr. Horjus Talabur Horje, Carmen S: No conflict of intereset||Dr. Jansen, Jeroen M: No conflict of intereset||Dr. Hoekstra, Jildou: No conflict of intereset||Prof. Dr. Weersma, Rinse K: No conflict of intereset||Dr. van Schaik, Fiona DM: No conflict of intereset||Dr. Hoentjen, Frank: No conflict of intereset||Dr. Pierik, Marieke J: No conflict of intereset

Page 23 of 135

DOP59 Colombel, Jean-Frédéric:|:|Grants: AbbVie, Janssen, Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enterome, Ferring, Genentech, Genfit, Intestinal Biotech Development, Ipsen, Janssen, Landos, MedImmune, Merck, Novartis, Pfizer Inc, Shire, Takeda, Tigenix, Viela Bio ||Osterman, Mark T:|:|Grants: UCB|Personal fees: AbbVie, Janssen, Lycera, Merck, Pfizer Inc, Takeda, UCB||Ibanez, Patricio:|:|Personal fees: Pfizer Inc||Thorpe, Andrew J:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Zhang, Haiying:|:|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Reinisch, Walter:|:|Grants: Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GMbH, Immundiagnostik, MSD|Personal fees: 4SC, Abbott Laboratories, AbbVie, Aesca, Amgen, AM Pharma, AOP Orphan, Aptalis, Arena Pharmaceuticals, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, ChemoCentryx, Covance, Danone, Austria, Elan, Eli Lilly, Ernst & Young, Falk Pharma GMbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, Index, Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, MedAhead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestlé, Novartis, Ocera, Otsuka, Parexel, PDL, Pfizer Inc, Pharmacosmos, Philip Morris Institute, PLS Education, Proctor & Gamble, Prometheus, Laboratories, Protagonist, Provention, Robarts Clinical Trials, Roland, Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres, Therapeutics, SetPoint Medical, Shire, Sigmoid, Takeda, Therakos, TiGenix, UCB, Vifor, Yakult, Zealand, Zyngenia

DOP60 Dr. Danese, Silvio:|:|Lecture fee(s): AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, Merck Sharp & Dohme Corp., Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, Merck Sharp & Dohme Corp., Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim||Dr. Subramanian, Kavitha: No conflict of intereset||Dr. Van Zyl, Jan:|:|Financial support for research: PPD, Roche AbbVie||Mr. Adsul, Shashi:|:|Employee of Takeda, owns Takeda stock||Mr. Lindner, Dirk:|:|Employee of Takeda, owns Takeda stock||Ms. Roth, Jeannine:|:|Employee of Takeda, owns Takeda stock||Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, Takeda, Pfizer, Johnson & Johnson Lecture fee(s): Merck Sharp & Dohme Corp., AbbVie, Takeda, Ferring, Centocor, Hospirentera, Pfizer, Johnson & Johnson, Genentech/Roche, Tillotts Consultancy: Merck Sharp & Dohme Corp., AbbVie, Takeda, Ferring, Centocor, Hospira, Pfizer, Johnson & Johnson, Genentech/Roche, Celgene, Mundipharma, Celltrion, SecondGenome, Prometheus, Gilead, Galapagos, ProDigest, Abivax, GlaxoSmithKline, Tillotts

DOP61 Lichtenstein, Gary R:|:|Personal fees: AbbVie, American Regent, Celgene, Cellceutix, Eli Lily, Endo, Ferring, Gilead, Janssen Biotech, Merck, Morphic Therapeutic, Pfizer Inc, Prometheus Laboratories, Romark, Salix/Valeant, Shire Pharmaceuticals, Takeda, UCB|Other: Associate Editor (Honorarium): American Journal of Gastroenterology Editor (Honorarium): Gastroenterology and Hepatology (Gastro-Hep Communications) Editor (Honorarium): Springer Science and Business Media Honorarium (CME Program): American Regent Honorarium (CME Program): Merck Honorarium (CME Program): Romark Author (Honorarium): Up-To-Date Funding to University of PA (IBD Fellow Education): Janssen Orthobiotech Funding to University of PA (IBD Fellow Education): Pfizer In Funding to University of PA (IBD Fellow Education): Takeda Book royalty: SLACK||Loftus Jr, Edward V:|:|Grants: AbbVie, Amgen, Celgene, Genentech, Gilead, Janssen, Pfizer Inc, Robarts Clinical Trials, Takeda, UCB|Personal fees: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Exact Sciences, Genentech, Gilead, Janssen, Pfizer Inc, Takeda, UCB||Wei, Shu-Chen:|:|Personal fees: AbbVie, AbGenomics, Celltrion, Eisai, Excelsior Biopharma Inc, Ferring, Gilead, Janssen, Pfizer Inc, Takeda, Tanabe, Tillotts , TSPC (Taiwan Specialty Pharma Corp.)||Damião, Adérson OMC:|:|Personal fees: Takeda, Pfizer Inc||Judd, Donna:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Chan, Gary:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Zhang, Haiying:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Wang, Wenjin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Thorpe, Andrew J:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Bloom, Stuart:|:|Personal fees: AbbVie, Janssen, Pfizer Inc, Takeda

DOP62 Dr. Rottoli, Matteo: No conflict of intereset||Dr. Tanzanu, Marta: No conflict of intereset||Dr. Vago, Gabriele: No conflict of intereset||Dr. Belvedere, Angela: No conflict of intereset||Dr. Parlanti, Daniele: No conflict of intereset||Dr. Pezzuto, Paola: No conflict of intereset||Dr. Bosi, Simone: No conflict of intereset||Dr. Caputo, Francesca: No conflict of intereset||Prof. Rizzello, Fernando: No conflict of intereset||Prof. Gionchetti, Paolo: No conflict of intereset||Prof. Poggioli, Gilberto: No conflict of intereset Page 24 of 135

DOP63 Dr. Fiorino, Gionata: No conflict of intereset||Dr. Allocca, Mariangela: No conflict of intereset||Dr. Gilardi, Daniela: No conflict of intereset||Mrs. Alfieri, Marina: No conflict of intereset||Dr. Danieli, Patrizia: No conflict of intereset||Dr. Furfaro, Federica: No conflict of intereset||Dr. Roda, Giulia: No conflict of intereset||Dr. Loy, Laura: No conflict of intereset||Dr. Zilli, Alessandra: No conflict of intereset||Mrs. Radice, Simona: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent: No conflict of intereset||Prof. Danese, Silvio: No conflict of intereset

DOP64 Dr. WONG, Jamie: No conflict of intereset||Dr. Bursavich, Matthew: No conflict of intereset||Dr. Blanco, Natalia: No conflict of intereset||Dr. Camblin, Adam: No conflict of intereset||Ms. Cappellucci, Laura: No conflict of intereset||Ms. Cohen, Rhianna: No conflict of intereset||Dr. Cui, Dan: No conflict of intereset||Ms. Krumpoch, Megan: No conflict of intereset||Dr. Zhong, Cheng: No conflict of intereset||Mr. Hahn, Kris: No conflict of intereset||Dr. Lee, Dooyoung: No conflict of intereset||Dr. Lippa, Blaise: No conflict of intereset||Dr. Lin, Fu-Yang: No conflict of intereset||Dr. Lugovsky, Alex: No conflict of intereset||Mrs. McShea, Molly: No conflict of intereset||Mr. Mostafavi, Siavash: No conflict of intereset||Dr. Moy, Terry: No conflict of intereset||Mr. Sullivan, Andrew: No conflict of intereset||Dr. Troast, Dawn: No conflict of intereset||Dr. Wang, Liangsu: No conflict of intereset||Dr. Rogers, Bruce: No conflict of intereset

DOP65 Steere , Boyd:|:|Current employee and shareholder of Eli Lilly and Company||Schmitz, Jochen:|:|Current employee and shareholder of Eli Lilly and Company||Powell, Nicholas:|:|Grants (Takeda)|Consulting (Allergan, Abbvie, Takeda, Celgene, Lilly, Ferring, Vifor) |Support for travel for meetings to support study (Abbvie, Allergan, Takeda, Ferring, Janssen)|Non-financial support: Provision of writing assistance, medicines, equipment, or administrative support ,(Takeda)||Higgs, Richard:|:|Current employee and shareholder of Eli Lilly and Company||Gottlieb, Klaus:|:|Current employee and shareholder of Eli Lilly and Company||Liu, Yushi:|:|Current employee and shareholder of Eli Lilly and Company||Jia, Bochao:|:|Current employee and shareholder of Eli Lilly and Company||Tuttle, Jay L:|:|Current employee and shareholder of Eli Lilly and Company||Sandborn, William J:|:|research grants from Atlantic Healthcare Limited, Amgen, Genentech, Gilead Sciences, Abbvie, Janssen, Takeda, Lilly, Celgene/Receptos,Pfizer, Prometheus Laboratories (now Prometheus Biosciences); consulting fees from Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen, Kyowa Kirin Pharmaceutical Research, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust, HART), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna Biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts Pharma, UCB Pharma, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals; and stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Progenity, Ritter Pharmaceuticals, Ventyx Biosciences, Vimalan Biosciences. Spouse: Opthotech - consultant, stock options; Progenity - consultant, stock; Oppilan Pharma - employee, stock options; Escalier Biosciences - employee, stock options; Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories) - employee, stock options; Ventyx Biosciences – employee, stock options; Vimalan Biosciences – employee, stock options. ||Sands, Bruce E:|:|Research Support - Theravance Biopharma|Consultant - Abbvie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella Bioscience, Celltrion Healthcare, Genentech, Hoffmann-La Roche AG, Janssen, Lilly, Morphic Therapeutic, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Laboratorie, Salix, Shire, Takeda Pharmaceuticals , TARGET PharmaSolutions, Theravance Biopharma, Vivelix Pharmaceuticals|Advisory Committee - Arena Pharmaceuticals, Ironwood Pharmaceuticals||Krishnan, Venkatesh:|:|Current employee and shareholder of Eli Lilly and Company

Page 25 of 135

DOP66 Dr. Roda, Giulia: No conflict of intereset||Dr. Dunkin, David: No conflict of intereset||Dr. Correale, Carmen: No conflict of intereset||Dr. Vetrano, Stefania: No conflict of intereset||Dr. Merlino, Francesco: No conflict of intereset||Dr. Marinelli, Luciana: No conflict of intereset||Dr. Novellino, Ettore: No conflict of intereset||Dr. Mayer, Lloyd: No conflict of intereset||Dr. Yeretssian, Garabet: The author changed affiliation after the course of the work. GY is currently employed by the Leona M. And Harry B. Helmsley Charitable Trust, but the article in no way represents the work, views or opinion of Helmsley||Prof. Danese, Silvio: No conflict of intereset

DOP67 Dr. Shin, Jieun: No conflict of intereset||Ha, Nina: No conflict of intereset||Bae, Daekwon: No conflict of intereset||Dr. Lee, Yong Jae: No conflict of intereset||Dr. Choi, Young Il: No conflict of intereset||Dr. Ryu, Keun Ho: No conflict of intereset||Youn, Gi Soo: No conflict of intereset||Prof. Park, Jinseu: No conflict of intereset

DOP68 Ms. XU, Yuejie: No conflict of intereset||Dr. zhang, MingMing: No conflict of intereset||Prof. Xu, GuiFang: No conflict of intereset||Prof. Dr. Zou, XiaoPing: No conflict of intereset

DOP69 Dr. Chee, Desmond: No conflict of intereset||Dr. Honap, Sailish: No conflict of intereset||Dr. Chapman, Thomas P: No conflict of intereset||Dr. Kent, Alexandra J: No conflict of intereset||Dr. Patel, Mehul: No conflict of intereset||Dr. Hayee, Bu: No conflict of intereset||Dr. Dubois, Patrick: No conflict of intereset||Ms. Medcalf, Lucy: No conflict of intereset||Ms. Sharma, Esha: No conflict of intereset||Ms. Begum, Yesmina: No conflict of intereset||Dr. Ray, Shuvra:|:|Lecture fees: Abbvie, Takeda||Meeting support fees: Pharmacosmos||Dr. Kennedy, James: No conflict of intereset||Ms. Cripps, Sarah: No conflict of intereset||Ms. Elworthy, Claire: No conflict of intereset||Dr. Walsh, Alissa:|:|Sponsorship/speaking fees from Abbvie, Ferring, GSK, Janssen, Takeda, Vifor||Dr. Goodhand, James R:|:|J.R.G received honoraria from Falk, Abbvie and Shield therapeutics for unrelated topics.||Dr. Ahmad, Tariq:|:|T.A. has received unrestricted research grants, advisory board fees, speaker honorariums and support to attend international meetings from AbbVie, Merck, Janssen, Takeda, Ferring, Tillotts, Ferring, Pfizer, NAPP, Celltrion, Hospira for unrelated topics, no financial relationships with any organizations that might have an interest in the submitted work in the previous three years no other relationships or activities that could appear to have influenced the submitted work||Prof. Satsangi, Jack: No conflict of intereset||Dr. Kennedy, Nicholas A:|:|N.A.K has consulted for Falk and received honoraria from Falk, Allergan, Pharmacosmos and Takeda for unrelated topics and is a deputy editor of Alimentary Pharmacology & Therapeutics Journal.||Dr. Irving, Peter:|:|Lecture fees: Abbvie, Warner, Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Pfizer. ||Financial support for research: MSD, Takeda, Pfizer. ||Advisory fees: Abbvie, Warner, Chilcott, Takeda, MSD, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis

DOP70 Globig, Anna-Maria: No conflict of intereset||Otto-Mora, Patricia: No conflict of intereset||Hipp, Anna: No conflict of intereset||Heeg, Maximilian: No conflict of intereset||Schwacha, Henning: No conflict of intereset||Tomov, Vesselin: No conflict of intereset||Thimme, Robert: No conflict of intereset||Hasselblatt, Peter: No conflict of intereset||Bengsch, Bertram: No conflict of intereset

DOP71 Rosh, Joel:|:|Grant/Research Support: Abbvie, Janssen; Consultant/Advisory Boards: Abbvie, Janssen, Lilly, Pfizer||Dr. Turner, Dan:|:|received consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Biogen, Neopharm, Uniliver, Atlantic Health, Shire, Celgene, Lilly, Roche||Dr. Griffiths, Anne:|:|Consultant/advisory board member: Abbvie, Janssen, Lilly; Speaker fees: Abbvie, Janssen, Nestle; Research support (investigator initiated) Abbvie|||Dr. Jacobstein, Douglas:|:|former employee of Janssen Research and Development, LLC; current employee of Provention Bio||Dr. Adedokun, Omoniyi:|:|employee of Janssen Research and Development, LLC |||Dr. Padgett, Lakshmi:|:|employee of Janssen Research and Development, LLC |||Dr. Terry, Natalie:|:|employee of Janssen Research and Development, LLC |||Dr. O'Brien, Christopher:|:|employee of Janssen Research and Development, LLC |||Dr. Hyams, Jeffrey:|:|Advisory Board: Janssen, Abbvie; Consultant: Pfizer, Lilly, Boehringer Ingelheim, Roche, Allergan

Page 26 of 135

DOP72 Danese, Silvio:|:|Consultancy fees: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ely Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer Inc, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc., and Vifor||Klopocka, Maria:|:|Payment for lectures: Janssen, Takeda, Ferring, Alfa-Sigma, and Pharmabest;|Travel/accommodation/meeting expenses: Ferring, Janssen, Takeda, Alfa-Sigma, Pharmabest, and Polish Foundation for Gastroenterology|||Scherl, Ellen J:|:|Grants: Abbott (AbbVie), AstraZeneca, CCFA, Janssen Research & Development, Johns Hopkins University, , National Institute of Diabetes and Digestive and Kidney (NIDDK), National Institute of Health (NIH), New York Crohn’s Foundation, Pfizer, UCB, UCSF–CCFA Clinical Research Alliance, Genentech. Seres Therapeutics, Celgene|Corporation|Consultant/Advisory Board: AbbVie, Crohn’s and Colitis Foundation of America (CCFA), Entera Health, Evidera, GI Health Foundation, Janssen, Protagonist Therapeutics, Seres Health, Takeda Pharmaceuticals|Stock Shareholder: Gilead|Honoraria: GIHealth Foundation for non-branded speaker’s bureau, Janssen for nonbranded speaker’s bureau||Romatowski, Jacek: No conflict of intereset||Allegretti, Jessica R:|:|Grants: Merck and Co;|Consultant: Pfizer Inc, Takeda, Janssen, and Finch Therapeutics||Peeva, Elena:|:|Employee and shareholder of Pfizer Inc||Vincent, Michael S:|:|Employee and shareholder of Pfizer Inc||Schoenbeck, Uwe:|:|Employee of Pfizer Inc||Xi, Li:|:|Employee and shareholder of Pfizer Inc||Ye, Zhan:|:|Employee and shareholder of Pfizer Inc||Hassan-Zahraee, Mina:|:|Employee of Pfizer Inc||Rath, Natalie:|:|Employee of Pfizer Inc||Li, Gang:|:|Employee and shareholder of Pfizer Inc||Neelakantan, Srividya:|:|Employee and shareholder of Pfizer Inc||Banfield, Christopher:|:|Employee of Pfizer Inc||Lepsy, Christopher:|:|Employee and shareholder of Pfizer Inc||Chandra, Deepa:|:|Employee and shareholder of Pfizer Inc||Hung, Kenneth E:|:|Employee and shareholder of Pfizer Inc

DOP73 Sands, Bruce E:|:|Grants: Theravance Biopharma|Personal fees: AbbVie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella BiosScence, Celltrion Healthcare, Eli Lilly, Genentech/F. Hoffmann-La Roche, Ironwood Pharmaceuticals, Janssen, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Laboratories, Salix, Shire, Takeda, TARGET PharmaSolutions, Theravance Biopharma, Vivelix|Non-financial support: Eli Lilly, Janssen, Pfizer Inc, Takeda, TARGET PharmaSolutions|Other: Honoraria for speaking in a CME programme: The Academy for Continued Healthcare Learning, Integritas Communications||Moss, Alan C:|:|Grant: Pfizer Inc|Personal fees: Pfizer Inc||Armuzzi, Alessandro:|:|Grants: MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Chiesi, Eli Lilly, Ferring, Hospira, Janssen, Mitsubishi-Tanabe, Mylan, MSD, Mundipharma, Nikkiso, Otsuka, Pfizer Inc, Roche, Samsung Bioepis, Sandoz, Sofar, Takeda, TiGenix, Zambon||Marshall, John K:|:|Personal fees: AbbVie, Allergan, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Ferring, Janssen, Lupin, Merck, Pfizer Inc, Pharmascience, Shire, Takeda, Teva Pharmaceuticals||Lindsay, James O:|:|Grants: AbbVie, Gilead, Pfizer Inc, Shire, Takeda|Personal fees: AbbVie, Allergan (Warner Chilcott), Atlantic Healthcare, Bristol-Myers Squibb, Celgene, Celltrion, Eli Lilly, Ferring, Gilead, GSK, Janssen, MSD, NAPP, Norgine, Pfizer Inc, Shire, Takeda, Tillotts, Vifor||Sandborn, William J:|:|Grants: AbbVie, Amgen, Atlantic Healthcare Limited, Celgene/Receptos, Eli Lilly, Genentech, Gilead, Janssen, Pfizer Inc, Prometheus Laboratories (now Prometheus Biosciences), Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Eli Lilly, Ferring, Forbion, Genentech, Gilead, Gossamer Bio, Incyte, Janssen, Kyowa Kakko Kirin Co. Ltd., Landos Biopharma, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Biosciences, Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts, UCB, Ventyx Biosciences, Vimalan Biosciences, Vivelix|Other: Spouse: Consultant, Stock options: Escalier Biosciences, Opthotech, Oppilan Pharma, Progenity, Prometheus Biosciences, Ventyx Biosciences, Vimalan Biosciences||Danese, Silvio:|:|Consultancy: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer Inc, Roche, Sandoz, Takeda, TiGenix, UCB, Vifor ||Zeroncio, Marco:|:|Personal fees: Janssen, Pfizer Inc, Takeda||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer

Page 27 of 135

DOP74 Prof. Dr. Kopylov, Uri:|:|Speaker fees/advisory Janssen Medtronic|Abvvie Takeda MSD; Research support, Janssen|Takeda Medtronic||Dr. Hanzel, Jurij:|:||lecture fees from Biogen, Janssen and Takeda||Dr. Liefferinckx, Claire:|:|Consultancy fees: Takeda|Speaker fees: Sandoz, Janssen, Abbvie||Dr. De Marco, Davide:|:|none||Dr. Imperatore, Nicola:|:|none||Dr. Plevris, Nikola:|:|| Consultancy fees from Takeda and speaker fees and travel support from AbbVie, Takeda, Norgine and Janssen.||Dr. Baston-Rey, Iria: No conflict of intereset||Dr. Harris, Richard: No conflict of intereset||Ms. Truyens, Marie: No conflict of intereset||Dr. Domislovic, Viktor: No conflict of intereset||Prof. Vavricka, Stephan: No conflict of intereset||Dr. Biemans, Vince: No conflict of intereset||Ms. Myers, Sally: No conflict of intereset||Prof. Shaji, Sebastian: No conflict of intereset||Prof. Ben-Horin, Shomron:|:|Research support|or consultancy/Advisory board fees from MSD,|AbbVie, Janssen, CellTrion, Pfizer, GSK, and|Takeda||Dr. González Lama, Yago:|:|educational grants and payments for lecturing or consultancy from AbbVie, Takeda, Janssen, Pfizer, Amgen, Ferring.||Dr. Gilletta, Cyrielle: No conflict of intereset||Dr. Bar-Gil Shitrit , Ariella:|:|Advisory Board/Speakers Bureau – Takeda, Janssen, AbbVie, Neopharm, Pfizer||Funding (Grants/Honoraria) : Takeda, Janssen||Speaker/Consulting Fees: Takeda, Janssen, AbbVie, Neopharm||Dr. Zelinkova, Zuzana: No conflict of intereset||Dr. Weishof, Roni:|:|lecture fees from Janssen and Abbvie.|||Dr. Storan, Darragh: No conflict of intereset||Dr. Zittan, Eran: No conflict of intereset||Dr. Franchimont, Denis: No conflict of intereset||Dr. Cremer, Anneline: No conflict of intereset||Dr. Afif, Waqqas:|:|Janssen/Abbvie/Takeda/Arena Pharmaceuticals||Advisory board/consultant/investigator||Pfizer/Merck/Ferring/Novartis||Advisory board||Prometheus/Theradiag/Eli-Lilly||Investigator||Dr. Castiglione, Fabiana: No conflict of intereset||Prof. Lees, Charles: No conflict of intereset||Prof. Dr. Barrero de Acosta, Manuel:|:|MBA has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Takeda and Janssen.||Dr. Lobaton, Triana: No conflict of intereset||Prof. Dr. Doherty, Glen: No conflict of intereset||Prof. Dr. Krznaric, Zeljko: No conflict of intereset||Dr. Pierik, Marieke: No conflict of intereset||Dr. Hoentjen, Frank:|:|Frank Hoentjen has served on advisory boards or as speaker for Abbvie, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz and Dr Falk||Funding (Grants/Honoraria) : Dr Falk, Janssen-Cilag, Abbvie||Consulting Fees: Celgene||Dr. Drobne, David:|:|David Drobne has served as a speaker, a consultant and an advisory board member for MSD, Abbvie, Takeda, Pfizer, Janssen, Amgen, Biogen and Krka.

DOP75 Rubin, David T:|:|Grants: AbbVie, Genentech/F. Hoffmann-La Roche, Janssen, Prometheus Laboratories, Takeda|Personal fees: AbbVie, AbGenomics, Allergan, Biomica, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Check-Cap, Dizal Pharmaceuticals, Eli Lilly, GalenPharma/Atlantica, Genentech/F. Hoffmann-La Roche, Gilead, Glenmark, GSK, Janssen, Mahana Therapeutics, Narrow River Mgmt, Pfizer Inc, Prometheus Laboratories, Reistone, Seres Therapeutics, Shire, Takeda, TARGET PharmaSolutions, Techlab|Other: Board of Trustees: American College of Gastroenterology; Co-Founder, CFO: Cornerstones Health (non-profit); Co-Founder: GoDuRn||Dubinsky, Marla C:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Panés, Julian:|:|Grants: AbbVie, MSD|Personal fees: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, F. Hoffmann-La Roche, Gilead, GoodGut, GSK, Immunic, Janssen, MSD, Nestlé, Oppilan, Pfizer Inc, Progenity, Robarts Clinical Trials, Takeda, Theravance, TiGenix||Wu, Deng-Chyang: No conflict of intereset||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Guo, Xiang:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lai, Chacun:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kwok, Kenneth:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese , Lenny:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc

DOP76 Dr. Peyrin-Biroulet, Laurent:|:|Investigator and Advisor for Janssen||Dr. Sandborn, William:|:|Investigator and Advisor for Janssen||Dr. Sands, Bruce:|:|Investigator and Advisor for Janssen||Dr. Scherl, Ellen:|:|Investigator and Advisor for Janssen||Dr. Marano, Colleen:|:|Salaried employee for Janssen||Dr. O'Brien, Christopher:|:|Salaried employee for Janssen||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen||Dr. Johanns, Jewel:|:|Salaried employee for Janssen||Dr. Zhou, Yiying:|:|Salaried employee for Janssen||Dr. Abreu, Maria:|:|Investigator and Advisor for Janssen||Dr. Arasaradnam, Ramesh P.:|:|Investigator and Advisor for Janssen||Dr. Rowbotham, David S.:|:|Investigator and Advisor for Janssen||Dr. Leong, Rupert W.L.:|:|Investigator and Advisor for Janssen||Dr. Danese, Silvio:|:|Investigator and Advisor for Janssen

Page 28 of 135

DOP77 Mr. Biemans, Vince: No conflict of intereset||Prof. Dr. van der Woude, Janneke: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Dr. van der Meulen- de Jong, Andrea: No conflict of intereset||Dr. Löwenberg, Mark: No conflict of intereset||Dr. de Boer, Nanne: No conflict of intereset||Prof. Dr. Oldenburg, Bas: No conflict of intereset||Dr. Srivastava, Nidhi: No conflict of intereset||Dr. Jansen, Jeroen: No conflict of intereset||Dr. Bodelier, Alexander: No conflict of intereset||Dr. West, Rachel: No conflict of intereset||Dr. de Vries, Annemarie: No conflict of intereset||Dr. Haans, Jeoffrey: No conflict of intereset||Dr. de Jong, Dirk: No conflict of intereset||Dr. Hoentjen, Frank: No conflict of intereset||Pierik, Marieke: No conflict of intereset

DOP78 Mr. Vadstrup, Kasper: No conflict of intereset||Alulis, Sarah: No conflict of intereset||Borsi, Andras: No conflict of intereset||Olsen, Jens: No conflict of intereset||Jørgensen, Tine Rikke: No conflict of intereset||Munkholm, Pia: No conflict of intereset||Qvist, Niels: No conflict of intereset

DOP79 Dr. Sandborn, William: No conflict of intereset||Dr. Panés, Julian:|:|Consulting fees from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Genentech, GlaxoSmithKline, Janssen, MSD, Nestle, Oppilan, Progenity, Pfizer, Robarts, Roche, Second Genome, Takeda, Theravance, TiGenix, and Topivert; speaker fees from AbbVie, Biogen, Ferring, Janssen, MSD, Shire Pharmaceuticals, Takeda, and Tillotts; and research funding from AbbVie and MSD.||Dr. Peyrin-Biroulet, Laurent:|:|Honoraria from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, and Amgen; grants from Abbvie, MSD, and Takeda; stock options CT-SCOUT.||Dr. Louis, Edouard:|:|Research grants from Takeda and Pfizer; educational grants from AbbVie, MSD, Takeda, and Janssen; speaker fees from AbbVie, Ferring, MSD, Falk, Takeda, Hospira, Janssen, and Pfizer; advisory board for AbbVie, Ferring, MSD, Takeda, Celgene, Hospira, Janssen, and Pfizer; and consultant for AbbVie. ||Dr. Greenbloom, Susan:|:|No conflicts to disclose; investigator for AbbVie.||Dr. Zhou, Wen:|:|AbbVie employee and may own AbbVie stock and/or options.

DOP80 Mr. Alric, Hadrien: No conflict of intereset||Prof. Amiot, Aurélien:|:|AA received honoraria from Abbvie, Hospira, Takeda, Gilead, Biocodex, Janssen, Tillotts, Ferring and MSD||Dr. Kirchgesner, Julien: No conflict of intereset||Prof. Tréton, Xavier:|:|XT received honoraria from Abbvie, MSD, Takeda, Ferring, Norgine and Janssen.||Prof. Allez, Mathieu:|:|MA received honoraria from Abbvie, MSD, Janssen, Takeda, Pfizer, Novartis, Ferring, Tillotts, Celgene and Genentech/Roche.||Prof. Bouhnik, Yoram:|:|YB received honoraria from Abbvie, Biogaran, Boehringer Ingelheim, Celgene, Ferring, Gilead, Hospira, Janssen, Mayoly-Spindler, MSD, Norgine, Pfizer, Roche, Samsung Bioepis, Sandoz, Sanofi, Shire, Takeda, UCB.||Prof. Beaugerie, Laurent:|:|LB received honoraria from Janssen, Pfizer, Allergan, AbbVie, Janssen, MSD, Ferring Pharmaceuticals, Mayoly-Spindler, Takeda and Tillotts, and research support from Abbott, Ferring Pharmaceuticals, Hospira-Pfizer, Janssen, MSD, Takeda and Tillotts.||Prof. Carbonnel, Franck:|:|FC received honoraria from Amgen, BMS, Enterome, Ferring, Janssen, Medtronic, Pfizer, Pharmacosmos and Roche as well as lecture fees from Abbvie, Astra, BMS, Ferring, Janssen, MSD, Pfizer, Pileje, Takeda and Tillotts.||Dr. Meyer, Antoine: No conflict of intereset

DOP81 Dubinsky, Marla C:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Chou, Jen-Wei: No conflict of intereset||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Wang, Wenjin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Guo, Xiang:|:|Other: Employee: Pfizer Inc||Vermeire, Séverine:|:|Grants: AbbVie, Johnson & Johnson, MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Abivax, Celgene, Dr. Falk Pharma, Ferring, Galapagos, Genentech, GSK, Hospira, Janssen, MSD, Mundipharma, Pfizer Inc, ProDigest, Progenity, Second Genome, Shire, Takeda, Tillotts

DOP82 Bloemendaal , Felicia M.: No conflict of intereset||Becker, Marte: No conflict of intereset||Dr. Koelink, Pim J.: No conflict of intereset||Dr. van der Bilt, Jarmilla D.: No conflict of intereset||Prof. Dr. Bemelman, Willem A.: No conflict of intereset||Prof. Dr. D'Haens, Geert R.A.M.: No conflict of intereset||Dr. Buskens, Christianne J.: No conflict of intereset||Dr. Wildenberg, Manon E.: No conflict of intereset

Page 29 of 135

DOP83 Mr. Creyns, Brecht: No conflict of intereset||Dr. Gabriele, Dragoni:|:|Personal fees from Abbvie, Takeda and Pfizer. ||Mr. Jonathan, Cremer: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Bislenghi, Gabriele: No conflict of intereset||Prof. Dr. Marc, Ferrante:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda| ||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Van Assche, Gert:|:|Research grant from Abbott and Ferring Pharmaceuticals; lecture fees from Janssen, MSD and Abbott; consultancy fees from PDL BioPharma, UCB Pharma, Sanofi-Aventis, Abbott, Abbvie, Ferring, Novartis, Biogen Idec, Janssen Biologics, NovoNordisk, Zealand Pharma A/S, Millenium/Takeda, Novartis and Bristol Mayer Squibb.||Prof. Dr. Ceuppens, Jan: No conflict of intereset||Prof. Dr. D'Hoore, Andre:|:|Research grant: Johnson & Johnson|Consultancy: Takeda|Speaker’s fee: Duomed, Janssen, Johnson & Johnson, Lifebond, Olympus, Takeda||Prof. Dr. De Hertogh, Gert:|:|Consulting fees from Glaxo Smith Kline, Shire Pharmaceuticals, Teva Pharma, Galapagos, Genentech, Novartis Pharma, Fast Forward Pharmaceuticals, Takeda and Janssen R&D.||Prof. Dr. Breynaert, Christine:|:|Consultancy fee Ablynx.

DOP84 Dr. Serena, Carolina: No conflict of intereset||Millan, Monica: No conflict of intereset||Dr. Ejarque, Miriam: No conflict of intereset||Dr. Saera-Vila, Alfonso: No conflict of intereset||Ms. Monfort-Ferré, Diandra: No conflict of intereset||Dr. Bautista, Michelle: No conflict of intereset||Dr. Menacho, Margarita: No conflict of intereset||Dr. Martí, Marc: No conflict of intereset||Dr. Espin, Eloy: No conflict of intereset||Dr. Vendrell, Joan: No conflict of intereset||Dr. Fernández-Veledo, Sonia: No conflict of intereset

DOP85 Dr. Bruckner, Ramona Sonja: No conflict of intereset||Ms. Barnhoorn, Marieke C.: No conflict of intereset||Dr. Mei, Hailiang: No conflict of intereset||Dr. Kiełbasa, Szymon M.: No conflict of intereset||Mr. Harrijvan, Tom J.: No conflict of intereset||Ms. Hakuno, Sarah K.: No conflict of intereset||Mr. van der Reijden, Johan J.: No conflict of intereset||Dr. van der Meulen-de Jong, Andrea E.: No conflict of intereset||Dr. Hawinkels, Luuk J. A. C.: No conflict of intereset

DOP86 HARTMANN, Leonie: No conflict of intereset||Mrs. Siegmund, Britta: No conflict of intereset||Mr. Weidinger, Carl: No conflict of intereset||Mr. Becker, Christoph: No conflict of intereset||Mr. Neurath, Markus F.: No conflict of intereset||Mrs. Günther, Claudia: No conflict of intereset

DOP87 Ms. Bauset, Cristina: No conflict of intereset||Ms. Gisbert-Ferrandiz, Laura: No conflict of intereset||Dr. Ortiz-Masia, Dolores: No conflict of intereset||Ms. Coll, Sandra: No conflict of intereset||Ms. Mamie, Celine: No conflict of intereset||Dr. Scharl, Michael: No conflict of intereset||Dr. Calatayud, Sara: No conflict of intereset||Dr. Barrachina, M Dolores: No conflict of intereset||Dr. Cosín-Roger, Jesús: No conflict of intereset

DOP88 Dr. Lim, Zixiang: No conflict of intereset||Dr. Welman, Christopher: No conflict of intereset||Dr. Raymond, Warren: No conflict of intereset||Dr. Thin, Lena: No conflict of intereset

DOP89 Dr. Haberman Ziv, Yael: No conflict of intereset||Minar, Phillip: No conflict of intereset||Karns, Rebekah: No conflict of intereset||Dexheimer, Phillip: No conflict of intereset||Ghandikota, Sudhir: No conflict of intereset||Tegge, Samuel: No conflict of intereset||Shapiro, Daniel: No conflict of intereset||Shuler, Brianne: No conflict of intereset||Venkateswaran, Suresh: No conflict of intereset||Braun, Tzipi: No conflict of intereset||Aronow, Bruce: No conflict of intereset||Gibson, Greg: No conflict of intereset||Hyams, Jeffrey: No conflict of intereset||Kugathasan, Subra: No conflict of intereset||Jegga, Anil: No conflict of intereset||Denson, Lee: No conflict of intereset

DOP90

P001

Mr. SEO, Dong Hyuk: No conflict of intereset||Mr. Ma, Hyun Woo: No conflict of intereset||Dr. Kim, Soochan: No conflict of intereset||Ms. Kim, Da Hye: No conflict of intereset||Ms. Kim, Hyun Kyung: No conflict of intereset||Dr. Lee, Sun Hwa: No conflict of intereset||Dr. Kim, Sunghwan: No conflict of intereset||Mr. Ahn, Jae Young: No conflict of intereset||Mr. Yoon, Se Hoon: No conflict of intereset||Mr. Kim, Dae Kwon: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset

Page 30 of 135

P002

Hageman, Ishtu: No conflict of intereset||Mr. Li Yim , Andrew: No conflict of intereset||Mr. Joustra, Vincent: No conflict of intereset||Mr. Ghiboub, Mohammed: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset||Dr. Te Velde, Anje: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Dr. Paulusma, Coen: No conflict of intereset||Dr. Henneman, Peter: No conflict of intereset||Prof. Dr. De Jonge, Wouter: No conflict of intereset

P003

Mr. Diab, Joseph: No conflict of intereset||Dr. Hansen, Terkel: No conflict of intereset||Dr. Goll, Rasmus: No conflict of intereset||Dr. Stenlund, Hans: No conflict of intereset||Dr. Jensen, Einar: No conflict of intereset||Prof. Moritz, Thomas: No conflict of intereset||Prof. Dr. Florholmen, Jon: No conflict of intereset||Forsdahl, Guro: No conflict of intereset

P004

Dr. CHENG, Lili: No conflict of intereset||Ms. Venkataraman, Sarayu: No conflict of intereset||Dr. Zhao, Li: No conflict of intereset||Mr. Lee, Larry: No conflict of intereset||Ms. Tang, Tenny: No conflict of intereset||Dr. Liu, David: No conflict of intereset||Dr. Mattheakis, Larry: No conflict of intereset

P005

Dr. Jeffery, Louisa E: No conflict of intereset||Dr. Shivaji, Uday Nagesh: No conflict of intereset||Dr. Zardo, Davide: No conflict of intereset||Dr. Acharjee, Animesh: No conflict of intereset||Dr. Nardone, Olga Maria: No conflict of intereset||Dr. Smith, Samuel CL: No conflict of intereset||Dr. Gkoutos, Georgios: No conflict of intereset||Prof. Visweswariah, Sandhya S: No conflict of intereset||Prof. Dr. Ghosh, Subrata: No conflict of intereset||Dr. Iacucci, Marietta: No conflict of intereset

P006

Mr. Lo Sasso, Giuseppe:|:|The research described in this abstract was sponsored by Philip Morris International ||Mrs. Gijzen, Linda: No conflict of intereset||Mr. Marescotti, Diego:|:|The research described in this abstract was sponsored by Philip Morris International ||Mrs. Naumovska, Elena: No conflict of intereset||Raineri, Elisa: No conflict of intereset||Mr. Nicolas, Arnaud: No conflict of intereset||Lanz, Henriette: No conflict of intereset||Mr. Guerrera, Diego:|:|The research described in this abstract was sponsored by Philip Morris International ||Mr. van Vught, Remko: No conflict of intereset||Mr. Joore, Jos: No conflict of intereset||Mr. Vulto, Paul: No conflict of intereset||Mr. Peitsch, Manuel C.:|:|The research described in this abstract was sponsored by Philip Morris International ||Mrs. Hoeng, Julia:|:|The research described in this abstract was sponsored by Philip Morris International ||Mrs. Kurek, Dorota: No conflict of intereset

P007

Mrs. SÜNDERHAUF, Annika: No conflict of intereset||Ms. Hicken, Maren: No conflict of intereset||Ms. Skibbe, Kerstin: No conflict of intereset||Ms. Schlichting, Heidi: No conflict of intereset||Dr. Hirose, Misa: No conflict of intereset||Prof. Dr. Perner, Sven: No conflict of intereset||Prof. Dr. Ibrahim, Saleh: No conflict of intereset||Dr. Derer, Stefanie: No conflict of intereset||Prof. Dr. Sina, Christian: No conflict of intereset

P008

Dr. Escudero-Hernández, Celia:|:|CEH has received financial support from Ferring Pharmaceuticals (Switzerland). ||Dr. van Beelen Granlund, Atle: No conflict of intereset||Dr. Bruland, Torunn: No conflict of intereset||Prof. Dr. Sandvik, Arne K.: No conflict of intereset||Dr. Koch, Stefan:|:|S.K. is a Wallenberg Molecular Medicine fellow, and receives financial support from the Knut and Alice Wallenberg Foundation (KAW). He has also received financial support from Ferring Pharmaceuticals (Switzerland).||Dr. Østvik, Ann Elisabet: No conflict of intereset||Dr. Münch, Andreas:|:|A.M. has received financial support from Ferring Pharmaceuticals (Switzerland), salary for consultancies from Tillotts, Ferring, Vifor and Dr Falk Pharma, and speaker’s honoraria from Tillotts and Vifor.

P009

Dr. Filidou, Eirini: No conflict of intereset||Dr. Kokkotis, George: No conflict of intereset||Ms. Tarapatzi, Gesthimani: No conflict of intereset||Ms. Boulkou, Marianna: No conflict of intereset||Dr. Arvanitidis, Konstantinos: No conflict of intereset||Dr. Drygiannakis, Ioannis: No conflict of intereset||Dr. Valatas, Vasilis: No conflict of intereset||Prof. Dr. Koutroubakis, Ioannis: No conflict of intereset||Prof. Dr. Vradelis, Stergios: No conflict of intereset||Prof. Dr. Kolios, George: No conflict of intereset||Prof. Dr. Bamias, Georgios: No conflict of intereset

P010Dr. Filip, Rafal: No conflict of intereset||Mr. Bar, Piotr: No conflict of intereset||Prof. Bartusik-Aebisher, Dorota: No conflict of intereset||Prof. Aebisher, David: No conflict of intereset

P011

Ms. López Cauce, Beatriz: No conflict of intereset||Dr. Puerto, Marta: No conflict of intereset||Prof. Dr. García, Juan J.: No conflict of intereset||Mr. Miranda-Bautista, José: No conflict of intereset||Dr. Vaquero, Javier: No conflict of intereset||Prof. Dr. Bañares, Rafael: No conflict of intereset||Prof. Dr. Menchén, Luis: No conflict of intereset

Page 31 of 135

P012

Ungar, Bella:|:|BU has received research grants / lectures fees from Janssen, Takeda, Abbvie and Neopharm.||Mr. Ben-Shatach, Zohar: No conflict of intereset||Ms. Haj-Natour, Ola: No conflict of intereset||Ms. Yavzori, Miri: No conflict of intereset||Dr. Fudim, Ella: No conflict of intereset||Dr. Picard, Orit: No conflict of intereset||Dr. Coscas, Daniel: No conflict of intereset||Dr. Lahat, Adi: No conflict of intereset||Prof. Dr. Lidar, Merav: No conflict of intereset||Prof. Dr. Eliakim, Rami:|:|Received consultant and speaker fees from Jannsen Abbvie Medtronic and Takeda||Prof. Dr. Kopylov, Uri:|:|received research support from Jannsen, Takeda, and Medtronic and Lecture/advisory fees from Abbvie, Jannsen, Takeda, MSD and Medtronic||Prof. Dr. Ben-Horin, Shomron:|:|received consulting and advisory board fees and/or research support from AbbVie, MSD, Janssen, Takeda and CellTrion.

P013

Prof. Loza, Mabel:|:|She has participated/participate as scientific advisors and/or collaborative researchers with Companies (Lilly/Oncostellae) that have had/have programs on JAC kinases as targets. ||Dr. Brea, Jose Manuel:|:|He has participated/participate as scientific advisors and/or collaborative researchers with Companies (Lilly/Oncostellae) that have had/have programs on JAC kinases as targets. ||Dr. Calviño-Suarez, Cristina: No conflict of intereset||Dr. Baston-Rey, Iria: No conflict of intereset||Dr. Ferreiro-Iglesias, Rocío: No conflict of intereset||Prof. Dr. Dominguez-Munoz, J. Enrique: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P014

Ms. Baer, Hannah Moana:|:|H Baer is receiving a PhD stipend from the Medical Research Council. ||Dr. MacDonald, Elizabeth: No conflict of intereset||Ms. Ferguson, Annabelle: No conflict of intereset||Mrs. Scott, Ann-Marie: No conflict of intereset||Dr. Khan, Muhammad Imran: No conflict of intereset||Ms. Bain, Kym Antionette:|:|K Bain is receiving a PhD stipend partially funded by AstraZeneca.||Dr. Ijaz, Umer Zeeshan: No conflict of intereset||Dr. Cole, John: No conflict of intereset||Dr. Ramanujam, Meera:|:|M Ramanujam is employed by Boehringer Ingelheim Pharmaceuticals Inc. ||Prof. Nibbs, Robert John Benjamin: No conflict of intereset||Dr. Gaya, Daniel Richard:|:|Dr Gaya has received speaker honoraria & travel grants from vifor, Abbvie, Pfizer & Takeda.||Prof. Milling, Simon William Francis:|:|S Milling received speaker’s fees from Janssen and participated in medical board meetings with Pfizer. He also receives fees in his role as Editor in Chief of Immunology.

P015

Ms. WEIß, Franziska: No conflict of intereset||Mrs. Lee, In-Fah M.: No conflict of intereset||Mrs. Fromm, Anja: No conflict of intereset||Mrs. Hu, Jia Chen E.: No conflict of intereset||Dr. Breiderhoff, Tilman: No conflict of intereset||Prof. Fromm, Michael: No conflict of intereset||Prof. Schulzke, Jörg D.: No conflict of intereset||Dr. Krug, Susanne M.: No conflict of intereset

P016

Prof. Dr. Tarasova, Galina: No conflict of intereset||Dr. Volkov, Alexander: No conflict of intereset||Prof. Dr. Iakovlev, Aleksei: No conflict of intereset||Mr. Ghazudin, Tadzudin: No conflict of intereset||Dr. Shcherbakova, Inna: No conflict of intereset

P017

Ms. Boronat-Muñoz, Alicia: No conflict of intereset||Ms. Cejudo-Garces, Andrea: No conflict of intereset||Ms. Lledo-Gil, Paula: No conflict of intereset||Cosín-Roger, Jesús: No conflict of intereset||Ms. Coll, Sandra: No conflict of intereset||Dr. Navarro-Vicente, Francisco: No conflict of intereset||Dr. Alos, Rafa: No conflict of intereset||Prof. Dr. Calatayud, Sara: No conflict of intereset||Prof. Dr. Barrachina, Mª Dolores: No conflict of intereset||Prof. Dr. Ortiz-Masiá, Dolores: No conflict of intereset

P018

Ms. FART, Frida: No conflict of intereset||Dr. Salihovic, Samira: No conflict of intereset||Dr. McGlinchey, Aidan: No conflict of intereset||Dr. Orešič, Matej: No conflict of intereset||Prof. Halfvarson, Jonas: No conflict of intereset||Prof. Hyötyläinen, Tuulia: No conflict of intereset||Dr. Schoultz, Ida: No conflict of intereset

Page 32 of 135

P019

P020

Mr. McLellan, Paul: No conflict of intereset||Mr. Lavelle , Aonghus: No conflict of intereset||Mr. Brot, Loic: No conflict of intereset||Mrs. Straube, Marjolène: No conflict of intereset||Mrs. de Sordi , Luisa: No conflict of intereset||Mr. Grill, Jean-Pierre: No conflict of intereset||Dr. Bourrier , Anne: No conflict of intereset||Dr. Kirchgesner, Julien: No conflict of intereset||Mr. Chatel, Jean Marc: No conflict of intereset||Prof. Dr. Beaugerie, Laurent: No conflict of intereset||Prof. Dr. Sokol, Harry: No conflict of intereset||Prof. Dr. Seksik, Philippe: No conflict of intereset

P021

Dr. Jukes, Cailtin: No conflict of intereset||Ms. Ricci, Liviana: No conflict of intereset||Ms. von Coburg, Elena: No conflict of intereset||Dr. Nasr, Maha: No conflict of intereset||Dr. Walker, Alan W.: No conflict of intereset||Dr. Duncan, Sylvia H.: No conflict of intereset||Prof. Hegazy, Ahmed Nabil: No conflict of intereset

P022

Mr. Kershaw, Jim:|:|Jim Kershaw is an Employee of Adelphi Real World||Ms. Wild, Rosie:|:|Rosie Wild is an Employee of Adelphi Real World||LUKANOVA, Rina:|:|Rina Lukanova is an Employee of Adelphi Real World||Dr. Bruce Wirta, Sara:|:|Sara Bruce Wirta is an Employee of Johnson & Johnson||Dr. Sikirica, Mirko:|:|Mirko Sikirica is an Employee and Shareholder of Johnson & Johnson

P023

Prof. Dr. JIN, Younggeon:|:|Consulting||Madan, Jay:|:|Support for travel for meetings to support study, Shareholder||Dr. Radha B, Krishnan:|:|Consulting||Prof. Dr. Anthony, Blikslager:|:|Consulting

P024

Dr. Wiecek, Sabina: No conflict of intereset||Wojtyniak, Alicja: No conflict of intereset||Pindur, Barbara: No conflict of intereset||Prof. Grzybowska-Chlebowczyk, Urszula: No conflict of intereset

Mr. Brand, Eelco:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |EB is supported by the Alexandre Suerman program for MD and PhD students of the University Medical Centre Utrecht, Netherlands, and is co-applicant on an unrestricted Investigator Initiated Research Grants research grant of Pfizer. ||Ms. Roosenboom, Britt:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |BR reports no conflicts of interest. ||Ms. Malvar Fernandez, Beatriz:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |BMF reports no conflicts of interest. ||Ms. Lutter, Lisanne:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |LL reports no conflicts of interest.||Ms. van Koolwijk, Elly:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |EvK reports no conflicts of interest.|||Dr. van Lochem, Ellen G.:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |EGvL reports no conflicts of interest.|||Dr. Horjus Talabur Horje, Carmen S.:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |CSHTH reports no conflicts of interest.|||Dr. Reedquist, Kris A.:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |KAR is co-applicant on an unrestricted Investigator Initiated Research Grants research grant of Pfizer.||Dr. van Wijk, Femke:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |FvW is co-applicant on a received Investigator Initiated Research Grants research grant of Pfizer.||Prof. Dr. Oldenburg, Bas:|:|The research presented in this abstract was funded by an unrestricted investigator initiated research grant of Pfizer (ASPIRE 2017). The funding party did not have any role in the design, conduct, analyses or reporting of the study. |BO unrestricted grants: Abbvie, Janssen, Pfizer, Ferring, dr. Falk, Takeda; advisory board: Janssen, Pfizer, Takeda, Cablon

Page 33 of 135

P025

Dr. Rodrigues, Bruno: No conflict of intereset||Dr. Pascoal, Livia Bitencourt: No conflict of intereset||Dr. Coope, Andressa: No conflict of intereset||Prof. Dr. Ayrizono, Maria Lourdes Setsuko: No conflict of intereset||Dr. Camargo, Michel Gardere: No conflict of intereset||Prof. Dr. Velloso, Licio Augusto: No conflict of intereset||Prof. Dr. Fagundes, João José: No conflict of intereset||Prof. Dr. Leal, Raquel Franco: No conflict of intereset

P026

Dr. Preda, Carmen Monica: No conflict of intereset||Dr. Manuc, Teodora: No conflict of intereset||Dr. Chifulescu, Andreea Elena: No conflict of intereset||Dr. Istratescu, Doina: No conflict of intereset||Prof. Dr. Louis, Edouard: No conflict of intereset||Prof. Dr. Diculescu, Mircea: No conflict of intereset||Dr. Cristian, Tieranu: No conflict of intereset||Prof. Dr. Gheorghe, Liliana-Simona: No conflict of intereset||Prof. Dr. Manuc, Mircea: No conflict of intereset

P027

Dr. Takeru, Nakano: No conflict of intereset||Dr. Kakuta, Yoichi: No conflict of intereset||Dr. Izumiyama, Yasuhiro: No conflict of intereset||Dr. Ichikawa, Ryo: No conflict of intereset||Dr. Okamoto, Daisuke: No conflict of intereset||Dr. Moroi, Rintaro: No conflict of intereset||Dr. Kuroha, Masatake: No conflict of intereset||Dr. Kanazawa, Yositake: No conflict of intereset||Dr. Kinouchi, Yoshitaka: No conflict of intereset||Dr. Masamune, Atsushi: No conflict of intereset

P028

Ms. Marlina, Erni: No conflict of intereset||Ms. Hirani, Banbai: No conflict of intereset||Dr. Mercadante, Valeria: No conflict of intereset||Dr. Shephard, Martina: No conflict of intereset||Prof. Kishida, Shosei: No conflict of intereset||Dr. Sebepos-Rogers, Greg: No conflict of intereset||Dr. McMillan, Roddy: No conflict of intereset||Dr. Hodgson, Tim: No conflict of intereset||Dr. Leeson, Rachel: No conflict of intereset||Prof. Porter, Stephen: No conflict of intereset||Dr. Barber, Julie: No conflict of intereset||Prof. Fedele, Stefano: No conflict of intereset||Prof. Smith, Andrew:|:|AMS received part-funding for this project from Ferring Pharmaceuticals

P029 Prof. Dr. Hahm, Ki Baik: No conflict of intereset

P030

Dr. Tarassishin, Leonid: No conflict of intereset||Dr. Kim, Eunsoo: No conflict of intereset||Dr. Eisele, Caroline: No conflict of intereset||Dr. Barre, Amelie: No conflict of intereset||Dr. Thjømøe, Anne: No conflict of intereset||Dr. Mørk, Einar: No conflict of intereset||Prof. Dubinsky , Marla: No conflict of intereset||Prof. Stone, Joanne: No conflict of intereset||Dr. Nair, Nilendra: No conflict of intereset||Dr. Debebe, Anketse: No conflict of intereset||Dr. Hawkins, Kelly: No conflict of intereset||Dr. Rendon, Alexa: No conflict of intereset||Dr. Sabino, Joao: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset||Prof. Colombel, Jean-Frederic: No conflict of intereset||Prof. Peter, Inga: No conflict of intereset||Dr. Hu, Jianzhong: No conflict of intereset

P031

Mrs. TAKAGI, Hiroko: No conflict of intereset||Mr. Sato, Masayoshi: No conflict of intereset||Mr. Kazuyuki, Fujii: No conflict of intereset||Mr. Shibuya, Isao: No conflict of intereset||Mr. Oka, Daisuke: No conflict of intereset||Mr. Yamaya, Naomitsu: No conflict of intereset||Mr. Inagaki, Katsuya: No conflict of intereset

P032

Dr. Vieujean, Sophie: No conflict of intereset||Dr. Hu, Shurong: No conflict of intereset||Dr. Bequet, Emeline: No conflict of intereset||Ms. Salee, Catherine: No conflict of intereset||Mrs. Massot, Charlotte: No conflict of intereset||Dr. Bletard, Noëlla: No conflict of intereset||Mr. Pierre, Nicolas: No conflict of intereset||Ms. Quesada calvo, Florence: No conflict of intereset||Ms. Baiwir, Dominique: No conflict of intereset||Mr. Mazzucchelli, Gabriel: No conflict of intereset||Prof. De Pauw, Edwin: No conflict of intereset||Prof. Dr. Delvenne, Philippe: No conflict of intereset||Ms. Meuwis, Marie-Alice: No conflict of intereset||Prof. Dr. Louis, Edouard: No conflict of intereset

P033

Mr. MANZINI, Roberto: No conflict of intereset||Atrott, Kirstin: No conflict of intereset||Ms. Schwarzfischer, Marlene: No conflict of intereset||Laimbacher, Andrea: No conflict of intereset||Mrs. Lang, Silvia: No conflict of intereset||Prof. Dr. Rogler, Gerhard: No conflict of intereset||Prof. Dr. Scharl, Michael: No conflict of intereset||Dr. Spalinger, Marianne Rebecca: No conflict of intereset

P034

Dr. Taylor Meadows, Kristen: No conflict of intereset||Dr. Kennedy, Michael:|:|Employment, Gossamer Bio Inc.||Mr. Naiman, Zachary:|:|Employment, Gossamer Bio, Inc.||Dr. Sergeeva, Masha:|:|Employment, Gossamer Bio, Inc.||Ms. Paulson, Bryanna:|:|Employment, Gossamer Bio, Inc.||Dr. Opiteck, Gregory:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Slee, Debbie:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Carter, Laura:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Salter-Cid, Luisa:|:|Employment and stock, Gossamer Bio, Inc.

Page 34 of 135

P035

Dr. KIYOHARA, Hiroki:|:|Mitsubishi Tanabe Pharma||Dr. Toyonaga, Takahiko: No conflict of intereset||Mr. Kuronuma, Satoshi: No conflict of intereset||Dr. Ueno, Aito: No conflict of intereset||Dr. Okabayashi, Shinji: No conflict of intereset||Dr. Ozaki, Ryo: No conflict of intereset||Dr. Takeuchi, Osamu: No conflict of intereset||Dr. Coulthard, Sally A.: No conflict of intereset||Dr. Redfern, Christopher P. F.: No conflict of intereset||Dr. Terai, Hideki: No conflict of intereset||Dr. Tanaka, Yoichi: No conflict of intereset||Dr. Nakano, Masaru: No conflict of intereset||Prof. Dr. Hibi, Toshifumi:|:|Lecture fees from Aspen Japan K.K, Abbvie GK, Ferring, Gilead Sciences, Janssen, JIMRO, Kissei Pharmaceutical, Mitsubishi-Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda Pharmaceutical, Zeria Pharmaceutical.|Advisory/consultancy fees from Abbvie GK, Bristol-Myers, Squibb, Celltrion, EA Pharma, Eli Lilly, Gilead Sciences, Janssen, Kyorin, Mitsubishi-Tanabe Pharma, Nichi-Iko Pharmaceutical, Pfizer, Takeda Pharmaceutical, Zeria Pharmaceutical.|Research grants from Abbvie GK, EA Pharma, JIMRO, Otuska Holdings, and Zeria Pharmaceuticals.||Dr. Kobayashi, Taku:|:|Personal fees from Alfresa Pharma, Covidien, Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda Pharmaceutical, Thermo Scientific, Abbvie GK, Ajinomoto Pharma, Asahi Kasei Medical, Astellas, Celltrion, EA Pharma Co.,Ltd, Mitsubishi-Tanabe Pharma, ZERIA, Eisai Co.,Ltd, Gilead Sciences and JIMRO Co.,Ltd.||Grants from Abbvie GK, EA Pharma Co.,Ltd, Otsuka Holdings Co.,Ltd, ZERIA, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, Thermo Fisher Scientific, Alfresa Pharma, Nippon Kayaku and Asahi Kasei medical.

P036

Dr. Churchhouse, Antonia MD: No conflict of intereset||Ms. Billard, Caroline V: No conflict of intereset||Prof. Dr. Arends, Mark J: No conflict of intereset||Dr. Myant, Kevin B: No conflict of intereset

P037

Dr. CAMPBELL, James:|:|Full time employee and shareholder of ChemoCentryx, Inc.||Ms. Ertl, Linda:|:|Full time employee and shareholder of ChemoCentryx, Inc||Ms. Ebsworth, Karen:|:|Full time employee and shareholder of ChemoCentryx, Inc.||Dr. McMahon, Jeffrey:|:|Full time employee and shareholder of ChemoCentryx, Inc.||Dr. Zhang, Penglie:|:|Full time employee and shareholder of ChemoCentryx, Inc.||Ms. Chhina, Vicky:|:|Full time employee and shareholder of ChemoCentryx, Inc.||Dr. Charo, Israel:|:|Consultant and shareholder of ChemoCentryx, Inc.||Dr. Schall, Thomas:|:|CEO and Chairman of the Board for ChemoCentryx, Inc.

P038

Mrs. GARRIDO TRIGO, Alba: No conflict of intereset||Ms. Corraliza, Ana M: No conflict of intereset||Ms. Veny, Marisol: No conflict of intereset||Mr. Lozano, Juanjo: No conflict of intereset||Dr. Ricart, Elena: No conflict of intereset||Dr. Ordás, Ingrid: No conflict of intereset||Ms. Masamunt, Maria Carme: No conflict of intereset||Dr. Panés, Julian: No conflict of intereset||Mr. Hemberg, Martin: No conflict of intereset||Ms. Salas, Azucena: No conflict of intereset

P039 Mrs. TRISTAN, Eva: No conflict of intereset

P040

Dr. Chaparro, Maria:|:| M Chaparro has served as a speaker, or has received research or education funding from MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma.||Dr. Azkargorta, Mikel: No conflict of intereset||Dr. Lapitz, Ainhoa: No conflict of intereset||Dr. Ortega-Moreno, Lorena: No conflict of intereset||Iloro, Ibon: No conflict of intereset||Dr. Arbelaiz, Ander: No conflict of intereset||Dr. Escobes, Iraide: No conflict of intereset||Dr. Fernández-Tomé, Samuel: No conflict of intereset||Mrs. Marin, Alicia C: No conflict of intereset||Dr. Baldan-Martin, Montserrat: No conflict of intereset||Dr. Falcon-Perez, Juan M: No conflict of intereset||Prof. Bujanda, Luis: No conflict of intereset||Dr. Bernardo, David: No conflict of intereset||Dr. Banales, Jesús: No conflict of intereset||Dr. Elortza, Félix: No conflict of intereset||Prof. Gisbert, Javier P:|:|JP Gisbert has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Hospira, Pfizer, Kern Pharma, Biogen, Takeda, Janssen, Roche, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, Vifor Pharma.

P041Prof. Dr. Park, Young Sook: No conflict of intereset||Prof. KIm, Seung Won: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset

P042

Prof. Spinelli, Antonino:|:|Takeda and Pfizer as consultant/speaker||Ms. Lönnfors, Sanna: No conflict of intereset||Ms. Avedano, Luisa: No conflict of intereset||Dr. Bojic, Daniela: No conflict of intereset

P043

Ms. Rodríguez Sillke, Yasmina: No conflict of intereset||Dr. Schumann, Michael: No conflict of intereset||Dr. Lissner, Donata: No conflict of intereset||Dr. Branchi, Federica: No conflict of intereset||Dr. Glauben, Rainer: No conflict of intereset||Prof. Dr. Siegmund, Britta: No conflict of intereset

P044

Dr. GOLAN-GERSTL, Regina: No conflict of intereset||Dr. Koroukhov, Nikolay: No conflict of intereset||Mrs. Elbaum Shiff, Yaffa: No conflict of intereset||Mr. Shilo, Itamar: No conflict of intereset||Prof. Reif, Shimon: No conflict of intereset

Page 35 of 135

P045

Dr. Ortega Moreno, Lorena: No conflict of intereset||Dr. Fernández Tomé, Samuel: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Mrs. Marin, Alicia: No conflict of intereset||Ms. Mora Gutiérrez, Irene: No conflict of intereset||Dr. Santander, Cecilio: No conflict of intereset||Dr. Baldán, Montserrat: No conflict of intereset||Dr. Gisbert, Javier: No conflict of intereset||Dr. Bernardo, David: No conflict of intereset

P046

Mrs. Gisbert-Ferrandiz, Laura: No conflict of intereset||Dr. Cosín-Roger, Jesús: No conflict of intereset||Mrs. Coll, Sandra: No conflict of intereset||Mrs. Bauset, Cristina: No conflict of intereset||Dr. Ortiz-Masiá, Dolores: No conflict of intereset||Dr. Navarro-Vicente, Francisco: No conflict of intereset||Dr. Alos, Rafael: No conflict of intereset||Dr. Calatayud, Sara: No conflict of intereset||Prof. Barrachina, Maria Dolores: No conflict of intereset

P047

Dr. Domislović, Viktor: No conflict of intereset||Mortensen, Joachim Høg: No conflict of intereset||Karsdal, Morten Asser: No conflict of intereset||Dr. Brinar, Marko: No conflict of intereset||Manon-Jensen, Tina: No conflict of intereset||Prof. Krznarić, Željko: No conflict of intereset

P048

GHIBOUB, Mohammed: No conflict of intereset||Dr. de Bruyn, Jessica: No conflict of intereset||Prof. Reedquist, Kris: No conflict of intereset||Prof. Radstake, Timothy: No conflict of intereset||Wichers, Catharina: No conflict of intereset||Wildenberg, Manon: No conflict of intereset||Dr. Broen, Jasper: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Prof. de Jonge, Wouter: No conflict of intereset

P049

Prof. Dr. Thorlacius, Henrik: No conflict of intereset||Dr. Bjoerk, Anders: No conflict of intereset||Mr. Nordle, Örjan: No conflict of intereset||Dr. Hedlund, Gunnar: No conflict of intereset

P050

Mr. LOGAN, Michael: No conflict of intereset||Mr. Gkikas, Konstantinos: No conflict of intereset||Dr. Svolos, Vaios: No conflict of intereset||Dr. Nichols, Ben: No conflict of intereset||Prof. Milling, Simon:|:|SM has participated in medical board meetings with Pfizer||Dr. Ijaz, Umer: No conflict of intereset||Dr. Hansen, Richard:|:|RH had received speakers/consultancy fees or conference support from Nutricia, Dr Falk, MSD Immunology and 4D Pharma||Prof. Russell, Richard K:|:|RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson, Nutricia & 4D Pharma||Dr. Gerasimidis, Konstantinos:|:|K Gerasimidis received research grants, speakers fees and had conference attendance paid by Nutricia, Nestle and Dr Falk

P051

Dr. Tavares de Sousa, Helena: No conflict of intereset||Prof. Dr. Gullo, Irene: No conflict of intereset||Dr. Castelli, Claudia: No conflict of intereset||Prof. Dr. Dias, Cláudia Camila: No conflict of intereset||Prof. Dr. Magro, Fernando: No conflict of intereset

P052

Dr. Notararigo, Sara: No conflict of intereset||Dr. Martin-Pastor, Manuel: No conflict of intereset||Dr. Dominguez Munoz, J. Enrique: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P053

Ms. Coquant, Garance: No conflict of intereset||Ms. Aguanno, Doriane: No conflict of intereset||Dr. Peyrottes, Agathe: No conflict of intereset||Mr. Brot, Loic: No conflict of intereset||Prof. Thenet , Sophie: No conflict of intereset||Dr. Grill, Jean-Pierre: No conflict of intereset||Dr. De Sordi, Luisa: No conflict of intereset||Prof. Dr. Seksik, Philippe: No conflict of intereset

P054

Mr. GEORGOPOULOS, Ioannis: No conflict of intereset||Ms. Mavrigiannaki, Eleftheria: No conflict of intereset||Ms. Stasinopoulou, Sotiria: No conflict of intereset||Mr. Renieris, Georgios: No conflict of intereset||Dr. NIkolakis, Georgios: No conflict of intereset||Prof. Kollias, Georgios: No conflict of intereset||Prof. Dr. Tiniakos, Dina: No conflict of intereset||Prof. Papaconstantinou, Ioannis: No conflict of intereset

P055

Ms. GARNEVI FÁVERO, Aline: No conflict of intereset||Ms. Cordeiro , Tainá Sabater: No conflict of intereset||Ms. Silva, Karina Nascimento: No conflict of intereset||Mr. Cardili, Leonardo: No conflict of intereset||Prof. Dr. Silva, Marcelo José Dias: No conflict of intereset||Prof. Dr. Paiotti, Ana Paula Ribeiro: No conflict of intereset

P056

Ms. DA SILVA, Karina Nascimento: No conflict of intereset||Ms. Cordeiro, Taina Sabater: No conflict of intereset||Ms. Fávero, Aline Garnevi: No conflict of intereset||Prof. Dr. Bogsan, Cristina Stewart: No conflict of intereset||Prof. Dr. Sinigaglia, Rita de Cássia: No conflict of intereset||Prof. Dr. Miszputen, Sender Jankiel: No conflict of intereset||Prof. Dr. Ambrogini-Júnior, Orlando: No conflict of intereset||Prof. Dr. Paiotti, Ana Paula Ribeiro: No conflict of intereset

P057

Filidou, Eirini: No conflict of intereset||Ms. Tarapatzi, Gesthimani: No conflict of intereset||Ms. Boulkou, Marianna: No conflict of intereset||Dr. Arvanitidis, Konstantinos: No conflict of intereset||Prof. Dr. Vradelis, Stergios: No conflict of intereset||Dr. Valatas, Vasilis: No conflict of intereset||Prof. Dr. Bamias, Georgios: No conflict of intereset||Prof. Dr. Kolios, George: No conflict of intereset||Prof. Dr. Koutroubakis, Ioannis: No conflict of intereset||Dr. Drygiannakis, Ioannis: No conflict of intereset

Page 36 of 135

P058

Dr. Czuber-Dochan, Wladyslawa: No conflict of intereset||Ms. Homer, Rebecca: No conflict of intereset||Prof. Dr. Brookes, Matthew: No conflict of intereset||Dr. Selinger, Christian: No conflict of intereset||Dr. Purewal, Satvinder: No conflict of intereset||Dr. Chapman, Sarah: No conflict of intereset||Dr. Steed, Helen: No conflict of intereset

P059

Ms. Treveil, Agatha: No conflict of intereset||Mr. Pavlidis, Polychronis: No conflict of intereset||Ms. Tsakmaki, Anastasia: No conflict of intereset||Mr. Bewick, Gavin: No conflict of intereset||Mr. Korcsmaros, Tamas: No conflict of intereset||Mr. Powell, Nick: No conflict of intereset

P060

Ms. Letizia, Marilena: No conflict of intereset||Mrs. Yerinde, Cansu: No conflict of intereset||Ms. Sand, Annedret: No conflict of intereset||Dr. Schlickeiser, Stephan: No conflict of intereset||Mrs. Kaufmann , Ulrike: No conflict of intereset||Prof. Dr. Siegmund, Britta: No conflict of intereset||Prof. Dr. Feske, Stefan: No conflict of intereset||Dr. Weidinger, Carl: No conflict of intereset

P061

Bislenghi, Gabriele: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.|||Dr. Caenepeel, Clara: No conflict of intereset||Dr. Verstockt, Sare: No conflict of intereset||Prof. Dr. Wolthuis, Albert: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Dr. D'Hoore, André:|:|Research grant: Johnson & Johnson|Consultancy: Takeda|Speaker’s fee: Duomed, Janssen, Johnson & Johnson, Lifebond, Olympus, Takeda|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

P062

Mrs. Becker, Emily: No conflict of intereset||Mr. Wiendl, Maximilian: No conflict of intereset||Mrs. Schulz-Kuhnt, Anja: No conflict of intereset||Dr. Atreya, Imke: No conflict of intereset||Prof. Dr. Atreya, Raja: No conflict of intereset||Prof. Dr. Neurath, Markus:|:|Research funding from Takeda, Roche and Shire||Dr. Zundler, Sebastian:|:|Research funding from Takeda, Roche and Shire

P063

Dr. Nagaishi, Takashi: No conflict of intereset||Dr. Tsugawa, Naoya: No conflict of intereset||Dr. Yamada, Daiki: No conflict of intereset||Dr. Watabe, Taro: No conflict of intereset||Dr. Onizawa, Michio: No conflict of intereset||Prof. Dr. Watanabe, Mamoru: No conflict of intereset

P064Dr. Wu, Xian-rui: No conflict of intereset||Dr. Lan, Ping: No conflict of intereset||Dr. Wu, Xiao-jian: No conflict of intereset||Dr. Gao, Xiang: No conflict of intereset

P065

Dr. Viladomiu, Monica: No conflict of intereset||Metz, Maeva: No conflict of intereset||Dr. Lima, Svetlana: No conflict of intereset||Dr. Guo, Chun-jun: No conflict of intereset||Dr. Simpson, Kenneth: No conflict of intereset||Dr. Scherl, Ellen: No conflict of intereset||Dr. LONGMAN, Randy: No conflict of intereset

P066

Dr. Borycka-Kiciak, Katarzyna: No conflict of intereset||Dr. Pietrzak, Anna: No conflict of intereset||Ferenc, Karolina: No conflict of intereset||Pietrzak, Piotr: No conflict of intereset||Janaszek, Lukasz: No conflict of intereset||Prof. Tarnowski, Wieslaw: No conflict of intereset||Prof. Zabielski, Romuald: No conflict of intereset

Page 37 of 135

P067

Dr. Dragoni, Gabriele:|:|Gabriele Dragoni has received travel grants from AbbVie, Pfizer and Takeda.||Mr. Creyns, Brecht: No conflict of intereset||Prof. Dr. De Hertogh, Gert:|:|Gert De Hertogh received consulting fees from Glaxo Smith Kline, Shire Pharmaceuticals, Teva Pharma, Galapagos, Genentech, Novartis Pharma, Fast Forward Pharmaceuticals, Takeda and Janssen R&D.||Dr. Verstockt, Bram:|:|Bram Verstockt received research grant from Pfizer, consultancy fees from Janssen and Sandoz, and Speaker’s fee from Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda.||Mr. Wollants, Willem-Jan: No conflict of intereset||Mr. Ke, Bo-Jun: No conflict of intereset||Dr. Marcellis, Lukas: No conflict of intereset||Prof. Matteoli, Gianluca: No conflict of intereset||Prof. Dr. D'Hoore, André:|:|André D'Hoore received research grant from Johnson & Johnson, consultancy from Takeda and speaker’s fee from Duomed, Janssen, Johnson & Johnson, Lifebond, Olympus and Takeda.||Prof. Dr. Galli, Andrea: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Marc Ferrante received research grant from Amgen, Biogen, Janssen, Pfizer, Takeda; Consultancy from Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda and Speaker’s fee from Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda.||Prof. Dr. Vermeire, Séverine:|:|Séverine Vermeire received research grant from MSD, Abbvie, Takeda, Janssen, Pfizer; Consultancy from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen and Speaker’s fee from AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots.

P068

Semikina, Elena: No conflict of intereset||Potapov, Alexander: No conflict of intereset||Ms. Tsvetkova, Valeriya: No conflict of intereset||Mr. Anoushenko, Anton: No conflict of intereset||Dr. Akulova, Svetlana: No conflict of intereset

P069

Dr. Wu, Xianrui: No conflict of intereset||Dr. LIU, Xuanhui: No conflict of intereset||Dr. Lan, Nan: No conflict of intereset||Dr. Zheng, Xiaobin: No conflict of intereset||Dr. Chen, Yufeng: No conflict of intereset||Dr. Cai, Zerong: No conflict of intereset||Prof. Lan, Ping: No conflict of intereset||Prof. Wu, Xiaojian: No conflict of intereset

P070

Mr. Madgwick, Matthew:|:|M Madgwick's PhD studentship is funded but the UKRI-BBSRC and BenevolentAI.||Dr. Sudhakar, Padhmanand: No conflict of intereset||Ms. Tabib, Nasim Seyed: No conflict of intereset||Dr. Norvaisas, Povilas:|:|P Norvaisas an employee of BenevolentAI||Dr. Creed, Paidi:|:|P Creed is an employee of BenevolentAI||Dr. Verstockt, Bram:|:|B Verstockt received financial support for research from Pfizer; lecture fees from Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda; consultancy fees from Janssen.||Dr. Vermeire, Séverine:|:|S Vermeire received financial support for research from MSD, Abbvie, Janssen, Takeda and Pfizer; lecture fees from Abbott, Abbvie, Merck Sharpe & Dohme, Ferring|Pharmaceuticals, Pfizer, Takeda, Galapagos/Gilead and UCB Pharma; consultancy fees from Pfizer, Ferring Pharmaceuticals, Shire Pharmaceuticals Group, Merck Sharpe & Dohme, Abbvie, Takeda, Prodigest, Celgene, Galapagos, Gilead, Arena Pharmaceuticals,|Genentech/Roche, Abivax, and AstraZeneca Pharmaceuticals||Dr. Korcsmáros, Tamás:|:|The work in T Korcsmáros' lab is partially supported by BenevolentAI and Unilever.

P071

Ms. Poletti, Martina: No conflict of intereset||Dr. Hautefort, Isabelle: No conflict of intereset||Ms. Treveil, Agatha: No conflict of intereset||Ms. Demeter, Amanda: No conflict of intereset||Ms. Rodriguez, Elena: No conflict of intereset||Dr. Brion, Arlaine: No conflict of intereset||Dr. Goldson, Andrew: No conflict of intereset||Dr. Divekar, Devina: No conflict of intereset||Dr. Schofield, Zoe: No conflict of intereset||Dr. O’Neill, Ian: No conflict of intereset||Dr. Lister, Ashleigh: No conflict of intereset||Lipscombe, James: No conflict of intereset||Prof. Watson, Alastair: No conflict of intereset||Dr. Macaulay, Iain: No conflict of intereset||Prof. Dr. Hall, Lindsay:|:|The work of the Hall group is supported by the Wellcome Trust.||Dr. Korcsmaros, Tamas:|:|The Korcsmaros group is receiving project-based funding from BenevolentAI and Unilever.

Page 38 of 135

P072

P073

Dr. Carrasco Garcia, Anna: No conflict of intereset||Dr. Rao, Anna: No conflict of intereset||Ms. Kokkinou, Efthymia: No conflict of intereset||Dr. Haapaniemi, Staffan: No conflict of intereset||Dr. Lindforss, Ulrik: No conflict of intereset||Mr. Winberg, Martin E: No conflict of intereset||Ms. Casado-Bedmar, Maite: No conflict of intereset||Dr. Fenton, Thomas: No conflict of intereset||Mr. Jørgensen, Peter: No conflict of intereset||Dr. Nordenvall, Caroline: No conflict of intereset||Dr. Agace, William: No conflict of intereset||Dr. Keita, Åsa V: No conflict of intereset||Dr. Söderholm, Johan D: No conflict of intereset||Dr. Mjösberg, Jenny: No conflict of intereset

P074

Dr. Martin Cardona, Albert: No conflict of intereset||Dr. Carrasco García, Anna: No conflict of intereset||Dr. Tristán Lopez, Eva: No conflict of intereset||Dr. Zabana Abdo, Yamile: No conflict of intereset||Dr. Aceituno Quintanilla, Montse: No conflict of intereset||Dr. Ferrer Cassadó, Carme: No conflict of intereset||Dr. Horta Sangenis, Diana: No conflict of intereset||Dr. Ruiz-Campos, Laura: No conflict of intereset||Dr. Loras Alastruey, Carme: No conflict of intereset||Dr. Andujar Murcia, Xavi: No conflict of intereset||Dr. Benítez Leiva, Olga: No conflict of intereset||Dr. Fernández-Bañares, Fernando: No conflict of intereset||Dr. Esteve Comas, Maria: No conflict of intereset

P075

O'Connell, Lauren: No conflict of intereset||Olli, Kristine: No conflict of intereset||Rapp, Caroline: No conflict of intereset||Collins, Colm: No conflict of intereset||McNamee, Eoin: No conflict of intereset||Jensen, Owen: No conflict of intereset||Jedlicka, Paul: No conflict of intereset||Allison, Kristen: No conflict of intereset||Goldberg, Matthew: No conflict of intereset||Gerich, Mark: No conflict of intereset||Evans, Christopher: No conflict of intereset||Dr. AHERNE, Carol: No conflict of intereset

P076

Dr. Franzin, Martina: No conflict of intereset||Dr. Lucafò, Marianna: No conflict of intereset||Prof. Dr. Lagatolla, Cristina: No conflict of intereset||Prof. Dr. Stocco, Gabriele: No conflict of intereset||Prof. Dr. Decorti, Giuliana: No conflict of intereset

Mrs. Démaris, Alix: No conflict of intereset||Ms. Grišić, Ana-Marija: No conflict of intereset||Prof. Dr. Huisinga, Wilhelm:|:|Prof.Dr. Wilhelm Huisinga reports research grants from an industry consortium (AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Grünenthal GmbH, F. Hoffmann-La Roche Ltd., Merck KGaA and Sanofi) for the PharMetrX PhD program.||Prof. Dr. Walter, Reinisch:|:|Walter Reinisch has served |- as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult, |- as a consultant for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, Elan, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, Mallinckrodt, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Robarts Clinical Trial, Schering-Plough, Second Genome, Setpointmedical, Sigmoid, Takeda, Therakos, Tigenix, UCB, Vifor, Zyngenia, and 4SC, |- as an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zyngenia, and 4SC, and |- has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, MSD||Prof. Dr. Kloft, Charlotte:|:|Prof. Dr. Charlotte Kloft reports research grants from an industry consortium (AbbVie Deutschland GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Grünenthal GmbH, F. Hoffmann-La Roche Ltd., Merck KGaA and Sanofi) for the PharMetrX program, the Innovative Medicines Initiative–Joint Undertaking (‘DDMoRe’) and Diurnal Ltd.

Page 39 of 135

P077

Dr. Adegbola, Samuel: No conflict of intereset||Dr. Sarafian, Magali: No conflict of intereset||Dr. Sahnan, Kapil: No conflict of intereset||Dr. Tozer, Phil: No conflict of intereset||Dr. Ding, Nik: No conflict of intereset||Prof. Faiz, Omar: No conflict of intereset||Mr. Warusavitarne, Janindra: No conflict of intereset||Prof. Phillips, Robin: No conflict of intereset||Prof. Dr. Holmes, Elaine: No conflict of intereset||Prof. Dr. Hart, Ailsa: No conflict of intereset

P078

Prof. Dr. Tarasova, Galina: No conflict of intereset||Dr. Volkov, Alexander: No conflict of intereset||Prof. Dr. Iakovlev, Aleksei: No conflict of intereset||Dr. Ghazudin, Tadzudin: No conflict of intereset||Dr. Shcherbakova, Inna: No conflict of intereset

P079

Ms. Ouboter, Laura: No conflict of intereset||Ms. Barnhoorn, Marieke C.: No conflict of intereset||Dr. Hawinkels, Luuk J.A.C.: No conflict of intereset||Dr. van Pel , Melissa: No conflict of intereset||Prof. Dr. Zwaginga, Jaap Jan: No conflict of intereset||Prof. Dr. Verspaget, Hein W.: No conflict of intereset||Prof. Dr. Koning, Frits: No conflict of intereset||Dr. Pascutti, M. Fernanda: No conflict of intereset||Dr. van der Meulen - de Jong, Andrea E.: No conflict of intereset

P080

Wu, Xian-rui: No conflict of intereset||ZHOU, Chi: No conflict of intereset||Liu, Hua-shan: No conflict of intereset||Xuan-hui, Liu: No conflict of intereset||Hu, Tuo: No conflict of intereset||Zheng, Xiao-bin: No conflict of intereset||Liang, Zhen-xing: No conflict of intereset||Wu, Xiao-jian: No conflict of intereset||Gao, Xiang: No conflict of intereset||He, Xiao-sheng: No conflict of intereset||Ke, Jia: No conflict of intereset||Chen, Yu-feng: No conflict of intereset||He, Xiao-wen: No conflict of intereset||Hu, Jian-cong: No conflict of intereset||Zou, Yifeng: No conflict of intereset||Lan, Ping: No conflict of intereset

P081

Prof. Dr. Iakovlev, Alexey Alexandrovich: No conflict of intereset||Dr. Volkov, Alexander: No conflict of intereset||Dr. Bashtovaya, Olga: No conflict of intereset||Shcherbakova, Inna: No conflict of intereset||Ghazudin, Tadzudin: No conflict of intereset||Dr. Leonova, Galina: No conflict of intereset||Tarasova, Galina: No conflict of intereset

P082

Mr. Chen, Yiding: No conflict of intereset||Ms. Ma, Chunxiang: No conflict of intereset||Dang, Yuan: No conflict of intereset||Ms. Chen, Kexin: No conflict of intereset||Ms. Shen, Silan: No conflict of intereset||Jiang, Mingshan: No conflict of intereset||Dr. Zeng, Zhen: No conflict of intereset||Prof. Dr. Zhang, Hu: No conflict of intereset

P083

Dr. Gamliel, Adir: No conflict of intereset||Dr. Werner, Lael: No conflict of intereset||Mrs. Salamon, Naomi: No conflict of intereset||Mrs. Pinsker, Marina: No conflict of intereset||Dr. Weiss, Batia: No conflict of intereset||Dr. Shouval, Dror:|:|Research grant - Takeda|Consulting fees - AbbVie

P084

Dr. Sanctuary, Megan: No conflict of intereset||Ms. Wilkinson, Cinthia: No conflict of intereset||Ms. Jones, Ashleigh: No conflict of intereset||Dr. Murphy, Brittany: No conflict of intereset||Dr. Hoffenberg, Edward: No conflict of intereset||Dr. COLLINS, Colm: No conflict of intereset

P085

Horn, Veronika: No conflict of intereset||Ms. Borek, Zuzanna: No conflict of intereset||Ms. Mantzivi, Eleni: No conflict of intereset||Ms. Urbicht, Marie: No conflict of intereset||Ms. Boesel, Diana: No conflict of intereset||Dr. Baumgart, Sabine: No conflict of intereset||Dr. Sonnenberg, Elena: No conflict of intereset||Dr. Lissner, Donata: No conflict of intereset||Prof. Siegmund, Britta: No conflict of intereset||Dr. Mei, Henrik: No conflict of intereset||Prof. Hegazy, Ahmed Nabil: No conflict of intereset

P086

Ms. C. Marin, Alicia: No conflict of intereset||Dr. Fernández-Tomé, Samuel: No conflict of intereset||Dr. Ortega Moreno, Lorena: No conflict of intereset||Dr. Martin Dominguez, Veronica: No conflict of intereset||Dr. Casabona, Sergio: No conflict of intereset||Dr. Becerro, Irene: No conflict of intereset||Ms. Mora-Gutiérrez, Irene: No conflict of intereset||Mr. Villacañas-Gil, Ignacio: No conflict of intereset||Dr. Baldan-Martin, Montserrat: No conflict of intereset||Dr. Moreno-Monteagudo, Jose Andres: No conflict of intereset||Dr. Santander, Cecilio: No conflict of intereset||Dr. Chaparro, Maria: No conflict of intereset||Dr. Bernardo, David: No conflict of intereset||Dr. P. Gisbert, Javier: No conflict of intereset

P087

Mr. PEHRSSON, Martin:|:|Full-time employee||Dr. Domislović, Viktor: No conflict of intereset||Prof. Karsdal, Morten Asser:|:|Full-time employee, Shareholder||Prof. Brinar, Marko: No conflict of intereset||Dr. Barisic, Ana: No conflict of intereset||Prof. Krznaric, Zeljko: No conflict of intereset||Dr. Manon-Jensen, Tina:|:|Full-time employee, Shareholder||Dr. Mortensen, Joachim Høg:|:|Full time employee

P088

Dr. Jun, Yu Kyung: No conflict of intereset||Prof. Koh, Seong-Joon: No conflict of intereset||Prof. Gang, Hyun Woo: No conflict of intereset||Mr. Chung, Kee-Young: No conflict of intereset||Prof. Han, Ji Min: No conflict of intereset||Prof. Kim, Ji Won: No conflict of intereset||Prof. Kim, Byeong Gwan: No conflict of intereset||Prof. Lee, Kook Lae: No conflict of intereset||Prof. Im, Jong Pill: No conflict of intereset||Prof. Kim, Joo Sung: No conflict of intereset

Page 40 of 135

P089

Dr. Notararigo, Sara: No conflict of intereset||Dr. Viñuela Roldán, Juan Evaristo: No conflict of intereset||Dr. Quiroga, Adriano: No conflict of intereset||Prof. Dr. Dominguez-Munoz, J. Enrique: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P090

Dr. Choe, A Reum: No conflict of intereset||Dr. Kim, Seong-Eun: No conflict of intereset||Dr. Lee, Hyun Ae: No conflict of intereset||Dr. Yoo, Seul Gi: No conflict of intereset||Dr. Kim, Tae Oh: No conflict of intereset||Dr. Tae, Chung Hyun: No conflict of intereset||Dr. Moon, Chang Mo: No conflict of intereset||Dr. Jung, Hye-Kyung: No conflict of intereset||Dr. Shim, Ki-Nam: No conflict of intereset||Dr. Jung, Sung-Ae: No conflict of intereset

P091

Mr. Gkikas, Konstantinos:|:|Studentship funded in partnership from the University of Glasgow and Nestle Health Science.||Mr. Logan, Michael:|:|Studentship funded by the EPSRC.||Dr. Nichols, Ben: No conflict of intereset||Ms. Clark , Clare M.:|:|Studentship funded from Glasgow Children's Hospital Charity.||Dr. Ijaz , Umer Z.:|:|Dr Ijaz is funded by NERC Independent Research Fellowship NE/L011956/1.||Ms. Gervais, Lisa: No conflict of intereset||Ms. Duncan, Hazel: No conflict of intereset||Mrs. Garrick, Vikki: No conflict of intereset||Ms. Curtis, Lee: No conflict of intereset||Ms. Buchanan, Elaine: No conflict of intereset||Mrs. Cardigan, Tracey: No conflict of intereset||Dr. Armstrong, Lawrence: No conflict of intereset||Dr. Delahunty, Caroline: No conflict of intereset||Dr. Flynn, Diana M.: No conflict of intereset||Dr. Barclay, Andrew R.: No conflict of intereset||Dr. Tayler, Rachel: No conflict of intereset||Dr. Hansen, Richard:|:|RH has received speakers/consultancy fees or conference support from Nutricia, Dr Falk, MSD Immunology and 4D Pharma.||Prof. Russell, Richard K.:|:|RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson, Nutricia & 4D Pharma. ||Dr. Gerasimidis, Konstantinos:|:|K Gerasimidis has received research grants, speakers fees and had conference attendance paid by Nutricia, Nestle and Dr Falk

P092

Dr. Uzzan, Mathieu: No conflict of intereset||Dr. Martin, Jerome: No conflict of intereset||Dr. Keningsberg, Effi: No conflict of intereset||Dr. Castro-Dopico, Tomas: No conflict of intereset||Dr. Huang, Ruiqi: No conflict of intereset||Dr. Ungaro, Ryan: No conflict of intereset||Dr. Cohen, Benjamin: No conflict of intereset||Dr. Rahman, Adeeb: No conflict of intereset||Dr. Rosenstein, Adam: No conflict of intereset||Dr. Gurunathan, Sakteesh: No conflict of intereset||Dr. Dubinsky, Marla: No conflict of intereset||Dr. Clatworthy, Menna: No conflict of intereset||Dr. Suarez-Farinas, Mayte: No conflict of intereset||Dr. Argmann, Carmen: No conflict of intereset||Dr. Colombel, Jean-Frederic: No conflict of intereset||Dr. Mehandru, Saurabh: No conflict of intereset

P093

Ms. CERANTOLA, Silvia: No conflict of intereset||Ms. Ridolfi, Manuela: No conflict of intereset||Ms. Faggin, Sofia: No conflict of intereset||Ms. Tegon, Martina: No conflict of intereset||Ms. Bussolaro, Gloria: No conflict of intereset||Ms. Salviato, Eleonora: No conflict of intereset||Ms. Bistoletti, Michela: No conflict of intereset||Dr. Caputi, Valentina: No conflict of intereset||Prof. Dr. Giaroni, Cristina: No conflict of intereset||Prof. Dr. Giron, Maria Cecilia: No conflict of intereset

P094

Mrs. Bakke, Ingunn: No conflict of intereset||Mrs. Bruland, Torunn: No conflict of intereset||Ms. Eriksen, Kaja Sørgård: No conflict of intereset||Mrs. Skovdahl, Helene Kolstad: No conflict of intereset||Ms. Gopalakrishnan, Shreya: No conflict of intereset||Mrs. Thorsvik, Silje: No conflict of intereset||Mr. Granlund, Atle van Beelen: No conflict of intereset||Prof. Dr. Sandvik, Arne Kristian: No conflict of intereset||Dr. Østvik, Ann Elisabeth: No conflict of intereset

P095

Dr. Roosenboom, Britt: No conflict of intereset||Dr. Horjus Talabur Horje, Carmen: No conflict of intereset||Dr. Smids, Carolijn: No conflict of intereset||Dr. Leeuwis, Jan Willem: No conflict of intereset||Ms. Van Koolwijk, Elly: No conflict of intereset||Dr. Groenen, Marcel: No conflict of intereset||Dr. Wahab, Peter: No conflict of intereset||Dr. Van Lochem, Ellen: No conflict of intereset

P096

Dr. Moret, Ines: No conflict of intereset||Dr. Cerrillo, Elena: No conflict of intereset||Mr. Saez-Gonzalez, Esteban: No conflict of intereset||Dr. Hervas, David: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Mr. Tortosa, Luis: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. Gadea, José: No conflict of intereset||Beltran Niclos, Ana Belen: No conflict of intereset

P097

Prof. Dr. Hong, Sung Noh: No conflict of intereset||Dr. Song, Joo Hye: No conflict of intereset||Dr. Seong, Gyeol: No conflict of intereset||Dr. Kong, Sung Min: No conflict of intereset||Dr. Shin, Jong Beom: No conflict of intereset||Prof. Dr. Eun Ran, Kim: No conflict of intereset||Prof. Dr. Dong Kyung, Chang: No conflict of intereset||Prof. Dr. Young-Ho, Kim: No conflict of intereset

P098

Dr. Gobbetti, Thomas: No conflict of intereset||Kathryn, Fountain: No conflict of intereset||Dr. Beal, Allison: No conflict of intereset||Dr. Rowles, Alison: No conflict of intereset||Dr. Pearse, Gail: No conflict of intereset||Harada, Isobel: No conflict of intereset||Dr. Bertin, John: No conflict of intereset||Dr. Haynes, Andrea: No conflict of intereset||Dr. Berger, Scott: No conflict of intereset

Page 41 of 135

P099

Mr. Walaas, Gunnar A: No conflict of intereset||Mrs. Bakke, Ingunn: No conflict of intereset||Mr. Granlund, Atle vB: No conflict of intereset||Ms. Escuderos-Hernândez, Celia:|:|Received financial support from Ferring Pharmaceuticals ||Mrs. Bruland, Torunn: No conflict of intereset||Mrs. Røyset, Elin S.: No conflict of intereset||Dr. Thorsvik, Silje: No conflict of intereset||Mr. Münch, Andreas:|:|Received financial support from Ferring Pharmaceuticals (Switzerland). |Received salary for consultancies from Tillotts, Ferring, Vifor and Dr Falk Pharma, and speaker’s honoraria from Tillotts and Vifor.||Dr. Østvik, Ann E:|:|Received grant from Tillotts||Prof. Dr. Sandvik, Arne K: No conflict of intereset

P100 Mrs. TRISTAN, Eva: No conflict of intereset

P101

Mr. PEHRSSON, Martin: No conflict of intereset||Dr. Domislović, Viktor: No conflict of intereset||Prof. Karsdal, Morten Asser:|:|Full-time employee, and shareholder||Prof. Brinar, Marko: No conflict of intereset||Dr. Barisic, Ana: No conflict of intereset||Prof. Krznaric, Zeljko: No conflict of intereset||Dr. Manon-Jensen, Tina:|:|Full-time employee, and shareholder||Dr. Mortensen, Joachim Høg:|:|Full-time employee

P102

Ms. He, Huan: No conflict of intereset||Dr. Hu, Jun: No conflict of intereset||Dr. Wang, Wei: No conflict of intereset||Prof. Dr. Zhang, Min: No conflict of intereset||Ms. Zheng, Meifen: No conflict of intereset||Ms. Peng, Xiang: No conflict of intereset||Ms. Zhang, Yuanqi: No conflict of intereset||Ms. Zhou, Min: No conflict of intereset||Dr. Liu, Tao: No conflict of intereset||Dr. Zhao, Junzhang: No conflict of intereset||Mr. Zhang, Qi: No conflict of intereset||ZHI, Min: No conflict of intereset

P103

Dr. Song, Eun Mi: No conflict of intereset||Mrs. Joo, Yang Hee: No conflict of intereset||Dr. Lim, Ji Young: No conflict of intereset||Dr. Choe, A Reum: No conflict of intereset||Prof. Tae, Chung Hyun: No conflict of intereset||Prof. Moon, Chang Mo: No conflict of intereset||Prof. Kim, Seong-Eun: No conflict of intereset||Prof. Jung, Hye-Kyung: No conflict of intereset||Prof. Shim, Ki-Nam: No conflict of intereset||Prof. Jung, Sung-Ae: No conflict of intereset

P104

Mrs. Zaiatz Bittencourt, Vanessa: No conflict of intereset||Prof. Dr. Ryan, Elizabeth: No conflict of intereset||Ms. Jones, Fiona: No conflict of intereset||Prof. Dr. Doherty, Glen: No conflict of intereset

P105

Mrs. Kim, Jae Hyeon: No conflict of intereset||Ms. Ahn, Jae Bum: No conflict of intereset||Ms. Kim, Da Hye: No conflict of intereset||Dr. Kim, Soochan: No conflict of intereset||Mr. Ma, Hyun Woo: No conflict of intereset||Ms. Che, Xiumei: No conflict of intereset||Ms. Seo, Dong Hyuk: No conflict of intereset||Prof. Dr. Kim, Tae Il: No conflict of intereset||Prof. Dr. Kim, Won Ho: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset||Dr. Kim, Seung Won: No conflict of intereset

P106

Canaletti, Claudia: No conflict of intereset||Dr. Colombo, Federico: No conflict of intereset||Dr. Dessì, Andrea: No conflict of intereset||Dr. Geccherle, Eleonora: No conflict of intereset||Dr. Tongiorgi, Alessandra: No conflict of intereset||Dr. Cai, Piero: No conflict of intereset||Dr. Giudici, Fabiola: No conflict of intereset||Dr. Mocci, Giammarco: No conflict of intereset||Ms. Onidi, Francesca Maria: No conflict of intereset||Dr. Orlando, Ambrogio: No conflict of intereset||Dr. Mortillaro, Maria Grazia: No conflict of intereset||Dr. Bossa, Federico: No conflict of intereset||Ms. Martino, Giuseppina: No conflict of intereset||Dr. Placentino, Maria: No conflict of intereset||Dr. Guidi, Luisa: No conflict of intereset||Dr. Pugliese, Daniela: No conflict of intereset||Dr. Tiberio, Lorenza: No conflict of intereset||Dr. Costa, Francesco: No conflict of intereset||Dr. Deledda, Giuseppe: No conflict of intereset||Dr. Geccherle, Andrea: No conflict of intereset||Dr. Paolini, Alessandro: No conflict of intereset||Dr. Tonello, Cinzia Francesca: No conflict of intereset||Dr. Pecoraro, Giulia Maria: No conflict of intereset||Dr. Monica, Fabio: No conflict of intereset

P107

Cineus, Roodline: No conflict of intereset||Ms. Boesel, Diana: No conflict of intereset||Ms. Hainbuch, Saskia: No conflict of intereset||Dr. Jukes, Caitlin: No conflict of intereset||Mr. Hsieh, Yu-Hsin: No conflict of intereset||Ms. Reich, Jana: No conflict of intereset||Ms. Borek, Zuzanna: No conflict of intereset||Dr. Kuehl, Anja: No conflict of intereset||Prof. Hegazy, Ahmed Nabil: No conflict of intereset

P108 Mr. OWEN, John: No conflict of intereset||Ms. Baker, Rebecca: No conflict of intereset

P109

Ruiz Castro, Pedro Antonio:|:|All authors are employees of Philip Morris International.||Dr. Yepiskoposyan, Hasmik:|:|All authors are employees of Philip Morris International.||Dr. Szostak, Justyna:|:|All authors are employees of Philip Morris International.||Dr. Talikka , Marja:|:|All authors are employees of Philip Morris International.||Dr. Hoeng , Julia:|:|All authors are employees of Philip Morris International

P110

Mr. HUHN, Meik: No conflict of intereset||Mrs. Herrero San Juan, Martina: No conflict of intereset||Dr. Melcher, Balint: No conflict of intereset||Ms. Dreis, Caroline: No conflict of intereset||Ms. Schmidt, Katrin: No conflict of intereset||Prof. Dr. Pfeilschifter, Josef M.: No conflict of intereset||Prof. Dr. Vieth, Michael: No conflict of intereset||Prof. Dr. Stein, Jürgen: No conflict of intereset||Prof. Dr. Radeke, Heinfried H.: No conflict of intereset

Page 42 of 135

P111

Mr. WIESE, Jakob Johann: No conflict of intereset||Mr. Fascì, Alberto: No conflict of intereset||Dr. Kühl, Anja A: No conflict of intereset||Prof. Dr. Siegmund, Britta: No conflict of intereset||Dr. Prüß, Magdalena Sarah: No conflict of intereset||Dr. Schumann, Michael: No conflict of intereset

P112

Prof. Vranesic Bender, Darija: No conflict of intereset||Ms. Cengic, Lea: No conflict of intereset||Mrs. Ljubas Kelecic, Dina: No conflict of intereset||Mrs. Karas, Irena: No conflict of intereset||Mrs. Grbin Hodžić, Altana: No conflict of intereset||Dr. Domislović, Viktor: No conflict of intereset||Prof. Dr. Brinar, Marko: No conflict of intereset||Dr. Juričić, Marina: No conflict of intereset||Prof. Dr. Krznarić, Željko: No conflict of intereset

P113

Dr. Ortega Moreno, Lorena: No conflict of intereset||Dr. Sanz-Garcia, Ancor: No conflict of intereset||Mrs. Fernández de la Fuente, Marina J.: No conflict of intereset||Mr. Arroyo Solera, Ricardo: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Dr. Fernandez-Tome, Samuel: No conflict of intereset||Ms. Marin, Alicia C.: No conflict of intereset||Ms. Mora-Fernandez, Irene: No conflict of intereset||Dr. Fernandez, Paloma: No conflict of intereset||Dr. Baldan-Martin, Montserrat: No conflict of intereset||Dr. Bernardo, David: No conflict of intereset||Dr. P. Gisbert, Javier: No conflict of intereset

P114

Dr. BUSACCA, Anita: No conflict of intereset||Dr. Ingrassia Strano, Giuseppe: No conflict of intereset||Dr. Giuffrida, Enrica: No conflict of intereset||Dr. Guida, Laura: No conflict of intereset||Dr. Scrivo, Barbara: No conflict of intereset||Dr. Carrozza, Lucio: No conflict of intereset||Dr. Calvaruso, Vincenza: No conflict of intereset||Dr. Cappello, Maria: No conflict of intereset

P115

Di Stefano, Serena: No conflict of intereset||Dr. Liefferinckx, Claire:|:|Consultancy fees: Takeda|Speaker fees: Sandoz, Janssen, Abbvie|||Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie|||Amininejad, Leila: No conflict of intereset||Van Gossum, André: No conflict of intereset||Devière, Jacques: No conflict of intereset||Van de Stadt, Jean: No conflict of intereset||Franchimont, Denis:|:| Denis Franchimont received educational grants from Abbvie, Takeda, MSD, and received honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira. ||Buggenhout, Alexis: No conflict of intereset

P116

Ms. Aardoom, Martine: No conflict of intereset||Mr. Kemos, Polychronis: No conflict of intereset||Prof. Ruemmele, Frank M.: No conflict of intereset||Dr. van Ommen, C. Heleen: No conflict of intereset||Prof. Croft, Nick M.: No conflict of intereset||Dr. de Ridder, Lissy: No conflict of intereset

P117

Dr. Mortensen, Joachim: No conflict of intereset||Dr. Lunder, Aida Kapic: No conflict of intereset||Dr. Manon-Jensen, Tina:|:|Full time employee at Nordic Bioscience. Hold stocks in Nordic Bioscience||Prof. Karsdal , Morten Asser:|:|Full time employee at Nordic Bioscience. Hold stocks in Nordic Bioscience. ||Dr. Nielsen, Mette Juul:|:|Full time employee at Nordic Bioscience||Dr. Leeming, Diana Julie:|:|Full time employee at Nordic Bioscience. Hold stocks in Nordic Bioscience||Dr. Hov, Johannes Roksund: No conflict of intereset||Dr. Negård, Anne: No conflict of intereset||Dr. Jahnsen, Jørgen: No conflict of intereset||Prof. Moum, Bjørn: No conflict of intereset||Dr. Vesterhus, Mette: No conflict of intereset||Dr. Høivik, Marte Lie: No conflict of intereset||Dr. Kristensen, Vendel A.: No conflict of intereset

P118

Dr. Uchiyama, Kazuhiko: No conflict of intereset||Dr. Kubota, Mariko: No conflict of intereset||Prof. Azuma, Yuka: No conflict of intereset||Dr. Yasuda, Ritsu: No conflict of intereset||Dr. Shun, Takayama: No conflict of intereset||Dr. Takagi, Tomohisa: No conflict of intereset||Dr. Naito, Yuji: No conflict of intereset||Prof. Yoshito, Itoh: No conflict of intereset

P119

Dr. Thomann, Anne: No conflict of intereset||Dr. Schmitgen, Mike: No conflict of intereset||Ms. Kmuche, Dagny: No conflict of intereset||Dr. Griebe, Martin: No conflict of intereset||Prof. Dr. Ebert, Matthias: No conflict of intereset||Prof. Dr. Wolf, Robert Christian: No conflict of intereset||Dr. Reindl, Wolfgang: No conflict of intereset

Page 43 of 135

P120

Dr. Dulai, Parambir:|:|research support from Takeda, Pfizer, Abbvie, Janssen, Polymedco, ALPCO, Buhlmann, and consulting fees from Takeda, Pfizer, Abbvie and Janssen||Dr. Singh, Siddharth:|:|received research grants from AbbVie, and consulting fees from AbbVie, Takeda, Pfizer, AMAG Pharmaceuticals.||Dr. Jairath, Vipul:|:|received has received consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Arena pharmaceuticals, Genetech, Pendopharm, Sandoz, Merck, Takeda, Janssen, Robarts Clinical Trials, Topivert, Celltrion; speaker’s fees from Takeda, Janssen, Shire, Ferring, Abbvie, Pfizer||Dr. Ma, Christopher:|:|served as a consultant for Robarts Clinical Trials, Inc., advisory board for Janssen, AbbVie, speakers fees from Janssen, Pfizer||Dr. Narula, Neeraj:|:|received honoraria from Janssen, Abbvie, Takeda, Pfizer, Merck, and Ferring. MM has received speaker and consultant fees for Takeda, Abbvie, Janssen, and Pfizer||Vande Casteele, Niels:|:|received research support from R-Biopharm and Takeda and consulting fees from Boehringer Ingelheim, Janssen, Pfizer, Progenity, Prometheus and Takeda||Dr. Peyrin-Biroulet, Laurent:|:|recieved honoraria from AbbVie, Janssen, Genentech, Ferring, from Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals , Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen ; grants from Abbvie, MSD, Takeda ; stock options : CT-SCOUT. ||Dr. Vermeire, Severine:|:|received grant support from AbbVie, MSD, Janssen and Takeda; received speaker fees from AbbVie, MSD, Takeda, Ferring, Dr. Falk Pharma, Hospira, Pfizer Inc and Tillots; and served as a consultant for AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Amgen, Gilead, Mundipharma, Hospira, Celgene, Second Genome, and Janssen||Dr. D’Haens, Geert:|:|served as advisor for Abbvie, Ablynx, Amakem, AM Pharma, Avaxia, Biogen, Bristol Meiers Squibb, Boerhinger Ingelheim, Celgene, Celltrion, Cosmo, Covidien, Ferring, DrFALK Pharma, Engene, Galapagos, Gilead, Glaxo Smith Kline, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millenium/Takeda, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Novonordisk, Pfizer, Prometheus laboratories/Nestle, Protagonist, Receptos, Robarts Clinical Trials, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor and received speaker fees from Abbvie, Ferring, Johnson and Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Shire, Millenium/Takeda, Tillotts and Vifor. ||Dr. Feagan, Brian:|:|received grant/research support from Millennium Pharmaceuticals, Merck, Tillotts Pharma, AbbVie, Novartis Pharmaceuticals, Centocor, Elan/Biogen, UCB Pharma, Bristol-Myers Squibb, Genentech, ActoGenix and Wyeth Pharmaceuticals; consulting fees from Millennium Pharmaceuticals, Merck, Centocor, Elan/Biogen, Janssen-Ortho, Teva Pharmaceuticals, Bristol-Myers Squibb, Celgene, UCB Pharma, AbbVie, AstraZeneca, Serono, Genentech, Tillotts Pharma, Unity Pharmaceuticals, Albireo Pharma, Given Imaging, Salix Pharmaceuticals, Novonordisk, GSK, ActoGenix, Prometheus Therapeutics and Diagnostics, Athersys, Axcan, Gilead, Pfizer, Shire, Wyeth, Zealand Pharma, Zyngenia, GiCare Pharma and Sigmoid Pharma; and speaker’s bureau fees from UCB, AbbVie and J&J/Janssen. ||Dr. Sandborn, William:|:|received research grants from Atlantic Healthcare Limited, Amgen, Genentech, Gilead Sciences, Abbvie, Janssen, Takeda, Lilly, Celgene/Receptos; consulting fees from Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen, Kyowa Kirin Pharmaceutical Research, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Prizer, Precision IBD, Progenity, Prometheus Laboratories, Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust, HART), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna Biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts Pharma, UCB Pharma, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals; and stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan Pharma, Precision IBD, Progenity, Ritter Pharmaceuticals, Ventyx Biosciences, Vimalan Biosciences. Spouse: Opthotech - consultant, stock options; Progenity - consultant, stock; Oppilan Pharma - employee, stock options; Escalier Biosciences - employee, stock options; Precision IBD - employee, stock options; Ventyx Biosciences – employee, stock options; Vimalan Biosciences – employee, stock options.

Page 44 of 135

P121

Dr. SHARMA, Neel: No conflict of intereset||Dr. Savelkoul, Edo: No conflict of intereset||Dr. Disney, Ben: No conflict of intereset||Dr. Shah, Ashit: No conflict of intereset||Dr. De Silva, Shanika: No conflict of intereset||Dr. Pattni, Sanjeev: No conflict of intereset||Prof. Iacucci, Marietta: No conflict of intereset||Dr. Cooney, Rachel: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset

P122Prof. Dr. Yamamoto-Furusho, Jesús Kazuo: No conflict of intereset||Dr. Mendieta-Escalante, Erick Arturo: No conflict of intereset

P123

Dr. Atlan, Lilian: No conflict of intereset||Dr. Pratt, Li-tal: No conflict of intereset||Dr. Cohen, Shlomi: No conflict of intereset||Dr. Shiran, Shelly: No conflict of intereset||Dr. Yerushalmy-feler, Anat: No conflict of intereset

P124

Dr. Weintraub, Yael: No conflict of intereset||Dr. Cohen , Shlomi: No conflict of intereset||Mrs. Chapnik, Nava: No conflict of intereset||Dr. Yerushalmy-Feler, Anat: No conflict of intereset||Dr. Ben-Tov, Amir: No conflict of intereset||Prof. Dr. Dotan, Iris: No conflict of intereset||Prof. Tauman, Riva: No conflict of intereset||Prof. Dr. Froy, Oren: No conflict of intereset

P125

Dr. Neri, Benedetto: No conflict of intereset||Dr. Romeo, Samanta: No conflict of intereset||Dr. Ruffa, Alessandra: No conflict of intereset||Dr. Calabrese, Emma: No conflict of intereset||Dr. Sena, Giorgia: No conflict of intereset||Dr. Grasso, Enrico: No conflict of intereset||Dr. Zorzi, Francesca: No conflict of intereset||Prof. Palmieri, Giampiero: No conflict of intereset||Dr. Soldati, Salvatore: No conflict of intereset||Prof. Biancone, Livia: No conflict of intereset

P126

Dubinsky, Marla C: No conflict of intereset||Dr. Naegeli, April:|:|Employee and stockholder at Eli Lilly and Company||Dr. Dong, Yan:|:|Employee and stockholder at Eli Lilly and Company||Dr. Lissoos, Trevor:|:|Employee and stockholder at Eli Lilly and Company||Dr. Arora, Vipin:|:|Employee and stockholder at Eli Lilly and Company||Irving, Peter: No conflict of intereset

P127

Mrs. Straksyte, Vestina: No conflict of intereset||Kiudelis, Gediminas: No conflict of intereset||Prof. Kupcinskas, Limas: No conflict of intereset||Mrs. Zaboriene , Inga: No conflict of intereset

P128

Ms. RUBÍN DE CÉLIX VARGAS, Cristina: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Dr. Moreno, José Andrés: No conflict of intereset||Dr. Santander, Cecilio: No conflict of intereset||Dr. Gisbert, Javier Pérez: No conflict of intereset

P129

Mrs. Straksyte, Vestina: No conflict of intereset||Kiudelis, Gediminas: No conflict of intereset||Prof. Kupcinskas, Limas: No conflict of intereset||Mrs. Zaboriene, Inga: No conflict of intereset

P130

Dr. Collin, Remi: No conflict of intereset||Dr. Minet-Quinard, regine: No conflict of intereset||Mrs. Blayac, laurianne: No conflict of intereset||Dr. Manlay, Luc: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset

P131

Prof. Dr. Roblin, Xavier: No conflict of intereset||Dr. Jardin, sabine: No conflict of intereset||Dr. cuilleron, muriel: No conflict of intereset||Dr. veyrard, pauline: No conflict of intereset||Prof. Dr. boschetti, gilles: No conflict of intereset||Dr. berger, anne emmanuelle: No conflict of intereset||Prof. Dr. flourie, bernard: No conflict of intereset||Prof. Dr. nancey, stephane: No conflict of intereset||Prof. paul, stephane: No conflict of intereset

P132

Dr. MORÃO, Bárbara: No conflict of intereset||Dr. Frias Gomes, Catarina: No conflict of intereset||Dr. Gouveia, Catarina: No conflict of intereset||Dr. Costa Santos, Maria Pia: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset

P133

Dr. Núñez, Paulina: No conflict of intereset||Dr. Sepúlveda, Eduardo: No conflict of intereset||Mrs. Simian, Daniela: No conflict of intereset||Dr. Figueroa, Carolina: No conflict of intereset||Mrs. Flores, Lilian: No conflict of intereset||Dr. Ibáñez, Patricio: No conflict of intereset||Kronberg, Udo: No conflict of intereset||Dr. Lubascher, Jaime: No conflict of intereset||Dr. Pizarro, Gonzalo: No conflict of intereset||Dr. Quera, Rodrigo: No conflict of intereset

P134

Dr. Fenech, Valerie Anne: No conflict of intereset||Dr. Kamperidis, Nikolaos: No conflict of intereset||Ms. Tyrrell, Tracey: No conflict of intereset||Dr. Dyall, Lovesh: No conflict of intereset||Dr. Fofaria, Rishi: No conflict of intereset||Dr. Misra, Ravi: No conflict of intereset||Ms. Barber, Susan: No conflict of intereset||Ms. Randall, Sophie: No conflict of intereset||Ms. Shah, Jaina: No conflict of intereset||Dr. Arebi , Naila:|:|Lecture fees from Takeda, Janssen, Pfizer and Abbvie

Page 45 of 135

P135

Bhala, Neeraj: No conflict of intereset||Prof. Hart, Ailsa:|:|AH has served as consultant, advisory board member or speaker for AbbVie, Atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the Global Steering Committee for Genentech. ||Dr. Watts, David:|:|DW has previously received support from AbbVie in the form of educational grants (attending congress) and honoraria for attending advisory boards. ||Dr. Lewis, Stephen: No conflict of intereset||Prof. Ghosh, Subrata:|:|Steering committees (AbbVie, Janssen, Celgene), consultancies (Takeda, Boehringer Ingelheim, Gilead, Eli Lilly, Roche), speaker commitments (AbbVie, Janssen, Celltrion, Takeda, Gilead). ||Mr. van Haaren, Stijn:|:|SvH is an employee of AbbVie. ||Dr. Hansell, Chris:|:|CH is an employee of AbbVie.||Dr. Ahmad, Tariq:|:|TA has received unrestricted grants for research, advisory board fees and support to attend conferences from AbbVie, Janssen, Merck, Celltrion, Cellgene, Takeda, Ferring, Tillotts

P136

Mrs. Mami, Alia: No conflict of intereset||Prof. Dr. Nancey, Stéphane: No conflict of intereset||Dr. Pugliese, Daniela: No conflict of intereset||Dr. Molander, Pauliina: No conflict of intereset||Prof. Dr. Boschetti, Gilles: No conflict of intereset||Dr. Nogueira, Islaine: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset

P137

Dr. Abou Rached, Antoine: No conflict of intereset||Dr. Sanyour, Joyce: No conflict of intereset||Dr. Karaki, Jocelyne: No conflict of intereset||abi abdalllah, nancy: No conflict of intereset||Dr. Ghoussoub, Sarah: No conflict of intereset

P138

Dr. Castelli, Paola: No conflict of intereset||Dr. Abuquteish, Dua’: No conflict of intereset||Dr. Di Ruscio, Mirko: No conflict of intereset||Dr. Lunardi, Gianluigi: No conflict of intereset||Prof. Zamboni, Giuseppe: No conflict of intereset||Prof. Riddell, Robert: No conflict of intereset

P139

Dr. Imperatore, Nicola: No conflict of intereset||Dr. Foggia, Maria: No conflict of intereset||Dr. Rispo, Antonio: No conflict of intereset||Dr. Patturelli, Marta: No conflict of intereset||Dr. Calabrese, Giulio: No conflict of intereset||Dr. Testa, Anna: No conflict of intereset||Dr. Nardone, Olga: No conflict of intereset||Dr. Pellegrini, Lucienne: No conflict of intereset||Dr. Guarino, Alessia Dalila: No conflict of intereset||Dr. Ricciolino, Simona: No conflict of intereset||Prof. Tosone, Grazia: No conflict of intereset||Prof. Castiglione, Fabiana: No conflict of intereset

P140

Dr. Domislović, Viktor: No conflict of intereset||Knežević-Štromar, Ivana: No conflict of intereset||Premužić, Marina: No conflict of intereset||Brinar, Marko: No conflict of intereset||Vranešić Bender, Darija: No conflict of intereset||Milinković, Anica: No conflict of intereset||Matašin, Marija: No conflict of intereset||Mikolašević, Ivana: No conflict of intereset||Krznarić, Željko: No conflict of intereset

P141

Dr. Norsa, Lorenzo: No conflict of intereset||Dr. Ferrari, Alberto: No conflict of intereset||Dr. Arrigo, Serena: No conflict of intereset||Dr. Bramuzzo, Matteo: No conflict of intereset||Dr. Deganello Saccomani, Marco: No conflict of intereset||Dr. Di Nardo, Giovanni: No conflict of intereset||Dr. Illiceto, Maria Teresa: No conflict of intereset||Prof. Miele, Erasmo: No conflict of intereset||Dr. Paci, Monica: No conflict of intereset||Prof. Romano, Claudio: No conflict of intereset||Dr. Romeo, Erminia: No conflict of intereset||Dr. Daperno , Marco: No conflict of intereset||Dr. oliva, Salvatore: No conflict of intereset

P142

Dr. GOODSALL, Thomas: No conflict of intereset||Dr. Noy, Richard: No conflict of intereset||Ms. Nguyen, Tran: No conflict of intereset||Dr. Costello, Samuel: No conflict of intereset||Dr. Jairath, Vipul: No conflict of intereset||Dr. Bryant, Robert: No conflict of intereset

P143

Mr. Sævik, Fredrik: No conflict of intereset||Prof. Dr. Gilja, Odd Helge:|:|Has received speaker honoraria from the following companies:|AbbVie, Bracco, Almirall, GE Healthcare, Takeda AS, Meda AS, Ferring AS and Allergan. He has served as consultant for Bracco, GE Healthcare, Takeda and Samsung.|||Nylund, Kim:|:|Has served as speaker Takeda, MSD, MEDA AS, Ferring Pharmaceuticals

P144

Dr. Dunleavy, Katie: No conflict of intereset||Dr. Ungaro, Ryan:|:|Has served as an advisory board member or consultant for Janssen, Pfizer, and Takeda; research grants from Abbvie, Boehringer Ingelheim, and Pfizer.||Ms. Manning, Laura:|:|Consulting fees from Halen Brands.||Dr. Novak, Joshua: No conflict of intereset||Dr. Gold, Stephanie: No conflict of intereset||Dr. Colombel, Jean-Frederic:|:|Dr. Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, |Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.

Page 46 of 135

P145

Dr. Phillips, Frank: No conflict of intereset||Dr. Verstockt, Bram: No conflict of intereset||Sladek, Malgorzata: No conflict of intereset||Dr. de Boer, Nanne: No conflict of intereset||Dr. Katsanos, Kostas: No conflict of intereset||Dr. Karmiris, Konstantinos: No conflict of intereset||Dr. Albshesh, Ahmad: No conflict of intereset||Dr. Eriksson, Carl: No conflict of intereset||Dr. Bergemalm, Daniel: No conflict of intereset||Dr. Molner, Tamas: No conflict of intereset||Dr. Ellul, Pierre: No conflict of intereset

P146

Jairath, Vipul:|:|VJ has received consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Arena pharmaceuticals, Genetech, Pendopharm, Sandoz, Merck, Takeda, Janssen, Robarts Clinical Trials, Topivert, Celltrion; speaker’s fees from Takeda, Janssen, Shire, Ferring, Abbvie, Pfizer||Lee, Wan-Ju:|:|WJ Lee is an employee of AbbVie and may own AbbVie stock||Zhou, Wen:|:|W Zhou is an employee of AbbVie and may own AbbVie stock||Heap, Graham:|:|G Heap is an employee of AbbVie and may own AbbVie stock||Butler, James:|:|J Butler is an employee of AbbVie and may own AbbVie stock||Shields, Alan L:|:|AL Shields is employed by Adelphi Values, that receives payment from AbbVie in support of this study||Ollis, Sarah:|:|S Ollis is employed by Adelphi Values, that receives payment from AbbVie in support of this study||Harpaz, Noam:|:|N Harpaz has received scientific consultant fees from AbbVie

P147 Mr. STEENHUIS, Maarten: No conflict of intereset||Mr. van Son, Koen: No conflict of intereset

P148

Dr. Cannatelli, Rosanna: No conflict of intereset||Nardone, Olga: No conflict of intereset||Shivaji, Uday: No conflict of intereset||Smith, Samuel Clarke Luis: No conflict of intereset||Bazarova, Alina: No conflict of intereset||Dr. Zardo, Davide: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset||Iacucci, Marietta: No conflict of intereset

P149

Kim, Jin-Oh: No conflict of intereset||Prof. Dr. Jeon, Seong Ran: No conflict of intereset||Dr. Park, Heesu: No conflict of intereset||Prof. Dr. Kim, Hyun Gun: No conflict of intereset||Prof. Dr. Ko, Bong Min: No conflict of intereset||Ms. Park, Sueyon: No conflict of intereset

P150

Dr. Mak, Joyce Wing Yan: No conflict of intereset||Dr. Yip, Terry Cheuk Fung: No conflict of intereset||Mr. Lam, Hon Man: No conflict of intereset||Ms. Cheng , Tsz Yan: No conflict of intereset||Dr. Wong , Sunny Hei: No conflict of intereset||Prof. Dr. Chan , Francis Ka Leung: No conflict of intereset||Prof. Dr. Ng, Siew Chien: No conflict of intereset||Prof. Dr. Wong , Vincent Wai Sun: No conflict of intereset||Prof. Dr. Wong , Grace Lai Hung: No conflict of intereset

P151

Ms. Van Wassenaer, Elsa: No conflict of intereset||Dr. Diederen, Kay: No conflict of intereset||Dr. Kindermann, Angelika: No conflict of intereset||Dr. van Leeuwen, Ester M. M.: No conflict of intereset||Prof. Dr. D'Haens, Geert R.: No conflict of intereset||Prof. Dr. Benninga, Marc A.: No conflict of intereset||Dr. Koot, Bart G.P.: No conflict of intereset

P152

Dr. Echarri Piudo, Ana: No conflict of intereset||Dr. Molina Arriero, Gema: No conflict of intereset||Dr. Sierra Ausin, Mónica: No conflict of intereset||Dr. Calvo Moya, Marta: No conflict of intereset||Dr. Pérez Calle, José Lázaro: No conflict of intereset||Ms. Fraga Iriso, Rebeca: No conflict of intereset||Ms. Morete Pérez, María Carmen: No conflict of intereset||Dr. Botella Mateu, Belén: No conflict of intereset||Dr. Ollero Pena, Virginia: No conflict of intereset||Ms. Enriquez Rodriguez, Miriam: No conflict of intereset||Dr. Nos Mateu, Pilar: No conflict of intereset||Dr. Castro Senosiain, Beatriz: No conflict of intereset||Dr. Martín Rodriguez, Daniel: No conflict of intereset||Dr. Mancenido Marcos, Noemi: No conflict of intereset

P153

Dr. Duricova, Dana:|:|Lecture fee for Takeda, Janssen, Pfizer||Dr. Bortlik, Martin:|:|Lecture fee for Takeda, Janssen, AbbVie, Pfizer||Dr. Kratka, Zuzana: No conflict of intereset||Mrs. Slaba, Lenka: No conflict of intereset||Mrs. Kovarova, Tereza: No conflict of intereset||Prof. Lukas, Milan: No conflict of intereset||Mrs. Pfeiferova, Martina: No conflict of intereset

P154Rai, Victoria: No conflict of intereset||Dr. Traboulsi, Cindy: No conflict of intereset||Mr. Gulotta, George: No conflict of intereset||Prof. Dr. Rubin, David: No conflict of intereset

P155

Dr. Amihai, Rottenstreich: No conflict of intereset||Dr. Mishael, Tali: No conflict of intereset||Prof. Dr. Grisaru-Granovski, Sorina: No conflict of intereset||Dr. Koslowsky, Binyamin: No conflict of intereset||Mrs. Abitbol, Guila: No conflict of intereset||Prof. Goldin, Eran: No conflict of intereset||Dr. Bar-Gil Shitrit, Ariella:|:|Advisory Board/Speakers Bureau – Takeda, Janssen, AbbVie, Neopharm, Pfizer|Funding (Grants/Honoraria) : Takeda, Janssen|Speaker/Consulting Fees: Takeda, Janssen, Abbvie, Neopharm

P156

Ms. QUAH, Stephanie: No conflict of intereset||Prof. Dr. Gorelik, Alexandra: No conflict of intereset||Dr. Tsoi, Edward: No conflict of intereset||Dr. Chow, Elizabeth: No conflict of intereset||Dr. Sivanesan, Suresh: No conflict of intereset||Prof. Brown, Gregor: No conflict of intereset||Dr. Anwar, Shahzaib: No conflict of intereset||Dr. Taylor, Andrew: No conflict of intereset||Prof. Macrae, Finlay: No conflict of intereset

Page 47 of 135

P157

Abreu, Maria Teresa:|:|MTA has served as a consultant for AbbVie, Prometheus, Takeda, Janssen, Focus Medical Communications, Celgene Corporation, SERES, Eli Lilly Pharmaceuticals, Pfizer, Shire, Roche, Boehringer Ingelheim, Amgen, Gilead, Allergan, and Landos Biopharma. Received Grant research support from Takeda, Prometheus, Pfizer and has participated on the Speaker’s Bureau for Takeda, Focus Medical Communications, Cornerstones Health, and Imedex.||Dr. Cataldi, Fabio:|:|FC is an employee of Arena Pharmaceuticals, Inc., and may own stock and/or options.||Van Horn, Katelyn:|:|KVH is a full-time employee of Health Union, LLC. The survey was conducted by Health Union, LLC, and the analysis was funded by Arena Pharmaceuticals, Inc. Health Union, LLC, and Arena Pharmaceuticals were responsible for the analysis and decision to submit the abstract. All authors critically reviewed the abstract and approved the final version for submission. MTA wrote the first draft of the abstract and edited revisions. Medical writing and editorial support were provided by Health Union, LLC, and Global Outcomes Group, Inc., which was funded by Arena Pharmaceuticals, Inc.||Herbert, Leslie Beth:|:|LBH is a full-time employee of Health Union, LLC.||Fridman, Moshe:|:|MF has served as a consultant for Arena Pharmaceuticals, Inc., Takeda, Shire, CSL Behring, Novo Nordisk, and GlaxoSmithKline.||Setyawan, Juliana:|:|JS is an employee of Arena Pharmaceuticals, Inc., and may own stock and/or options.

P158

Dr. Stidham, Ryan:|:|RWS has served as a consultant for Abbvie, Janssen, Merck, and Takeda. He has received research funding from Abbvie and UCB.||This work was funded by research grants from the National Institutes of Health (K23-DK101687, RWS) and the United States Department of Defense (CDMRP-PR151614 RWS/AKW).||Mr. Enchakalody, Binu: No conflict of intereset||Dr. Waljee, Akbar: No conflict of intereset||Prof. Dr. Su, Grace: No conflict of intereset||Dr. Al-Hawary, Mahmoud: No conflict of intereset||Dr. Wasnik, Ashish: No conflict of intereset

P159

Dr. Rodríguez-Lago, Iago: No conflict of intereset||Dr. Merino, Olga: No conflict of intereset||Dr. Azagra, Irene: No conflict of intereset||Dr. Maiz, Ainara: No conflict of intereset||Dr. Zapata, Eva: No conflict of intereset||Dr. Higuera, Rebeca: No conflict of intereset||Dr. Montalvo, Isabel: No conflict of intereset||Dr. Fernández-Calderón, María: No conflict of intereset||Dr. Arreba, Paz: No conflict of intereset||Dr. Carrascosa, Juan: No conflict of intereset||Dr. Iriarte, Ainara: No conflict of intereset||Prof. Muñoz-Navas, Miguel: No conflict of intereset||Dr. Cabriada, José Luis: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P160

Prof. Dr. Eliakim, Rami:|:|This work was supported by a generous grant from the Leona M. and Harry B. Helmsley Charitable Trust||Dr. Yablecovitch, Doron: No conflict of intereset||Dr. Lahat, Adi: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Dr. Shachar, Eyal: No conflict of intereset||Dr. Carter, Dan: No conflict of intereset||Mrs. Selinger, Limor: No conflict of intereset||Mrs. Neuman, Sandra: No conflict of intereset||Prof. Dr. Ben-Horin, Shomron: No conflict of intereset||Prof. Dr. Kopylov, Uri:|:|Lecture fees : Abbvie Takeda Jannsen Medtronic MSD|Research support- Jannsen Tajeda Medtronic

P161

Dr. SAIR, Asmae: No conflict of intereset||Dr. Lagdali, Nawal: No conflict of intereset||Prof. Ben El Barhdadi, Imane: No conflict of intereset||Dr. Berhili, Camelia: No conflict of intereset||Prof. Borahma, Mohamed: No conflict of intereset||Prof. Ajana, Fatima Zahra: No conflict of intereset

P162

Dr. Scrivo, Barbara: No conflict of intereset||Dr. Celsa, Ciro: No conflict of intereset||Dr. Busacca, Anita: No conflict of intereset||Dr. Giuffrida, Enrica: No conflict of intereset||Prof. Pipitone, Rosaria Maria: No conflict of intereset||Prof. Grimaudo, Stefania: No conflict of intereset||Prof. Calogero, Cammà: No conflict of intereset||Prof. Petta, Salvatore: No conflict of intereset||Dr. Cappello, Maria: No conflict of intereset

P163

Dr. DI RUSCIO, Mirko: No conflict of intereset||Dr. Vernia, Filippo: No conflict of intereset||Dr. Variola, Angela: No conflict of intereset||Dr. Lunardi, Gianluigi: No conflict of intereset||Dr. Resimini, Silvia: No conflict of intereset||Dr. Geccherle, Andrea: No conflict of intereset

P164

Dr. Ferreira, Sandro: No conflict of intereset||Dr. Abiodoun Sadissou, Ibrahin: No conflict of intereset||Dr. Serafim Parra, Rogerio: No conflict of intereset||Dr. Ribeiro Feitosa, Marley: No conflict of intereset||Dr. Sanches Lizarte Neto, Fermino: No conflict of intereset||Prof. Dr. Pretti da Cunha Tirapelli, Daniela: No conflict of intereset||Prof. Dr. Naiara zambelli Ramalho, Leandra: No conflict of intereset||Prof. Dr. Feres, Omar: No conflict of intereset||Prof. Dr. Ribeiro da Rocha, José Joaquim: No conflict of intereset||Prof. Dr. Donadi, Eduardo Antônio: No conflict of intereset||Prof. Dr. de Almeida Troncon, Luiz Ernesto: No conflict of intereset

P165 Dr. Mahmood, Tariq: No conflict of intereset||Dr. Mahmood, taha: No conflict of intereset

P166

Dr. Vicente Costa, Rita: No conflict of intereset||Dr. CURRAIS, Pedro: No conflict of intereset||Dr. Simões, Carolina: No conflict of intereset||Dr. Pinto, Luisa: No conflict of intereset||Dr. Correia, Luís: No conflict of intereset

P167

Dr. Variola, Angela: No conflict of intereset||Dr. DI RUSCIO, Mirko: No conflict of intereset||Dr. Vernia, Filippo: No conflict of intereset||Dr. Resimini, Silvia: No conflict of intereset||Dr. Lunardi, Gianluigi: No conflict of intereset||Dr. Geccherle, Andrea: No conflict of interesetPage 48 of 135

P168

Dr. FREITAS, Marta: No conflict of intereset||Dr. Cúrdia Gonçalves , Tiago: No conflict of intereset||Dr. Boal Carvalho , Pedro: No conflict of intereset||Dr. Dias de Castro , Francisca: No conflict of intereset||Dr. Rosa, Bruno: No conflict of intereset||Dr. Moreira, Maria João: No conflict of intereset||Prof. Dr. Cotter, José: No conflict of intereset

P169 Prof. Dr. LAW, Ngai-Moh: No conflict of intereset

P170

Dr. Gutiérrez Casbas, Ana: No conflict of intereset||Ms. Muñoz, Roser: No conflict of intereset||Mr. Rodríguez, Andrés: No conflict of intereset||Dr. Sempere, Laura: No conflict of intereset||Mr. Cameo, José Ignacio: No conflict of intereset

P171Dr. ZEMEL, Meir: No conflict of intereset||Dr. Solo, Elian: No conflict of intereset||Prof. Klausner, Joseph: No conflict of intereset||Prof. Tulchinsky, Hagit: No conflict of intereset

P172

Ms. Velasco Rodríguez-Belvís, Marta: No conflict of intereset||Ms. Palomino Pérez, Laura María: No conflict of intereset||Ms. Sánchez Fernández-Bravo, Carmen: No conflict of intereset||Mr. Jose Luis, León Falconi: No conflict of intereset||Ms. Sanchiz Perea, Ana: No conflict of intereset||Ms. Cañedo Villarroya, Elvira: No conflict of intereset||Dr. Domínguez Ortega, Gloria: No conflict of intereset||Dr. Pedrón Giner, Consuelo Carmen: No conflict of intereset||Ms. Rodríguez Manchón, Silvia: No conflict of intereset||Mr. Martínez Pérez, Jorge: No conflict of intereset||Ms. Muñoz González, Almudena: No conflict of intereset||Dr. Muñoz Codoceo, Rosa Ana: No conflict of intereset

P173

Mrs. Shchigoleva, Anastasiia:|:|The study was supported by the charity foundation «Pravmir».||Prof. Dr. Shumilov, Petr:|:|The study was supported by the charity foundation «Pravmir».

P174Prof. Dr. Yamamoto-Furusho, Jesús Kazuo: No conflict of intereset||Dr. Parra-Holguin, Norma N: No conflict of intereset||Dr. Fresán-Orellana, Ana: No conflict of intereset

P175

Prof. Dr. Arias Loste, Maria Teresa: No conflict of intereset||Dr. García García, María José: No conflict of intereset||Dr. Rodriguez-Duque, Juan Carlos: No conflict of intereset||Prof. Dr. Iruzubieta, Paula: No conflict of intereset||Dr. Rivas, Coral: No conflict of intereset||Dr. Pascual, Marta: No conflict of intereset||Dr. Castro, Beatriz: No conflict of intereset||Mr. García, Agustín: No conflict of intereset||Ms. Lopez-Montejo, Lorena: No conflict of intereset||Mrs. Rasines , Laura: No conflict of intereset||Mr. Garcia-Nieto, Enrique: No conflict of intereset||Ms. Cagigal, María Luisa: No conflict of intereset||Prof. Dr. Rivero, Montserrat: No conflict of intereset||Prof. Dr. Crespo , Javier: No conflict of intereset

P176

Dr. Wilkens, Rune Thordahl: No conflict of intereset||Dr. Nylund, Kim:|:|Kim Nylund has served as speaker for Takeda, MSD, MEDA AS and Ferring|Pharmaceuticals||Dr. Petersen, Frauke: No conflict of intereset||Dr. De Voogd, Floris: No conflict of intereset||Dr. Maaser, Christian: No conflict of intereset||Dr. Kucharzik, Torsten: No conflict of intereset||Dr. Maconi, Giovanni: No conflict of intereset||Dr. Allocca, Mariangela:|:|Dr. Allocca reports personal fees from Nikkiso Europe , personal fees from Janssen, personal fees from Pfizer, outside the submitted work; .||Dr. Lu, Cathy: No conflict of intereset||Dr. Palmela, Carolina: No conflict of intereset||Dr. Vaughan, Rose: No conflict of intereset||Dr. Christensen, Britt:|:|Dr. Christensen reports grants and personal fees from Abbvie, grants and personal fees from Janssen , personal fees from Novartis, personal fees from Gilead, grants from Takeda, grants and non-financial support from Pfizer, outside the submitted work; .||Dr. Novak, Kerri L.: No conflict of intereset

P177

Ungar, Bella:|:|BU has received research grants / lectures fees from Janssen, Takeda, Abbvie and Neopharm.||Dr. Malickova, Karin: No conflict of intereset||Dr. Hanžel, Jurij:|:|has received advisory fees from Biogen, Janssen and Takeda. ||Dr. Abu-Arisha, Muhammad: No conflict of intereset||Dr. Paul, Stephane: No conflict of intereset||Dr. Rocha, Catia: No conflict of intereset||Mr. Ben-Shatach, Zohar: No conflict of intereset||Ms. Haj-Natour, Ola: No conflict of intereset||Ms. Yavzori, Miri: No conflict of intereset||Dr. Fudim, Ella: No conflict of intereset||Dr. Picard, Orit: No conflict of intereset||Prof. Dr. Eliakim, Rami:|:|Received consultant and speaker fees from Jannsen Abbvie Medtronic and Takeda||Prof. Dr. Kopylov, Uri:|:|received research support from Jannsen, Takeda, and Medtronic and Lecture/advisory fees from Abbvie, Jannsen, Takeda, MSD and Medtronic||Prof. Dr. Lukas, Milan: No conflict of intereset||Prof. Dr. Drobne, David:|:|Speaker and consultant fees from MSD, Abbvie, Takeda, Pfizer, Janssen, Krka, Dr. Falk Pharma.||Prof. Dr. Chowers, Yehuda:|:|received consultation fees from Abbvie, celtrion, Pfizer and Takeda and grants from Abbvie and Takeda. ||Prof. Dr. Roblin, Xavier:|:|from Abbvie, amgen, celltrion, sandoz, MSD, Theradiag, Pfizer, Takeda, Janssen and Gilead||Prof. Dr. Magro, Fernando: No conflict of intereset||Prof. Dr. Ben-Horin, Shomron:|:|received consulting and advisory board fees and/or research support from AbbVie, MSD, Janssen, Takeda and CellTrion. All other authors have nothing to declare.

P178

Dr. Razanskaite, Violeta: No conflict of intereset||Prof. Williamson, Paula: No conflict of intereset||Prof. Young, Bridget: No conflict of intereset||Dr. Bodger, Keith: No conflict of intereset

Page 49 of 135

P179

Dr. Fenech, Valerie Anne: No conflict of intereset||Dr. Kamperidis, Nikolaos: No conflict of intereset||Ms. Tyrrell, Tracey: No conflict of intereset||Dr. Dyall, Lovesh: No conflict of intereset||Dr. Misra, Ravi: No conflict of intereset||Ms. Barber, Susan: No conflict of intereset||Ms. Randall, Sophie: No conflict of intereset||Dr. Arebi, Naila:|:|Lecture fees from Takeda, Janssen, Pfizer and Abbvie

P180

Mr. Stevens, Toer: No conflict of intereset||Dr. Wildenberg, Manon:|:|Speaker fees from Takeda, Tillotts, research grants from Glaxo Smith Kline.||Mr. Koželj, Matic: No conflict of intereset||Dr. Novak, Gregor:|:|has served as speaker and/or advisor for Takeda, Abbvie, MSD, Janssen, Octal pharma, Amgen, Pfizer, Ferring, Falk Pharma. ||Dr. Gecse, Krisztina:|:|served as speaker and/or advisor for Amgen, AbbVie, Biogen, Boehringer Ingelheim, Ferring, Hospira, Immunic AG, Janssen, MSD, Pfizer, Samsung Bioepis, Sandoz, Takeda, Tigenix and Tillotts.||Dr. Duijvestein, Marjolijn: No conflict of intereset||Dr. Löwenberg, Mark:|:|Speaker and/or principal investigator for Abbvie, Celgene, Covidien, Dr. Falk, Ferring Pharmaceuticals, Gilead, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, Protagonist therapeutics, Receptos, Takeda, Tillotts, Tramedico. Research grants from AbbVie, Merck Sharp & Dohme, Achmea healthcare and ZonMW.||Dr. Drobne, David:|:|reports speaker and consultant fees from MSD, Abbvie, Takeda, Pfizer, Janssen, Krka, Dr. Falk Pharma, Ferring.||Prof. Dr. D'Haens, Geert:|:|has served as advisor for Abbvie, Ablynx, Allergan, Amakem, Amgen, AM Pharma, Avaxia, Biogen, Bristol Meiers Squibb, Boerhinger Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Ferring, DrFALK Pharma, Eli Lilly, Engene, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millenium/Takeda, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Prometheus laboratories/Nestle, Protagonist, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor. Received speaker fees from Abbvie, Biogen, Ferring, Johnson and Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shirse, Millenium/Takeda, Tillotts and Vifor. Received research grants from Abbvie, Johnson and Johnson, MSD, Medtronics, DrFALK Pharma, Glaxo Smith Kline, Takeda, Samsung, Pfizer, Prometheus, Robarts Clinical Trials.

P181 Mr. JORA, Sami: No conflict of intereset

P182

Mr. Rueda Garcia, Jose Luis: No conflict of intereset||Mrs. Suárez Ferrer, Cristina: No conflict of intereset||Mr. Martín-Arranz, Eduardo: No conflict of intereset||Mr. Poza, Joaquín: No conflict of intereset||Mrs. Sánchez-Azofra, María: No conflict of intereset||Mrs. García-Ramirez, Laura: No conflict of intereset||Mrs. Poladura, Belén: No conflict of intereset||Mrs. Verges, Tamara: No conflict of intereset||Mr. Noci, Jesús: No conflict of intereset||Ms. Martín-Arranz, María Dolores: No conflict of intereset

P183

Dr. Agrawal, Manasi: No conflict of intereset||Bento-Miranda, Mario: No conflict of intereset||Walsh, Samantha: No conflict of intereset||Prof. Dr. Colombel, Jean-Frederic:|:|Dr. Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, |Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.|||Dr. Ungaro, Ryan:|:|Dr Ungaro reports consulting/advisory board for Takeda, Pfizer and Jansen, and research support from Boehringer Ingelheim, Abbie and Pfizer.

P184

Mr. van der Holst, Adrianus Maria: No conflict of intereset||Mr. Otten, Tim: No conflict of intereset||Mr. van Renterghem, Alexander R.P.K.M.: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Mrs. van Loo, Ellen S.: No conflict of intereset||Ms. van Praag, Elise M.: No conflict of intereset||Dr. Buskens, Christianne J.: No conflict of intereset||Prof. Dr. Stassen, Laurents P.S.: No conflict of intereset

Page 50 of 135

P185

Dr. Dulai, Parambir:|:|Steering committee Takeda; Consulting Takeda, Janssen; Honorarium for speaker events Takeda; Travel support Takeda, Janssen; Grant support Takeda, Pfizer||Dr. Feagan, Brian:|:|Grant support from AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Roche, Genentech, Johnson & Johnson, Janssen, Millennium, Pfizer, Receptos, Tillotts, and UCB; and has served as a consultant or advisory board member for AbbVie, ActoGeniX, Akros, Albireo, Amgen, AstraZeneca, Avaxia Biologics, Avir Pharma, Baxter Healthcare Corp, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Elan/Biogen, enGene, Ferring Pharmaceuticals, Galapagos, Genentech/Roche, GiCare Pharma, Gilead, Given Imaging, GlaxoSmithKline, Inception IBD Inc, Ironwood Pharmaceuticals, Johnson & Johnson, Janssen, Japan Tobacco, Kyowa Hakko Kirin Co Ltd, Lexicon, Lilly, Lycera Biotech, Merck, Mesoblast Ltd, Millennium, Nektar, Nestlé, Novartis, Novo Nordisk, Pfizer, Prometheus Therapeutics & Diagnostics, Protagonist, Receptos, Salix, Shire, Sigmoid Pharma, Synergy Pharmaceuticals Inc, Takeda, Teva Pharmaceutical Industries Ltd, TiGenix, Tillotts, UCB, Vertex Pharmaceuticals, VHsquared Ltd, Warner Chilcott, Wyeth, Zealand Pharma, and Zyngenia||Dr. Sands, Bruce:|:|Consulting/advisory board or honorarium: 4D Pharma, AbbVie, Allergan Sales, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Capella BioScience, Celgene, EnGene, Ferring, Gilead, Janssen, Lilly, Lyndra, MedImmune, Oppilan Pharma, Otsuka, Palatin Technologies, Pfizer, Progenity, Rheos Pharmaceuticals, Seres Therapeutics, Synergy Pharmaceuticals, Takeda, Target PharmaSolutions, Theravance Biopharma R&D, Inc., TiGenix, Vivelix Pharmaceuticals, WebMD||Dr. Lasch, Karen:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc||Dr. Lirio, Richard:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc|||Dr. Feng, Ding:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc

P186

Dr. Karmiris, Konstantinos: No conflict of intereset||Dr. Fotinogiannopoulou, Kalliopi: No conflict of intereset||Dr. Velegraki, Magdalini: No conflict of intereset||Dr. Koureta, Evgenia: No conflict of intereset||Dr. Axiaris, Georgios: No conflict of intereset||Dr. Kateri, Christina: No conflict of intereset||Dr. Kokkotis, Georgios: No conflict of intereset||Dr. Kapizioni, Christina: No conflict of intereset||Dr. Markopoulos, Panagiotis: No conflict of intereset||Dr. Katsoula, Anastasia: No conflict of intereset||Dr. Gklavas, Antonios: No conflict of intereset||Prof. Dr. Papaconstantinou, Ioannis: No conflict of intereset||Prof. Dr. Giouleme, Olga: No conflict of intereset||Dr. Tsironi, Eftychia: No conflict of intereset||Dr. Michalopoulos, Georgios: No conflict of intereset||Prof. Dr. Bamias, Georgios: No conflict of intereset||Dr. Papadopoulos, Vasileios: No conflict of intereset||Prof. Dr. Kapsoritakis, Andreas: No conflict of intereset||Dr. Zampeli, Evanthia: No conflict of intereset||Dr. Michopoulos, Spyridon: No conflict of intereset||Dr. Karatzas, Pantelis: No conflict of intereset||Prof. Dr. Papatheodoridis, Georgios: No conflict of intereset||Dr. Theodoropoulou, Angeliki: No conflict of intereset||Prof. Dr. Koutroubakis, Ioannis E.: No conflict of intereset

P187 Prof. Korkmaz, Huseyin: No conflict of intereset||Dr. Fidan, Kemal: No conflict of intereset

P188

Dr. Fiorindi, Camilla: No conflict of intereset||Dr. Cricchio, Marta: No conflict of intereset||Prof. Ficari, Ferdinando: No conflict of intereset||Dr. Alpigiano, Giovanna: No conflict of intereset||Dr. Scaringi, Stefano: No conflict of intereset||Dr. Giudici, Francesco: No conflict of intereset

P189

Dr. Yorulmaz, Elif: No conflict of intereset||Dr. Yigit, Betul: No conflict of intereset||Prof. Erturk, Mehmet Sukru: No conflict of intereset||Dr. Erdem, Umut: No conflict of intereset||Dr. Yanc, Ugur: No conflict of intereset||Prof. Yorulmaz, Hatice: No conflict of intereset||Dr. Bilik Oyman, Gamze: No conflict of intereset||Prof. Sezgin, Orhan: No conflict of intereset

P190

Dr. GOODSALL, Thomas: No conflict of intereset||Ms. Nguyen, Tran: No conflict of intereset||Dr. Ma, Christopher: No conflict of intereset||Dr. Jairath, Vipul: No conflict of intereset||Dr. Bryant, Robert: No conflict of intereset

P191

Vranesic Bender, Darija: No conflict of intereset||Dr. Domislović, Viktor: No conflict of intereset||Barišić, Ana: No conflict of intereset||Karas, Irena: No conflict of intereset||Ljubas Kelečić, Dina: No conflict of intereset||Dr. Brinar, Marko: No conflict of intereset||Turk, Nikša: No conflict of intereset||Prof. Krznarić, Željko: No conflict of intereset

P192

Dr. Molina Arriero, Gema: No conflict of intereset||Dr. Pradera Cibreiro, Carmen: No conflict of intereset||Dr. De las Heras Sotos, Cristina: No conflict of intereset||Ms. Fraga Iriso, Rebeca: No conflict of intereset||Dr. Ollero Pena, Virginia: No conflict of intereset||Ms. Morete Pérez, María Carmen: No conflict of intereset||Dr. Echarri Piudo, Ana: No conflict of intereset

P193

Dr. Samaan, Mark:|:|Served as a speaker, a consultant and/or an advisory board member for Janssen, Takeda, MSD, Falk, Sandoz||Dr. Cunningham, Georgina: No conflict of intereset||Dr. Tamilarasan, Gokul: No conflict of intereset||Dr. Ray, Shuvra: No conflict of intereset||Dr. Mawdsley, Joel: No conflict of intereset||Dr. Anderson, Simon: No conflict of intereset||Prof. Sanderson, Jeremy: No conflict of intereset||Arkir, Zehra: No conflict of intereset||Dr. Irving, Peter:|:|Served as a speaker, a consultant and/or an advisory board member for Abbvie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, and has received research funding from MSD, Takeda

Page 51 of 135

P194

Ms. JEMMALI, Chayma: No conflict of intereset||Ms. Laabidi, Asma: No conflict of intereset||Ms. Hafi, Marwa: No conflict of intereset||Ms. Ben Mustapha, Nadia: No conflict of intereset||Ms. Serghini, Meriem: No conflict of intereset||Ms. Fekih, Monia: No conflict of intereset||Ms. Boubaker , Jalel: No conflict of intereset

P195

Dr. Buchanan, Vanessa: No conflict of intereset||Dr. Griffin, Susan: No conflict of intereset||Dr. Lee, James:|:|Acts as a Consultant for PredictImmune||Dr. Eoin, McKinney:|:|Chief Scientific Officer and Consultant for PredictImmune||Mr. Paul, Kinnon:|:|CEO for PredictImmune||Dr. HILLS, Karen: No conflict of intereset

P196

Dr. MARAFINI, Irene: No conflict of intereset||Dr. Longo, Lucia: No conflict of intereset||Dr. Salvatori, Silvia: No conflict of intereset||Dr. Miri Lavasani, Damun: No conflict of intereset||Dr. Pianigiani, Federica: No conflict of intereset||Prof. Calabrese, Emma: No conflict of intereset||Dr. Rossi, Rodolfo: No conflict of intereset||Prof. Siracusano, Alberto: No conflict of intereset||Prof. Di Lorenzo, Giorgio: No conflict of intereset||Prof. Monteleone, Giovanni: No conflict of intereset

P197

Dr. DYALL, Lovesh: No conflict of intereset||Dr. Kamperidis , Nikolaos: No conflict of intereset||Dr. Fofaria, Rishi: No conflict of intereset||Dr. Fenech, Valerie: No conflict of intereset||Ms. Tyrrell, Tracey: No conflict of intereset||Ms. Barber, Susan: No conflict of intereset||Ms. Shah, Jaina: No conflict of intereset||Ms. Randall, Sophie: No conflict of intereset||Ms. Okpeh, Comfort: No conflict of intereset||Dr. Arebi, Naila:|:|Dr Arebi has received lecture fees from Takeda, Janssen, Pfizer and AbbVie.

P198

Mr. Saldana, Roberto: No conflict of intereset||Dr. Savini, Claudia: No conflict of intereset||Mr. Bella Castillo, Pablo: No conflict of intereset||Dr. Vera Mendoza, Isabel: No conflict of intereset||Nos Mateu, Pilar: No conflict of intereset

P199

Ms. Twum-Barima, Charlene: No conflict of intereset||Ms. Iqbal, Nusrat: No conflict of intereset||Ms. Reza, Lillian: No conflict of intereset||Ms. Vaizey, Carolynne: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Mr. Tozer, Phil: No conflict of intereset

P200

Dr. Rodríguez-Lago, Iago: No conflict of intereset||Dr. Merino, Olga: No conflict of intereset||Dr. Azagra, Irene: No conflict of intereset||Dr. Maiz, Ainara: No conflict of intereset||Dr. Zapata, Eva: No conflict of intereset||Dr. Higuera, Rebeca: No conflict of intereset||Dr. Montalvo, Isabel: No conflict of intereset||Dr. Fernández-Calderón, María: No conflict of intereset||Dr. Arreba, Paz: No conflict of intereset||Dr. Carrascosa, Juan: No conflict of intereset||Dr. Iriarte, Ainara: No conflict of intereset||Dr. Muñoz-Navas, Miguel: No conflict of intereset||Dr. Cabriada, José Luis: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P201

Ms. MacDonald, Sonja: No conflict of intereset||Ms. Heisler, Courtney Grace: No conflict of intereset||Ms. Mathias, Holly: No conflict of intereset||Dr. Mirza, Raza: No conflict of intereset||Dr. Jones, Jennifer: No conflict of intereset

P202

Mr. Mitselos, Ioannis: No conflict of intereset||Ms. Lamouri, Chara: No conflict of intereset||Mr. Theopistos, Vasileios: No conflict of intereset||Mr. Kavvadias, Athanasios: No conflict of intereset||Mr. Moutzoukis, Miltiadis: No conflict of intereset||Ms. Beka, Eleni: No conflict of intereset||Prof. Katsanos, Konstantinos: No conflict of intereset||Christodoulou, Dimitrios: No conflict of intereset

P203

Dr. ISMAIL, M Syafiq: No conflict of intereset||Dr. Murphy, Greg: No conflict of intereset||Dr. Kelly, Ciaran: No conflict of intereset||Dr. O'Riordan, Fiona: No conflict of intereset||Dr. Semenov, Serhiy: No conflict of intereset||Dr. Sihag, Sandeep: No conflict of intereset||Dr. Breslin, Niall: No conflict of intereset||Dr. Anthony, O'Connor: No conflict of intereset||Prof. Ryan, Barbara: No conflict of intereset||Prof. McNamara, Deirdre: No conflict of intereset

P204

Dr. BAKKALOGLU, Oguz Kagan: No conflict of intereset||Dr. Eskazan, Tugce: No conflict of intereset||Dr. Bozcan, Selma: No conflict of intereset||Dr. Yıldırım, Suleyman: No conflict of intereset||Dr. Kurt, Enes Ali: No conflict of intereset||Prof. Hatemi, Ali İbrahim: No conflict of intereset||Prof. Erzin, Yusuf: No conflict of intereset||Prof. Celik, Ferhat: No conflict of intereset

P205Yang, Xin Yu: No conflict of intereset||Ms. Tchogna, Sonia A.: No conflict of intereset||Mrs. Deslandres, Colette: No conflict of intereset||Jantchou, Prevost: No conflict of intereset

P206

Dr. Ollech, Jacob: No conflict of intereset||Harel, Sasha: No conflict of intereset||Yadgar, Karin: No conflict of intereset||Asayag, Noa: No conflict of intereset||Cahan, Amos: No conflict of intereset||Lederman, Natan: No conflict of intereset||Matz, Eran: No conflict of intereset||Prof. Balicer, Ran: No conflict of intereset||Feldman, Becca: No conflict of intereset||Brufman, Ilan: No conflict of intereset||Haklai, Ziona: No conflict of intereset||Prof. Turner, Dan: No conflict of intereset||Prof. Dotan, Iris: No conflict of intereset

P207Prof. YAO, Jiayin: No conflict of intereset||Dr. Peng, Xiang: No conflict of intereset||Dr. Jiang, Yi: No conflict of intereset||Prof. Zhi, Min: No conflict of intereset

Page 52 of 135

P208

Bhala, Neeraj: No conflict of intereset||Prof. Hart, Ailsa:|:|AH has served as consultant, advisory board member or speaker for AbbVie, Atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the Global Steering Committee for Genentech. ||Dr. Watts, David:|:|DW has previously received support from AbbVie in the form of educational grants (attending congress) and honoraria for attending advisory boards. ||Dr. Lewis, Stephen: No conflict of intereset||Prof. Ghosh, Subrata:|:|Steering committees (AbbVie, Janssen, Celgene), consultancies (Takeda, Boehringer Ingelheim, Gilead, Eli Lilly, Roche), speaker commitments (AbbVie, Janssen, Celltrion, Takeda, Gilead). ||Mr. van Haaren, Stijn: No conflict of intereset||Dr. Hansell, Chris:|:|CH is an employee of AbbVie. ||Dr. Ahmad, Tariq:|:|TA has received unrestricted grants for research, advisory board fees and support to attend conferences from AbbVie, Janssen, Merck, Celltrion, Cellgene, Takeda, Ferring, Tillotts.

P209

SAHU, Pabitra: No conflict of intereset||Dr. Kumar, Sudheer: No conflict of intereset||Dr. Jain, Saransh: No conflict of intereset||Dr. Singh Mohil, Namrata: No conflict of intereset||Dr. Sahni, Peush: No conflict of intereset||Dr. Pal, Sujoy: No conflict of intereset||Dr. Ranjan Das, Nihar: No conflict of intereset||Dr. Nayak, Baibaswata: No conflict of intereset||Mr. Sachdev, Vikas: No conflict of intereset||Dr. Kumar Singh, Mukesh: No conflict of intereset||Dr. Kedia, Saurabh: No conflict of intereset||Prof. Makharia, Govind: No conflict of intereset||Prof. Ahuja, Vineet: No conflict of intereset

P210Dr. CAMPBELL, Iona: No conflict of intereset||Dr. Brownson, Emily: No conflict of intereset||Dr. Robertson, Elaine: No conflict of intereset

P211

Dr. Melnik, Pesach: No conflict of intereset||Dr. Matar, Manar: No conflict of intereset||Prof. Dr. Shamir, Raanan:|:|Research grant from Abbvie||Prof. Dr. Assa, Amit:|:|Lectures and consult fee from Abbvie|Research grants from Abbvie and Janssen

P212

Dr. GUTIERREZ BECKER, Benjamin: No conflict of intereset||Dr. Gamez Serna, Citlalli: No conflict of intereset||Dr. Thalhammer, Andreas: No conflict of intereset||Dr. Oh, Young: No conflict of intereset||Dr. Drawnel, Faye: No conflict of intereset||Dr. Arcadu, Filippo: No conflict of intereset||Dr. Prunotto, Marco: No conflict of intereset

P213

Prof. Dr. Li, Yue: No conflict of intereset||Dr. Tong, Yuanren: No conflict of intereset||Dr. Lu, Keming: No conflict of intereset||Prof. Dr. Yu, Sheng: No conflict of intereset||Prof. Dr. Qian, Jiaming: No conflict of intereset

P214Ms. Eddy, Carolyn: No conflict of intereset||Dr. Stanton, Sonia: No conflict of intereset||Subramaniam, Kavitha: No conflict of intereset

P215 Ms. SEO, Ji Hyun: No conflict of intereset||Prof. Dr. Lee, Jong Lyul: No conflict of intereset

P216

Ms. Hamilton, Rhona: No conflict of intereset||Dr. Shields, Stephanie: No conflict of intereset||Dr. MacDonald, Jonathan: No conflict of intereset||Dr. Dunlop, Allan: No conflict of intereset||Dr. Perry, Martin: No conflict of intereset||Dr. McGucken, Andrew: No conflict of intereset||Dr. Gribben, Elaine: No conflict of intereset||Dr. Galloway, Peter: No conflict of intereset

P217

Dr. Lyutakov, Ivan: No conflict of intereset||Prof. Lozanov, Valentin: No conflict of intereset||Sugareva, Paulina: No conflict of intereset||Dr. Nakov, Radislav: No conflict of intereset||Valkov, Hristo: No conflict of intereset||Mr. Dimov, Anastas: No conflict of intereset||Prof. Vladimirov, Borislav: No conflict of intereset||Prof. Penchev, Plamen: No conflict of intereset

P218

Dr. Kanmura, Shuji: No conflict of intereset||Dr. Komaki, Yuga: No conflict of intereset||Dr. Komaki, Fukiko: No conflict of intereset||Dr. Tanaka, Akihito: No conflict of intereset||Dr. Sasaki, Fumisato: No conflict of intereset||Prof. Ido, Akio: No conflict of intereset

P219

Mrs. Fierens, Liselotte: No conflict of intereset||Mrs. Van de Pavert, Iris: No conflict of intereset||Dr. Walentynowicz, Marta: No conflict of intereset||Ms. Coenen, Sofie: No conflict of intereset||Ms. Geens, Patricia: No conflict of intereset||Ms. Weyts, Ellen: No conflict of intereset||Prof. Dr. Van Oudenhove, Lukas: No conflict of intereset||Prof. Dr. Vlaeyen, Johan: No conflict of intereset||Prof. von Leupoldt, Andreas: No conflict of intereset||Prof. Dr. Van Assche, Gert:|:|Honoraria and/or research support to institution from Abbvie, Ferring, Takeda, Janssen, MSD, Roche, Pfizer||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Prof. Van Diest, Ilse: No conflict of intereset

Page 53 of 135

P220

Dr. Shivaji, Uday Nagesh: No conflict of intereset||Mrs. Bazarova, Alina: No conflict of intereset||Dr. Critchlow, Tamsin: No conflict of intereset||Dr. Smith, Samuel CL: No conflict of intereset||Dr. Nardone, Olga Maria: No conflict of intereset||Ms. Love, Melanie: No conflict of intereset||Ms. Davis, Joanne: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset||Dr. Iacucci, Marietta: No conflict of intereset

P221

Dr. LEVARTOVSKY, Asaf: No conflict of intereset||Dr. Barash, Yiftach: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Dr. Klang, Eyal: No conflict of intereset||Dr. Soffer, Shelly: No conflict of intereset||Prof. Kopylov, Uri: No conflict of intereset

P222

Prof. Grzybowska-Chlebowczyk, Urszula Ewa: No conflict of intereset||Dr. Buczyńska, Anna: No conflict of intereset||Dr. Niewiem, Monika: No conflict of intereset||Dr. Flak-Wancerz, Anna: No conflict of intereset||Dr. Kałużna-Czyż, Monika: No conflict of intereset||Dr. Więcek, Sabina: No conflict of intereset

P223Dr. Sakata, Yasuhisa: No conflict of intereset||Tsuruoka, Nanae: No conflict of intereset||Esaki, Motohiro: No conflict of intereset

P224

Dr. Coskun, Ufuk: No conflict of intereset||Kelly, Kim: No conflict of intereset||Dr. Hunter, Theresa:|:|Dr. Hunter is an employee and shareholder of Eli Lilly and Company.||Newton, Louise: No conflict of intereset||Symonds, Tara: No conflict of intereset||Delbecque, Laure:|:|Dr. Delbeque is an employee and shareholder of Eli Lilly and Company.

P225

KADER, Rawen: No conflict of intereset||Dr. Middleton, Paul: No conflict of intereset||Dr. Ahmad, Omer: No conflict of intereset||Dr. Dart, Robin: No conflict of intereset||Dr. McGuire, Joshua: No conflict of intereset||Dr. Sebepos-Rogers, Gregory: No conflict of intereset||Dr. Segal, Jonathan: No conflict of intereset||Dr. Shakweh, Eathar: No conflict of intereset||Dr. Samaan, Mark: No conflict of intereset

P226

Ms. Heisler, Courtney Grace: No conflict of intereset||Ms. Gawdat, Kareem: No conflict of intereset||Ms. Nazer, Nancy: No conflict of intereset||Dr. Stewart, Michael: No conflict of intereset||Ms. Currie, Barbara: No conflict of intereset||Ms. Phalen-Kelly, Kelly: No conflict of intereset||Dr. Jones, Jennifer: No conflict of intereset

P227

Dr. Cannatelli, Rosanna: No conflict of intereset||Zardo, Davide: No conflict of intereset||Nardone, Olga: No conflict of intereset||Bazarova, Alina: No conflict of intereset||Shivaji, Uday: No conflict of intereset||Smith, Samuel Charles Lloyd: No conflict of intereset||Ghosh, Subrata: No conflict of intereset||Iacucci, Marietta: No conflict of intereset

P228

Dr. Busacca, Anita: No conflict of intereset||Dr. Mascaretti, Riccardo: No conflict of intereset||Dr. Carrozza, Lucio: No conflict of intereset||Dr. Guida, Laura: No conflict of intereset||Prof. De Grazia, Simona: No conflict of intereset||Dr. Peralta, Sergio: No conflict of intereset||Dr. Calvaruso, Vincenza: No conflict of intereset||Dr. Cappello, Maria: No conflict of intereset

P229

Gomes, Catarina: No conflict of intereset||Sousa, Mafalda: No conflict of intereset||Ponte, Ana: No conflict of intereset||Pinho, Rolando: No conflict of intereset||Rodrigues, Adélia: No conflict of intereset||Dr. Rocha Silva, João Carlos: No conflict of intereset||Afecto, Edgar: No conflict of intereset||Carvalho, João: No conflict of intereset

P230

Dr. Oba, Jane: No conflict of intereset||Dr. Deboni, Mariana: No conflict of intereset||Dr. Toma , Ricardo: No conflict of intereset||Dr. Sobrado, Carlos: No conflict of intereset||Dr. Azevedo, Matheus: No conflict of intereset||Dr. Carlos, Alexandre: No conflict of intereset||Dr. Borba, Marcelo: No conflict of intereset||Dr. Damião, Aderson: No conflict of intereset||Prof. Dr. Carrilho, Flair: No conflict of intereset||Prof. Dr. Silva, Clovis: No conflict of intereset

P231

Dr. Caon, Ana Elisa: No conflict of intereset||Dr. Martins, Camilla: No conflict of intereset||Dr. Cruz, Marilia: No conflict of intereset||Dr. Leite Barros, Luisa: No conflict of intereset||Dr. Azevedo, Matheus: No conflict of intereset||Dr. Queiroz, Natalia: No conflict of intereset||Dr. Carlos, Alexandre: No conflict of intereset||Dr. Milane, Luciane: No conflict of intereset||Dr. Oba, Jane: No conflict of intereset||Dr. Braga, Michelle: No conflict of intereset||Prof. Sipahi, Aytan: No conflict of intereset||Dr. Damião, Aderson: No conflict of intereset||Prof. Dr. Cançado, Eduardo: No conflict of intereset

P232

Dr. Gonzalez, Raquel Analia: No conflict of intereset||Dr. Gómez, Estanislao J.: No conflict of intereset||Dr. Pereyra, Lisandro: No conflict of intereset||Dr. Mella, José Manuel: No conflict of intereset||Dr. Panigadi, Guillermo Nicolás: No conflict of intereset||Dr. Fischer, Carolina: No conflict of intereset||Dr. Roel, Mariela: No conflict of intereset||Dr. Cimmino, Daniel: No conflict of intereset||Dr. Pedreira, Silvia: No conflict of intereset||Dr. Boerr, Luis Alberto: No conflict of intereset

Page 54 of 135

P233

P234

Prof. Dr. Babayeva-Sadigova, Gulustan: No conflict of intereset||Prof. Babayev , Zeynal: No conflict of intereset||Dr. Asadova , Gunay: No conflict of intereset||Dr. Mahmudov, Umud: No conflict of intereset||Dr. Quliyev , Farid: No conflict of intereset||Dr. Mirzazade, Orkhan: No conflict of intereset

P235

Dr. Mortensen, Joachim:|:|full time employee at Nordic Bioscience||Dr. Godskesen, Line Elberg: No conflict of intereset||Ms. Lindholm, Majken:|:|Full time employee at Nordic Bioscience||Prof. Krag, Aleksander: No conflict of intereset||Prof. Karsdal, Morten Asser:|:|full time employee at Nordic Bioscience. Hold stocks in Nordic Bioscience||Dr. Manon-Jensen, Tina:|:|Full time employee at Nordic Bioscience. Hold stocks in Nordic Bioscience||Prof. Kjeldsen, Jens: No conflict of intereset

P236

Dr. FUJIMOTO, Koji: No conflict of intereset||Dr. Watanabe, Kenji:|:|Olympus Corporation; Board membership, Lecture fee, Providing endoscopic equipment for clinical investigation||Dr. Hori, Kazutoshi: No conflict of intereset||Dr. Kaku, Koji: No conflict of intereset||Dr. Kinoshita, Naohiko: No conflict of intereset||Dr. Koshiba, Ryoji: No conflict of intereset||Dr. Kojima, Kentaro: No conflict of intereset||Dr. Sato, Toshiyuki: No conflict of intereset||Dr. Kawai, Mikio: No conflict of intereset||Dr. Kamikozuru, Koji: No conflict of intereset||Dr. Yokoyama, Yoko: No conflict of intereset||Dr. Miyazaki, Takako: No conflict of intereset||Dr. Hida, Nobuyuki: No conflict of intereset||Prof. Dr. Nakamura, Shiro: No conflict of intereset

Dr. Reinisch, Walter:|:|Advisory board: Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC|Consultant: Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC|Investigator: Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult||Dr. El Azzouzi, Bouchra:|:|Employee: Roche|Stock Holder: Roche||Mr. Li, Regan:|:|Employee: Roche|Stock Holder: Roche||Mr. Lacey, Stuart:|:|Employee: Roche|Stock Holder: Roche||Dr. Daperno, Marco:|:|Advisory board: Abbvie, Janssen, Pfizer, Takeda, Norgine|Consultant: Bioclinica|Investigator: Janssen, Takeda, Roche, GILEAD, Arena, Abbvie|Speaker: Abbvie, Janssen, Pfizer, Mundifarma, Takeda, MSD, Chiesi, SOFAR, Norgine, Ferring||Dr. Mishkin, Daniel:|:|Consultant: GI Reviewers, LLC|Founder: GI Reviewers, LLC||Dr. Park, Kun Tae:|:|Employee: Genentech|Stock Holder: Genentech||Dr. Hassanali, Azra:|:|Employee: Genentech||Dr. Hussain, Fez:|:|Employee: IQVIA||Dr. Oh, Young: No conflict of intereset

Page 55 of 135

P237

Lördal, Mikael:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Burisch, Johan:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Langholz, Ebbe:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Knudsen, Torben:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Voutilainen, Markku:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Moum, Bjørn:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Ms. Saebo, Borghild:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support. ||Dr. Paula, Haiko:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Ms. Malmgren, Carolina:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Dr. Coskun, Mehmet:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.||Prof. Melberg, Hans Olav:|:|This study was funded by Takeda AS. We thank Sandre Lirhus for analytic support, and we thank Wiebke Griemberg and Melissa Bauer for medical writing support.

P238

Mr. Aslan, Nurullah: No conflict of intereset||Mr. Rossel, Jean-Benoit: No conflict of intereset||Mrs. Pittet, Valérie: No conflict of intereset||Mrs. Safroneeva, Ekaterina: No conflict of intereset||Dr. Godat, Sébastien: No conflict of intereset||Prof. Dr. Vavricka, Stephan: No conflict of intereset||Dr. Greuter, Thomas: No conflict of intereset||Dr. Biedermann, Luc: No conflict of intereset||Prof. Dr. Straumann, Alex: No conflict of intereset||Prof. Dr. Scharl, Michael: No conflict of intereset||Dr. Schaad, Marie: No conflict of intereset||Prof. Dr. Hahnloser, Dieter: No conflict of intereset||Prof. Dr. Rogler, Gerhard: No conflict of intereset||Prof. Dr. Schoepfer, Alain: No conflict of intereset

P239

Dr. Mak, Joyce Wing Yan: No conflict of intereset||Ms. Ho, Lok Tung Carmen: No conflict of intereset||Ms. Wong , Kylie: No conflict of intereset||Ms. Cheng , Tsz Yan: No conflict of intereset||Dr. Yip, Terry Cheuk Fung: No conflict of intereset||Dr. Leung, Wai Keung: No conflict of intereset||Dr. Li, Michael: No conflict of intereset||Dr. Lo, Fu Hang: No conflict of intereset||Dr. Ng, Ka Man: No conflict of intereset||Dr. Sze, Shun Fung: No conflict of intereset||Dr. Leung , Chi Man: No conflict of intereset||Dr. Tsang , Steven Woon Choy: No conflict of intereset||Dr. Shan, Edwin Hok Shing: No conflict of intereset||Dr. Chan, Kam Hon: No conflict of intereset||Dr. Lam, Belsy C.Y.: No conflict of intereset||Dr. Hui, Aric J.: No conflict of intereset||Dr. Chow, Wai Hung: No conflict of intereset||Prof. Ng, Siew Chien: No conflict of intereset

Page 56 of 135

P240

Dr. Ungaro, Ryan:|:|Advisory board member or consultant for Janssen, Pfizer, and Takeda; research grants from Abbvie, Boehringer Ingelheim, and Pfizer. ||Dr. Jordan, Robyn: No conflict of intereset||Dr. Yzet, Clara: No conflict of intereset||Dr. Bossuyt, Peter:|:|PB has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz and Pentax. ||Dr. Baert, Filip:|:|FB has received research grants from Abbvie, Chiesi, Ipsen, MSD, Roche, speakers and consultancy fees from Abbvie, Falk, Ferring, Janssen, Mundipharma, MSD, Pfizer, Takeda, and Vifor. ||Dr. Vanasek, Thomas:|:|T Vaňásek has served as advisory member for Hospira, Pfizer and Takeda, has received lecture fees from Takeda.||Dr. D'Haens, Geert R.: No conflict of intereset||Dr. Wilhelmus Joustra, Vincent: No conflict of intereset||Dr. Panaccione, Remo:|:|RP has received Consultant fees from AbbVie, ActoGeniX, AGI Therapeutics, Alba Therapeutics Albireo, Alfa Wasserman, Amgen, AM-Pharma BV, Anaphore, Aptalis, Astellas, Athersys, Atlantic Healthcare, BioBalance, Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Celek, Cellerix, Cerimon, ChemoCentryx, CoMentis, Cosmo Technologies, Coronado Biosciences, Cytokine Pharmasciences, Eagle, Eisai Medical Research, Elan, EnGene, Eli Lilly, Enteromedics, Exagen Diagnostics, Ferring, Flexion Therapeutics, Funxional Therapeutics, Genentech, Genzyme, Gilead, Given Imaging, GlaxoSmithKline, Human Genome Sciences, Ironwood, Janssen, KaloBios, Lexicon, Lycera, Meda, Merck & Co., Merck Research Laboratories, MerckSerono, Millennium, Nisshin Kyorin, Novo Nordisk, NPS Pharmaceuticals, Optimer, Orexigen, PDL Biopharma, Pfizer, Procter and Gamble, Prometheus Laboratories, ProtAb, Purgenesis Technologies, Receptos, Relypsa, Salient, Salix, Santarus, Shire Pharmaceuticals, Sigmoid Pharma, Sirtris (a GSK company), S.L.A. Pharma (UK), Targacept, Teva, Therakos, Tillotts, TxCell SA, UCB Pharma, Vascular Biogenics, and Viamet.||Dr. Novacek, Gottfried:|:|Speaker honorary/advisory board: AbbVie, MSD, Janssen, Takeda, Pfizer, |Ferring, Vifor|||Dr. Reinisch, Walter:|:|WR is a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor and Yakult; consultant for: Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, Elan, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma Lipid Therapeutics Mallinckrodt MedImmune Millenium Mitsubishi

P241

Dr. Gupta, Vipin: No conflict of intereset||Dr. Mohsen, Waled: No conflict of intereset||Dr. Adams, Alex: No conflict of intereset||Dr. Murphy, Aisling: No conflict of intereset||Dr. Sathananthan, Dharshan: No conflict of intereset||Mrs. Cripps, Sarah: No conflict of intereset||Dr. Brain, Oliver: No conflict of intereset||Dr. Palmer, Rebecca: No conflict of intereset||Dr. Ambrose, Timothy: No conflict of intereset||Mr. George, Bruce: No conflict of intereset||Dr. Walsh, Alissa: No conflict of intereset||Prof. Dr. Travis, Simon: No conflict of intereset||Prof. Dr. Satsangi, Jack: No conflict of intereset

P242

Dr. Rottenstreich, Amihai: No conflict of intereset||Dr. Fridman Lev, Shira: No conflict of intereset||Dr. Rotem, Reut: No conflict of intereset||Dr. Mishael, Tali: No conflict of intereset||Dr. Koslowsky, Binyamin: No conflict of intereset||Prof. Goldin, Eran: No conflict of intereset||Prof. Grisaru-Granovsky, Sorina: No conflict of intereset||Dr. Bar-Gil Shitrit, Ariella:|:|Advisory Board/Speakers Bureau – Takeda, Janssen, AbbVie, Neopharm, Pfizer|Funding (Grants/Honoraria) : Takeda, Janssen|Speaker/Consulting Fees: Takeda, Janssen, AbbVie, Neopharm

Page 57 of 135

P243

Zhao, Mirabella:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support. ||Prof. Lördal, Mikael:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support. ||Prof. Langholz, Ebbe:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support. ||Prof. Knudsen, Torben:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support. ||Prof. Voutilainen, Markku:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Dr. Høivik, Marte Lie:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support. ||Prof. Moum, Bjørn:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Ms. Saebo, Borghild:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Dr. Haiko, Paula:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Ms. Malmgren, Carolina:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Dr. Coskun, Mehmet:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Prof. Melberg, Hans Olav:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.||Prof. Burisch, Johan:|:|This study was funded by Takeda AS. The authors thank Sandre Lirhus for analytic support and Melissa Bauer for medical writing support.

P244

Dr. Fiorino, Gionata: No conflict of intereset||Dr. Gilardi, Daniela: No conflict of intereset||Dr. Bonovas, Stefanos: No conflict of intereset||Prof. Di Sabatino, Antonio: No conflict of intereset||Dr. Angeli, Enzo: No conflict of intereset||Dr. Gaffuri, Nicola: No conflict of intereset||Dr. Allocca, Mariangela: No conflict of intereset||Dr. Furfaro, Federica: No conflict of intereset||Dr. Roda, Giulia: No conflict of intereset||Dr. Lenti, Marco: No conflict of intereset||Dr. Nicola, Aronico: No conflict of intereset||Dr. Mengoli, Caterina: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent: No conflict of intereset||Prof. Danese, Silvio: No conflict of intereset

P245

Dr. Smith, Rebecca: No conflict of intereset||Dr. Taylor, Kirstin: No conflict of intereset||Dr. Friedman, Antony: No conflict of intereset||Dr. Su, Heidi: No conflict of intereset||Dr. Con, Danny: No conflict of intereset||Prof. Gibson, Peter: No conflict of intereset

P246

Prof. Cha, Jae Myung: No conflict of intereset||Prof. Park, Sang Hyoung: No conflict of intereset||Dr. Rhee, Kyoung Hoon: No conflict of intereset||Prof. Hong, Sung Noh: No conflict of intereset||Prof. Kim, Young-Ho: No conflict of intereset||Prof. Seo, Seung In: No conflict of intereset||Prof. Kim, Kyung Ho: No conflict of intereset||Dr. Jeong, Seung Kyu: No conflict of intereset||Dr. Lee, Ji Hyun: No conflict of intereset||Dr. Park, Sun Yong: No conflict of intereset||Dr. Park, Hyunju: No conflict of intereset||Prof. Kim, Joo Sung: No conflict of intereset||Prof. Im, Jong Pil: No conflict of intereset||Prof. Yoon, Hyuk: No conflict of intereset||Dr. Kim, Sung Hoon: No conflict of intereset||Dr. Jang, Jisun: No conflict of intereset||Prof. Kim, Jeong Hwan: No conflict of intereset||Dr. Suh, Seong O: No conflict of intereset||Dr. Kim, Young Kyun: No conflict of intereset||Mrs. Kim, Ye-jee: No conflict of intereset||Prof. Ye, Byong Duk: No conflict of intereset||Prof. Yang, Suk-Kyun:|:|This work was partially supported by a Korean Health Technology R&D Project grant from the Korea Health Industry Development Institute to Suk-Kyun Yang (A120176), funded by the Ministry of Health & Welfare, and by a research grant from Janssen Korea.

P247

Dr. Sempere Robles, Laura: No conflict of intereset||Dr. Purificación , Bernabeu: No conflict of intereset||Dr. Cameo, José: No conflict of intereset||Dr. Gutiérrez, Ana: No conflict of intereset||Dr. Laveda, Raquel: No conflict of intereset||Dr. García, MariFe: No conflict of intereset||Dr. Aguas, Mariam: No conflict of intereset||Dr. Medina, Lucia: No conflict of intereset||Dr. Martinez, Antonio: No conflict of intereset||Dr. Jimenez, Nuria: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. Jover, Rodrigo: No conflict of intereset||Prof. Dr. van-der Hofstadt , Carlos: No conflict of intereset||Prof. Dr. Ruiz, Maria Teresa: No conflict of intereset

Page 58 of 135

P248

P249

Karpin, Jordan: No conflict of intereset||Rodriguez, Tina: No conflict of intereset||Traboulsi, Cindy: No conflict of intereset||Rai, Victoria: No conflict of intereset||Prof. Dr. Rubin, David: No conflict of intereset

Dr. Tadbiri, Sara: No conflict of intereset||Dr. Nachury, Maria: No conflict of intereset||Prof. Bouhnik, Yoram:|:|Yoram Bouhnik has received lecture and consulting fees from Abbvie, Biogaran, Boehringer-Ingelheim, CTMA, Ferring, Gilead, Hospira, ICON, Inception IBD, Janssen, Lilly, Mayoli Spindler, Merck, MSD, Norgine, Pfizer, Robarts Clinical Trials, Roche, Sanofi, Shire, Takeda, UCB and Vifor Pharma. This author has also stock ownership of Inception IBD, San Diego, CA, USA.||Dr. Serrero, Melanie:|:|Melanie Serrero has received lecture fees from Abbvie, Ferring ||Dr. Jerome, Filippi:|:|Jerome Filippi has received lecture and consulting fees from Abbvie, Astellas pharma, Covidien, Ferring, Jansen, MSD, Pfizer, Takeda.||Prof. Roblin, Xavier:|:|Xavier Roblin reported a relationship with MSD, Abbvie, Amgen, Sandoz, Pfizer, Takeda and Janssen.||Dr. Bourrier, Anne: No conflict of intereset||Prof. Bouguen, Guillaume:|:|Guillaume Bouguen received lecture fees from Abbvie, Ferring, MSD, Takeda and Pfizer and consultant fees from Takeda, Janssen.||Prof. Franchimont, Denis: No conflict of intereset||Savoye, Guillaume:|:|Guillaume Savoye has received lecture fees from Vifor Pharma, Takeda, Pfizer, HAC Pharma, Abbvie, MSD, and Ferring France. This author has also received travel accommodations from Ferring, Abbvie, and MSD France as well as a research grant from Ferring.||Buisson, Anthony:|:|Anthony Buisson has received research funding from Pfizer, lecture fees from Abbvie, Ferring, Hospira, MSD, Janssen, Sanofi-Aventis, Takeda and Vifor Pharma and consulting fees from Abbvie, Biogen, Janssen, Pfizer and Takeda.||Prof. Louis, Edouard:|:|EL has received fees|for: Educational Grant: fees for Educational activities paid|by the Company, MSD, AbbVie; speaker fees: AbbVie, Ferring, MSD, Chiesi, Mitsubishi Pharma, Hospira,|Janssen, Takeda; serving on an advisory board: AbbVie, Ferring, MSD, Takeda, Mitsubishi Pharma, Celltrion, Prometheus.||Prof. Nancey, Stephane:|:|Stephane Nancey has received consulting fees from Merck, Abbvie, Takeda, Ferring, Norgine, Vifor Pharma, Novartis, Janssen Cilag, Hospira, Takeda and HAC Pharma.|||Prof. Abtibol, Vered:|:|Vered Abitbol has received lecture fees from Ferring, MSD, Vifor Pharma and Abbvie.||Prof. Reimund, Jean-Marie:|:|Jean-Marie Reimund has received consulting fees from Hospira. This author has also received lectures fees from Abbvie, Ferring, Janssen and Takeda. This author has also received travel accommodations from Ferring, Abbvie, MSD, Janssen, Pfizer, Hospira and Takeda.||Prof. DeWitt, Olivier:|:|Olivier DeWit has received lecture fees from MSD.||Dr. Vuitton, lucine:|:|Lucine Vuitton has received lecture fees from Abbvie, MSD, Takeda, Ferring, Janssen and Pfizer, and research grants from MSD, Takeda and Pfizer.||Dr. Matthieu, Nicolas: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent:|:|Laurent Peyrin-Biroulet has received consulting fees from Merck, Abbvie, Janssen, Genentech, Ferring, Norgine, Tillots, Vifor, Shire, Therakos, Pharmacosmos, Pilège, BMS, UCB-Pharma, Hospira, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, Pfizer, and HAC-Pharma. This author has also received lecture fees from Merck, Abbvie, Takeda, Janssen Cilag, Ferring, Norgine, Tillots, Vifor, Therakos, HAC-Pharma, and Mitsubishi.||Dr. Gilletta, Cyrielle: No conflict of intereset||Prof. Allez, Matthieu:|:|Matthieu Allez has received honoraria from Novo Nordisk, MSD, Abbvie, Ferring, Genentech, Janssen, Pfizer, GSK, Hospira, UCB, Novartis, Takeda, Mayolo-Spindler.||Dr. Viennot, Stephanie:|:|Stephanie Viennot has received consulting fees from Abbvie, MSD, Takeda, Vifor Pharma and Ferring. Mathurin Fumery has received lecture fees from Abbvie, MSD and Ferring.||Prof. Bourreille, Arnaud:|:|Arnaud Bourreille have received board and lecture fees from Abbvie, Ferring, Janssen, MSD, Norgine, and Takeda||Dr. Dib, Nina: No conflict of intereset||Dr. Brixi, Hedia: No conflict of intereset||Dr. Boualit, Medina: No conflict of intereset||Dr. Plastaras, Laurianne: No conflict of intereset||Dr. Altwegg, Romain:|:|Romain Altwegg has received board or lectures fees from Abbvie, Janssen, Pfizer, Takeda||Dr. Fumery, Mathurin:|:|Mathurin Fumery has received lecture and consulting fees from Abbvie, MSD, Boehringer, Pfizer, Takeda, Janssen and Ferring.||Dr. Caillo, Ludovic: No conflict of intereset||Laharie, David:|:|David Laharie has received consulting and lecture fees from AbbVie, Ferring, Janssen Cilag, MSD, Pfizer, and Takeda.||Dr. Amiot, Aurelien:|:|Aurelien Amiot has received consulting fees from Abbvie, Hospira, Takeda, Gilead and Biocodex as well as lecture fees and travel accommodations from Abbvie, Janssen, Biocodex, Hospira, Ferring, Takeda and MSD. This author has also received advisory board fees from Gilead, Takeda and Abbvie.

Page 59 of 135

P250

Dr. Gordon, Claire: No conflict of intereset||Dr. Chee, Desmond: No conflict of intereset||Dr. Hamilton, Ben: No conflict of intereset||Dr. Chanchlani, Neil: No conflict of intereset||Dr. Heerasing , Neel M: No conflict of intereset||Dr. Hendy, Peter: No conflict of intereset||Dr. Lin, Simeng: No conflict of intereset||Dr. Wesley, Emma: No conflict of intereset||Mr. Daniels, Ian: No conflict of intereset||Dr. Goodhand, James R:|:|J.R.G received honoraria from Falk, Abbvie and Shield therapeutics for unrelated topics.||Dr. Kennedy, Nicholas A:|:|N.A.K has consulted for Falk and received honoraria from Falk, Allergan, Pharmacosmos and Takeda for unrelated topics and is a deputy editor of Alimentary Pharmacology & Therapeutics Journal.||Dr. Ahmad, Tariq:|:|T.A. has received unrestricted research grants, advisory board fees, speaker honorariums and support to attend international meetings from AbbVie, Merck, Janssen, Takeda, Ferring, Tillotts, Ferring, Pfizer, NAPP, Celltrion, Hospira for unrelated topics, no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

P251

Dr. FREITAS, Marta: No conflict of intereset||Dr. Cúrdia Gonçalves, Tiago: No conflict of intereset||Dr. Boal Carvalho, Pedro: No conflict of intereset||Dr. Dias de Castro, Francisca: No conflict of intereset||Dr. Rosa, Bruno: No conflict of intereset||Dr. Moreira, Maria João: No conflict of intereset||Prof. Dr. Cotter, José: No conflict of intereset

P252

Ms. Sleutjes, Jasmijn: No conflict of intereset||Dr. Roeters van Lennep, Jeanine E: No conflict of intereset||Mr. Verploegh, Pepijn JP: No conflict of intereset||Prof. Dr. van der Woude, Christien J: No conflict of intereset||Dr. de Vries, Annemarie C: No conflict of intereset

P253

Prof. Dr. Babayeva-Sadigova, Gulustan: No conflict of intereset||Prof. Babayev , Zeynal: No conflict of intereset||Dr. Mahmudov , Umud: No conflict of intereset||Dr. Asadova , Gunay: No conflict of intereset||Dr. Quliyev , Farid: No conflict of intereset||Dr. Mirzazade , Orkhan: No conflict of intereset

P254

Dr. Cassinotti, Andrea: No conflict of intereset||Dr. Fociani, Paolo: No conflict of intereset||Dr. Beretta, Elena: No conflict of intereset||Prof. Duca, Piergiorgio: No conflict of intereset||Prof. Nebuloni, Manuela: No conflict of intereset||Prof. Ardizzone, Sandro: No conflict of intereset

P255

Dr. Imperatore, Nicola: No conflict of intereset||Dr. Pellegrini, Lucienne: No conflict of intereset||Prof. Bucci, Luigi: No conflict of intereset||Dr. Rispo, Antonio: No conflict of intereset||Dr. Guarino, Alessia Dalila: No conflict of intereset||Dr. Testa, Anna: No conflict of intereset||Dr. Peltrini, Roberto: No conflict of intereset||Dr. Amendola, Alfonso: No conflict of intereset||Dr. Patturelli, Marta: No conflict of intereset||Prof. Castiglione, Fabiana: No conflict of intereset

P256

Lyons, Paul:|:|Dr Lyons is a co-inventor on a patent covering the method of assessing prognosis in IBD. He holds founding equity in PredictImmune and consults for the company.||Noor, Nurulamin: No conflict of intereset||Dr. Lee, James C:|:|DrLee is a co-inventor on a patent covering the method of assessing prognosis in IBD. He acts as a consultant for PredictImmune.||Dr. McKinney, Eoin F:|:|Dr McKinney is a co-inventor on a patent covering the method of assessing prognosis in IBD. He holds founding equity in PredictImmune and consults for the company.||Dr. Parkes, Miles: No conflict of intereset||Prof. Smith, Kenneth G C:|:|Professor Smith is a co-inventor on a patent covering the method of assessing prognosis in IBD. He holds founding equity in PredictImmune and consults for the company.

P257

Dr. Suarez Ferrer, Cristina Julia: No conflict of intereset||Mr. Poza Cordon, Joaquin: No conflict of intereset||Crivillen Anguita, Olivia: No conflict of intereset||Martin Arranz, Eduardo: No conflict of intereset||Rueda Garcia, Jose Luis: No conflict of intereset||Sanchez Azofra, Maria: No conflict of intereset||Garcia Ramirez, Laura: No conflict of intereset||Noci Belda, Jesus: No conflict of intereset||Martin Arranz, Maria Dolores: No conflict of intereset

P258Mr. Scott, Glyn: No conflict of intereset||Mrs. Gower, Lisa: No conflict of intereset||Ms. Roads, Naomi: No conflict of intereset||Ms. Lewis, Wendy: No conflict of intereset

P259Ms. JOHNSON, Lara: No conflict of intereset||Mr. Lee, Matthew: No conflict of intereset||Prof. Jones, Georgina: No conflict of intereset||Prof. Lobo, Alan: No conflict of intereset

P260

Mr. Del Hoyo Francisco, Javier: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. Faubel, Raquel: No conflict of intereset||Dr. Bastida, Guillermo: No conflict of intereset||Ms. Muñoz, Diana: No conflict of intereset||Ms. Valero, Elena: No conflict of intereset||Mr. Garrido, Alejandro: No conflict of intereset||Ms. Savini, Claudia: No conflict of intereset||Bella, Pablo: No conflict of intereset||Peña, Beatriz: No conflict of intereset||Dr. Aguas, Mariam: No conflict of intereset

P261

Mr. Attauabi, Mohamed: No conflict of intereset||Dr. Zhao, Mirabella: No conflict of intereset||Prof. Dr. Bendtsen, Flemming: No conflict of intereset||Dr. Burisch, Johan: No conflict of intereset

Page 60 of 135

P262

Mr. Geng, Si Yuan: No conflict of intereset||Ms. Ridha, Zainab: No conflict of intereset||Ms. Pham, Bao Linh: No conflict of intereset||Ms. Tran, Evelyn: No conflict of intereset||Mr. Peixoto, Artur: No conflict of intereset||Ms. Tchogna, Sonia A.: No conflict of intereset||Mrs. Deslandres , Colette: No conflict of intereset||Jantchou, Prevost: No conflict of intereset

P263

Ferreira, Sandro: No conflict of intereset||Dr. Queiróz Marques de Mendonça, Rafaella: No conflict of intereset||Dr. Steltenpool Tonin Borges, Ingrid: No conflict of intereset||Dr. de Avelar Cardoso, Pedro Henrique: No conflict of intereset||Dr. Rose Otoboni Aprile, Lílian: No conflict of intereset||Dr. Serafim Parra, Rogerio: No conflict of intereset||Dr. Ribeiro Feitosa, Marley: No conflict of intereset||Prof. Dr. Feres, Omar: No conflict of intereset||Prof. Dr. Ribeiro da Rocha, José Joaquim: No conflict of intereset||Prof. Dr. de Ameida Troncon, Luiz Ernesto: No conflict of intereset

P264

Ms. YOON, Yoo Eun: No conflict of intereset||Kim, Hyung mi: No conflict of intereset||Kim, Jie-Hyun: No conflict of intereset||Youn, Young Hoon: No conflict of intereset||Park, Hyo jin: No conflict of intereset||Park, Jae jun: No conflict of intereset

P265

Dr. Skalinskaya, Maria: No conflict of intereset||Dr. Skazyvaeva, Ekaterina: No conflict of intereset||Dr. Zhuravleva, Mariia: No conflict of intereset||Prof. Dr. Bakulin, Igor: No conflict of intereset||Mrs. Komarova , Diana: No conflict of intereset||Mrs. Rasmagina, Irina: No conflict of intereset||Mrs. Ivanova, Kristina: No conflict of intereset

P266

Dr. Hong, Seung Wook: No conflict of intereset||Dr. Soh, Hosim: No conflict of intereset||Dr. Lee, Hyun Jung: No conflict of intereset||Mr. Han, Kyungdo: No conflict of intereset||Dr. Park, Seona: No conflict of intereset||Dr. Moon, Jeong Min: No conflict of intereset||Dr. Kang, Eun Ae: No conflict of intereset||Dr. Chun, Jaeyoung: No conflict of intereset||Dr. Im, Jong Pil: No conflict of intereset||Dr. Kim, Joo Sung: No conflict of intereset

P267

Dr. Reggev, Shirley: No conflict of intereset||Ms. Goran, Ganit: No conflict of intereset||Prof. Sarid, Orly: No conflict of intereset||Dr. Schwartz, Doron: No conflict of intereset||Ms. Sergienko, Ruslan: No conflict of intereset||Prof. Slonim-Nevo, Vered: No conflict of intereset||Prof. Friger, Michael: No conflict of intereset||Mrs. Nemirovsky, Anna: No conflict of intereset||Mrs. Vinogradov, Ekaterina: No conflict of intereset||Prof. Monsonego, Alon: No conflict of intereset||Prof. Greenberg, Dan: No conflict of intereset||Prof. Dr. Odes, Selwyn (Shmuel): No conflict of intereset

P268

Dr. Kabir, Misha: No conflict of intereset||Dr. Fofaria, Rishi: No conflict of intereset||Mr. Basset, Paul: No conflict of intereset||Dr. Arebi, Naila: No conflict of intereset||Mr. Tozer, Phil: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Dr. Wilson, Ana: No conflict of intereset

P269

Dr. Bossuyt, Peter: No conflict of intereset||Prof. Dr. De Hertogh, Gert: No conflict of intereset||Mr. Eelbode, Tom: No conflict of intereset||Prof. Dr. Vermeire, Séverine: No conflict of intereset||Prof. Dr. Bisschops, Raf: No conflict of intereset

P270

Dr. Rocha Silva, João Carlos: No conflict of intereset||Dr. Rodrigues, Jaime: No conflict of intereset||Dr. Rodrigues, Adelia: No conflict of intereset||Dr. Silva, Ana: No conflict of intereset||Dr. Fernades, Carlos: No conflict of intereset||Dr. Sousa, Ana: No conflict of intereset||Dr. Sousa, Mafalda: No conflict of intereset||Dr. Gomes, Ana Catarina: No conflict of intereset||Dr. Afeto, Edgar: No conflict of intereset||Dr. Carvalho, João: No conflict of intereset

P271

Dr. Doherty, Jayne: No conflict of intereset||Dr. Moore, Rebecca: No conflict of intereset||Ms. Kivlehan, Clodagh: No conflict of intereset||Prof. Twomey, Patrick: No conflict of intereset||Prof. McAuliffe, Fionnuala: No conflict of intereset||Dr. Cullen, Garret: No conflict of intereset

Page 61 of 135

P272

P273

Allocca, Mariangela: No conflict of intereset||Dr. Fiorino, Gionata: No conflict of intereset||Furfaro, Federica: No conflict of intereset||Dr. Zilli, Alessandra: No conflict of intereset||Dr. Gilardi, Daniela: No conflict of intereset||Mrs. Radice, Simona: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent: No conflict of intereset||Prof. Danese, Silvio: No conflict of intereset

P274

Dr. KIM, Jin Yong: No conflict of intereset||Prof. Dr. Park, Sang Hyoung: No conflict of intereset||Kim, Ye-Jee: No conflict of intereset||Park, Jae Cheol: No conflict of intereset||Noh, Soomin: No conflict of intereset||Lee, Jung Su: No conflict of intereset||Kim, Jeongseok: No conflict of intereset||Ham, Nam Seok: No conflict of intereset||Oh, Eun Hye: No conflict of intereset||Prof. Dr. Hwang, Sung Wook: No conflict of intereset||Prof. Dr. Yang, Dong-Hoon: No conflict of intereset||Prof. Dr. Ye, Byong Duk: No conflict of intereset||Prof. Dr. Byeon, Jeong-Sik: No conflict of intereset||Prof. Dr. Myung, Seung-Jae: No conflict of intereset||Prof. Dr. Yang, Suk-Kyun: No conflict of intereset

P275

Mr. Chin, Yew Fung: No conflict of intereset||Dr. PUJJI, Ojas: No conflict of intereset||Dr. Wilkinson, Ben: No conflict of intereset||Dr. Mohan, Siddhartha: No conflict of intereset||Mr. Nnaji, Martin: No conflict of intereset||Ms. Yassin, Nuha: No conflict of intereset

P276

Dr. Yamada, Satoshi: No conflict of intereset||Dr. Yamamoto, Shuji: No conflict of intereset||Dr. Honzawa, Yusuke: No conflict of intereset||Dr. Hayashi, Yuki: No conflict of intereset||Dr. Kitamoto, Hiroki: No conflict of intereset||Dr. Okabe, Makoto: No conflict of intereset||Prof. Dr. Seno, Hiroshi: No conflict of intereset

P277

Dr. Sena, Giorgia: No conflict of intereset||Dr. neri, benedetto: No conflict of intereset||Dr. lolli, elisabetta: No conflict of intereset||Dr. Calabrese, emma: No conflict of intereset||Prof. sica, giuseppe: No conflict of intereset||Prof. monteleone, giovanni: No conflict of intereset||Prof. biancone, livia: No conflict of intereset

P278

Dr. SAKURAI, Toshiyuki:|:|Research funding: Tanabe Mitsubishi Pharma. and Abbvie GK ||Dr. Yoshihiro, Akita: No conflict of intereset||Dr. Haruna, Miyashita: No conflict of intereset||Dr. Ryosuke, Miyazaki: No conflict of intereset||Dr. Yuki, Maruyama: No conflict of intereset||Dr. Mariko, Shimada: No conflict of intereset||Dr. Tomoko, Saito: No conflict of intereset||Dr. Takushi, Yamasaki: No conflict of intereset||Prof. Dr. Masayuki, Saruta:|:|Lecture fee: Abbvie GK, Mitsubishi Tanabe Pharma., Janssen Pharma., Takeda Pharma., Zeria Pharma., Kissei Pharma., Pfizer Japan Inc., and Mochida Pharma.|Manuscript fees: EA Pharma.

Dr. Cheung, Vincent Ting Fung:|:|VTFC has received speaker fees from Janssen and support for travel to conferences from Viforpharma, Janssen and VHSquared. His research is funded by the Norman Collisson Foundation.||Dr. Gupta, Tarun:|:|TG is supported by a clinical training fellowship from the Lee Placito Fund. ||Dr. Olsson-Brown, Anna:|:|AOB is an MRC Clinical Training Fellow based at the University of Liverpool supported by the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics, which is funded by the Medical Research Council, Roche Pharma, Eli Lilly and Company Limited, UCB Pharma, Novartis, the University of Liverpool and the University of Manchester. She has received honoraria for speaking at educational events from Roche Pharma, Bristol-Myers-Squibb (BMS) and MSD. She has received honoraria for attending BMS advisory boards. ||Dr. Subramanian, Sreedhar: No conflict of intereset||Dr. Sasson, Sarah Christina:|:|SCS is funded by an Oxford-Celgene Postdoctoral Fellowship.||Dr. Heseltine, Jonathan: No conflict of intereset||Dr. Fryer, Eve: No conflict of intereset||Dr. Collantes, Elena: No conflict of intereset||Dr. Sacco, Joseph J:|:|JJS has received speaker fees from BMS and Pierre Fabre; acted as a consultant for BMS, MSD, Amgen, Delcath and Immunocore; and his institution has received research grants from BMS and AZ. ||Prof. Pirmohamed, Munir:|:|MP is the director of the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics. ||Prof. Simmons, Alison:|:|AS is supported by a Wellcome Investigator Award and UK Medical Research Council.||Prof. Klenerman, Paul: No conflict of intereset||Dr. Fairfax, Benjamin Peter:|:|BPF is supported by a Wellcome Intermediate Clinical Fellowship (201488/Z/16/Z). ||Dr. Payne, Miranda Jane: No conflict of intereset||Prof. Middleton, Mark Ross:|:|MRM has acted as a consultant for Amgen, AstraZeneca, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Immunocore, Lilly, Merck, Millennium, Novartis, Physiomics, Rigontec, and Roche; his institution has received research grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Clovis, Eisai, GlaxoSmithKline, Immunocore, Merck, Millennium, Novartis, Pfizer, Rigontec, Roche, and Vertex. ||Dr. Brain, Oliver:|:|OB has received speaker fees from BMS and has received a research grant from Celgene.

Page 62 of 135

P279

Dr. Corr, Alison: No conflict of intereset||Ms. Reza, Lillian: No conflict of intereset||Dr. Lung, Phillip: No conflict of intereset||Mr. Jenkins, Ian: No conflict of intereset||Mr. Antoniou, Anthony: No conflict of intereset||Dr. Latchford, Andrew: No conflict of intereset||Dr. Wilson, Ana: No conflict of intereset||Dr. Arebi, Naila: No conflict of intereset||Dr. Burling, David: No conflict of intereset||Mr. Warusavitarne, Janindra: No conflict of intereset||Prof. Faiz, Omar: No conflict of intereset||Dr. Thomas-Gibson, Siwan: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Mr. Tozer, Phil: No conflict of intereset

P280

Fasoulas, Kostantinos: No conflict of intereset||Ms. Katsimpeli, Aristi: No conflict of intereset||Kevrekidou, Polyxeni: No conflict of intereset||Kafalis, Nikolaos: No conflict of intereset||Stergiou, Evdoxia: No conflict of intereset||Bouzoukas, Sokratis: No conflict of intereset||Dr. Lazaraki, Georgia: No conflict of intereset||Dr. Tzilves, Dimitris: No conflict of intereset||Soufleris, Konstantinos: No conflict of intereset

P281

HOLMER, Ariela: No conflict of intereset||Dr. Boland, Brigid:|:|Research support from Prometheus Biosciences||Dr. Singh, Siddharth: No conflict of intereset||Neill, Jennifer: No conflict of intereset||Le, Helen: No conflict of intereset||Miralles, Ara: No conflict of intereset||Collins, Angelina: No conflict of intereset||Sandborn, William:|:|Research support from Prometheus Biosciences||Dr. Dulai, Parambir:|:|Research support from Prometheus Biosciences

P282

Dr. Goren, Idan: No conflict of intereset||Dr. Yanai, Henit: No conflict of intereset||Dr. Pal, Partha: No conflict of intereset||Ms. Adigopula , Bhargavi: No conflict of intereset||Mrs. Pendyala, Sushmitha: No conflict of intereset||Dr. Ganesh, Girish: No conflict of intereset||Ms. Yadgar, Karin: No conflict of intereset||Dr. Banerjee*, Rupa: No conflict of intereset||Prof. Dotan*, Iris: No conflict of intereset

P283

Dr. Kormilitzin, Andrey: No conflict of intereset||Dr. Walsh, Alissa Jane: No conflict of intereset||Dr. Matini, Lawrence: No conflict of intereset||Ms. Kantschuster, Ramona: No conflict of intereset||Mrs. Lepetyukh, Marianna: No conflict of intereset||Mrs. Wilson, Jean: No conflict of intereset||Dr. Brain, Oliver: No conflict of intereset||Dr. Palmer, Rebecca: No conflict of intereset||Dr. Ambrose, Timothy: No conflict of intereset||Prof. Satsangi, Jack: No conflict of intereset||Prof. Travis, Simon P L: No conflict of intereset

P284

Dr. Variola, Angela: No conflict of intereset||Dr. Bertolini, Elena: No conflict of intereset||Dr. Di Ruscio, Mirko: No conflict of intereset||Dr. Vernia, Filippo: No conflict of intereset||Dr. Geccherle, Andrea: No conflict of intereset||Dr. Beltrami, Marina: No conflict of intereset||Dr. Tinazzi, Ilaria: No conflict of intereset||Dr. Macchioni, Pierluigi: No conflict of intereset

P285Dr. SANDHU, Kirn: No conflict of intereset||Dr. Ayling, Ruth: No conflict of intereset||Dr. Naik, Sandhia: No conflict of intereset

P286

Dr. Rodriguez Gutiérrez, Cristina: No conflict of intereset||Dr. Elosua Gonzalez, Alfonso: No conflict of intereset||Dr. Prieto Martínez, Carlos: No conflict of intereset||Dr. Rubio Iturria, Saioa: No conflict of intereset||Dr. Vicuña, Miren Arregui: No conflict of intereset||Dr. Nantes Castillejo, Óscar: No conflict of intereset

P287Mr. Lie, Mitchell R K L: No conflict of intereset||Mrs. Paulides, Emma: No conflict of intereset||Prof. van der Woude, Christien Janneke: No conflict of intereset

P288

Dr. Sipeki, Nóra:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.|||Kovats, Patricia:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.|||Dr. Balogh, Boglarka: No conflict of intereset||Dr. Shums, Zakera:|:|Regarding financial conflicts of interest Zakera Shums is employed by Inova Diagnostics, Inc., San Diego, California and is getting personal fees from the company.||Dr. Norman, Gary L.:|:|Regarding financial conflicts of interest Gary L. Norman is employed by Inova Diagnostics, Inc., San Diego, California and is getting personal fees from the company.||Prof. Dr. Antal-Szalmas, Peter: No conflict of intereset||Dr. Papp, Maria:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.

P289

Mrs. Tavakoli, Paris: No conflict of intereset||Prof. Vollmer-Conna , Ute: No conflict of intereset||Dr. Vazquez Campos , Xabier: No conflict of intereset||Mr. Hadzi-Pavlovic, Dusan: No conflict of intereset||Prof. Grimm, Michael: No conflict of intereset

P290

Mrs. Kontola, Kristi: No conflict of intereset||Dr. Oksanen, Pia: No conflict of intereset||Mrs. Huhtala, Heini: No conflict of intereset||Dr. Tunturi-Hihnala, Helena: No conflict of intereset||Dr. Jussila, Airi: No conflict of intereset

P291Prof. Dr. Yamamoto-Furusho, Jesús Kazuo: No conflict of intereset||Dr. Mendieta-Escalante, Erick A: No conflict of intereset

P292

Dr. Castro, Beatriz: No conflict of intereset||Dr. García García, María José: No conflict of intereset||Dr. Pascual, Marta: No conflict of intereset||Dr. Fernández-Forcelledo, José Luis: No conflict of intereset||Prof. Dr. Crespo, Javier: No conflict of intereset||Prof. Dr. Rivero, Montserrat: No conflict of intereset

Page 63 of 135

P293

Dr. BUSACCA, Anita: No conflict of intereset||Dr. Scrivo, Barbara: No conflict of intereset||Dr. Giuffrida, Enrica: No conflict of intereset||Dr. Guida, Laura: No conflict of intereset||Dr. Carrozza, Lucio: No conflict of intereset||Dr. Calvaruso, Vincenza: No conflict of intereset||Dr. Cappello, Maria: No conflict of intereset

P294

Dr. Ozgur, Duygu: No conflict of intereset||Dr. Hatemi, Ali Ibrahim: No conflict of intereset||Prof. Erzin, Yusuf: No conflict of intereset||Prof. Çelik, Aykut: No conflict of intereset

P295

Ms. Le Berre, Catherine: No conflict of intereset||Prof. Dr. Bourreille, Arnaud: No conflict of intereset||Dr. Flamant, Mathurin: No conflict of intereset||Prof. Dr. Bouguen, Guillaume: No conflict of intereset||Prof. Dr. Siproudhis, Laurent: No conflict of intereset||Dr. Dewitte, Marie: No conflict of intereset||Dr. Dib, Nina: No conflict of intereset||Dr. Cesbron-Metivier, Elodie: No conflict of intereset||Mr. Goronflot, Thomas: No conflict of intereset||Mr. Gourraud, Pierre-Antoine: No conflict of intereset||Mrs. Kerdreux , Elise: No conflict of intereset||Mrs. Poinas, Alexandra: No conflict of intereset||Dr. Trang-Poisson, Caroline: No conflict of intereset

P296

Dr. SHARMA, Neel: No conflict of intereset||Mr. Virk, Arjun: No conflict of intereset||Ms. Nardone, Olga: No conflict of intereset||Dr. Smith, Samuel: No conflict of intereset||Dr. Rimmer, Peter: No conflict of intereset||Dr. Shivaji, Uday: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset||Prof. Iacucci, Marietta: No conflict of intereset

P297

Dr. Nardone, Olga Maria: No conflict of intereset||Dr. Jeffery, Louisa: No conflict of intereset||Ms. Bazarova, Alina: No conflict of intereset||Dr. Acharjee, Animesh: No conflict of intereset||Prof. Gkoutos, Georgios: No conflict of intereset||Dr. Zardo, Davide: No conflict of intereset||Dr. Shivaji, Uday N: No conflict of intereset||Dr. Smith, Samuel CL: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset||Dr. Iacucci, Marietta: No conflict of intereset

P298

Wong, Darren: No conflict of intereset||Ms. Kantschuster, Ramona: No conflict of intereset||Dr. Matini, Lawrence: No conflict of intereset||Mr. Simadibrata, Daniel: No conflict of intereset||Mrs. Lepetyukh, Marianna: No conflict of intereset||Mrs. Wilson, Jean: No conflict of intereset||Dr. Brain, Oliver: No conflict of intereset||Dr. Palmer, Rebecca: No conflict of intereset||Dr. Ambrose, Timothy: No conflict of intereset||Prof. Dr. Satsangi, Jack: No conflict of intereset||Prof. Dr. Travis, Simon: No conflict of intereset||Walsh, Alissa Jane: No conflict of intereset

P299

Dr. González-Bernardo, Oscar: No conflict of intereset||Dr. Vivas, Santiago: No conflict of intereset||Dr. de Francisco, Ruth: No conflict of intereset||Dr. Pérez-Martínez, Isabel: No conflict of intereset||Dr. Castaño-García, Andrés: No conflict of intereset||Dr. Jiménez-Beltrán, Víctor: No conflict of intereset||Dr. Flórez-Díez, Pablo: No conflict of intereset||Dr. Martínez-González, Susana: No conflict of intereset||Ms. Rolle, Valeria: No conflict of intereset||Dr. Suárez, Patricio: No conflict of intereset||Dr. Suárez, Adolfo: No conflict of intereset||Dr. Riestra Menéndez, Sabino: No conflict of intereset

P300

Dr. DIPASQUALE, Valeria: No conflict of intereset||Dr. Catena, Maria Ausilia: No conflict of intereset||Dr. Paiano, Lucia: No conflict of intereset||Prof. Trimarchi, Giuseppe: No conflict of intereset||Prof. Romeo, Carmelo: No conflict of intereset||Prof. Navarra, Giuseppe: No conflict of intereset||Prof. Mattioli, Girolamo: No conflict of intereset||Prof. Romano, Claudio: No conflict of intereset

P301

Dr. Canavese, Gabriella: No conflict of intereset||Dr. Saragoni , Luca: No conflict of intereset||Dr. Salviato , Tiziana: No conflict of intereset||Dr. Reggiani Bonetti , Luca: No conflict of intereset||Dr. Leoncini , Giuseppe: No conflict of intereset||Dr. Baron , Luigi: No conflict of intereset||Dr. Facchetti , Mattia: No conflict of intereset||Dr. Vignale , Chiara: No conflict of intereset||Prof. Villanacci , Vincenzo: No conflict of intereset

P302

HOLMER, Ariela: No conflict of intereset||Boland, Brigid:|:|Research support from Prometheus Biosciences.||Singh, Siddharth: No conflict of intereset||Le, Helen: No conflict of intereset||Neill, Jennifer: No conflict of intereset||Miralles, Ara: No conflict of intereset||Collins, Angelina: No conflict of intereset||Sandborn, William:|:|Research support from Prometheus Biosciences.||Dr. Dulai, Parambir:|:|Research support from Prometheus Biosciences.

P303

Mrs. MAYOR DELGADO, Patricia: No conflict of intereset||Suarez Ferrer, Cristina J.: No conflict of intereset||Poza Cordon, Joaquín: No conflict of intereset||Martin Arranz, Eduardo: No conflict of intereset||Rueda Garcia, Jose Luis: No conflict of intereset||Sanchez Azofra, María: No conflict of intereset||Cuadros Martinez, Marta: No conflict of intereset||Ruiz Ramirez, Maria Angeles: No conflict of intereset||Martin Arranz, Maria Dolores: No conflict of intereset

P304

Dr. Phillips, Frank: No conflict of intereset||Dr. Verstockt, Bram: No conflict of intereset||Dr. Ribaldone, Davide: No conflict of intereset||Dr. Guerra, Ivan: No conflict of intereset||Dr. Teich, Niels: No conflict of intereset||Dr. Katsanos, Kostas: No conflict of intereset||Dr. Filip, Rafal: No conflict of intereset||Dr. Molner, Tamas: No conflict of intereset||Dr. Karmiris, Konstantinos: No conflict of intereset Page 64 of 135

P305

Dr. Sipeki, Nóra:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.||Kovats, Patricia:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.|||Deutschmann, Claudia: No conflict of intereset||Prof. Dr. Schierack, Peter: No conflict of intereset||Roggenbuck, Dirk:|:|Dirk Roggenbuck is a shareholder of GA Generic Assays and Medipan GmbH and has a managerial position in both companies. ||Dr. Maria, Papp:|:|The work is supported by the EFOP-3.6.1-16-016-00022 project. The project is co-financed by the European Union and the European Social Fund.

P306

Dr. Skalinskaya, Maria: No conflict of intereset||Dr. Skazyvaeva, Ekaterina: No conflict of intereset||Prof. Dr. Bakulin, Igor: No conflict of intereset||Mrs. Rasmagina, Irina: No conflict of intereset||Mrs. Komarova, Diana: No conflict of intereset||Mrs. Ivanova, Kristina: No conflict of intereset

P307

Mr. De Jong, Michiel: No conflict of intereset||Dr. Vos, Shoko: No conflict of intereset||Prof. Nagtegaal, Iris: No conflict of intereset||Ms. van Herwaarden, Yasmijn: No conflict of intereset||Dr. Derikx, Lauranne: No conflict of intereset||Dr. Hoentjen, Frank: No conflict of intereset

P308

Mr. KUTSCHERA, Maximilian: No conflict of intereset||Prof. Waldhör, Thomas: No conflict of intereset||Dr. Gröchenig, Hans Peter: No conflict of intereset||Dr. Haas, Thomas: No conflict of intereset||Dr. Wenzl, Heimo: No conflict of intereset||Dr. Steiner, Pius: No conflict of intereset||Prof. Koch, Robert: No conflict of intereset||Dr. Feichtenschlager, Thomas: No conflict of intereset||Dr. Eckhardt, Gerald: No conflict of intereset||Dr. Mayer, Andreas: No conflict of intereset||Dr. Kirchgatterer, Andreas: No conflict of intereset||Dr. Ludwiczek, Othmar: No conflict of intereset||Dr. Platzer, Reingard: No conflict of intereset||Dr. Papay, Pavol: No conflict of intereset||Dr. Gartner, Johanna: No conflict of intereset||Dr. Fuchssteiner, Harry: No conflict of intereset||Dr. Peters, Paul-Gerhard: No conflict of intereset||Dr. Reicht, Gerhard: No conflict of intereset||Prof. Moser, Gabriele: No conflict of intereset||Prof. Dejaco, Clemens: No conflict of intereset||Dr. Primas, Christian: No conflict of intereset||Prof. Novacek, Gottfried: No conflict of intereset||Dr. Miehsler, Wolfgang: No conflict of intereset

P309

Mr. DAUDE, Sébastien: No conflict of intereset||Dr. Remen, Thomas: No conflict of intereset||Mr. Chateau , Thomas: No conflict of intereset||Prof. Danese, Silvio:|:|He served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, MSD, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alphawasserman, Genentech, Grunenthal, Pfizer, AstraZeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor and Johnson and Johnson, and Nikkiso Europe GMBH. M Nedeljkovic works for Tillotts Pharma AG (Fivasa®). ||Prof. Gastin, Isabelle: No conflict of intereset||Prof. Baumann, Cédric: No conflict of intereset||Prof. Gueant, Jean Louis: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent:|:|He reports personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen; grants from Abbvie, MSD, Takeda; stock options: CTMA.

P310

Dr. Takagi, Tomohisa: No conflict of intereset||Dr. Uchiyama, Kazuhiko: No conflict of intereset||Dr. Kajiwara, Mariko: No conflict of intereset||Dr. Azuma, Yuka: No conflict of intereset||Dr. Takayama, Shun: No conflict of intereset||Dr. Yasuda, Ritsu: No conflict of intereset||Dr. Inoue, Ken: No conflict of intereset||Dr. Ryohei, Hirose: No conflict of intereset||Dr. Dohi, Osamu: No conflict of intereset||Dr. Yoshida, Naohisa: No conflict of intereset||Dr. Kamada, Kazuhiro: No conflict of intereset||Dr. Ishikawa, Takeshi: No conflict of intereset||Dr. Yagi, Nobuaki: No conflict of intereset||Dr. Naito, Yuji: No conflict of intereset||Dr. Itoh, Yoshito: No conflict of intereset

P311

Dr. Stidham, Ryan:|:|Disclosures:|RWS has served as a consultant for Abbvie, Janssen, Merck and Takeda||Funding Support:|This research was funded by a grant from Abbvie (RWS, VV)||Mr. Yu, Deahan: No conflict of intereset||Dr. Lahiri, Shibamouli: No conflict of intereset||Prof. Vydiswaran, Vinod: No conflict of intereset

P312Dr. Lev Zion, Raffi: No conflict of intereset||Ms. Focht, Gili: No conflict of intereset||Ms. Asayag, Noa: No conflict of intereset||Prof. Turner, Dan: No conflict of intereset

P313

Ms. de Jong, Djuna Chanel: No conflict of intereset||Ms. Wasmann, Karin: No conflict of intereset||Dr. Buskens, Christianne: No conflict of intereset||Prof. Dr. Bemelman, Willem: No conflict of intereset||Dr. Löwenberg, Mark: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset||Prof. Dr. Ponsioen, Cyriel: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Dr. Hompes, Roel: No conflict of intereset||Dr. Duijvestein, Marjolijn: No conflict of intereset

Page 65 of 135

P314

Rodriguez, Tina: No conflict of intereset||Karpin, Jordan: No conflict of intereset||Traboulsi, Cindy: No conflict of intereset||Rai, Victoria: No conflict of intereset||Prof. Dr. Rubin, David: No conflict of intereset

P315

Mrs. Oliveira, Leticia: No conflict of intereset||Yukie Sassaki, Ligia: No conflict of intereset||Elisa Valencise Quagli, Ana: No conflict of intereset||Ribeiro de Barros, Jaqueline: No conflict of intereset

P316 Prof. Moon, Won: No conflict of intereset||Prof. Dr. Seo , Kwang Il: No conflict of intereset

P317

Les, Anda: No conflict of intereset||Dr. Iacob, Razvan: No conflict of intereset||Dr. Costache, Roxana: No conflict of intereset||Prof. Dr. Gheorghe, Liana: No conflict of intereset||Prof. Dr. Gheorghe, Cristian: No conflict of intereset

P318

Dr. Skalinskaya, Maria: No conflict of intereset||Bakulin, Igor: No conflict of intereset||Skazyvaeva, Ekaterina: No conflict of intereset||Dr. Rasmagina, Irina: No conflict of intereset||Mr. Mashevskii, Gleb: No conflict of intereset||Ms. Shelyakina, Natalia: No conflict of intereset||Dr. Ivanova, Kristina: No conflict of intereset||Dr. Berest, Dmitrii: No conflict of intereset

P319

Dr. Gubonina, Irina Vladimirovna: No conflict of intereset||Prof. Grinevich, Vladimir: No conflict of intereset||Dr. Poluektov, Maxim: No conflict of intereset||Ms. Kolodin, Timur: No conflict of intereset||Mrs. Lapteva, Svetlana: No conflict of intereset||Mrs. Gamzaeva, Ainura: No conflict of intereset||Mrs. Gubonina, Nadezda: No conflict of intereset

P320

Dr. GAZELAKIS, Kathryn: No conflict of intereset||Ms. Chu, Isabel: No conflict of intereset||Dr. Martin, Catherine: No conflict of intereset||Dr. Ward, Mark: No conflict of intereset||Prof. Sparrow, Miles: No conflict of intereset

P321

Dr. JOO, Yu Young: No conflict of intereset||Prof. Lee, Bo-In: No conflict of intereset||Prof. Kim, Seung-Jun: No conflict of intereset||Prof. Lee, Han Hee: No conflict of intereset||Prof. Kim, Jin Su: No conflict of intereset||Prof. Park, Jae Myung: No conflict of intereset||Prof. Cho, Young-Seok: No conflict of intereset||Prof. Lee, Kang Moon: No conflict of intereset||Prof. Kim, Sang Woo: No conflict of intereset||Prof. Choi, Hwang: No conflict of intereset||Prof. Choi, Myung-Gyu: No conflict of intereset

P322

Dr. NUÑEZ ORTIZ, Andrea: No conflict of intereset||Dr. Trigo Salado, Claudio: No conflict of intereset||Dr. De la Cruz Ramírez, María Dolores: No conflict of intereset||Dr. Márquez Galán, José Luis: No conflict of intereset||Dr. Herrera Justiniano, José Manuel: No conflict of intereset||Dr. Leo Carnerero, Eduardo: No conflict of intereset

P323

Mr. Takacs, Michael:|:|Grant from Eurostars E!10684 opTIMISm||Ms. Hellige, Antje:|:|Grant from Eurostars E!10684 opTIMISm||Dr. Schuster, Thomas:|:|Grant from Eurostars E!10684 opTIMISm||Ms. Schleifenbaum, Susanne:|:|Grant from Eurostars E!10684 opTIMISm||Prof. Dr. Föll, Dirk:|:|Grant from Eurostars E!10684 opTIMISm||Dr. Weber, Jakob M.:|:|Grant from Eurostars E!10684 opTIMISm

P324 Dr. LIM, Chul-Hyun: No conflict of intereset||Dr. Kim, Jinsu: No conflict of intereset

P325

Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as an advisory board member and/or received lecture grants from AbbVie, Biogen, MSD, and Takeda Pharmaceuticals||Dr. Ventimiglia, Marco: No conflict of intereset||Prof. Fries, Walter: No conflict of intereset||Dr. Viola, Anna: No conflict of intereset||Dr. Sitibondo, Aldo: No conflict of intereset||Dr. Cappello, Maria:|:|Maria Cappello served as an advisory board member for AbbVie, MSD, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Chiesi, and Takeda Pharmaceuticals.||Dr. Scrivo, Barbara: No conflict of intereset||Dr. Busacca, Anita: No conflict of intereset||Dr. Privitera, Antonino Carlo: No conflict of intereset||Dr. Camilleri, Salvatore: No conflict of intereset||Dr. Garufi, Serena: No conflict of intereset||Dr. Di Mitri, Roberto: No conflict of intereset||Dr. Mocciaro, Filippo:|:|Filippo Mocciaro served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, MSD and Takeda Pharmaceuticals||Dr. Belluardo, Nunzio: No conflict of intereset||Dr. Giangreco, Emiliano: No conflict of intereset||Dr. Bertolami, Carmelo: No conflict of intereset||Dr. Renna, Sara:|:|Sara Renna served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, MSD and Takeda Pharmaceuticals ||Dr. Orlando, Rosalba: No conflict of intereset||Dr. Rizzuto, Giulia: No conflict of intereset||Prof. Cottone, Mario: No conflict of intereset||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals.

Page 66 of 135

P326

Mrs. Mahmmod, Shaden: No conflict of intereset||Mr. SCHULTHEISS, Johannes Paulus Damiaan: No conflict of intereset||Dr. Tan, Adriaan C I T L: No conflict of intereset||Dr. Lutgens, Maurice Wilhelmus Maria Dieudonné: No conflict of intereset||Dr. Gilissen, Lennard P L: No conflict of intereset||Mr. Mahmmod, Nofel: No conflict of intereset||Dr. van der Meulen - de Jong, Andrea E:|:|Has served on advisory boards, or as speaker or consultant for Takeda, Tramedico, AbbVie, and has received grants from Takeda.||Prof. Dr. Dijkstra, Gerard:|:|Unrestricted research grants from Abbvie, Takeda and Ferring Pharmaceuticals. Advisory boards for Mundipharma and Pharmacosmos. Received speakers fees from Takeda and Janssen Pharmaceuticals||Dr. van Bodegraven, Ad a:|:|Has been a consultant for medical issues or provided paid lectures for AbbVie, Biogen, Ferring, Janssen-Cilag, MSD, Pfizer, Samsung, Takeda, TEVA, and Tramedico||Prof. Dr. Oldenburg, Bas:|:|speaker: Ferring, MSD, Abbvie. Advisory boards: Ferring, MSD, Abbvie, Takeda, Pfizer, Janssen. Research Grants: Abbvie, Ferring, Takeda, Pfizer, MSD, dr. Falk||Dr. Fidder, Herma H:|:|H.H. Fidder has done consultation for Abbvie BV, Janssen BV, Ferring BV and Takeda BV.

P327

Ms. Rundquist, Sara:|:|SR received speaker’s fee from Takeda. SR was supported by grants from the research committee in Region Örebro County and the Regional Agreement on Medical Training and Clinical Research between Region Örebro County and Örebro University (ALF).||Sachs, Michael: No conflict of intereset||Eriksson, Carl:|:|CE received grant support/lecture fee/advisory board from: Takeda, Janssen Cilag, Pfizer, Abbvie||Olén, Ola:|:|OO has been PI on projects at Karolinska Institutet partly financed by investigator-initiated grants from Janssen and Ferring, and also report a grant from Pfizer in the context of a national safety monitoring program. None of those studies have any relation to the present study. Karolinska Institutet has received fees for lectures and participation on advisory boards from Janssen, Ferring, Takeda, and Pfizer regarding topics not related to the present study.|OO was supported by grants from the Swedish Medical Society (Project grants; Fund for Research in Gastroenterology; and Ihre Foundation), Mag-tarmfonden, Karolinska Institutet Foundations, the Young Scholar Award from the Strategic Research Area Epidemiology program at Karolinska Institutet, and the Regional Agreement on Medical Training and Clinical Research between Stockholm County Council and Karolinska Institutet (ALF).||Montgomery, Scott: No conflict of intereset||Halfvarson, Jonas:|:|JH has served as a speaker, a consultant and/or an advisory board member for Abbvie, Celgene, Celltrion, Ferring, Hospira, Janssen, Medivir, MSD, Olink Proteomics, Pfizer, Prometheus Laboratories Inc., RenapharmaVifor, Sandoz, Shire, Takeda, Thermo Fisher, Tillotts Pharma. Received research funding from Janssen, MSD, Takeda.

P328

Mrs. Van Lingen, Emilie: No conflict of intereset||Dr. van der Meulen-de Jong, a.e.: No conflict of intereset||Mrs. Vendrik, k e w.: No conflict of intereset||Prof. Dr. Kuijper, e j: No conflict of intereset||Dr. Terveer, e m.: No conflict of intereset||Dr. Keller, j j: No conflict of intereset

P329

Mrs. Lansdorp, Corine: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset||Dr. Buskens, Chrstianne: No conflict of intereset||Dr. Löwenberg, Mark: No conflict of intereset||Prof. Dr. Stoker, Jaap: No conflict of intereset||Prof. Dr. Bemelman, Willem: No conflict of intereset||Prof. Dr. D'Haens, Geert:|:|G’DH has received consulting fees from Robarts Clinical Trials; personal fees from Ablynx, Amakem, Amgen, AM Pharma, Boehringer-Ingelheim, Bristol Myers Squibb, Cosmo, Celgene, Celtrion, Covidien, Engene, Galapagos, Medimetrics, Mundipharma, Mitsubishi, Novonordisk, Pfizer, Receptos, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Topivert, Versant and Vifor; grants and personal fees from Abbvie, Ferring, Glaxo Smith Kline, Jansen Biologics, Hospira, Merck Sharp Dome, Prometheus Labs, Robarts Clinical Trials, Takeda and Tillotts; and grants from Dr Falk Pharma and Photopill.||Prof. Dr. van Hulst, Rob: No conflict of intereset

P330

Mr. THOMAS, Pepijn: No conflict of intereset||Dr. West, Rachel: No conflict of intereset||Dr. Russel, Maurice: No conflict of intereset||Mr. Jansen, Jeroen: No conflict of intereset||Ms. van Lint, Jette: No conflict of intereset||Dr. Jessurun , Naomi: No conflict of intereset||Dr. Römkens , Tessa: No conflict of intereset||Dr. Hoentjen, Frank: No conflict of intereset

P331

Howaldt, Stefanie: No conflict of intereset||Jacob, Ian:|:|Ian Jacob is an employee of Health Economics and Outcomes Research Ltd. and received funding from Norgine Ltd. to undertake the analysis outlined in this study.||Sampson, Mark:|:|Mark Sampson is an employee and stockholder at Shield Therapeutics PLC.||Akriche, Fatma:|:|Fatma Akriche is an employee of Norgine Ltd.

P332

Dr. Schwartz, Doron: No conflict of intereset||Mr. Sergienko, Ruslan: No conflict of intereset||Ms. Goren, Ganit: No conflict of intereset||Dr. Reggev, Shirley: No conflict of intereset||Prof. Friger, Michael: No conflict of intereset||Nemirovsky, Anna: No conflict of intereset||Prof. Monsonego, Alon: No conflict of intereset||Prof. Greenberg, Dan: No conflict of intereset||Prof. Sarid, Orly: No conflict of intereset||Prof. Slonim-Nevo, Vered: No conflict of intereset||Prof. Dr. Odes, Selwyn (Shmuel): No conflict of intereset

Page 67 of 135

P333

Mrs. Sharma, Esha: No conflict of intereset||Dr. Cunningham, Georgina: No conflict of intereset||Dr. Dawson, Patrick: No conflict of intereset||Dr. D'Errico, Francesca: No conflict of intereset||Dr. Honap, Sailish:|:|Lecture fees: Pfizer, Janssen, Takeda.|Meeting support fees: Pfizer, Janssen, Dr Falk Pharma, Vifor Pharma.||Dr. Lim, Samuel: No conflict of intereset||Dr. Luber, Raphael: No conflict of intereset||Dr. Meade, Susanna: No conflict of intereset||Dr. Pavlidis, Polychronis: No conflict of intereset||Dr. Reynolds, Rebecca: No conflict of intereset||Dr. Irving, Peter:|:|Lecture fees: Abbvie, Warner, Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Pfizer.|Financial support for research: MSD, Takeda, Pfizer.|Advisory fees: Abbvie, Warner, Chilcott, Takeda, MSD, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis

P334

Travis, Simon:|:|Grants: AbbVie, BÜHLMANN, Celgene, Eli Lilly, IOIBD, Janssen, Norman Collisson Foundation, Takeda, UCB, Vifor|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Asahi, Astellas, Biocare, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, BÜHLMANN, Celgene, Chemocentryx, Cosmo, Eli Lilly, Enterome, F. Hoffmann-La Roche, Ferring, Genentech, Giuliani SpA, GSK, Immunocore, Immunometabolism, Indigo, Janssen, Lexicon, Merck, MSD, Neovacs, Novartis, NovoNordisk, NPS Pharmaceuticals, Pfizer Inc, Proximagen, Receptos, Shire, Sigmoid Pharma, SynDermix, Takeda, Theravance, Tillotts, Topivert, UCB, VHsquared, Vifor, Zeria|Other: Employee: Oxford University Hospitals NHS Foundation Trust, The University of Oxford||Dotan, Iris:|:|Personal fees: AbbVie, Altman Research, Arena, Celltrion, DSM, Ferring, Falk Pharma, Genentech/Roche, Janssen, MSD, Neopharm, Medtronic/Given Imaging, Nestle, Pfizer Inc, Protalix, Rafa Laboratories, Sublimity, Takeda||Danese, Silvio:|:|Consultancy: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer Inc, Roche, Sandoz, Takeda, TiGenix, UCB, Vifor ||Chiorean, Michael:|:|Grants: Takeda|Personal fees: AbbVie, Arena Pharmaceuticals, Celgene, Janssen, Medtronic, Pfizer Inc, Prometheus Laboratories|Takeda||Yamamoto-Furusho, Jesús:|:|Grants: Bristol-Myers Squibb, Celgene, Pfizer Inc, Shire, Takeda|Personal fees: AbbVie, Alfasigma, Almirall, Celltrion, Danone, Farmasa, Ferring, Janssen, Hospira, Pfizer Inc, Takeda, UCB |Other: past President of the Pan American Crohn’s and Colitis Organisation (PANCCO)||Ponce de Leon, Dario:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health||Maller, Eric:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Colombel, Jean-Frédéric:|:|Grants: AbbVie, Janssen, Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enterome, Ferring, Genentech, Genfit, Intestinal Biotech Development, Ipsen, Janssen, Landos, MedImmune, Merck, Novartis, Pfizer Inc, Shire, Takeda, Tigenix, Viela Bio

P335

Dr. Sitibondo, Aldo: No conflict of intereset||Dr. Viola, Anna: No conflict of intereset||Dr. Costantino, Giuseppe: No conflict of intereset||Centritto, Andrea: No conflict of intereset||Dr. Belvedere, Alessandra: No conflict of intereset||Pisana, Valentina: No conflict of intereset||Dr. Abbruzzese, Alfredo: No conflict of intereset||Prof. Alibrandi, Angela: No conflict of intereset||Prof. Fries, Walter: No conflict of intereset

P336

Mr. Nnaji, Martin: No conflict of intereset||Dr. Chin, Yew Fung: No conflict of intereset||Dr. Pujji , Ojas: No conflict of intereset||Dr. Wilkinson, Ben: No conflict of intereset||Dr. Mohan, Siddhartha: No conflict of intereset||Ms. Yassin, Nuha A.: No conflict of intereset

P337

Ms. Oh, Eun Hye: No conflict of intereset||Ms. A-Ran , Yoon: No conflict of intereset||Ms. Ye-Jee, Kim: No conflict of intereset||Dr. Jeongseok, Kim: No conflict of intereset||Dr. Namseok, Nam: No conflict of intereset||Prof. Dr. Sang Hyoung, Park: No conflict of intereset||Prof. Dr. Dong-Hoon , Yang: No conflict of intereset||Prof. Dr. Jeong-Sik, Byeon: No conflict of intereset||Prof. Dr. Seung-Jae, Myung: No conflict of intereset||Prof. Dr. Suk-Kyun , Yang: No conflict of intereset||Prof. Dr. Byong Duk, Ye: No conflict of intereset

P338

Ms. Willett, Natalie: No conflict of intereset||Ms. Heisler, Courtney Grace: No conflict of intereset||Ms. Nazer, Nancy: No conflict of intereset||Ms. Currie, Barbara: No conflict of intereset||Ms. Phalen-Kelly, Kelly: No conflict of intereset||Dr. Stewart, Michael: No conflict of intereset||Dr. Jones, Jennifer: No conflict of intereset

P339

Dr. Zhu, Xia: No conflict of intereset||Dr. Chao, Kang: No conflict of intereset||Prof. Gao, Xiang: No conflict of intereset||Prof. Huang, Min: No conflict of intereset||Prof. Wang, Xue-ding: No conflict of intereset

Page 68 of 135

P340

Ms. Asscher, Vera: No conflict of intereset||Mr. Biemans, Vince: No conflict of intereset||Dr. Pierik, Marie:|:|Dr. Pierik has served on advisory boards, or as speaker or consultant for Abbvie, Janssen-Cilag, MSD, Takeda, Ferring, Dr Falk , and Sandoz and has received unrestricted grants from, Janssen-Cilag, Abbvie and Takeda outside the submitted work||Prof. Dr. Dijkstra, Gerard:|:|Prof. Dr. Dijkstra received unrestricted research grants from Abbvie, Takeda and Ferring Pharmaceuticals. Advisory boards for Mundipharma and Pharmacosmos. Received speakers fees from Takeda and Janssen Pharmaceuticals.||Dr. Van der Meulen-de Jong, Andrea:|:|Dr. van der Meulen - de Jong has served on advisory boards, or as speaker or consultant for Takeda, Tramedico, AbbVie, and has received grants from Takeda.||Dr. Löwenberg, Mark:|:|Dr. Löwenberg has served as speaker and/or principal investigator for: Abbvie, Celgene, Covidien, Dr. Falk, Ferring Pharmaceuticals, Gilead, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, Protagonist therapeutics, Receptos, Takeda, Tillotts, Tramedico. He has received research grants from AbbVie, Merck Sharp & Dohme, Achmea healthcare and ZonMW.||Dr. van der Marel, Sander: No conflict of intereset||Dr. de Boer, Nanne:|:|Dr. de Boer has served as a speaker for AbbVie, Takeda and MSD. He has served as consultant and principal investigator for Takeda and TEVA Pharma B.V. He has received (unrestricted) research grants from Dr. Falk and Takeda.||Dr. Bodelier, Alexander:|:|Dr. Bodelier has served as speaker and/ or participant in advisory board for: Abbvie, Merck Sharp & Dohme, Takeda, Vifor Pharma, Mundipharma.||Mr. Jansen, Jeroen:|:|Dr. Jansen has served on advisory boards, or as speaker or consultant for Abbvie, Amgen, Ferring, Fresenius, Janssen, MSD, Pfizer, Takeda. ||Dr. West, Rachel:|:|Dr. West has participated in advisory board and/or received financial compensation from the following companies: Jansen and Abbvie.||Dr. Haans, Jeoffrey:|:|Dr. Haans reports personal fees from advisory boards for Takeda Nederland B.V., personal fees from advisory boards for Lamepro B.V.||Dr. van Dop, Willemijn: No conflict of intereset||Prof. Dr. Weersma, Rinse:|:|Prof. Dr. Weersma has received unrestricted research grants from Takeda, Tramedico and Ferring. ||Dr. Hoentjen, Frank:|:|Dr. Hoentjen has served on advisory boards, or as speaker or consultant for Abbvie, Celgene, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz and Dr Falk , and has received unrestricted grants from Dr Falk, Janssen-Cilag, Abbvie.||Dr. Maljaars, Jeroen:|:|Dr. Maljaars has served as a speaker and an advisory board member for Abbvie, Takeda and Janssen-Cilag.

Page 69 of 135

P341

P342

Colombel, Jean-Frederic:|:|Grants: AbbVie, Janssen, Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enterome, Ferring, Genentech, Genfit, Intestinal Biotech Development, Ipsen, Janssen, Landos, MedImmune, Merck, Novartis, Pfizer Inc, Shire, Takeda, Tigenix, Viela Bio ||Bushmakin, Andrew G:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Cappelleri, Joseph C:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kulisek, Nicole:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Santana, Genoile O:|:|Personal Fees: AbbVie, Ferring, Janssen, Pfizer Inc, Takeda, UCB Pharma||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Ponce de Leon, Dario:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lakatos, Peter L:|:|Grant: AbbVie, MSD, Pfizer Inc|Personal fees: AbbVie, Arena Pharmaceuticals, Celltrion, Falk Pharma GmbH, Ferring, Genetech, Janssen, Merck, Pharmacosmos, Pfizer Inc, Roche, Shire, Takeda

Vickers, Adrian:|:|AV is an employee of RTI Health Solutions, which received funding from Shire, a Takeda company, for this study.||Nag, Arpita:|:|AN is an employee of Shire, a Takeda company.||Devine, Beth:|:|BD is a consultant for Shire, a Takeda company, and Mallinckrodt Pharmaceuticals.||Dr. Sands, Bruce E:|:|BES has received consultancy fees from AbbVie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella Bioscience, Celltrion Healthcare, Genentech, F Hoffmann-La Roche AG, Ironwood Pharmaceuticals, Janssen, Lilly, Morphic Therapeutic, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Laboratorie, Salix, Shire, Takeda, TARGET PharmaSolutions, Theravance Biopharma and Vivelix Pharmaceuticals, and research support from Theravance Biopharma.|This study was conducted by RTI Health Solutions, and funded by Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies.|Medical writing support was provided by Katie Pillidge, PhD, of PharmaGenesis London, London, UK, and funded by Shire International GmbH, a member of the Takeda group of companies.|||Panaccione, Remo:|:|RP has received consultancy fees from AbbVie, Abbott, Alba Therapeutics, Allergan, Amgen, Aptalis, AstraZeneca, Atlantic Healthcare, Baxter, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cosmo Technologies, Coronado Biosciences, Cubist, Eisau Medical Research, Elan, Eli Lilly, enGene, EnteroMedics, Exagen Diagnostics, Ferring, Genentech, Genzyme, Gilead, Given Imaging, GSK, Hospira, Human Genome Sciences, Janssen, Merck & Co., Merck Research Laboratories, Merck Serono, Millennium, Nisshin Kyorin, Novo Nordisk, Pfizer Inc, Qu Biologics, Receptos, Relypsa, Salient, Salix Pharmaceuticals, Santarus, Shire, Sigmoid Pharma, and Takeda; speakers bureau fees from AbbVie, Aptalis, Celgene, Ferring, Janssen, Merck, Pfizer Inc, Prometheus Laboratories, Shire and Takeda; and financial support for research from AbbVie, Ferring, Janssen, Shire and Takeda.||Peyrin-Biroulet, Laurent:|:|LPB has received personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine ; Mylan, Lilly, Fresenius, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera; grants from Abbvie, MSD and Takeda; and holds stock options in CTMA.||Danese, Silvio:|:|SD has received consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer, Roche, Sandoz, Takeda, TiGenix, UCB Inc., and Vifor.||Vermeire, Séverine:|:|SV has received consultancy fees from AbbVie, Arena, Celgene, Dr. Falk Pharma, Eli Lilly, Ferring, Galapagos, Genentech/Roche, Gilead, Hospira, Janssen, MSD, Mundipharma, Pfizer, ProDigest, Progenity, Second Genome, Shire,a Takeda and Tillots, and research support from AbbVie, Janssen, MSD, Pfizer and Takeda.||Gorelick, Kenneth J:|:|KJG has been a consultant for Pfizer and Shire, a Takeda company.||Goetsch, Martina:|:|MG is an employee of and owns stock options in Shire, a Takeda company.||Hartley, Louise:|:|LH is an employee of RTI Health Solutions, which received funding from Shire, a Takeda company, for this study.

Page 70 of 135

P343

Akyüz, Filiz: No conflict of intereset||Ms. Ormeci, Asli: No conflict of intereset||Namazova, Nazrin: No conflict of intereset||Ms. Guzel, Merve: No conflict of intereset||Ms. Abbasgoulizadeh, Anna: No conflict of intereset||Ms. Tahincioğlu, Letisya: No conflict of intereset||Ms. Alaskarlı, Süphane: No conflict of intereset||Dr. Gürel, Erdem: No conflict of intereset||Dr. Bilgin, Ersel: No conflict of intereset||Dr. Atasoy, Alp: No conflict of intereset||Dr. Cavus, Bilger: No conflict of intereset||Prof. Demir, Kadir: No conflict of intereset||Prof. Besısık, Fatih: No conflict of intereset||Prof. Kaymakoğlu, Sabahattin: No conflict of intereset

P344

Dr. TRUYENS, Marie: No conflict of intereset||Dr. Geldof, Jeroen: No conflict of intereset||Ms. Dewitte, Goedele: No conflict of intereset||Mrs. Glorieus, Elien: No conflict of intereset||Prof. Dr. Hindryckx, Pieter: No conflict of intereset||Dr. Lobaton Ortega, Triana: No conflict of intereset

P345

Dr. Adegbola, Samuel: No conflict of intereset||Dr. Sarafian, Magali: No conflict of intereset||Dr. Sahnan, Kapil: No conflict of intereset||Dr. Pechlivanis, Alex: No conflict of intereset||Prof. Phillips, Robin: No conflict of intereset||Prof. Knowles, Charles: No conflict of intereset||Dr. Haddow, James: No conflict of intereset||Mr. Warusavitarne, Janindra: No conflict of intereset||Prof. Faiz, Omar: No conflict of intereset||Mr. Tozer, Phil: No conflict of intereset||Prof. Dr. Holmes, Elaine: No conflict of intereset||Prof. Dr. Hart, Ailsa: No conflict of intereset

P346

Dr. Liefferinckx, Claire:|:|Consultancy fees: Takeda|Speaker fees: Sandoz, Janssen, Abbvie|||Fassin, Manon: No conflict of intereset||Ms. Thomas, Debby: No conflict of intereset||Ms. Minsart, Charlotte: No conflict of intereset||Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie|||Amininejad, Leila: No conflict of intereset||Tafciu, Vjola: No conflict of intereset||Wambacq, Valérie: No conflict of intereset||Van Gossum, André: No conflict of intereset||Franchimont, Denis:|:|Denis Franchimont received educational grants from Abbvie, Takeda, MSD, and received honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira.

P347

Mr. Bejar, Sergio: No conflict of intereset||Dr. Bastida Paz, Guillermo: No conflict of intereset||Dr. Aguas, Mariam: No conflict of intereset||Mr. Garrido Marín, Alejandro: No conflict of intereset||Dr. Marques, Reme: No conflict of intereset||Ms. Valero Pérez, Elena: No conflict of intereset||Mr. del Hoyo Francisco, Javier: No conflict of intereset||Mr. Tortosa Seguí, Lluis: No conflict of intereset||Ms. Muñoz Gómez, Diana: No conflict of intereset||Prof. Poveda, Jose Luis: No conflict of intereset||Dr. Nos Mateu, Pilar: No conflict of intereset

P348

Dr. Kim, Jeongseok: No conflict of intereset||Prof. Dr. Yoon, Hyuk: No conflict of intereset||Prof. Dr. Lee, Kang-Moon: No conflict of intereset||Prof. Dr. Jung, Sung-Ae: No conflict of intereset||Prof. Dr. Park, Dong Il: No conflict of intereset||Prof. Dr. Choi, Chang Hwan: No conflict of intereset||Prof. Dr. Kim, Eun Soo: No conflict of intereset||Prof. Dr. Jung, Yunho: No conflict of intereset||Prof. Dr. Eun, Chang Soo: No conflict of intereset||Prof. Dr. Kim, Tae Oh: No conflict of intereset||Prof. Dr. Kang, Sang Bum: No conflict of intereset||Prof. Dr. Kim, You Sun: No conflict of intereset||Prof. Dr. Seo, Geom-Seog: No conflict of intereset||Prof. Dr. Lee, Chang Kyun: No conflict of intereset||Prof. Dr. Im, Jong Pil: No conflict of intereset||Prof. Dr. Park, Soo Jung: No conflict of intereset||Prof. Dr. Byeon, Jeong-Sik: No conflict of intereset||Prof. Dr. Myung, Seung-Jae: No conflict of intereset||Prof. Dr. Yang , Suk-Kyun: No conflict of intereset||Prof. Dr. Ye, Byong Duk:|:|Research grant: CELLTRION, Inc., Pfizer Korea||Consulting fees: Abbvie Korea, Chong Kun Dang Pharm., Daewoong Pharma, Ferring Korea, Janssen Korea, Kangstem Biotech, Kuhnil Pharm., Medtronic Korea, Shire Korea, Takeda Korea, IQVIA, Cornerstones Health, Robarts Clinical Trials Inc., Takeda||Speaking fees: Abbvie Korea, CELLTRION, Inc. Ferring Korea, Janssen Korea, Pfizer Korea, Shire Korea, Takeda Korea, IQVIA

P349

Dr. Núñez, Paulina: No conflict of intereset||Dr. Figueroa, Carolina: No conflict of intereset||Mrs. Flores, Lilian: No conflict of intereset||Dr. Ibáñez, Patricio: No conflict of intereset||Kronberg, Udo: No conflict of intereset||Dr. Lubascher, Jaime: No conflict of intereset||Dr. Pizarro, Gonzalo: No conflict of intereset||Dr. Quera, Rodrigo: No conflict of intereset||Mrs. Simian, Daniela: No conflict of intereset

P350

Mrs. Chauhan, Usha K.: No conflict of intereset||Ms. Popov, Jelena: No conflict of intereset||Ms. Kalantar, Mona: No conflict of intereset||Mrs. Wolfe, Melanie: No conflict of intereset||Dr. Moayyedi, Paul: No conflict of intereset||Dr. Marshall, John. K.: No conflict of intereset||Dr. Halder , Smita: No conflict of intereset||Prof. Kaasalainen, Sharon: No conflict of intereset

P351

Dr. PEREIRA GUEDES, Tiago: No conflict of intereset||Dr. Sequeira, Patricia: No conflict of intereset||Dr. Freire, Ligia: No conflict of intereset||Prof. Dr. Castro-Poças, Fernando: No conflict of intereset||Dr. Rocha, Anabela: No conflict of intereset||Prof. Dr. Santos, Marisa: No conflict of intereset||Prof. Dr. Pedroto, Isabel: No conflict of intereset||Dr. Lago, Paula: No conflict of intereset

Page 71 of 135

P352

Dr. Komaki, Yuga: No conflict of intereset||Dr. Kanmura, Shuji: No conflict of intereset||Dr. Yutsudo, Kazuki: No conflict of intereset||Dr. Kosuke, Kuwazuru: No conflict of intereset||Dr. Komaki, Fukiko: No conflict of intereset||Dr. Tanaka, Akihito: No conflict of intereset||Dr. Nishimata , Nobuaki: No conflict of intereset||Dr. Sameshima, Yoichi: No conflict of intereset||Dr. Sasaki, Fumisato: No conflict of intereset||Dr. Ooi, Hidehisa: No conflict of intereset||Dr. Tokushige, Koichi: No conflict of intereset||Dr. Sameshima, Yukinori: No conflict of intereset||Prof. Dr. Ido, Akio: No conflict of intereset

P353 Dr. PRINGLE, Rachel: No conflict of intereset||Assadsangabi, Arash: No conflict of intereset

P354

Dr. RAMAN, Maitreyi: No conflict of intereset||Dr. Vallance, Jeff: No conflict of intereset||Dr. Lyden, Kate: No conflict of intereset||Dr. Alana, Schick: No conflict of intereset||Dr. Ohland, Christina: No conflict of intereset||Dr. McCoy, Kathy: No conflict of intereset||Ms. Kaur, Sandeep: No conflict of intereset||Dr. Panaccione, Remo: No conflict of intereset||Dr. Reimer, Raylene: No conflict of intereset||Dr. Taylor, Lorian: No conflict of intereset

P355

Dr. Buisson, Anthony: No conflict of intereset||Prof. Dr. Fumery, Mathurin: No conflict of intereset||Dr. Serrero, Melanie: No conflict of intereset||Mrs. Orsat, Laurie: No conflict of intereset||Prof. Dr. Nancey, Stéphane: No conflict of intereset||Dr. Rivière, Pauline: No conflict of intereset||Dr. Altwegg, Romain: No conflict of intereset||Prof. Dr. Peyrin-Biroulet, Laurent: No conflict of intereset||Dr. Nachury, Maria: No conflict of intereset||Prof. Dr. Hébuterne, Xavier: No conflict of intereset||Dr. Gilletta, Cyrielle: No conflict of intereset||Dr. Flamant, Mathurin: No conflict of intereset||Dr. Viennot, Stéphanie: No conflict of intereset||Prof. Dr. Bouguen, Guillaume: No conflict of intereset||Prof. Dr. Amiot, Aurélien: No conflict of intereset||Dr. Mathieu, Stéphane: No conflict of intereset||Dr. Vuitton, Lucine: No conflict of intereset||Dr. Plastaras, Laurianne: No conflict of intereset||Prof. Dr. Bourreille, Arnaud: No conflict of intereset||Dr. Caillo, Ludovic: No conflict of intereset||Dr. Goutorbe, Felix: No conflict of intereset||Dr. Fumery, Morgane: No conflict of intereset||Dr. Pineton de Chambrun, Guillaume: No conflict of intereset||Dr. Attar, Alain: No conflict of intereset||Prof. Dr. Roblin, Xavier: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Prof. Dr. Pariente, Benjamin: No conflict of intereset

P356 Dr. Andersson, Per: No conflict of intereset||Dr. Karling, Pontus: No conflict of intereset

P357

Mr. Bacsur, Péter: No conflict of intereset||Dr. Szántó, Kata: No conflict of intereset||Mrs. Madácsy, Tamara: No conflict of intereset||Dr. Kata, Diána: No conflict of intereset||Dr. Ferenci, Tamás: No conflict of intereset||Dr. Rutka, Mariann: No conflict of intereset||Dr. Bálint, Anita: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Milassin, Ágnes: No conflict of intereset||Dr. Elekes, Gréta: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Prof. Dr. Nagy, Ferenc: No conflict of intereset||Dr. Földesi, Imre: No conflict of intereset||Dr. Maléth, József: No conflict of intereset||Dr. Farkas, Klaudia: No conflict of intereset||Prof. Dr. Molnár, Tamás: No conflict of intereset

P358

Dr. Singh, Arshdeep: No conflict of intereset||Dr. Sood, Ajit: No conflict of intereset||Dr. Midha, Vandana: No conflict of intereset||Dr. Mahajan, Ramit: No conflict of intereset||Ms. Bansal, Namita: No conflict of intereset||Dr. Kaur, Kirandeep: No conflict of intereset||Dr. Singh, Dharmatma: No conflict of intereset

P359

Ms. Arkenbosch, Jeanine: No conflict of intereset||Dr. van Ruler, Oddeke: No conflict of intereset||Dr. Dwarkasing, Roy S: No conflict of intereset||Dr. Schouten, W Ruud: No conflict of intereset||Dr. de Vries, Annemarie C:|:|A.C. de Vries has participated in advisory board and/or received financial compensation from the following companies: Jansen, Takeda, Abbvie and Tramedico. ||Dr. de Graaf, Eelco J R: No conflict of intereset||Prof. Dr. van der Woude, Christien Janneke:|:|C.J. van der Woude received grant support from Falk Benelux and Pfizer; received speaker fees from AbbVie, Takeda, Ferring, Dr. Falk Pharma, Hospira, Pfizer; and served as a consultant for AbbVie, MSD, Takeda, Celgene, Mundipharma and Janssen.

P360

Dr. Mazza, Stefano: No conflict of intereset||Dr. Fascì, Alberto: No conflict of intereset||Dr. Casini, Valentina: No conflict of intereset||Prof. Ricci, Chiara: No conflict of intereset||Dr. Munari, Francesca: No conflict of intereset||Dr. Pirola, Lorena: No conflict of intereset||Dr. Girelli, Carlo: No conflict of intereset||Dr. Lupinacci, Guido: No conflict of intereset||Prof. Pastorelli, Luca: No conflict of intereset||Dr. Cavallaro, Flaminia: No conflict of intereset||Dr. Piazza O'Sed, Nicole: No conflict of intereset||Dr. Ferraris, Luca: No conflict of intereset||Dr. Colucci, Alice: No conflict of intereset||Dr. Amato, Arnaldo: No conflict of intereset||Prof. Maurizio, Vecchi: No conflict of intereset||Dr. Fiorino, Gionata: No conflict of intereset||Prof. Caprioli, Flavio: No conflict of intereset

P361Dr. KO, Yanna: No conflict of intereset||Dr. Paramsothy, Sudarshan: No conflict of intereset||Prof. Leong, Rupert: No conflict of intereset

Page 72 of 135

P362

Dr. Liefferinckx, Claire:|:|Consultancy fees: Takeda|Speaker fees: Sandoz, Janssen, Abbvie|||Bossuyt, Peter:|:|PB has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, Takeda, Hospira, Janssen, MSD, BMS, Mundipharma, Roche, Pfizer, Sandoz and Pentax.||Thomas, Debby: No conflict of intereset||Rahier, Jean-François:|:|Speaker fee: abbvie, MSD, Takeda, Pfizer, Ferring, Falk|Consultancy: abbvie, MSD, Takeda, Pfizer, Janssen, Mundipharma, glaxosk|Research grant: takeda, abbvie|||Louis, Edouard:|:|E Louis has received fees for: |Research Grant: Takeda, Pfizer|Educational Grant: Abbvie, Takeda, Janssen|Speaker Fees: Abbvie, Ferring, MSD, Falk, Takeda, Hospira, Janssen, Pfizer, Celgene|Advisory Board: Abbvie, Ferring, MSD, Takeda, Celgene, Hospira, Janssen |Consultant: Abbvie|||Baert, Filip:|:|Receipt of grants/research supports: Abbvie, Amgen, Takeda, Janssen. |Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen. |Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen,|||Dewint, Pieter:|:|PD received research support from Biogen.||Pouillon, Lieven:|:|advisory board fees from Takeda, Janssen; and travel fees from AbbVie, Ferring, Takeda||Lambrecht, Guy: No conflict of intereset||Vermeire, Severine:|:|Receipt of grants/research supports: MSD, Abbvie, Takeda, Janssen, Pfizer|Receipt of honoraria or consultation fees: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, Gilead and Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots;|||Franchimont, Denis:|:|DF received educational grants from Abbvie, Takeda, MSD, and received honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira.

P363

Seeger, Wolfgang Alexander: No conflict of intereset||Dr. Thieringer, Juliane: No conflict of intereset||Dr. Esters, Philipp: No conflict of intereset||Mr. Allmendinger, Benjamin: No conflict of intereset||Dr. Schulze, Hermann: No conflict of intereset||Prof. Dr. Dignass, Axel: No conflict of intereset

P364

Dr. Lucafò, Marianna: No conflict of intereset||Dr. Bramuzzo, Matteo: No conflict of intereset||Dr. Pugnetti, Letizia: No conflict of intereset||Dr. Gerdol, Marco: No conflict of intereset||Dr. Greco, Samuele: No conflict of intereset||Dr. Paci, Monica: No conflict of intereset||Dr. Curci, Debora: No conflict of intereset||Mrs. Nonnis, Martina: No conflict of intereset||Dr. Renzo, Sara: No conflict of intereset||Prof. Dr. Lionetti, Paolo: No conflict of intereset||Dr. Tommasini, Alberto: No conflict of intereset||Prof. Dr. Decorti, Giuliana: No conflict of intereset||Prof. Stocco, Gabriele: No conflict of intereset

P365

Dr. LERCHOVA, Tereza: No conflict of intereset||Dr. Hradsky, Ondrej: No conflict of intereset||Mr. Kulich, Michal: No conflict of intereset||Prof. Veres, Gabor: No conflict of intereset||Prof. Dias, Jorge Amil: No conflict of intereset||Dr. Sladek, Malgorzata: No conflict of intereset||Prof. Kolacek, Sanja: No conflict of intereset||Prof. Van Biervliet, Stephanie: No conflict of intereset||Dr. Melek, Jan: No conflict of intereset||Dr. Serban, Daniela: No conflict of intereset||Dr. Winther, Katrine: No conflict of intereset||Dr. de Meij, Tim: No conflict of intereset||Dr. Schwarz, Jan: No conflict of intereset||Prof. Kolho, Kaija Leena: No conflict of intereset||Prof. Escher, Johanna C.: No conflict of intereset||Dr. Bronsky, Jiri: No conflict of intereset

P366

Dubinsky, Marla C:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Hudesman, David P:|:|Grants: Pfizer Inc|Personal fees: AbbVie, Janssen, Pfizer Inc, Salix, Takeda||Steinwurz, Flavio:|:|Personal fees: Ferring, Janssen, Pfizer Inc, Takeda, UCB||Kulisek, Nicole:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Ponce de Leon, Dario:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Magro, Fernando:|:|Grants: GEDII; National Science Foundation|Personal fees: AbbVie, Amgen, Biogen, Celgene, Celltrion, Dr. Falk Pharma, Ferring, Hospira, Janssen, Laboratórios Vitória, MSD, Pfizer Inc, Sandoz, Takeda, UCB, Vifor

P367

Ms. Calandrini, Lucia: No conflict of intereset||Mr. Salice, Marco: No conflict of intereset||Ms. Privitera Hrustemovic, Hana: No conflict of intereset||Ms. Peruzzi, Giulia: No conflict of intereset||Prof. Rizzello, Fernando: No conflict of intereset||Dr. Calabrese, Carlo: No conflict of intereset||Ms. Scaioli, Eleonora: No conflict of intereset||Dr. Belluzzi, Andrea: No conflict of intereset||Prof. Gionchetti, Paolo: No conflict of intereset

Page 73 of 135

P368

Mr. Kolar, Martin: No conflict of intereset||Dr. Lukas, Martin: No conflict of intereset||Dr. Malickova, Karin: No conflict of intereset||Ms. Prochazkova, Ludmila: No conflict of intereset||Dr. Bortlik, Martin: No conflict of intereset||Dr. Duricova, Dana: No conflict of intereset||Dr. Hruba, Veronika: No conflict of intereset||Dr. Machkova, Nadezda: No conflict of intereset||Dr. Mitrova, Katarina: No conflict of intereset||Dr. Vasatko, Martin: No conflict of intereset||Prof. Lukas, Milan: No conflict of intereset

P369

Ms. Ogresta, Doris: No conflict of intereset||Mr. Bišćanin, Alen: No conflict of intereset||Mr. Tomašić, Vedran: No conflict of intereset||Mr. Dorosulić, Zdravko: No conflict of intereset||Mr. Kralj, Dominik: No conflict of intereset||Ms. Forgač, Jelena: No conflict of intereset||Ms. Ćaćić, Petra: No conflict of intereset||Mr. Lerotić, Ivan: No conflict of intereset||Mr. Hrabar, Davor: No conflict of intereset

P370

Dr. Ledder, Oren: No conflict of intereset||Dr. Viala, Jerome: No conflict of intereset||Dr. Urlep , Darja: No conflict of intereset||Dr. Serban, Daniela: No conflict of intereset||Prof. De Ridder, Lissy: No conflict of intereset||Dr. Martinelli, Massimo: No conflict of intereset||Dr. Romano, Claudio: No conflict of intereset||Dr. Oliva, Salvatore: No conflict of intereset||Dr. Sharma9, Shishu: No conflict of intereset||Prof. Thomson, Mike: No conflict of intereset||Prof. Turner, Dan: No conflict of intereset

P371

Dr. Rodríguez-Lago, Iago:|:|Board Membership: Tillotts Pharma, Pfizer, Ferring and Adacyte.|Payments for lectures including service on speakers bureaus: MSD, Abbvie, Takeda, Tillots Pharma, Dr. Falk Pharma and Pfizer.|Payment for development of educational presentations: Otsuka Pharmaceutical.|Travel/ accommodations: MSD, Pfizer, Abbvie, Takeda, Janssen, Tillots Pharma, Shire Pharmaceutical, Dr. Falk Pharma, Otsuka Pharmaceutical and Ferring|||Dr. Mesonero Gismeno, Francisco:|:|Payment for development of educational presentations from MSD||Ms. Cañas, Mercedes: No conflict of intereset||Ms. Savini, Claudia: No conflict of intereset||Mr. Saldaña, Roberto: No conflict of intereset||Ms. Feo-Lucas, Lidia:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Ms. Fernandez, Sabela:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Dr. Cea-Calvo, Luis:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Dr. Juliá, Berta:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain

P372

Besuyen, Robin:|:|Employee and shareholder of Galapagos NV||Genovese, Mark:|:|Gilead Sciences Inc., Galapagos NV, AbbVie Inc. Eli Lilly and Company, Pfizer||de Vlam, Kurt:|:|Celgene; Eli Lilly and Company; Novartis; Pfizer, Inc.; and UCB||Gottenberg, Jacques-Eric:|:|AbbVie, Inc.; BMS; Eli Lilly and Company; Pfizer, Inc.; Roche; Sanofi-Genzyme; and UCB||Kalunian, Kenneth:|:|AbbVie, Inc.; Amgen; AstraZeneca; Biogen; BMS; Chemocentryx; Eli Lilly and Company; Equillium; Exagen; Genentech/Roche; Gilead Sciences, Inc.; GSK; Idosia; Janssen; Kirin; MedImmune; Nektar; Novartis; Pfizer, Inc.; Resolve; Roche; Takeda; and UCB.|||Bartok, Beatrix:|:|Employee of Gilead Sciences, Inc. and potential shareholder||Tan, YingMeei:|:|Employee of Gilead Sciences, Inc. and potential shareholder||Guo, Ying:|:|Employee of Gilead Sciences, Inc. and potential shareholder||Tasset, Chantal:|:|Employee of Galapagos NV and potential shareholder||Sundy, John:|:|Employee of Gilead Sciences, Inc. and potential shareholder||Walker, David:|:|Bristol-Myers Squibb; Gilead Sciences, Inc.; Eli Lilly and Company; Novartis; and Pfizer, Inc.||Takeuchi, Tsutomu: No conflict of intereset

P373

Dr. Malickova, Karin: No conflict of intereset||Pesinova, Veronika: No conflict of intereset||Prof. Dr. Bortlik, Martin: No conflict of intereset||Dr. Duricova, Dana: No conflict of intereset||Dr. Machkova, Nadezda: No conflict of intereset||Dr. Hruba, Veronika: No conflict of intereset||Dr. Lukas, Martin: No conflict of intereset||Dr. Mitrova, Katarina: No conflict of intereset||Vasatko, Martin: No conflict of intereset||Dr. Kostrejova, Marta: No conflict of intereset||Dr. Kolar, Martin: No conflict of intereset||Prof. Dr. Lukas, Milan: No conflict of intereset

P374

Dr. Adegbola, Samuel: No conflict of intereset||Dr. Mak, Wing Yan: No conflict of intereset||Dr. Sahnan, Kapil:|:|received honoraria from Takeda for sitting on an advisory board||Mr. Hiles, Stephen: No conflict of intereset||Mr. Bassett, Paul: No conflict of intereset||Dr. Lung, Phil: No conflict of intereset||Mr. Warusavitarne, Janindra: No conflict of intereset||Prof. Faiz, Omar: No conflict of intereset||Prof. Phillips, Robin: No conflict of intereset||Mr. Tozer, Phil:|:|received honoraria from Takeda for sitting on an advisory board. has received honoraria from Takeda for speaking at a symposium||Prof. Dr. Hart, Ailsa:|:|has served as a consultant, advisory board member or speaker for AbbVie, atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the global Steering committee for Genentech.

P375

Dr. PAI, Nikhil: No conflict of intereset||Ms. Popov, Jelena: No conflict of intereset||Ms. Hartung, Emily: No conflict of intereset||Mr. Hill, Lee: No conflict of intereset||Dr. Grzywacz, Kelly: No conflict of intereset||Mr. Godin, David: No conflict of intereset||Mr. Thabane, Lehana: No conflict of intereset||Dr. Lee, Christine: No conflict of intereset||Dr. Surette, Michael: No conflict of intereset||Dr. Moayyedi, Paul: No conflict of interesetPage 74 of 135

P376

Ms. Tchogna, Sonia A.: No conflict of intereset||Ms. Yang, Xin Yu: No conflict of intereset||Mrs. Deslandres, Colette: No conflict of intereset||Jantchou, Prevost: No conflict of intereset

P377

Dr. YOKOO, Takashi: No conflict of intereset||Dr. Yoshikawa, Shyusaku: No conflict of intereset||Dr. Masuda, Tsutomu: No conflict of intereset||Dr. Uchida, Hideki: No conflict of intereset||Dr. Nakao, Takeshi: No conflict of intereset||Dr. Kashizuka, Hisanori: No conflict of intereset||Dr. Yamaoka, Kentarou: No conflict of intereset||Dr. Inagaki, Mizumi: No conflict of intereset||Dr. Okamoto, Kouhei: No conflict of intereset||Dr. Inatsugi, Naoki: No conflict of intereset

P378

Dr. Calvo Moya, Marta Isabel: No conflict of intereset||Dr. Omella Usieto, Ignacio: No conflict of intereset||Dr. Vera Mendoza, Maria Isabel: No conflict of intereset||Dr. Matallana Royo, Virginia: No conflict of intereset||Dr. Gonzalez Partida, Irene: No conflict of intereset||Dr. Manso Manrique, Marta: No conflict of intereset||Dr. Menchén Viso, Belén: No conflict of intereset||Mrs. De Lucas Téllez de Meneses, Rocío: No conflict of intereset||Mrs. González Rodriguez, Macarena: No conflict of intereset||Mr. Bella del Castillo, Pablo: No conflict of intereset||Dr. González Lama, Yago: No conflict of intereset

P379

Mrs. VILLAR LUCAS, Carmen: No conflict of intereset||Ms. Quiñones Castro, Raisa: No conflict of intereset||Dr. Vaquero Ayala, Luis: No conflict of intereset||Ms. Suárez Álvarez, Patricia: No conflict of intereset||Dr. Fernández Gundin, Maria José: No conflict of intereset||Ms. Sierra Ausín, Mónica: No conflict of intereset

P380

Mr. LUCAS RAMOS, Javier: No conflict of intereset||Ms. Suarez Ferrer, Cristina: No conflict of intereset||Sanchez Azofra, María: No conflict of intereset||Poza Cordón, Joaquín: No conflict of intereset||Martín Arranz, Eduardo: No conflict of intereset||Dr. Martin Arranz, Maria Dolores: No conflict of intereset

P381

Dr. Shim, Hang Hock:|:|Advisory board member and/or consultant for Ferring, Janssen||Dr. Kong, San Choon: No conflict of intereset||Dr. Ong, Wan Chee: No conflict of intereset||Mr. Lim, Teong Guan: No conflict of intereset||Dr. Chan, Pak Wo: No conflict of intereset

P382

Mr. LI, Yousheng: No conflict of intereset||Dr. Zhou, Zhiyuan: No conflict of intereset||Dr. Yao, Danhua: No conflict of intereset||Dr. Zheng, Lei: No conflict of intereset||Dr. Duan, Yantao: No conflict of intereset||Dr. Liu, Bin: No conflict of intereset||Dr. Huang, Yuhua: No conflict of intereset

P383

Mr. Torle, Johan: No conflict of intereset||Mr. Dabir, Parag: No conflict of intereset||Mr. Korsgaard, Ulrik: No conflict of intereset||Mr. Christiansen, Jens Johannes: No conflict of intereset||Prof. Qvist, Niels: No conflict of intereset||Dr. El-Hussuna, Alaa: No conflict of intereset

P384

Dr. Frias Gomes, Catarina: No conflict of intereset||Dr. Morão, Barbara: No conflict of intereset||Dr. Neto Nascimento, Catarina: No conflict of intereset||Dr. Gouveia, Catarina: No conflict of intereset||Dr. Palmela, Carolina: No conflict of intereset||Strecht, João: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset

P385

Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Verstockt, Sare: No conflict of intereset||Dr. Alsaoud, Dahham: No conflict of intereset||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.|||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

Page 75 of 135

P386

Casanova, María José: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Dr. Nantes, Oscar: No conflict of intereset||Dr. Benítez, José Manuel: No conflict of intereset||Dr. Rojas-Feria, María: No conflict of intereset||Dr. Castro-Poceiro, Jesús: No conflict of intereset||Dr. Huguet, José María: No conflict of intereset||Dr. Martín-Cardona, Albert: No conflict of intereset||Dr. Aicart, Marta: No conflict of intereset||Dr. Tosca, Joan: No conflict of intereset||Dr. Martín-Rodríguez, María del Mar: No conflict of intereset||Dr. González-Muñoza, Carlos: No conflict of intereset||Mañosa, Miriam: No conflict of intereset||Dr. Leo-Carnerero, Eduardo: No conflict of intereset||Dr. Lamuela, Luis: No conflict of intereset||Dr. Pérez-Martínez, Isabel: No conflict of intereset||Dr. Bujanda, Luis: No conflict of intereset||Dr. Hinojosa, Joaquín: No conflict of intereset||Dr. Pajares, Ramón: No conflict of intereset||Argüelles-Arias, Federico: No conflict of intereset||Dr. Pérez-Calle, José Lázaro: No conflict of intereset||Dr. Rodríguez-González, Gloria Esther: No conflict of intereset||Guardiola, Jordi: No conflict of intereset||Dr. Barreiro-de Acosta, Manu: No conflict of intereset||Dr. Bermejo, Fernando: No conflict of intereset||Barrio, Jesús: No conflict of intereset||Dr. Beltrán, Belén: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Dr. Lorente, Rufo: No conflict of intereset||Dr. Gutierrez, Ana: No conflict of intereset||Dr. Domínguez-Cajal, Manuel: No conflict of intereset||Dr. Dueñas, Carmen: No conflict of intereset||Dr. Ponferrada-Díaz, Angel: No conflict of intereset||Dr. Van Domselaar, Manuel: No conflict of intereset||Ramírez-de la Piscina, Patricia: No conflict of intereset||Dr. Ramos, Laura: No conflict of intereset||Dr. Almela, Pedro: No conflict of intereset||Dr. Navarro-Llavat, Merce: No conflict of intereset||Dr. Botella, Belén: No conflict of intereset||Gisbert, Javier P: No conflict of intereset

P387

Yarur, Andres:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.||Dr. Mantzaris, Gerassimos J.:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.||Dr. Kopylov, Uri:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.||Ms. Bassel, Marielle:|:|In an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd.||Dr. Brett, Neil:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd.||Mr. Kim, Hankyul:|:|In an employee of Evidera. which received funding from Takeda Pharmaceuticals Company Ltd.||Dr. Lopez, Claudia:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Saha, Sumit:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Ms. Kifnidi, Christina:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Agboton, Christian:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Adsul, Shashi:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Demuth, Dirk:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Luo, Michelle:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Wang, Song:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Bressler, Brian:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.

P388

Mr. Ten Bokkel Huinink, Sebastiaan: No conflict of intereset||Ms. de Jong, Djuna: No conflict of intereset||Prof. Dr. van der Woude, Janneke: No conflict of intereset||Mr. Nieboer, Daan: No conflict of intereset||Prof. Steyerberg, Ewout: No conflict of intereset||Dr. Wolfhagen, Frank: No conflict of intereset||Dr. van Tuyl, Bas: No conflict of intereset||Dr. West, Rachel: No conflict of intereset||Dr. Romkens, Tessa: No conflict of intereset||Dr. Tan, Adriaan: No conflict of intereset||Dr. Hoentjen, Frank: No conflict of intereset||Dr. Mares, Wout: No conflict of intereset||Dr. Bodelier, Alexander: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Dr. Mallant, Rosalie: No conflict of intereset||Dr. de Boer, Nanne: No conflict of intereset||Dr. Reinders, Jurrrien: No conflict of intereset||Dr. van Boeckel, Petra: No conflict of intereset||Dr. Tack, Greetje: No conflict of intereset||Dr. Duijvestein, Marjolijn: No conflict of intereset||Prof. Dr. D’Haens, Geert: No conflict of intereset||Dr. de Vries, Annemarie: No conflict of intereset

Page 76 of 135

P389

Dr. van Hoeve, Karen:|:|Karen van Hoeve is currently receiving a research grant from Mundipharma Comm. VA and Celltrion Healthcare Co. |||Prof. Dreesen, Erwin:|:|Erwin Dreesen: is a postdoctoral research fellow of the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) and received consultancy fees from argenx and Janssen (all honoraria/fees paid to the department).||Prof. Dr. Hoffman, Ilse:|:|Ilse Hoffman reports having received lecture fee and payment for travel expenses from Nestlé, Nutricia, Mead Johnson, Novalac, Takeda, Abbvie||Prof. Dr. Ferrante , Marc:|:|Marc Ferrante reports having received research grant from Amgen, Biogen, Janssen, Pfizer, Takeda in addition consultancy fee from AbbVie, Boehringer Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda and a speakers fee from Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda. MF is a senior clinical investigator of the Research Foundation – Flanders (FWO).||Prof. Dr. Vermeire, Séverine:|:|Séverine Vermeire reports having received research grant from MSD, Abbvie, Takeda, Janssen, Pfizer in addition consultancy fee from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen and a speakers fee from AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots. SV is a senior clinical investigator of the Research Foundation – Flanders (FWO).

P390

Prof. Dr. Iakovlev, Alexey Alexandrovich: No conflict of intereset||Dr. Volkov, Alexander: No conflict of intereset||Dr. Shcherbakova, Inna: No conflict of intereset||Prof. Dr. Tarasova, Galina: No conflict of intereset||Prof. Malakhanov, Sergei: No conflict of intereset||Bashtovaya, Olga: No conflict of intereset

P391

Dr. Bislenghi, Gabriele: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Dr. Sabino, João Pedro Guedelha:|:|Speaker’s fee: Abbvie and Nestle Health Sciences||Prof. Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Dr. Martin Perez, Beatriz: No conflict of intereset||Prof. Dr. Wolthuis, Albert: No conflict of intereset||Prof. Dr. Vermeire, Severine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Prof. Dr. D'hoore, André:|:|Research grant: Johnson & Johnson|Consultancy: Takeda|Speaker’s fee: Duomed, Janssen, Johnson & Johnson, Lifebond, Olympus, Takeda

P392 Ms. YAO, Danhua: No conflict of intereset

P393

Prof. Afzali, Anita:|:|Consultant: Abbvie, Takeda, Janssen, Celgene, UCB; Speaker: Abbvie, Takeda, Janssen, UCB, Pfizer|||Prof. Armuzzi, Alessandro:|:|Consultant: AbbVie, Allergan, Amgen, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, MSD, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, Sofar, Takeda; Lecture fees: AbbVie, Amgen, Biogen, Bristol-Myers Squibb, Chiesi, Ferring, Hospira, Janssen, MSD, Mitsubishi Tanabe, Nikkiso, Pfizer, Samsung Bioepis, Sandoz, Takeda, Tigenix; Research grants: MSD, Takeda, Pfizer||Prof. Bouhnik, Yoram:|:|Honoraria: AbbVie, Biogaran, Biogen, Boehringer Ingelheim, Celgene, Ferring, Gilead, Hospira, Janssen, Mayoli Spindler, MSD, Norgine, Pfizer, Roche, Samsung Bioepis, Sandoz, Sanofi, Shire, Takeda, UCB; Grants: Pfizer, Takeda||Prof. Bressler, Brian:|:|Advisor/Speaker: Ferring, Janssen, AbbVie, Takeda, Pfizer, Novartis, Merck; Advisor: Robarts Clinical Trials, Celgene, Microbiome Insights, Merck, Amgen, Pendopharm, Genentech, BMS, Allergan, Protagonist; Research support: Janssen, AbbVie, GSK, BMS, Amgen, Genentech, Merck, BI, Qu Biologic, Celgene, Alvine; Stock options: Qu Biologic||Prof. Hart, Ailsa:|:|Consultant/Advisory Board/Speaker: AbbVie, Atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire, Takeda; Global Steering Committee: Genentech|||Rubin, David:|:|Consultant: AbbVie, Janssen, Takeda, Pfizer, Celgene; Grants: Takeda||||Dr. Sans, Miguel:|:|Honoraria: Pfizer, Takeda, Amgen, Celgene, Cheiesi, Gebro, Tillots, Kern, Ferring, Faes||Prof. Dr. Siegmund, Britta:|:|Consultant: AbbVie, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, Takeda; Speaker: AbbVie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Takeda; Served as representative of the Charité||Dr. Sninsky, David:|:|Speaker: Janssen, AbbVie, UCB, Takeda, Pfizer; Clinical researcher: Janssen, AbbVie, Takeda; Consultant: Celgene

P394

Mr. Vinh Luong, Thien: No conflict of intereset||Mrs. Dich Grandt, Sanne: No conflict of intereset||Dr. Negoi, Ionut: No conflict of intereset||Mr. Palubinskas, Saulius: No conflict of intereset||Dr. El-Hussuna, Alaa: No conflict of intereset

P395

Ms. REZA, Lillian: No conflict of intereset||Dr. Van Praag, Elise: No conflict of intereset||Ms. Iqbal, Nusrat: No conflict of intereset||Ms. Twum-Barima, Charlene: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Prof. Clark, Sue: No conflict of intereset||Mr. Tozer, Philip: No conflict of intereset Page 77 of 135

P396

Lee, Caroline A.:|:|Employee of Arena Pharmaceuticals, Inc.||Acevedo, Lisette:|:|Employee of Arena Pharmaceuticals, Inc. ||Oh, D. Alexander:|:|Employee of Arena Pharmaceuticals, Inc. ||Baweja, Preeti:|:|Employee of Arena Pharmaceuticals, Inc.||Gilder, Kye:|:|Employee of Arena Pharmaceuticals, Inc. ||Han, David:|:|Employee of PAREXEL International.||Jhee, Stanford:|:|Employee of PAREXEL International.||Komori, Kiyomi:|:|Employee of Arena Pharmaceuticals, Inc.||Mullin, Susan:|:|Employee of Arena Pharmaceuticals, Inc.||Nguyen-Cleary, Thai:|:|Employee of Arena Pharmaceuticals, Inc.||Schmelzer, Kara:|:|Employee of PAREXEL International.||Tang, Yong:|:|Employee of Arena Pharmaceuticals, Inc.||Zhang, Jinkun:|:|Employee of Arena Pharmaceuticals, Inc.||Grundy, John:|:|Employee of Arena Pharmaceuticals, Inc.

P397

Dr. Estorninho, João: No conflict of intereset||Prof. Dr. Freire, Paulo: No conflict of intereset||Dr. Lopes, Sandra: No conflict of intereset||Dr. Ferreira, Margarida: No conflict of intereset||Dr. Ferreira, Manuela: No conflict of intereset||Dr. Portela, Francisco: No conflict of intereset||Prof. Dr. Figueiredo, Pedro: No conflict of intereset

P398

Prof. Dr. Roblin, Xavier:|:|Abbvie, Amgen, Sandoz, MSD, Pfizer, Theradiag||Dr. williet, nicolas: No conflict of intereset||Dr. veyrard, pauline: No conflict of intereset||Prof. Dr. boschetti, gilles:|:|msd, abbvie||Dr. berger, anne emmanuelle: No conflict of intereset||Prof. Dr. nancey, stephane:|:|Abbvie, MSD, Pfizer||Prof. Dr. flourie, bernard: No conflict of intereset||Prof. paul, stephane:|:|theradiag, Abbvie, MSD

P399

Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Outtier, An: No conflict of intereset||Ms. Lefrère, Jolien: No conflict of intereset||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. De Hertogh, Gert: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda

P400Dr. Townsend, Cassandra: No conflict of intereset||Dr. Khanna, Reena: No conflict of intereset||Dr. Wilson, Aze Suzanne: No conflict of intereset

P401Dr. Shteyer, Eyal: No conflict of intereset||Cytter-Kuint, Ruth: No conflict of intereset||Winberg, Lena: No conflict of intereset

P402

Dr. Mahajna, Hussein: No conflict of intereset||Dr. Barash, Yiftach: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Dr. Soffer, Shelly: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Dr. Klang, Eyal: No conflict of intereset||Prof. Kopylov, Uri: No conflict of intereset

Page 78 of 135

P403

P404 Dr. Barnes, Alex: No conflict of intereset||Dr. Spizzo, Paul: No conflict of intereset

P405

Prof. Dr. Jung, Yoon Suk: No conflict of intereset||Mrs. Han, Minkyung: No conflict of intereset||Prof. Park, Sohee: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset

P406

Dr. Kato, Shingo: No conflict of intereset||Dr. Yamaga, Nagisa: No conflict of intereset||Dr. Ishibashi, Akira: No conflict of intereset||Dr. Kani, Kazuhito: No conflict of intereset||Prof. Nagoshi, Sumiko: No conflict of intereset

P407

Dr. Pujol Muncunill, Gemma: No conflict of intereset||Dr. Martínez-Osorio, Johanna: No conflict of intereset||Bossacoma-Busquets, Ferran: No conflict of intereset||Ms. Álvarez-Carnero, Laura: No conflict of intereset||Arrojo-Juárez, Joelle: No conflict of intereset||Dr. Vila-Miravet, Victor: No conflict of intereset||Martin De Carpi, Francisco Javier: No conflict of intereset

P408

Dr. Orfanoudaki, Eleni: No conflict of intereset||Prof. Gazouli, Maria: No conflict of intereset||Dr. Foteinogiannopoulou, Kalliopi: No conflict of intereset||Dr. Theodoraki, Eirini: No conflict of intereset||Legaki, Evangelia: No conflict of intereset||Prof. Dr. Koutroubakis, Ioannis: No conflict of intereset

P409

Ms. WANN, Sophie: No conflict of intereset||Dr. Norris, Richard: No conflict of intereset||Prof. Williams, Richard: No conflict of intereset||Dr. Basnayake, Chamara: No conflict of intereset||Dr. Lust, Mark: No conflict of intereset||Dr. Wright, Emily: No conflict of intereset||Prof. Kamm, Michael: No conflict of intereset||Dr. Connell, William: No conflict of intereset||Prof. Thompson, Alex: No conflict of intereset||Dr. Ding, Nik: No conflict of intereset

P410

Dr. Rudnik, Agata: No conflict of intereset||Dr. Piotrowicz, Grazyna: No conflict of intereset||Prof. Dr. Rydzewska, Grazyna: No conflict of intereset||Prof. Dr. Bidzan, Mariola: No conflict of intereset||Mrs. Ozgo, Emilia: No conflict of intereset

P411

Dr. Orfanoudaki, Eleni: No conflict of intereset||Dr. Theodoraki, Eirini: No conflict of intereset||Dr. Foteinogianopoulou, Kalliopi: No conflict of intereset||Dr. Mantaka, Aikaterini: No conflict of intereset||Prof. Dr. Koutroubakis, Ioannis: No conflict of intereset

P412Dr. Ito, Ayumi: No conflict of intereset||Dr. Shun, Murasugi: No conflict of intereset||Dr. Teppei, Omori: No conflict of intereset||Prof. Katsutoshi , Tokushuge: No conflict of intereset

Dr. Sandborn, William:|:|Personal fees from Kyowa Hakko Kirin, Millennium Pharmaceuticals, Celgene Cellular Therapeutics, Santarus, Salix Pharmaceuticals, Catabasis Pharmaceuticals, Vertex Pharmaceuticals, Warner Chilcott, Cosmo Pharmaceuticals, Ferring Pharmaceuticals, Sigmoid Biotechnologies, Tillotts Pharma, Am Pharma BV, Dr. August Wolff, Avaxia Biologics, Zyngenia, Ironwood Pharmaceuticals, Index Pharmaceuticals, Nestle, Lexicon Pharmaceuticals, UCB Pharma, Orexigen, Luitpold Pharmaceuticals, Baxter Healthcare, Ferring Research Institute, Novo Nordisk, Mesoblast Inc., Shire, Ardelyx Inc., Actavis, Seattle Genetics, MedImmune (AstraZeneca), Actogenix NV, Lipid Therapeutics Gmbh, Eisai, Qu Biologics, Toray Industries Inc, Teva Pharmaceuticals, Eli Lilly, Chiasma, TiGenix, Adheron Therapeutics, Immune Pharmaceuticals, Celgene, Arena Pharmaceuticals, Ambrx Inc., Akros Pharma, Vascular Biogenics, Theradiag, Forward Pharma, Regeneron, Galapagos, Seres Health, Ritter Pharmaceuticals, Theravance, Palatin, Biogen, University of Western Ontario (owner of Robarts Clinical Trials); Grants and personal fees from Prometheus Laboratories, AbbVie, Gilead Sciences, Boehringer Ingelheim, Amgen, Takeda, Atlantic Pharmaceuticals, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Pfizer, Nutrition Science Partners, Receptos, Amgen; grants, personal fees, and non-financial support from Janssen; grants from Broad Foundation, American College of Gastroenterology, Exact Sciences.||Dr. Loftus Jr, Edward V.:|:|Consulting for Janssen, Takeda, AbbVie, UCB, Amgen, Pfizer, Salix, Mesoblast, Eli Lilly, Celgene, and CVS Caremark; Research support from Janssen, Takeda, AbbVie, UCB, Amgen, Pfizer, Genentech, Gilead, Receptos, Celgene, MedImmune, Seres Therapeutics, and Robarts Clinical Trials.||Dr. Baert, Filip:|:|Grants: AbbVie, Amgen, Takeda, Janssen. Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen. Participation in a company-sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen.||Dr. Jansson, Johan:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options.||Dr. Chen, Jingjing:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc.; have stock or stock options.||Dr. Candela, Ninfa:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc.; have stock or stock options.||Dr. Lasch, Karen:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc.; have stock or stock options.||Dr. Kisfalvi, Krisztina:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc.; have stock or stock options.

Page 79 of 135

P413

Mrs. Ruiz-Ramirez, Maria Angeles: No conflict of intereset||Suarez, Cristina: No conflict of intereset||Poza, Joaquin: No conflict of intereset||Martin-Arranz, Eduardo: No conflict of intereset||Rueda-Garcia, Jose Luis: No conflict of intereset||Sanchez-Azofra, Maria: No conflict of intereset||Cuadros, Marta: No conflict of intereset||Mayor, Patricia: No conflict of intereset||Garcia-Ramirez, Laura: No conflict of intereset||Martin-Arranz, Maria Dolores: No conflict of intereset

P414

Dr. Khoo, Emi: No conflict of intereset||Dr. Lord, Anton: No conflict of intereset||Ms. Hanigan, Katherine: No conflict of intereset||Dr. Croft, Anthony: No conflict of intereset||Dr. Radford-Smith, Graham: No conflict of intereset

P415

Dr. GUBBIOTTI, Alessandro: No conflict of intereset||Dr. Barberio, Brigida: No conflict of intereset||Dr. Zingone, Fabiana: No conflict of intereset||Dr. D'Incà, Renata: No conflict of intereset||Dr. Bertani, Lorenzo: No conflict of intereset||Dr. Ferronato, Antonio: No conflict of intereset||Dr. Urbano, Maria Teresa: No conflict of intereset||Dr. Sablich, Renato: No conflict of intereset||Prof. Savarino, Edoardo Vincenzo: No conflict of intereset

P416

Dr. Pai, Nikhil: No conflict of intereset||Ms. Popov, Jelena: No conflict of intereset||Mr. Hill, Lee: No conflict of intereset||Ms. Hartung, Emily: No conflict of intereset||Dr. Grzywacz, Kelly: No conflict of intereset||Mr. Godin, David: No conflict of intereset||Dr. Thabane, Lehana: No conflict of intereset||Dr. Lee, Christine: No conflict of intereset||Dr. Khan, Waliul: No conflict of intereset||Dr. Surette, Michael: No conflict of intereset||Dr. Moayyedi, Paul: No conflict of intereset

P417Dr. FAIRBRASS, Keeley: No conflict of intereset||Dr. Hoshen, Deloar: No conflict of intereset||Prof. Ford, Alex C: No conflict of intereset||Gracie, Dave: No conflict of intereset

P418

Prof. Reinisch, Walter:|:|Walter Reinisch reports lecture fees from AbbVie, Actelion, Alpha Wasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson & Johnson, Millennium, Merck, NovoNordisk, Nycomed, Pfizer, Pharmacosmos, Schering-Plough, Salix, Takeda, UCB Pharma, and Vifor; consultant fees from AbbVie, Actelion, Alpha Wasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson & Johnson, Millennium, Merck, NovoNordisk, Nycomed, Pfizer, Pharmacosmos, Schering-Plough, Salix, Takeda, UCB Pharma, and Vifor; and serves as an advisory board member for AbbVie, Actelion, Alpha Wasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson & Johnson, Millennium, Merck, NovoNordisk, Nycomed, Pfizer, Pharmacosmos, Schering-Plough, Salix, Takeda, UCB Pharma, and Vifor.||Dr. Brodbeck, Jens:|:|Jens Brodbeck is an employee and stockholder of Gilead Sciences, Inc.||Dr. Galien, René:|:|René Galien is an employee of Galapagos.||Dr. Grant, Ethan:|:|Ethan Grant is an employee and stockholder of Gilead Sciences, Inc.||Prof. Hébuterne, Xavier:|:|Xavier Hébuterne reports clinical research funding from AbbVie, Abivax, Alphasigma, Celgene, Gilead, Eli Lilly, Enterome, Janssen, InDex Pharmaceuticals, Pfizer, Roche, Salix, Takeda, Theravance; serving on advisory boards for AbbVie, Arena, Arkopharma, Astellas, Janssen, Nutricia, Pfizer, Sangano, Takeda; and participating in lectures and educational activities for AbbVie, ARARD, Arkopharma, Baxter, Bristol Myers Squibb, Ferring, Janssen, MSD, Nutricia, Pfizer, Sanofi-Advantis, Tillots, and Takeda.||||Dr. Kłopocka, Maria:|:|Maria Kłopocka reports research funding from Galapagos; speaker fees from AbbVie, Alvogen, Ferring, and Takeda; and support to attend congresses from AbbVie, Alvogen, and Ferring.||Dr. Petryka, Robert:|:|Robert Petryka research funding from Galapagos.||Dr. Roblin, Xavier:|:|Xavier Roblin reports relationships with AbbVie, MSD, Janssen Cilag, and Takeda||Dr. Serone, Adrian:|:|Adrian Serone is an employee and stockholder of Gilead Sciences, Inc.||Dr. Tasset, Chantal:|:|Chantal Tasset is an employee of Galapagos||Dr. Yoon, Oh Kyu:|:|Oh Kyu Yoon is an employee and stockholder of Gilead Sciences, Inc.||Dr. Zaboli, Shiva:|:|Shiva Zaboli is an employee and stockholder of Gilead Sciences, Inc.||Prof. Vermeire, Séverine:|:|Séverine Vermeire reports financial support for research from AbbVie, Johnson & Johnson, MSD, Pfizer, and Takeda; lecture fees from AbbVie, Centocor, Ferring, Genentech/Roche Hospira, Johnson & Johnson, MSD, Pfizer, and Takeda; and consulting fees from AbbVie, Celgene, Celltrion, Centocor, Ferring, Galapagos, Genentech/Roche, Gilead, Hospira, Johnson & Johnson, Mundipharma, MSD, Pfizer, ProDigest, Prometheus, Second Genome, and Takeda.

Page 80 of 135

P419

Bressler, Brian:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd. ||Dr. Yarur , Andres:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd. ||Dr. Kopylov, Uri:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.||Ms. Bassel, Marielle:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd. ||Dr. Brett, Neil:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd.||Dr. Colby, Chris:|:|Is an employee of Evidera, which received funding from Takeda Pharmaceuticals Company Ltd. ||Dr. Lopez, Claudia:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Saha, Sumit:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Ms. Kifnidi, Christina:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Agboton, Christian:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Adsul, Shashi:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Demuth, Dirk:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Luo, Michelle:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Wang, Song:|:|Is an employee of Takeda Pharmaceuticals Company Ltd and holds Takeda stock or stock options.||Dr. Mantzaris, Gerassimo J.:|:|Received an honorarium from Takeda Pharmaceuticals Company Ltd.

P420

Dr. Wagner, Frank: No conflict of intereset||Dr. Mansfield, John:|:|Consultant: Genentech||Dr. Geier, Christian: No conflict of intereset||Dr. Dash, Ajit:|:|Employee Genentech||Dr. Wang, Yehong:|:|Genentech: Employee||Dr. Li, Chloe:|:|Genentech: Employee||Dr. Lekkerkerker, Annemarie:|:|Genentech: Employee||Dr. Lu, Timothy:|:|Genentech - Employee

P421

Ms. Dubois, Evelyne: No conflict of intereset||Ms. Moens, Annick: No conflict of intereset||Mr. Sabino, João: No conflict of intereset||Mr. Ferrante, Marc: No conflict of intereset||Vermeire, Séverine: No conflict of intereset

P422

Dr. Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie||Dr. Lobaton, Triana:|:|Lecture fees: Ferring, Janssen|Consultancy: Janssen||Dr. Vieujan, Sophie: No conflict of intereset||Dr. Bossuyt, Peter:|:|Financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan|Lecture fees from AbbVie, Takeda, Pfizer and Janssen|Advisory board fees from Abbvie, Takeda, Hospira, Janssen, MSD, BMS, Mundipharma, Roche, Pfizer, Sandoz and Pentax.||Dr. Rahier, Jean-François:|:|Speaker fee : Abbvie, Takeda, Pfizer, Ferring, Falk|Consultancy : Abbvie, Takeda, Hospira, Mundipharma, MSD, Pfizer, GlaxoSk, Janssen|Research grant: Takeda, Abbvie|||Dr. Baert, Filip:|:|Receipt of grants/research supports: Abbvie, Amgen, Takeda, Janssen. |Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen. |Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen, |||Dr. Dewit, Olivier:|:|Lecture and consultancy fees: Abbvie, Takeda, Janssen, Pfizer, Sandoz, Mylan, Ferring, Fresenius-Kabi, MSD, Prodigest||Dr. Somers, Michaël: No conflict of intereset||Dr. Macken, Elisabeth: No conflict of intereset||Dr. Vijverman, Anne: No conflict of intereset||Dr. Van Hootegem, Philippe: No conflict of intereset||Dr. Mana, Fazia: No conflict of intereset||Dr. Willandt, Barbara: No conflict of intereset||Dr. Caenepeel, Philip: No conflict of intereset||Dr. Humblet, Evelien: No conflict of intereset||Dr. D'Heygere, François: No conflict of intereset||Dr. Verreth, Annelies: No conflict of intereset||El Nawar, Abdo: No conflict of intereset||Dr. Coenegrachts, Jean-Louis: No conflict of intereset||Dr. Dewit, Sophie: No conflict of intereset||Dr. De Coninck, Steven: No conflict of intereset||Dr. Schoofs, Nele: No conflict of intereset||Dr. Delen, Stefan: No conflict of intereset||Dr. Dutre, Joris: No conflict of intereset||Dr. Thienpont, Clara: No conflict of intereset||Dr. Vanden Branden, Stijn: No conflict of intereset||Dr. Staessen, Dirk:|:|Grants from Abbvie, Merck, Janssen and Takeda|Consultancy fees from Takeda and Janssen|||Dr. Franchimont, Denis:|:|Educational grants from Abbvie, Takeda, MSD, |Honorarium fee for lectures or consultancy from Ferring, Falk, Chiesi, Abbvie, MSD, Centocor, Pfizer, Amgen, Janssen, Mundiphatma and Hospira

P423

Mrs. Radigina, Tatiana: No conflict of intereset||Dr. Illarionov, Alexey: No conflict of intereset||Dr. Kuptsova, Darya: No conflict of intereset||Prof. Dr. Potapov, Alexsader: No conflict of intereset||Prof. Dr. Petrichuk, Svetlana: No conflict of intereset

P424

Mr. FISCHER, Aren: No conflict of intereset||Dr. Oppe, Mark: No conflict of intereset||Ms. Stypa, Stephanie: No conflict of intereset||Mr. Lukyanov , Vasily: No conflict of intereset||Mr. Petrakis, Ioannis: No conflict of intereset

Page 81 of 135

P425

Dr. Macaluso, Fabio Salvatore: No conflict of intereset||Prof. Fries, Walter: No conflict of intereset||Dr. Viola, Anna: No conflict of intereset||Dr. Centritto, Andrea: No conflict of intereset||Dr. Cappello, Maria: No conflict of intereset||Dr. Giuffrida, Enrica: No conflict of intereset||Dr. Privitera, Antonino Carlo: No conflict of intereset||Dr. Piccillo, Giovita: No conflict of intereset||Dr. Magnano, Antonio: No conflict of intereset||Dr. Vinci, Elisa: No conflict of intereset||Dr. Vassallo, Roberto: No conflict of intereset||Dr. Trovatello, Antonino: No conflict of intereset||Dr. Belluardo, Nunzio: No conflict of intereset||Dr. Giangreco, Emiliano: No conflict of intereset||Dr. Camilleri, Salvatore: No conflict of intereset||Dr. Garufi, Serena: No conflict of intereset||Dr. Bertolami, Carmelo: No conflict of intereset||Dr. Ventimiglia, Marco: No conflict of intereset||Dr. Renna, Sara: No conflict of intereset||Dr. Orlando, Rosalba: No conflict of intereset||Dr. Rizzuto, Giulia: No conflict of intereset||Dr. Grova, Mauro: No conflict of intereset||Dr. Orlando, Ambrogio: No conflict of intereset

P426

Prof. Dr. Roblin, Xavier:|:|Abbvie, Janssen, takeda, Theradiag||Dr. genin, capucine: No conflict of intereset||Dr. williet, nicolas: No conflict of intereset||Dr. veyrard, pauline: No conflict of intereset||Prof. Dr. boschetti, gilles:|:|Abbvie, Takeda, Janssen||Dr. berger, anne emmanuelle: No conflict of intereset||Prof. Dr. flourie, bernard: No conflict of intereset||Prof. Dr. nancey, stephane:|:|Abbvie, Takeda, Janssen||Prof. Paul, stephane:|:|Theradiag, Abbvie, TAkeda

P427

Chen, Jingjing:|:|Employee of Takeda; holds Takeda stock or stock options||Ms. Hunter, Sharon:|:|Contractor of Takeda||Dr. Kisfalvi, Krisztina:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Lirio, Richard A.:|:|Employee of Takeda; holds Takeda stock or stock options

P428

P429

Ms. Yeo , Jia Qi: No conflict of intereset||Dr. Wee, Hwee Lin: No conflict of intereset||Dr. Cheen, Hua Heng: No conflict of intereset||Ms. WONG, Amanda: No conflict of intereset||Mr. Lim, Teong Guan: No conflict of intereset||Dr. Leong , Wai Fook: No conflict of intereset||Prof. Chowbay, Balram: No conflict of intereset||Dr. Salazar , Ennaliza: No conflict of intereset||Dr. Shim, Hang Hock: No conflict of intereset||Dr. Chan, Webber Pak Wo: No conflict of intereset||Dr. Kong, San Choon: No conflict of intereset||Dr. Ong, Wan Chee: No conflict of intereset

P430

Mr. de Voogd, Floris: No conflict of intereset||Mr. Joshi, Harshad: No conflict of intereset||Ms. Van Wassenaer, Elsa: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset

Dr. Gupta, Nitin:|:|Advisory Board and Speaker for: Janssen, AbbVie, Pfizer, Takeda||Dr. Sands, Bruce E: No conflict of intereset||Regueiro, Miguel:|:|Research Support: AbbVie, Janssen, Takeda, Pfizer|Unrestricted Educational Grants: AbbVie, Janssen, UCB, Pfizer, Takeda, Salix, Shire|Advisory Boards and Consultant: AbbVie, Janssen, UCB, Takeda, Pfizer, Miraca Labs, Amgen, Celgene, Seres, Allergan, Genentech, Gilead, Salix, Prometheus, TARGET PharmaSolutions|Royalties: Wolters Kluwer Health as Author/Editor of Up ToDate||Dr. Dubinsky, Marla:|:|Consultant: Pfizer, Janssen, AbbVie, Celgene, Salix, AbbVie, Takeda, Prometheus Labs, Arena, Genentech, Lilly|Research Support: Pfizer, AbbVie, Janssen||Dr. Rubin, David:|:|Abbvie Consultant and grant support|Abgenomics Consultant and stock options|Allergan, Inc. Consultant|American College of Gastroenterology Board of trustees|Biomica Consultant and stock options|Boehringer Ingelheim, Ltd. Consultant|Bristol-Myers Squibb Consultant|Celgene Corp/Syneos Consultant|Check-cap Consultant|Cornerstones Health, Inc. (non- profit) Co-Founder, CFO|Dizal Pharmaceuticals Consultant|GalenPharma/Atlantica Consultant|Genentech/Roche Consultant and grant support|Gilead Sciences Consultant|Glenmark Pharmaceuticals Consultant|GoDuRn, LLC Co-Founder|GSK (GlaxoSmithKline Services) Consultant|Janssen Pharmaceuticals Consultant and grant support|Lilly Consultant|Mahana Therapeutics Consultant|Narrow River Mgmt Consultant|Pfizer Consultant|Prometheus Laboratories Consultant and grant support|Reistone Consultant|Seres Therapeutics Consultant|Shire Consultant and grant support|Takeda Consultant and grant support|Target PharmaSolutions, Inc. Consultant|Techlab, Inc Consultant|Consultant||Hanson, John:|:|Pfizer- Speaker Bureau|AbbVie – Speaker Bureau|TARGET PharmaSolutions - steering committee|BMS - advisory board at AIBD|||Dr. Aberra, Faten:|:|Janssen: contracted research and consultant|Celgene: contracted research|AbbVie: contracted research|UBC: contracted research|Pfizer: consultant |Rebiotix: contracted research |Amgen: contracted research||Dr. Weiss, Michael: No conflict of intereset||Watkins, Stephanie:|:|Employee at TARGET PharmaSolutions||Gazis, Derek:|:|Employee of TARGET PharmaSolutions||Dr. Long, Millie:|:|Consulting/Advisory boards for Takeda, Pfizer, AbbVie, UCB, Janssen, Prometheus, Salix, Valeant, Target Pharmasolutions. |Grant support: Takeda, Pfizer

Page 82 of 135

P431

Aksan, Aysegül:|:|Dr Aksan has received lectuing fees and congress expenses from Vifor Pharma and financial support for research work from Immundiagnostik AG:||Dr. Böttger, Katharina: No conflict of intereset||Hein, Nathalena: No conflict of intereset||Ms. Caicedo-Zea, Yurani:|:|Yurani Caicedo-Zea is an employee of Immundiagnostik AG.||Ms. Diehl, Ina:|:|Ina Diehl is an employee of Immundiagnostik AG.||Ms. Schumann, Claudia:|:|Claudia Schumann is an employee of Immundiagnostik AG.||Dr. Armbruster, Franz-Paul:|:|Dr Armbruster is Managing Director of Immundiagnostik AG.||Prof. Dr. Stein, Jürgen Michael:|:|Jürgen Stein has received consultancy fees from Abbvie, Fresenius-Kabi, Immundiagnostik, MSD, Pharmacosmos, Takeda, GI Dynamics and Vifor. Dr. Stein has also received payment for lectures from Abbvie, Falk Foundation, Ferring, Immundiagnostik, MSD, Pharmacosmos, Takeda, Thermofischer, GI Dynamics and Vifor. Additionally, Dr. Stein has received payment for manuscript preparation from Abbvie, Falk Foundation and MSD.

P432

Dr. Pigniczki, Daniella: No conflict of intereset||Dr. Szántó, Kata: No conflict of intereset||Dr. Rutka, Mariann: No conflict of intereset||Dr. Farkas, Klaudia: No conflict of intereset||Dr. Bálint , Anita: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Prof. Molnár, Tamás: No conflict of intereset

P433

Hoque, Sami: No conflict of intereset||Dr. Boccaletti, Simona: No conflict of intereset||Puenpatom, Amy: No conflict of intereset||Dr. Brown, Chloe: No conflict of intereset||Dr. Black, Christopher: No conflict of intereset||Dr. Roberts, Jenna: No conflict of intereset||Dr. Rajkovic, Ivana: No conflict of intereset||Mr. Milligan, Gary: No conflict of intereset

P434

Dr. Chaparro, Maria: No conflict of intereset||Mrs. Garre, Ana: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Dr. Barreiro-de Acosta, Manu: No conflict of intereset||Dr. Casanova, María José: No conflict of intereset||Dr. De Castro, Luisa: No conflict of intereset||Dr. Fernández-Clotet, Agnés: No conflict of intereset||Dr. Hinojosa, Joaquín: No conflict of intereset||Dr. Boscá-Watts, Maia: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. López-García, Alicia: No conflict of intereset||Dr. Lorente, Rufo: No conflict of intereset||Dr. Manceñido, Noemí: No conflict of intereset||Dr. Martínez, Teresa: No conflict of intereset||Dr. Monfort, David: No conflict of intereset||Dr. Pérez-Calle, José Lázaro: No conflict of intereset||Dr. Villoria, Albert: No conflict of intereset||Dr. Angueira, Teresa: No conflict of intereset||Dr. Bermejo, Fernando: No conflict of intereset||Dr. Carbajo, Ana Y: No conflict of intereset||Dr. Carpio, Daniel: No conflict of intereset||Dr. González-Muñoza, Carlos: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Dr. Huguet, José M.: No conflict of intereset||Dr. Rivero, Montserrat: No conflict of intereset||Dr. Iglesias-Flores, Eva: No conflict of intereset||Dr. Sierra, Mónica: No conflict of intereset||Dr. Hernández-Villalba, Luis: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Gisbert, Javier P: No conflict of intereset

P435

Dr. Shivaji, Uday Nagesh: No conflict of intereset||Mrs. Bazarova, Alina: No conflict of intereset||Dr. Critchlow, Tamsin: No conflict of intereset||Dr. Nardone, Olga Maria: No conflict of intereset||Dr. Smith, Samuel CL: No conflict of intereset||Ms. Love, Melanie: No conflict of intereset||Ms. Davis, Joanne: No conflict of intereset||Prof. Ghosh, Subrata: No conflict of intereset||Dr. Iacucci, Marietta: No conflict of intereset

P436

Mr. LI, Yousheng: No conflict of intereset||Dr. Zheng, Lei: No conflict of intereset||Dr. Yao, Danhua: No conflict of intereset||Dr. Zhou, Zhiyuan: No conflict of intereset||Dr. Liu, Bin: No conflict of intereset||Dr. Huang, Yuhua: No conflict of intereset||Dr. Duan, Yantao: No conflict of intereset

P437Dr. Filip, Rafal: No conflict of intereset||Mrs. Pękala, Anna: No conflict of intereset||Mrs. Jarmakiewicz-Czaja, Sara: No conflict of intereset

P438

Dr. Barberio, Brigida: No conflict of intereset||Zingone, Fabiana: No conflict of intereset||Ferronato, Antonio: No conflict of intereset||Dr. Buda, Andrea: No conflict of intereset||Melatti, Piera: No conflict of intereset||Gubbiotti, Alessandro: No conflict of intereset||Massimi, Davide: No conflict of intereset||Casadei, Cesare: No conflict of intereset||Cingolani, Linda: No conflict of intereset||Savarino, Edoardo Vincenzo: No conflict of intereset

P439

Bouhnik, Yoram: No conflict of intereset||Prof. Roblin, Xavier: No conflict of intereset||Mr. Mrad, Raith: No conflict of intereset||Prof. Hebuterne, Xavier: No conflict of intereset||Prof. Laharie, David: No conflict of intereset||Dr. Tanasa Stefanescu, Carmen: No conflict of intereset||Prof. Nancey, Stephane: No conflict of intereset||Prof. Boureille, Arnaud: No conflict of intereset||Prof. Amiot, Aurelien: No conflict of intereset||Mr. Sebbah, Norman: No conflict of intereset||Prof. Peyrin Biroulet, Laurent: No conflict of intereset

P440

Dr. Mesonero Gismero, Francisco: No conflict of intereset||Ms. Fernández, Cristina: No conflict of intereset||Dr. Sánchez-Rodríguez, Eugenia: No conflict of intereset||Dr. García-García de Paredes, Ana: No conflict of intereset||Prof. Dr. Albillos, Agustín: No conflict of intereset||Dr. López-Sanromán, Antonio: No conflict of intereset Page 83 of 135

P441

Dr. Ollech, Jacob: No conflict of intereset||Dr. Normatov, Inessa: No conflict of intereset||Dr. Dwadasi, Sujaata: No conflict of intereset||Dr. Dalal, Sushila: No conflict of intereset||Dr. Micic, Dejan: No conflict of intereset||Dr. Israel, Amanda: No conflict of intereset||Mrs. Labas, Jennifer: No conflict of intereset||Dr. Joel, Pekow: No conflict of intereset||Prof. Cohen, Russell: No conflict of intereset||Prof. Rubin, David: No conflict of intereset||Dr. Atsushi, Sakuraba: No conflict of intereset

P442

Angriman, Imerio: No conflict of intereset||Dr. Tomassi, Monica: No conflict of intereset||Dr. Bordignon, Giovanni: No conflict of intereset||Prof. Bardini, Romeo: No conflict of intereset||Dr. Ruffolo, Cesare: No conflict of intereset||Dr. Scarpa, Marco: No conflict of intereset

P443

Ms. Van Praag, Elise: No conflict of intereset||Dr. van Rijn, Kyra: No conflict of intereset||Dr. Monraats, Melanie: No conflict of intereset||Dr. Stoker, Jaap:|:|Jaap Stoker is a research consultant for Robarts Clinical Trials and has a research agreement with Takeda.||Dr. Buskens, Christianne: No conflict of intereset

P444

Dr. ALRUTHIA, Yazed: No conflict of intereset||Ms. Alsharif, Wejdan: No conflict of intereset||Ms. Almuaythir, Ghadah: No conflict of intereset||Ms. Alrasheed, Hala: No conflict of intereset||Dr. Alharbi, Othman: No conflict of intereset||Dr. Azzam, Nahla: No conflict of intereset||Dr. Almadi, Majid: No conflict of intereset||Dr. Saeed, Maria: No conflict of intereset||Dr. HajkhderMullaissa, Baraa: No conflict of intereset||Prof. Dr. Aljebreen, Abdulrahman: No conflict of intereset

P445

Dr. OLLECH, Jacob: No conflict of intereset||Dr. Dwadasi, Sujaata: No conflict of intereset||Dr. Normatov, Inessa: No conflict of intereset||Dr. Israel, Amanda: No conflict of intereset||Ms. Rai, Victoria: No conflict of intereset||Mr. Sossenheimer, Phillip: No conflict of intereset||Dr. Christensen, Britt: No conflict of intereset||Dr. Dalal, Sushila:|:|has received grant support from Pfizer||Dr. Pekow, Joel:|:|has received grants from Takeda and Abbvie, and serves as a consultant for Verastem||Dr. Sakuraba, Atsushi:|:|has received funding from AbbVie, Celltrion and Takeda||Prof. Cohen, Russell:|:|RDC is a consultant at Abbvie, Celgene, Janssen, Pfizer, Takeda and UCB Pharma||Prof. Rubin, David:|:|consultant and has received grant support from Abbvie, Merck & Co., Janssen, Takeda and Pfizer

P446

Hassan-Zahraee, Mina:|:|Employee of Pfizer Inc||Ye, Zhan:|:|Employee and shareholder of Pfizer Inc||Xi, Li:|:|Employee and shareholder of Pfizer Inc||Baniecki, Mary Lynn:|:|Employee of Pfizer Inc||Li, Xingpeng:|:|Employee and shareholder of Pfizer Inc||Farin, William: No conflict of intereset||Tibaldi, Lorenzo: No conflict of intereset||Allegretti, Jessica R:|:|Grants: Merck and Co;|Consultant: Pfizer Inc, Takeda, Janssen, and Finch Therapeutics||Romatowski, Jacek: No conflict of intereset||Scherl, Ellen J:|:|Grants: Abbott (AbbVie), AstraZeneca, CCFA, Janssen Research & Development, Johns Hopkins University, National Institute of Diabetes and Digestive and Kidney (NIDDK), National Institute of Health (NIH), New York Crohn’s Foundation, Pfizer, UCB, UCSF–CCFA Clinical Research Alliance, Genentech. Seres Therapeutics, and Celgene;|Corporation consultant/advisory board: AbbVie, Crohn’s and Colitis Foundation of America (CCFA), Entera Health, Evidera, GI Health Foundation, Janssen, Protagonist Therapeutics, Seres Health, and Takeda Pharmaceuticals;|Stock shareholder: Gilead;|Honoraria: GIHealth Foundation for non-branded speaker’s bureau, Janssen for non-branded speaker’s bureau||Klopocka, Maria:|:|Payment for lectures: Janssen, Takeda, Ferring, Alfa-Sigma, and Pharmabest;|Travel/accommodation/meeting expenses: Ferring, Janssen, Takeda, Alfa-Sigma, Pharmabest, and Polish Foundation for Gastroenterology||Hyde, Craig:|:|Employee and shareholder of Pfizer Inc||Danese, Silvio:|:|Consultancy fees: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ely Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer Inc, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc., and Vifor||Longman, Randy:|:|Paid consultant for Pfizer Inc||Hung, Kenneth E:|:|Employee and shareholder of Pfizer Inc

P447

Dr. Wils, Pauline: No conflict of intereset||Prof. Seksik, Philippe: No conflict of intereset||Dr. Stefanescu, Carmen: No conflict of intereset||Prof. Nancey, Stephane: No conflict of intereset||Prof. Allez, Matthieu: No conflict of intereset||Prof. Laharie, David: No conflict of intereset||Dr. Pineton De Chambrun, Guillaume: No conflict of intereset||Dr. Altwegg, Romain: No conflict of intereset||Dr. Gilletta, Cyrielle: No conflict of intereset||Dr. Vuitton, Lucine: No conflict of intereset||Dr. Viennot, Stephanie: No conflict of intereset||Dr. Serrero, Melanie: No conflict of intereset||Prof. Fumery, Mathurin: No conflict of intereset||Prof. Savoye, Guillaume: No conflict of intereset||Dr. Collins, Michael: No conflict of intereset||Dr. Goutorbe, Felix: No conflict of intereset||Dr. Brixi, Hedia: No conflict of intereset||Prof. Bouguen, Guillaume: No conflict of intereset||Dr. Tavernier, Noemie: No conflict of intereset||Dr. Boualit, Medina: No conflict of intereset||Prof. Amiot, Aurelien: No conflict of intereset||Prof. Abitbol, Vered: No conflict of intereset||Prof. Pariente, Benjamin: No conflict of intereset

Page 84 of 135

P448

Danese, Silvio:|:|Investigator and advisor for Janssen||Dr. Panaccione, Remo:|:|Investigator and advisor for Janssen||Dr. Peyrin-Biroulet, Laurent:|:|Investigator and advisor for Janssen||Dr. Marano, Colleen:|:|Salaried employee for Janssen||Dr. O'Brien, Christopher D.:|:|Salaried employee for Janssen||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen||Dr. Zhou, Yiying:|:|Salaried employee for Janssen||Dr. Johanns, Jewel:|:|Salaried employee for Janssen||Dr. Scherl, Ellen:|:|Investigator and advisor for Janssen||Dr. Leong, Rupert W.L.:|:|Investigator and advisor for Janssen||Dr. Rowbotham, David S.:|:|Investigator and advisor for Janssen||Dr. Arasaradnam, Ramesh P.:|:|Investigator and advisor for Janssen||Dr. Sands, Bruce E.:|:|Investigator and advisor for Janssen

P449

Dr. CHUPIN, Antoine: No conflict of intereset||Mr. Perduca, Vittorio: No conflict of intereset||Dr. Bellanger, Christophe: No conflict of intereset||Prof. Carbonnel, Franck: No conflict of intereset||Dr. Dong, Catherine: No conflict of intereset

P450

Mr. Biemans, Vince: No conflict of intereset||Savelkoul, Edo: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Simsek, Melek: No conflict of intereset||Gabriels, Ruben: No conflict of intereset||Dr. Pierik, Marieke: No conflict of intereset||Dr. West, Rachel: No conflict of intereset||Dr. de Boer, Nanne: No conflict of intereset||Hoentjen, Frank: No conflict of intereset

P451

Dr. KUBESCH, Alica: No conflict of intereset||Mr. Rueter, Laurenz: No conflict of intereset||Dr. Farrag, Karima:|:|KF reports lecture fees from Janssen||Dr. Krause, Thomas:|:|TK reports consulting and lecture fees from Janssen||Dr. Stienecker, Klaus:|:|KS reports consulting and lecture fees from Janssen,||Dr. Hausmann, Johannes:|:|JH reports consulting fees from Janssen,||Dr. Filmann, Natalie: No conflict of intereset||Prof. Dignass, Axel:|:|AD reports consulting and lecture fees from Janssen||Prof. Stein, Jürgen:|:|JS reports consulting and lecture fees from Jansse||Dr. Blumenstein, Irina:|:|IB reports consulting and lecture fees from Janssen

P452

Prof. Dr. Jung, Yoon Suk: No conflict of intereset||Mrs. Han, Minkyung: No conflict of intereset||Prof. Park, Sohee: No conflict of intereset||Prof. Dr. Cheon, Jae Hee: No conflict of intereset

P453

Dr. Sato, Toshiyuki: No conflict of intereset||Kojima, Kentaro: No conflict of intereset||Dr. Koshiba, Ryoji: No conflict of intereset||Dr. Fujimoto, Koji: No conflict of intereset||Dr. Kawai, Mikio: No conflict of intereset||Dr. Kamikoduru, Koji: No conflict of intereset||Dr. Yokoyama, Yoko: No conflict of intereset||Dr. Miyazaki, Takako: No conflict of intereset||Dr. Watanabe, Kenji:|:|Grants: Kyorin Pharmaceutical Co. Ltd,　Zeria Pharmaceutical Co. Ltd. Mochida Pharmaceutical Co.,Ltd.|Personal Fees|o 　Consulting: Mochida Pharmaceutical Co.,Ltd. Pfizer Inc|o 　Support for travel for meetings to support study: Pfizer Inc|o 　Shareholder: none|o 　Fees participation in review activities such as data monitorin boards, statistical analysis, end point committees and the like: none|o 　Payment for writing or reviewing the manuscript: none|· Non-financial support:|· 　Provision of writing assistance, medicines, equipment, or administrative support: none|||Dr. Hida, Nobuyuki: No conflict of intereset||Prof. Dr. Nakamura, Shiro:|:| Grants: KYORIN Pharmaceutical Co.,Ltd. ;Zeria Pharmaceutical Co., Ltd. ;Mochida Pharmaceutical Co.,Ltd. ; Mitsubishi Tanabe Pharma Corporation|· Personal Fees|o 　Consulting: Zeria Pharmaceutical Co., Ltd. ;Mochida Pharmaceutical Co.,Ltd. ;Pfizer Inc. ;Aspen Japan K.K.;KYORIN Pharmaceutical Co.,Ltd. ; Mitsubishi Tanabe Pharma Corporation.|o 　Support for travel for meetings to support study: none.|o 　Shareholder: none.|o 　Fees participation in review activities such as data monitorin boards, statistical analysis, end point committees and the like: none.|o 　Payment for writing or reviewing the manuscript: none.|· Non-financial support:|· 　Provision of writing assistance, medicines, equipment, or administrative support: none.

P454

Dr. Bertani, Lorenzo: No conflict of intereset||Dr. Antonioli, Luca: No conflict of intereset||Dr. Fornili, Marco: No conflict of intereset||Dr. Fornai, Matteo: No conflict of intereset||Dr. Tapete, Gherardo: No conflict of intereset||Dr. Albano, Eleonora: No conflict of intereset||Dr. Baiano Svizzero, Giovanni: No conflict of intereset||Dr. Ceccarelli, Linda: No conflict of intereset||Dr. Mumolo, Maria Gloria: No conflict of intereset||Prof. Baglietto, Laura: No conflict of intereset||Prof. Dr. Marchi, Santino: No conflict of intereset||Prof. Dr. Blandizzi, Corrado: No conflict of intereset||Dr. Costa, Francesco: No conflict of intereset

P455

Dr. Wall, Catherine: No conflict of intereset||Dr. McCombie, Andrew: No conflict of intereset||Prof. Mulder, Roger: No conflict of intereset||Prof. Day, Andrew: No conflict of intereset||Prof. Gearry, Richard: No conflict of intereset

P456

CAMPBELL, Roisin: No conflict of intereset||Dr. Haddock , Rosie: No conflict of intereset||Dr. Parman, Krithivasan: No conflict of intereset||Dr. MacDonald, Jonathan: No conflict of intereset||Dr. Seenan, John Paul: No conflict of intereset

Page 85 of 135

P457

Dr. Oliveira, Antonio: No conflict of intereset||Dr. Costa-Santos, Maria Pia: No conflict of intereset||Dr. Frias Gomes, Catarina: No conflict of intereset||Dr. Sabino, João: No conflict of intereset||Dr. Sampaio, Ana: No conflict of intereset||Dr. Avedano, Luisa: No conflict of intereset||Dr. Leone, Salvo: No conflict of intereset||Prof. Dr. Colombel, Jean-Frédéric: No conflict of intereset||Dr. Torres, Joana: No conflict of intereset

P458

Dr. Hambli, Sofia: No conflict of intereset||Dr. Rogeau, Stéphanie: No conflict of intereset||Dr. Duveau, Nicolas: No conflict of intereset||Dr. Nachury, Maria: No conflict of intereset||Dr. Branche, Julien: No conflict of intereset||Dr. Gérard, Romain: No conflict of intereset||Dr. Wils, Pauline: No conflict of intereset||Dr. Lauriot Dit Prevost, Clémentine: No conflict of intereset||Mr. Lambin, Thomas: No conflict of intereset||Prof. Dr. Desreumaux, Pierre: No conflict of intereset||Prof. Dr. Labalette, Myriam: No conflict of intereset||Prof. Dr. Pariente, Benjamin: No conflict of intereset

P459Långvall, Patricia: No conflict of intereset||Dr. Shi, Chunliang: No conflict of intereset||Dr. Karling, Pontus: No conflict of intereset

P460

Clarke, Astrid:|:|Stockholder and employee of Gilead Sciences, Inc.||Dr. Di Paolo, Julie:|:|Gilead Sciences employee and potential shareholder||Dr. Downie, Bryan:|:|Gilead Sciences employee and potential shareholder||Dr. Meng, Amy:|:|Gilead Sciences employee and potential shareholder||Dr. Mollova, Nevena:|:|Gilead Sciences employee and potential shareholder||Dr. Yu, Yuanjiang:|:|Employee at Gilead Sciences||Dr. Han, Pei:|:|Employee at Gilead Sciences

P461

Dr. Fujii, Toshimitsu: No conflict of intereset||Dr. Hibiya, Shuji: No conflict of intereset||Dr. Maeyashiki, Chiaki: No conflict of intereset||Dr. Saito, Eiko: No conflict of intereset||Dr. Takenaka, Kento: No conflict of intereset||Dr. Motobayashi, Maiko: No conflict of intereset||Dr. Shimizu, Hiromichi: No conflict of intereset||Dr. Nagahori, Masakazu: No conflict of intereset||Prof. Ohtsuka, Kazuo: No conflict of intereset||Dr. Kurosaki, Masayuki: No conflict of intereset||Dr. Yauchi, Tsunehito: No conflict of intereset||Prof. Watanabe, Mamoru: No conflict of intereset

P462

Dr. Mañosa Ciria, Miriam: No conflict of intereset||Dr. Fernandez-Clotet, Agnès: No conflict of intereset||Dr. Hernández-Camba, Alejandro: No conflict of intereset||Dr. Muñoz Pérez, Roser: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Dr. Sierra, Monica: No conflict of intereset||Dr. Márquez, Lucía: No conflict of intereset||Dr. Delgado-Guillena, Pedro: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. Van Domselaar, Manuel: No conflict of intereset||Dr. Girona, Eva: No conflict of intereset||Dr. Sánchez-Rodríguez, Eugenia: No conflict of intereset||Dr. Martín-Arranz, Maria Dolores: No conflict of intereset||Dr. Lorente, Rufo: No conflict of intereset||Dr. Casas-Deza, Diego: No conflict of intereset||Dr. Boscá, Maia: No conflict of intereset||Dr. Cañete, Fiorella: No conflict of intereset||Dr. Calafat, Margalida: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset

Page 86 of 135

P463

P464

Ms. Van den Berghe, Nathalie: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Mrs. Gils, Ann:|:|AG served as a speaker for Merck Sharp & Dohme, Janssen Biologicals, Pfizer, Takeda, Novartis, and AbbVie, and received Investigator-Initiated Research Grants from Pfizer and a national grant from Takeda.||KU Leuven licensed antibodies for the infliximab, adalimumab, vedolizumab, golimumab, and ustekinumab ELISA to apDia and infliximab and adalimumab lateral flow assays to R-Biopharm.|||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Mrs. Thomas, Debby: No conflict of intereset

Vickers, Adrian:|:|AV is an employee of RTI Health Solutions, which received funding from Shire, a Takeda company, for this study.||Nag, Arpita:|:|AN is an employee of Shire, a Takeda company.||Devine, Beth:|:|BD is a consultant for Shire, a Takeda company, and Mallinckrodt Pharmaceuticals.||Dr. Sands, Bruce E:|:|BES has received consultancy fees from AbbVie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella Bioscience, Celltrion Healthcare, Genentech, F Hoffmann-La Roche AG, Ironwood Pharmaceuticals, Janssen, Lilly, Morphic Therapeutic, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Laboratorie, Salix, Shire, Takeda, TARGET PharmaSolutions, Theravance Biopharma and Vivelix Pharmaceuticals, and research support from Theravance Biopharma.|This study was conducted by RTI Health Solutions, and funded by Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies.|Medical writing support was provided by Katie Pillidge, PhD, of PharmaGenesis London, London, UK, and funded by Shire International GmbH, a member of the Takeda group of companies.||Panaccione, Remo:|:|RP has received consultancy fees from AbbVie, Abbott, Alba Therapeutics, Allergan, Amgen, Aptalis, AstraZeneca, Atlantic Healthcare, Baxter, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cosmo Technologies, Coronado Biosciences, Cubist, Eisau Medical Research, Elan, Eli Lilly, enGene, EnteroMedics, Exagen Diagnostics, Ferring, Genentech, Genzyme, Gilead, Given Imaging, GSK, Hospira, Human Genome Sciences, Janssen, Merck & Co., Merck Research Laboratories, Merck Serono, Millennium, Nisshin Kyorin, Novo Nordisk, Pfizer Inc, Qu Biologics, Receptos, Relypsa, Salient, Salix Pharmaceuticals, Santarus, Shire, Sigmoid Pharma, and Takeda; speakers bureau fees from AbbVie, Aptalis, Celgene, Ferring, Janssen, Merck, Pfizer Inc, Prometheus Laboratories, Shire and Takeda; and financial support for research from AbbVie, Ferring, Janssen, Shire and Takeda.||Peyrin-Biroulet, Laurent:|:|LPB has received personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, InDex Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine ; Mylan, Lilly, Fresenius, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera; grants from Abbvie, MSD and Takeda; and holds stock options in CTMA.||Danese, Silvio:|:|SD has received consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer, Roche, Sandoz, Takeda, TiGenix, UCB Inc., and Vifor.||Vermeire, Séverine:|:|SV has received consultancy fees from AbbVie, Arena, Celgene, Dr. Falk Pharma, Eli Lilly, Ferring, Galapagos, Genentech/Roche, Gilead, Hospira, Janssen, MSD, Mundipharma, Pfizer, ProDigest, Progenity, Second Genome, Shire, Takeda and Tillots, and research support from AbbVie, Janssen, MSD, Pfizer and Takeda.||Gorelick, Kenneth J:|:|KJG has been a consultant for Pfizer and Shire, a Takeda company.||Goetsch, Martina:|:|MG is an employee of and owns stock options in Shire, a Takeda company.||Hartley, Louise:|:|LH is an employee of RTI Health Solutions, which received funding from Shire, a Takeda company, for this study.

Page 87 of 135

P465

Prof. Bodini, Giorgia: No conflict of intereset||Dr. Demarzo, Maria Giulia: No conflict of intereset||Dr. Djahandideh, Afscin: No conflict of intereset||Dr. Baldissarro , Isabella: No conflict of intereset||Prof. Savarino, Edoardo: No conflict of intereset||Prof. Savarino, Vincenzo: No conflict of intereset||Dr. Jain, Anjali: No conflict of intereset||Dr. Risso, Paolo Marco: No conflict of intereset||Prof. Giannini , Edoardo Giovanni: No conflict of intereset

P466

Dr. Sanchis, Laura: No conflict of intereset||Dr. Molés, Jose Ramón: No conflict of intereset||Dr. Borrás, Joaquin: No conflict of intereset||Ms. Rodriguez, Josefa: No conflict of intereset||Dr. Cortés, Xavier: No conflict of intereset

P467Dr. Miller, Charles: No conflict of intereset||Ms. Morgan, Helen: No conflict of intereset||Dr. Steel, Alan: No conflict of intereset||Dr. Wahed, Mahmood: No conflict of intereset

P468

Barberio, Brigida: No conflict of intereset||Melatti, Piera: No conflict of intereset||Zingone, Fabiana: No conflict of intereset||Bertani, Lorenzo: No conflict of intereset||Ferronato, Antonio: No conflict of intereset||Dr. GUBBIOTTI, Alessandro: No conflict of intereset||Massimi, Davide: No conflict of intereset||D'Incà, Renata: No conflict of intereset||Savarino, Edoardo Vincenzo: No conflict of intereset

P469Mrs. Johnson, Heather: No conflict of intereset||Dr. Vythilingam, Siyamini: No conflict of intereset||Dr. McLaughlin, Simon: No conflict of intereset

P470

Ms. Knödler, Laura-Louise: No conflict of intereset||Dr. Thomann, Anne: No conflict of intereset||Prof. Dr. Ebert, Matthias P.: No conflict of intereset||Dr. Lis, Stefanie: No conflict of intereset||Dr. Reindl, Wolfgang: No conflict of intereset

P471

Dr. Shin, Jongbeom: No conflict of intereset||Dr. Seong, Gyeol: No conflict of intereset||Dr. Song, Joo Hye: No conflict of intereset||Dr. Kong, Sung Min: No conflict of intereset||Prof. Dr. Kim, Tea Jun: No conflict of intereset||Prof. Dr. Kim , Ean Ran: No conflict of intereset||Prof. Dr. Hong, Sung Noh: No conflict of intereset||Prof. Dr. Chang, Dong Kyung: No conflict of intereset||Prof. Dr. Kim, Young-ho: No conflict of intereset

P472

Dr. Hussain, Faizi: No conflict of intereset||Dr. DeLegge, Mark: No conflict of intereset||Mr. Copeman, Matthew: No conflict of intereset||Ms. Gallagher, Margaret-Beth: No conflict of intereset||Ms. Stewart, Tracy: No conflict of intereset||Dr. Georgiev, Georgi: No conflict of intereset

P473

Dr. Padilla Suarez, Camilo: No conflict of intereset||Ms. Webb, Katherine: No conflict of intereset||Ms. Persad, Nicola: No conflict of intereset||Ms. Sercombe, Judy: No conflict of intereset||Ms. Tyler, Emma: No conflict of intereset||Dr. Klimova, Katerina: No conflict of intereset

P474

Dr. Ito, Ayumi: No conflict of intereset||Dr. Murasugi, Syun: No conflict of intereset||Dr. Omori, Teppei: No conflict of intereset||Dr. Yonezawa, Maria: No conflict of intereset||Prof. Dr. Tokushige, Katutoshi: No conflict of intereset

Page 88 of 135

P475

P476

Dr. Schwartz, David:|:|Consultancy: AbbVie, UCB pharma, Janssen, Tigenix, Gilead, Pfizer, Genentech|Grants: UCB pharma|||Dr. Peyrin-Biroulet, Laurent:|:|Consultancy: AbbVie, Janssen, Genentech, Ferring, Tillotts, Pharmacosmos, Celltrion, Takeda, Boehringer Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen|Grants: AbbVie, MSD, Takeda|Stock options: CT-SCOUT|||Dr. Lasch, Karen:|:|Employee of Takeda holds relevant Takeda patents||Dr. Adsul, Shashi:|:|Employee of Takeda holds Takeda stock or stock options||Dr. Danese, Silvio:|:|Lecture fee(s): AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim|Consultancy: AbbVie, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer Inc, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim

P477

Pugliese, Daniela:|:|Speaker fee from Abbvie, Takeda, Janssen and Pfizer. ||Dr. Privitera, Giuseppe: No conflict of intereset||Prof. Armuzzi, Alessandro:|:|Consulting and/or advisory board fees from AbbVie, Allergan, Amgen, Biogen, Celgene, Celltrion, Ferring, Hospira, Janssen, Lilly, MSD, Mundipharma, Pfizer, Samsung Bioepis, Sofar and Takeda; lecture and/or speaker bureau fees from AbbVie, AstraZeneca, Chiesi, Ferring, Hospira, Janssen, MSD, Mitsubishi-Tanabe, Medtronic, Mundipharma, Nikkiso, Pfizer, Otsuka, Samsung Bioepis, Takeda, Tigenix and Zambon; and research grants from MSD and Takeda

P478

Dr. Sousa, Paula Cristina: No conflict of intereset||Dr. Estevinho, Manuela: No conflict of intereset||Prof. Dias, Claudia Camila: No conflict of intereset||Dr. Martins, Diana: No conflict of intereset||Dr. Cancela, Eugénia: No conflict of intereset||Dr. Pires, Francisco: No conflict of intereset||Dr. Carvalho, Catarina: No conflict of intereset||Dr. Ministro, Paula: No conflict of intereset||Prof. Dr. Magro, Fernando: No conflict of intereset

Sandborn, William J:|:|Grants: AbbVie, Amgen, Atlantic Healthcare Limited, Celgene/Receptos, Eli Lilly, Genentech, Gilead, Janssen, Pfizer Inc, Prometheus Laboratories (now Prometheus Biosciences), Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Eli Lilly, Ferring, Forbion, Genentech, Gilead, Gossamer Bio, Incyte, Janssen, Kyowa Kakko Kirin Co. Ltd., Landos Biopharma, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Biosciences, Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts, UCB, Ventyx Biosciences, Vimalan Biosciences, Vivelix|Other: Spouse: Consultant, Stock options: Escalier Biosciences, Opthotech, Oppilan Pharma, Progenity, Prometheus Biosciences, Ventyx Biosciences, Vimalan Biosciences||Gisbert, Javier P:|:|Personal fees: AbbVie, Biogen, Celgene, Casen Fleet, Chiesi, Dr. Falk Pharma, Faes Farma, Ferring, Gebro Pharma, Hospira, Janssen, Kern Pharma, MSD, Otsuka, Pfizer Inc, Roche, Sandoz, Shire , Takeda, Tillotts, Vifor||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Quirk, Daniel:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc|||Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Guo, Xiang:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Chiorean, Michael:|:|Grants: Takeda|Personal fees: AbbVie, Arena Pharmaceuticals, Celgene, Janssen, Medtronic, Pfizer Inc, Prometheus Laboratories,Takeda||Reinisch, Walter:|:|Grants: Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GMbH, Immundiagnostik, MSD|Personal fees: 4SC, Abbott Laboratories, AbbVie, Aesca, Amgen, AM Pharma, AOP Orphan, Aptalis, Arena Pharmaceuticals, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, ChemoCentryx, Covance, Danone, Austria, Elan, Eli Lilly, Ernst & Young, Falk Pharma GMbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, Index, Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, MedAhead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestlé, Novartis, Ocera, Otsuka, Parexel, PDL, Pfizer Inc, Pharmacosmos, Philip Morris Institute, PLS Education, Proctor & Gamble, Prometheus, Laboratories, Protagonist, Provention, Robarts Clinical Trials, Roland, Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres, Therapeutics, SetPoint Medical, Shire, Sigmoid, Takeda, Therakos, TiGenix, UCB, Vifor, Yakult, Zealand, Zyngenia

Page 89 of 135

P479

Dr. Matar, Manar: No conflict of intereset||Prof. Shamir, Raanan: No conflict of intereset||Prof. Turner, Dan: No conflict of intereset||Dr. Broide, Efrat: No conflict of intereset||Dr. Weiss, Batia: No conflict of intereset||Dr. Ledder, Oren: No conflict of intereset||Dr. Guz-Mark, Anat: No conflict of intereset||Dr. Rinawi, Firas: No conflict of intereset||Dr. Cohen, Shlomi: No conflict of intereset||Dr. Topf-Olivestone, Chani: No conflict of intereset||Prof. Shaoul, Ron: No conflict of intereset||Dr. Yerushalmi, Baruch: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Prof. Assa, Amit: No conflict of intereset

P480

Lukáš, Martin: No conflict of intereset||Mr. Kolar, Martin: No conflict of intereset||Dr. Vasatko, Martin: No conflict of intereset||Dr. Klvana, Pavel: No conflict of intereset||Dr. Leksa, Vaclav: No conflict of intereset||Dr. Dyntr, Jiri: No conflict of intereset||Dr. Baca, Lukas: No conflict of intereset||Dr. Pipek, Barbora: No conflict of intereset||Dr. Bahnikova, Barbora: No conflict of intereset||Dr. Summerova, Sandra: No conflict of intereset

P481

Dr. Colombo, Francesco: No conflict of intereset||Dr. Frontali, Alice: No conflict of intereset||Dr. Baldi, Caterina: No conflict of intereset||Dr. Lamperti, Giulia Maria Beatrice: No conflict of intereset||Prof. Maconi, Gianni: No conflict of intereset||Prof. Ardizzone, Sandro: No conflict of intereset||Prof. Foschi, Diego: No conflict of intereset||Dr. Sampietro, Gianluca: No conflict of intereset

P482

Prof. Afzali, Anita:|:|Consultant: AbbVie, Takeda, Janssen, Celgene, UCB; Speaker: AbbVie, Takeda, Janssen, UCB, Pfizer||Prof. Armuzzi, Alessandro:|:|Consultant: AbbVie, Allergan, Amgen, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, MSD, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, Sofar, Takeda; Lecture fees: AbbVie, Amgen, Biogen, Bristol-Myers Squibb, Chiesi, Ferring, Hospira, Janssen, MSD, Mitsubishi Tanabe, Nikkiso, Pfizer, Samsung Bioepis, Sandoz, Takeda, Tigenix; Research grants: MSD, Takeda, Pfizer||Prof. Bouhnik, Yoram:|:|Honoraria: AbbVie, Biogaran, Biogen, Boehringer Ingelheim, Celgene, Ferring, Gilead, Hospira, Janssen, Mayoli Spindler, MSD, Norgine, Pfizer, Roche, Samsung Bioepis, Sandoz, Sanofi, Shire, Takeda, UCB; Grants: Pfizer, Takeda||Prof. Bressler, Brian:|:|Advisor/Speaker: Ferring, Janssen, AbbVie, Takeda, Pfizer, Novartis, Merck; Advisor: Robarts Clinical Trials, Celgene, Microbiome Insights, Merck, Amgen, Pendopharm, Genentech, BMS, Allergan, Protagonist; Research support: Janssen, AbbVie, GSK, BMS, Amgen, Genentech, Merck, BI, Qu Biologic, Celgene, Alvine; Stock options: Qu Biologic||Prof. Hart, Ailsa:|:|Consultant/advisory board/speaker: AbbVie, Atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda; Global Steering Committee: Genentech.||Rubin, David:|:|Consultant: AbbVie, Janssen, Takeda, Pfizer, Celgene; Grants: Takeda||Dr. Sans, Miguel:|:|Honoraria: Pfizer, Takeda, Amgen, Celgene, Cheisi, Gebro, Tillots, Kern, Ferring, Faes||Prof. Dr. Siegmund, Britta:|:|Consultant: AbbVie, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, Takeda; Speaker: AbbVie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Takeda; Served as representative of the Charité.||Dr. Sninsky, Charles:|:|Speaker: Janssen, AbbVie, UCB, Takeda, Pfizer; Clinical researcher: Janssen, AbbVie, Takeda; Consultant: Celgene

P483

Dr. Shields, Stephanie: No conflict of intereset||Dr. Seenan, John Paul: No conflict of intereset||Dr. Nowell, Emma: No conflict of intereset||Dr. Dunlop, Allan: No conflict of intereset||Dr. Galloway, Peter: No conflict of intereset||Dr. Macdonald, Jonathan: No conflict of intereset

P484

Dr. Mohammad, Danah: No conflict of intereset||Dr. Alshahrani, Abdulaziz: No conflict of intereset||Mr. Bao, Yeuyang: No conflict of intereset||Dr. Alramdan, Raed: No conflict of intereset||Mr. Rajani, adam: No conflict of intereset||Mrs. Chauhan, Usha: No conflict of intereset||Dr. Salena, Bruno: No conflict of intereset||Dr. Tse, Frances: No conflict of intereset||Dr. Greenwald, Eric: No conflict of intereset||Dr. Albashir, Siwar: No conflict of intereset||Dr. Halder, Smita: No conflict of intereset||Dr. Armstrong, David: No conflict of intereset||Dr. Marshall, John: No conflict of intereset||Dr. Narula, Neeraj: No conflict of intereset

P485

Dr. Luber, Raphael: No conflict of intereset||Ms. O'Neill, Rhona: No conflict of intereset||Ms. Singh, Sukhpreet: No conflict of intereset||Ms. Arkir, Zehra: No conflict of intereset||Dr. Irving, Peter:|:|PI has received fees for speaking on behalf of or acting in an advisory capacity for AbbVie, Arena, Celgene, Ferring, Prometheus, Shire, Warner Chilcott, Takeda, MSD, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, VH2, Janssen, Sandoz, Lilly, Roche and has received financial support for research from MSD, Pfizer and Takeda

Page 90 of 135

P486

Dr. Cassinotti, Andrea: No conflict of intereset||Dr. Mezzina, Nicolò: No conflict of intereset||Dr. Di Paolo, Dhanai: No conflict of intereset||Dr. Lenti, Marco Vincenzo: No conflict of intereset||Dr. Bezzio, Cristina: No conflict of intereset||Dr. Stradella, Davide: No conflict of intereset||Dr. Mauri, Martina: No conflict of intereset||Dr. Zadro, Valentina: No conflict of intereset||Dr. Cortellezzi, Claudio: No conflict of intereset||Dr. Ricci, Chiara: No conflict of intereset||Dr. Casini, Valentina: No conflict of intereset||Dr. Radice, Elisa: No conflict of intereset||Dr. Massari, Alessandro: No conflict of intereset||Prof. Ardizzone, Sandro: No conflict of intereset||Dr. Pastorelli, Luca: No conflict of intereset||Dr. Di Sabatino, Antonio: No conflict of intereset||Dr. Manes, Gianpiero: No conflict of intereset||Prof. Caprioli, Flavio: No conflict of intereset||Prof. Vecchi, Maurizio: No conflict of intereset||Dr. Tari, Roberto: No conflict of intereset||Dr. Occhipinti, Pietro: No conflict of intereset||Dr. Fichera, Maria: No conflict of intereset||Dr. Invernizzi, Pietro: No conflict of intereset||Dr. Parravicini, Marco: No conflict of intereset||Dr. Segato, Sergio: No conflict of intereset||Dr. Pace, Fabio: No conflict of intereset||Prof. Testoni, Pier Alberto: No conflict of intereset||Dr. Tinelli, Carmine: No conflict of intereset||Dr. De Silvestri, Annalisa: No conflict of intereset

P487

Dr. Adegbola, Samuel: No conflict of intereset||Dr. Dibley, Lesley:|:|consultancy fees from GL|Assessments and speaker fees from Jannsen||Dr. Sahnan, Kapil:|:|honoraria from Takeda for sitting on an advisory board||Dr. Tozer, Phil:|:|has received honoraria from Takeda for speaking at a symposium|honoraria from Takeda for sitting on an advisory board||Ms. Wade, Tiffany: No conflict of intereset||Ms. Verjee, Azmina: No conflict of intereset||Ms. Sawyer, Rachel: No conflict of intereset||Mr. Mannick, Sameer: No conflict of intereset||Mr. McCluskey, Damian: No conflict of intereset||Dr. Yassin, Nuha: No conflict of intereset||Prof. Phillips, Robin: No conflict of intereset||Prof. Norton, Christine:|:|has received speaker’s fees from Ferring, AbbieVie, and Takeda||Prof. Hart, Ailsa:|:|has served as a consultant, advisory board member or speaker for AbbVie, atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the global Steering committee for Genentech.

P488

Ms. Velasco Rodríguez-Belvís, Marta: No conflict of intereset||Ms. Palomino Pérez, Laura María: No conflict of intereset||Ms. Sánchez Fernández-Bravo, Carmen: No conflict of intereset||Ms. Sanchiz Perea, Ana: No conflict of intereset||Mr. Jose Luis, León Falconi: No conflict of intereset||Dr. Domínguez Ortega, Gloria: No conflict of intereset||Ms. Cañedo Villarroya, Elvira: No conflict of intereset||Dr. Pedrón Giner, Consuelo Carmen: No conflict of intereset||Mr. Jorge, Martínez Pérez: No conflict of intereset||Ms. Rodríguez Manchón, Silvia: No conflict of intereset||Ms. Muñoz González, Almudena: No conflict of intereset||Dr. Muñoz Codoceo, Rosa Ana: No conflict of intereset

P489

Mrs. Simian, Daniela: No conflict of intereset||Dr. Núñez, Paulina: No conflict of intereset||Mrs. Flores, Lilian: No conflict of intereset||Dr. Figueroa, Carolina: No conflict of intereset||Dr. Ibáñez, Patricio: No conflict of intereset||Kronberg, Udo: No conflict of intereset||Dr. Lubascher, Jaime: No conflict of intereset||Dr. Pizarro, Gonzalo: No conflict of intereset||Dr. Quera, Rodrigo: No conflict of intereset

P490

Mrs. Borren, Nynke: No conflict of intereset||Mr. Tan, Will: No conflict of intereset||Ms. Jess, Alison: No conflict of intereset||Ms. Li, Pei-Hsuan Mimi: No conflict of intereset||Dr. Garber, John: No conflict of intereset||Dr. Luther, Jay: No conflict of intereset||Dr. Colizzo, Francis: No conflict of intereset||Dr. Khalili, Hamed:|:|Grant funding from Pfizer and Takeda. Consulting fees from AbbVie.||Dr. Ananthakrishnan, Ashwin:|:|Dr. Ananthakrishnan has served on advisory boards for Abbvie, Takeda, and Merck. He is supported by research funding from the Crohn’s and Colitis Foundation, National Institutes of Health, Chleck Family Foundation, and Pfizer

P491

Ms. CHU, Isabel: No conflict of intereset||Dr. Little, Robert: No conflict of intereset||Dr. Sparrow, Miles:|:|Dr. Sparrow reports personal fees from AbbVie, personal fees from Janssen, personal fees from Takeda, grants and personal fees from Ferring, personal fees from Pfizer, personal fees from MSD, personal fees from Celgene, and grants from Orphan, outside the submitted work.||Dr. Ward, Mark:|:|Dr. Ward reports grants and personal fees from AbbVie, personal fees and non-financial support from Janssen, personal fees and non-financial support from Takeda, non-financial support from Ferring, and prior speaker fees and meeting expenses from Shire, outside the submitted work.

P492

Dr. Frias Gomes, Catarina: No conflict of intereset||Dr. Neto Nascimento, Catarina: No conflict of intereset||Dr. Pereira, Flávio: No conflict of intereset||Dr. Caldeira, Ana: No conflict of intereset||Dr. Sousa, Rui: No conflict of intereset||Dr. Arieira, Cátia: No conflict of intereset||Dr. Xavier, Sofia: No conflict of intereset||Dr. Monteiro, Sara: No conflict of intereset||Dr. Dias de Castro, Francisca: No conflict of intereset||Dr. Leite, Silvia: No conflict of intereset||Prof. Dr. Cotter, José: No conflict of intereset||Prof. Dr. Santos, António Alberto: No conflict of intereset||Prof. Dr. Cravo, Marília: No conflict of intereset||Prof. Dr. Torres, Joana: No conflict of intereset||Dr. Palmela, Carolina: No conflict of intereset

Page 91 of 135

P493

Frontali, Alice: No conflict of intereset||Dr. Chierici, Andrea: No conflict of intereset||Prof. Treton, Xavier: No conflict of intereset||Dr. Maggiori, Léon: No conflict of intereset||Bouhnik, Yoram: No conflict of intereset||Prof. Dr. Panis, Yves: No conflict of intereset

P494

Dr. Shin, Seungyong: No conflict of intereset||Prof. Park, Soo Jung: No conflict of intereset||Dr. Kim, Young: No conflict of intereset||Prof. Im, Jong Pil: No conflict of intereset||Prof. Kim, Hyo Jong: No conflict of intereset||Prof. Lee, Kang-Moon: No conflict of intereset||Prof. Kim, Ji Won: No conflict of intereset||Prof. Jung, Sung-Ae: No conflict of intereset||Prof. Lee, Jun: No conflict of intereset||Prof. Kang, Sang Bum: No conflict of intereset||Prof. Shin, Sung Jae: No conflict of intereset||Prof. Kim, Eun Sun: No conflict of intereset||Prof. Kim, You Sun: No conflict of intereset||Prof. Kim, Tae Oh: No conflict of intereset||Prof. Kim, Hyun-Soo: No conflict of intereset||Prof. Park, Dong Il: No conflict of intereset||Prof. Kim, Hyung Kil: No conflict of intereset||Prof. Kim, Eun Soo: No conflict of intereset||Prof. Kim, Young-Ho: No conflict of intereset||Dr. Kim, Do Hyun: No conflict of intereset||Dr. Teng, Dennis: No conflict of intereset||Dr. Kim, Jong-Hwa: No conflict of intereset||Prof. Kim, Won-Young: No conflict of intereset||Prof. Choi, Chang Hwan: No conflict of intereset

P495

Dr. Omori, Teppei: No conflict of intereset||Dr. Kambayashi, Harutaka: No conflict of intereset||Dr. Murasugi, Shun: No conflict of intereset||Dr. Ito, Ayumi: No conflict of intereset||Dr. Yonezawa, Maria: No conflict of intereset||Prof. Tokushige, Katsutoshi: No conflict of intereset

P496

Mr. LI, Yousheng: No conflict of intereset||Dr. Liu, Bin: No conflict of intereset||Dr. Yao, Danhua: No conflict of intereset||Dr. Zheng, Lei: No conflict of intereset||Dr. Zhou, Zhiyuan: No conflict of intereset||Dr. Huang, Yuhua: No conflict of intereset||Dr. Duan, Yantao: No conflict of intereset

P497

Dr. Knezevic, Tamara: No conflict of intereset||Dr. Milic, Marija: No conflict of intereset||Dr. Kalaba, Ana: No conflict of intereset||Dr. Sreckovic, Slobodan: No conflict of intereset||Dr. Stopic, Bojan: No conflict of intereset||Prof. Dr. Svorcan, Petar: No conflict of intereset||Dr. Markovic, Srdjan: No conflict of intereset

P498Atanassova, Antonia: No conflict of intereset||Dr. Georgieva, Avgustina Chavdarova: No conflict of intereset||Mirchev, Milko: No conflict of intereset

P499

af Björkesten, Clas-Göran:|:|C.G. af Björkesten has received consultant fees from Abbvie, MSD, Mylan, Ferring, Janssen-Cilag, Pfizer, Takeda, has received lecture fees from: Abbvie, MSD, Pfizer, Ratiopharm, has received congress fees from AbbVie, Ferring, Meda, MSD, Mylan, Tillotts.||Ilus, Tuire:|:|Dr Ilus has recived lecture fees from Tillotts Pharma.||Hallinen, Taru:|:|T. Hallinen is a employe and shareholders of ESiOR Oy, the company commissioned by Janssen-Cilag Oy to help perform this study. T. Hallinen declare no personal conflict of interest. ||Soini, Erkki:|:|E. Soini is an employe and shareholders of ESiOR Oy, the company commissioned by Janssen-Cilag Oy to help perform this study. E. Soini declare no personal conflict of interest. ||Eberl, Anja:|:|A. Eberl has received research support from Janssen-Cilag and consulting fees from MSD, Pfizer and Takeda. Consulting or speaker fee from Janssen.||Hakala, Kalle: No conflict of intereset||Heikura, Mikko: No conflict of intereset||Hirsi, Eija:|:|E. Hirsi has received lecture fees from Janssen-Cilag, Tillotts Pharma, Takeda. ||Jussila, Airi:|:|A.Jussila has received speaker fees and travel support from Abbvie, Ferring, Janssen-Cilag, MSD, MEDA, Mylan, Pfizer, Takeda and Tillotts Pharma; has received consulting fees from Abbive, Janssen-Cilag, Pfizer, Takeda, Pfeizer, Tillotts Pharma and MSD. ||Kellokumpu, Mikko:|:| M. Kellokunmpu has received lecture fee from Pfizer and Takeda ||Koskela, Ritva:|:|Consulting fee MSD, Pfizer; lecture fee Ferring, MSD, Tillotts|||Koskinen, Inka:|:|Lecture fees from Tillots Pharma, MSD||Moilanen, Veikko: No conflict of intereset||Nielsen , Christian: No conflict of intereset||Nieminen, Urpo: No conflict of intereset||Nuutinen , Heikki:|:|H. Nuutinen has received lecture fees from Pfizer, Janssen-Cilag, Sanofi, Ferring, MSD, Abbvie, Takeda. ||Heikkinen, Markku: No conflict of intereset||Suhonen , Ulla-Maija: No conflict of intereset||Tillonen, Jyrki: No conflict of intereset||Utriainen, Karri:|:|K. Utriainen has received lecture fees from Abbvie, Takeda||Vihriälä, Ilkka: No conflict of intereset||Dr. Wennerström, Christina:|:|This study was supported by Janssen-Cilag Oy (Finland). Dr Wennerström is a employe of Janssen-Cilag.||Borsi , Andras:|:|This study was supported by Janssen-Cilag Oy (Finland). A. Borsi is a employe of Janssen-Cilag.||Nissinen, Riikka:|:|This study was supported by Janssen-Cilag Oy (Finland). R. Nissinen is an employe of Janssen-Cilag.||Koivunen, Minni:|:|This study was supported by Janssen-Cilag Oy (Finland). M. Koivunen is an employe of Janssen-Cilag.||Sipponen, Taina:|:|T. Sipponen has received speaker fees from Abbvie, Ferring, Janssen-Cilag, MSD, Pfizer, Takeda and Tillotts Pharma; has received consulting fees from Hospira, Janssen-Cilag, Pfizer, Takeda and MSD; and has received a research grant from Janssen-Cilag and Takeda.

Page 92 of 135

P500

Bletsa, Maria: No conflict of intereset||Ms. Karachaliou, Alexandra: No conflict of intereset||Dr. Kokkotis, Giorgios: No conflict of intereset||Ms. Tsoutska, Magdalini - Marta: No conflict of intereset||Ms. Andoniadi, Stiliani: No conflict of intereset||Prof. Dr. Papaconstantinou, Ioannis: No conflict of intereset||Prof. Kontogianni, Meropi: No conflict of intereset||Prof. Dr. Bamias, Giorgios: No conflict of intereset

P501

Ms. SÁNCHEZ RODRÍGUEZ, Eugenia: No conflict of intereset||Dr. Sánchez Aldehuelo, Rubén: No conflict of intereset||Dr. Guardiola, Jordi: No conflict of intereset||Dr. Gutiérrez Casbas, Ana: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Bermejo, Fernando: No conflict of intereset||Dr. Van-Domselaar, Manuel: No conflict of intereset||Dr. Mesonero Gismero, Francisco: No conflict of intereset||Dr. Suris, Gerard: No conflict of intereset||Dr. Muñoz Perez, Roser: No conflict of intereset||Mañosa, Míriam: No conflict of intereset||Dr. Jiménez Márquez, Laura: No conflict of intereset||Dr. Algaba García, Alicia: No conflict of intereset||Dr. López sanroman, Antonio: No conflict of intereset

P502

Dr. NAKAMURA, Takahiro: No conflict of intereset||Dr. Shah, Ravi: No conflict of intereset||Dr. Sachs, Michael: No conflict of intereset||Dr. Chang, Shannon: No conflict of intereset||Dr. Hudesman, David: No conflict of intereset||Dr. Click, Benjamin: No conflict of intereset||Dr. Axelrad, Jordan: No conflict of intereset

P503

Dr. Gonzalez Lama, Yago:|:|The author and group have received Grants and personal fees from AbbVie, Takeda, Jansen, MSD, Ferring, Amgen, ||Dr. Calvo, Marta:|:|The author and group have received Grants and personal fees from AbbVie, Takeda, Jansen, MSD||Dr. Matallana, Virginia:|:|The author and group have received Grants and personal fees from AbbVie, Takeda, Jansen, MSD||Dr. Gonzalez-Partida, Irene:|:|The author and group have received Grants and personal fees from AbbVie, Takeda, Jansen, MSD||Omella, Ignacio: No conflict of intereset||Dr. Vera, Maria Isabel:|:|The author and group have received Grants and personal fees from AbbVie, Takeda, Jansen, MSD,

P504Dr. Sweed, Gil:|:|CEO of DoctorsWeed Systems Ltd.||Prof. Shapira, Chen: No conflict of intereset||Dr. Naftali, Timna: No conflict of intereset

P505

Ms. Rosembert, Denise: No conflict of intereset||Dr. Malaviya, Anshuman: No conflict of intereset||Mrs. How, Jane: No conflict of intereset||Mrs. Tomlison, Jaqueline: No conflict of intereset||Ms. Toh, Fiona: No conflict of intereset||Ms. Roe, Maria: No conflict of intereset||Mrs. Nightingale , Allison: No conflict of intereset||Mrs. Garcia-Sueiro, Cristina: No conflict of intereset||Mrs. Herbert, Pippa: No conflict of intereset||Dr. Jadon, Deepak: No conflict of intereset||Dr. Norris, Paul: No conflict of intereset||Dr. Thomas, Justyn: No conflict of intereset||Mr. Magsino, Julien: No conflict of intereset||Dr. Negoescu, Andra: No conflict of intereset||Dr. Raine, Tim: No conflict of intereset

P506

Dr. Yanai, Henit: No conflict of intereset||Ms. Amir, Shira: No conflict of intereset||Dr. Avni Biron, Irit: No conflict of intereset||Dr. Tsadok Perets, Tsachi: No conflict of intereset||Prof. Dr. Shamir, Raanan: No conflict of intereset||Prof. Dr. Dotan, Iris: No conflict of intereset||Prof. Dr. Assa, Amit: No conflict of intereset

P507

Dr. Gadhok, Radha: No conflict of intereset||Dr. Fragkos, Konstantinos: No conflict of intereset||Dr. Honap, Sailash: No conflict of intereset||Ms. Hassan, Jasmine: No conflict of intereset||Ms. Whiteley, Lisa: No conflict of intereset||Ms. Ibarra, Ana: No conflict of intereset||Ms. Burgess, Natasha: No conflict of intereset||Dr. Vega, Roser: No conflict of intereset||Dr. Seward, Edward: No conflict of intereset||Dr. Mehta, Shameer: No conflict of intereset||Dr. McCartney, Sara: No conflict of intereset||Dr. Bloom, Stuart: No conflict of intereset||Dr. Parkes, Gareth: No conflict of intereset||Dr. Irving, Peter: No conflict of intereset||Prof. Lindsay, James O: No conflict of intereset||Dr. Kok, Klaartje Bel: No conflict of intereset||Dr. Rahman, Farooq: No conflict of intereset

P508

Dr. Goessens, Laurent: No conflict of intereset||Prof. Dr. Colombel, Jean-Frederic:|:|Dr. Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, |Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals

Page 93 of 135

P509

Dr. Sun, Wan:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Fennimore, Blair: No conflict of intereset||Dr. Beaulieu, Dawn B:|:|Consulting: Takeda, AbbVie||Dr. Arsenescu, Razvan:|:|Consulting fees / Takeda Speaking Bureau; Takeda Clinical trials||Dr. Stein, Adam:|:|Consulting: Abbvie; Speaker’s bureau: Abbvie, Pfizer ||Dr. Chen, Jingjing:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Lin, Tiffany:|:|Contracted by Takeda via Certara||Dr. McKnight, Sonya:|:|Employee of Takeda||Dr. Rosario, Maria:|:|Employee of Takeda at the time this research was conducted; has granted patents and pending patent applications relating to the clinical pharmacology of vedolizumab ||Dr. Lirio, Richard A:|:|Employee of Takeda; holds Takeda stock or stock options

P510

Dr. Sandborn, William: No conflict of intereset||Dr. Wolf, Doug:|:|Research grants/consulting/speaker bureau for Takeda, Abbvie, Janssen, UCB||Dr. D’haens, Geert:|:|Served as advisor for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Applied Molecular Therapeutics; Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, DSM Pharma; Echo Pharmaceuticals, Eli Lilly, Engene, Exeliom Biosciences; Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, ProciseDx, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill; Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor||Dr. Jansson, Johan:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Chen, Jingjing:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Uddin, Sharif:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Candela, Ninfa:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Lasch, Karen:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Kisfalvi, Krisztina:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options

P511

Dr. Bressler, Brian:|:|Personal Fees (Consulting)||Dr. Sattin, Bernie:|:|Employee of Janssen Canada||Dr. Williamson, Martin Alexander:|:|Employee of Janssen Canada||Dr. Khanna, Reena:|:|Personal Fees (Consulting)||Dr. Seow, Cynthia H:|:|Personal Fees (Consulting)||Dr. Dajnowiec, Dorota:|:|Employee of Janssen Canada||Karra, Kinda:|:|Employee of Janssen Canada||Dr. Gao, Long-Long:|:|Employee of Janssen Inc.||Dr. Afif, Waqqas:|:|Personal Fees (Consulting)

P512

Dr. XIAO, Yasi: No conflict of intereset||Dr. Lakatos, Peter L: No conflict of intereset||Dr. Bourdages, Raymond: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Afif, Waqqas: No conflict of intereset||Ms. Kohen, Rita: No conflict of intereset||Ms. Berberi, Marie: No conflict of intereset||Dr. Bessissow, Talat: No conflict of intereset

P513 withdrawn

P514

Dr. Lightner, Amy: No conflict of intereset||Dr. Buhulaigah, Hassan: No conflict of intereset||Dr. Zaghiyan, Karen: No conflict of intereset||Dr. Vaidya, Prashansha: No conflict of intereset||Dr. Regueiro, Miguel: No conflict of intereset||Dr. Fleshner, Phillip: No conflict of intereset

P515

Dr. Stodtmann, Sven:|:|Employee and shareholder of AbbVie||Ms. Friedel, Anna:|:|Employee and shareholder of AbbVie||Zhou, Wen:|:|Employee and shareholder of AbbVie||Dr. MOHAMED, Mohamed-Eslam:|:|Employee and shareholder of AbbVie

P516

Dr. Widbom, Lovisa: No conflict of intereset||Dr. Hultdin, Johan: No conflict of intereset||Dr. Ekblom, Kim: No conflict of intereset||Dr. Karling, Pontus: No conflict of intereset||Dr. Nilsson, Lena-Maria: No conflict of intereset

P517

Hill, Lee: No conflict of intereset||Ms. Popov, Jelena: No conflict of intereset||Ms. Hartung, Emily: No conflict of intereset||Ms. Moshkovich, Michal: No conflict of intereset||Ms. Figueiredo, Melanie: No conflict of intereset||Dr. Pai, Nikhil: No conflict of intereset

P518

Dr. Georgiev, Georgi: No conflict of intereset||Dr. Hussain, Fez: No conflict of intereset||Dr. Copeman, Mathew: No conflict of intereset||Dr. Delegge, Mark: No conflict of intereset||Mrs. Gallagher, Margaret-Beth: No conflict of intereset||Mrs. Stewart, Tracy: No conflict of intereset||Prof. Reinisch, Walter: No conflict of intereset

P519

Dr. LEE, Tanya: No conflict of intereset||Dr. Gilbert, Lauren: No conflict of intereset||Dr. Srinivasan, Ashish: No conflict of intereset||Dr. Lee, Allan: No conflict of intereset||Prof. van Langenberg, Daniel: No conflict of intereset||Dr. Martin, Catherine: No conflict of intereset||Dr. Ding, Nik: No conflict of intereset||Prof. Sparrow, Miles: No conflict of intereset

P520

Dr. Nicolás de Prado, Maria Isabel: No conflict of intereset||Iniesta Navalón, Carles: No conflict of intereset||Gomez Espin, Rosa: No conflict of intereset||Gil Candel, Mayte: No conflict of intereset||Serrano Díaz, Lidia: No conflict of intereset||Rentero Redondo, Lorena: No conflict of intereset||Martinez Crespo, Juan José: No conflict of intereset

Page 94 of 135

P521

GUZELA, Vivian: No conflict of intereset||Prof. Sobrado Júnior, Carlos: No conflict of intereset||Prof. Nadal, Sidney: No conflict of intereset||Prof. Nadal, Carmen Ruth: No conflict of intereset||Prof. Villa, Luisa Lina: No conflict of intereset||Ms. Gonçalves, Aline Pozzebon: No conflict of intereset||Mr. Boarini, Lucas Rodrigues: No conflict of intereset||Prof. Dr. Nahas, Sérgio Carlos: No conflict of intereset||Prof. Dr. Cecconello, Ivan: No conflict of intereset

P522

Bornheimer, Rebecca:|:|RB is an employee of Policy Analysis Inc., which received financial support from Shire, a member of the Takeda group of companies, for participation in the design of this study, data analysis, and interpretation of results.||Hass, Steve:|:|SH has received consultancy fees from Shire, a member of the Takeda group of companies.||Dr. NAG, Arpita:|:|AN is an employee of Shire, a member of the Takeda group of companies. |This study was funded by Shire, a member of the Takeda group of companies. Medical writing support was provided by Maxine Cox of PharmaGenesis London, London, UK, with funding from Shire International GmbH, a member of the Takeda group of companies.||Oster, Gerry:|:|GO is an employee of Policy Analysis Inc., which received financial support from Shire, a member of the Takeda group of companies, for participation in the design of this study, data analysis, and interpretation of results.

P523

Prof. Paupard, Thierry:|:|Member of Ferring scientific advisory board for QUARTZ Study|Advisory board : Janssen, Biogen|Training for Janssen regional team||Dr. Gonzalez, Florent:|:|Clinical Research : Ferring, Pfizer, MSD, Abbvie|Advisory Board : MSD, Ferring, Abbvie, Pfizer|Training: Abbvie, MSD, Takeda, Ferring, Tillotts, Mayoli, Janssen|Advices for research: Pfizer, MSD||Prof. Siproudhis, Laurent:|:|takeda, Ferring, MSD, Abbvie, Amgen, Janssen||Prof. Peyrin-Biroulet, Laurent:|:|Personal fees: Abbvie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celtrion, Takeda, Boerrhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen.|Grant: Abbvie, MSD, Takeda|Stock-options: CT-SCOUT

P524Ms. Volmar, Sabina: No conflict of intereset||Dr. Wildt, Signe: No conflict of intereset||Dr. Munck, Lars Kristian: No conflict of intereset

P525

Besuyen, Robin:|:|Is an employee and share holder of Galapagos.||Kavanaugh, Arthur:|:|Rresearch support, honoraria, or personal fees from Abbott; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene Corporation; Centocor-|Janssen; Eli Lilly and Company; Gilead Sciences, Inc.; Janssen Research & Development, LLC; Novartis; Pfizer, Inc.; Roche;|and UCB Pharma.||Westhovens, Rene:|:|Research support, honoraria, or personal fees from Celltrion, Inc.; Galapagos NV; and Gilead|Sciences, Inc.||Winthrop, Kevin:|:|Research support, honoraria, or personal fees from AbbVie, Inc.; Bristol-Myers Squibb; Eli Lilly and|Company; Galapagos NV; Gilead Sciences, Inc.; GSK; Pfizer, Inc.; Roche; and UCB Pharma.||Lee, Susan:|:|Is an employee of Gilead Sciences, Inc., and may hold stock.||Greer, Joy:|:|Is an employee of Gilead Sciences, Inc., and may hold stock.||DeZure, Adam:|:|Is an employee of Gilead Sciences, Inc., and may hold stock.||An, Di:|:|Is an employee of Gilead Sciences, Inc., and may hold stock||Ye, Lei:|:|Is an employee of Gilead Sciences, Inc., and may hold stock.||Sundy, John:|:|Is an employee of Gilead Sciences, Inc., and may hold stock.||Meuleners, Luc:|:|Is an employees of Galapagos NV.||Alten, Rieke:|:|Research support, honoraria, or personal fees from Galapagos NV; Gilead Sciences, Inc.; Novartis; and Pfizer, Inc.||Genovese, Mark:|:|Research support, honoraria, or personal fees from AbbVie, Inc.; Astellas; Eli Lilly and Company; EMD Merck Serono;|Galapagos NV; Genentech/Roche; Gilead Sciences, Inc.; GSK; Novartis; Pfizer, Inc.; R-Pharm; and Sanofi Genzyme.

P526Dr. Nordin, Fariza: No conflict of intereset||Dr. Shadbolt, Bruce: No conflict of intereset||Subramaniam, Kavitha: No conflict of intereset

P527 Mr. TASSONE, Daniel: No conflict of intereset||Dr. Ding, Nik: No conflict of intereset

P528Dr. Georgieva, Avgustina Chavdarova: No conflict of intereset||Prof. Atanassova, Antonia: No conflict of intereset||Prof. Mirchev, Milko: No conflict of intereset

P529

Dr. SONNINO, Micol: No conflict of intereset||Dr. Ocholi, Attah: No conflict of intereset||Ms. ElZein, Aya: No conflict of intereset||Dr. Saliakellis, Efstratios: No conflict of intereset||Prof. Pensabene, Licia: No conflict of intereset||Dr. Borrelli, Osvaldo: No conflict of intereset||Dr. Kiparissi, Fevronia: No conflict of intereset

P530

Dr. Diakite, Ibrahim:|:|Employment at Pharmerit International, which received funding to conduct this study||Dr. Schultz, Bob:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc||Dr. Carter, John:|:|Employment at Pharmerit International, which received funding to conduct this study||Dr. Snedecor, Sonya:|:|Employment at Pharmerit International, which received funding to conduct this study||Dr. Turpin, Robin:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc

P531

Watters, Christofer: No conflict of intereset||Dr. Lloyd, William: No conflict of intereset||Dr. Porteous, Mark: No conflict of intereset||Dr. Mohamed, Mohamed: No conflict of intereset||Kari, Samantha: No conflict of intereset||Mrs. Nelson, Elizabeth: No conflict of intereset||Dr. Saravanan, Ramasamy: No conflict of intereset Page 95 of 135

P532

Dr. EMONT, Cathy: No conflict of intereset||Dr. Gay, Claire: No conflict of intereset||Mrs. Parmentier, Anne-Laure: No conflict of intereset||Dr. Koch, Stéphane: No conflict of intereset||Dr. Ambregna, Sylvain: No conflict of intereset||Dr. Claudé, Guillaume: No conflict of intereset||Dr. Sage , Pablo: No conflict of intereset||Dr. Zhong, Peng: No conflict of intereset||Dr. Briot, Charline: No conflict of intereset||Dr. Vuitton, Lucine: No conflict of intereset

P533

Angriman, Imerio: No conflict of intereset||Dr. Bordignon, Giovanni: No conflict of intereset||Sciuto, Elisa: No conflict of intereset||Dr. Zini, Oscar: No conflict of intereset||Dr. Bortoli, Nicolò: No conflict of intereset||Dr. Gruppo, Mario: No conflict of intereset||Prof. Bardini, Romeo: No conflict of intereset||Dr. Ruffolo, Cesare: No conflict of intereset||Dr. Scarpa, Marco: No conflict of intereset

P534

Popov, Jelena: No conflict of intereset||Ms. Hartung, Emily: No conflict of intereset||Mr. Hill, Lee: No conflict of intereset||Ms. Chauhan, Usha: No conflict of intereset||Dr. Pai, Nikhil: No conflict of intereset

P535

Roblin, Xavier:|:|XR reports relationships with AbbVie, MSD, Janssen Cilag, and Takeda. ||Serone , Adrian:|:|AS is an employee and stockholder of Gilead Sciences Inc.||Dr. Yoon , Oh Kyu:|:|OY is an employee and stockholder of Gilead Sciences Inc.||Dr. Zhuo , Luting:|:|LZ is an employee and stockholder of Gilead Sciences Inc.||Grant, Ethan:|:|EG is an employee and stockholder of Gilead Sciences Inc.||Dr. Woo , Jacky:|:| JW was an employee of Gilead Sciences Inc at the time of study conduct.||Dr. Liu , Jinfeng:|:|JL is an employee and stockholder of Gilead Sciences Inc. ||Dr. Galien, Rene:|:|RG is an employee of Galapagos SASU.||Dr. D’Haens , Geert:|:|GD has served as advisor for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Applied Molecular Therapeutics; Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, DSM Pharma; Echo Pharmaceuticals, Eli Lilly, Engene, Exeliom Biosciences; Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, ProciseDx, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill; Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor.

P536Dr. Croft, Anthony: No conflict of intereset||Dr. Lord, Anton: No conflict of intereset||Dr. Radford-Smith, Graham: No conflict of intereset

P537

Dr. Iborra Colomino, Maria Isabel: No conflict of intereset||Dr. Beltrán, Belén: No conflict of intereset||Dr. Fernández-Clotet, Agnes: No conflict of intereset||Dr. Iglesias Flores, Eva: No conflict of intereset||Dr. Navarro, Pablo: No conflict of intereset||Dr. Rivero, Montserrat: No conflict of intereset||Dr. Gutiérrez, Ana: No conflict of intereset||Dr. Sierra-Ausin, Mónica: No conflict of intereset||Dr. Mesonero, Francisco: No conflict of intereset||Dr. Ferreiro-Iglesias, Rocío: No conflict of intereset||Dr. Hinojosa, Joaquín: No conflict of intereset||Calvet, Xavier: No conflict of intereset||Dr. Sicilia, Beatriz: No conflict of intereset||Dr. González-Muñoza, Carlos: No conflict of intereset||Dr. Antolín, Beatriz: No conflict of intereset||Dr. González Vivo, María: No conflict of intereset||Dr. Carbajo, Ana Y.: No conflict of intereset||Dr. García, Santiago: No conflict of intereset||Dr. Martín-Cardona, Albert: No conflict of intereset||Dr. Surís Marín, Gerard: No conflict of intereset||Dr. Martín-Arranz, María Dolores: No conflict of intereset||De Francisco, Ruth: No conflict of intereset||Dr. Cañete, Fiorella: No conflict of intereset||Dr. Carlos, Taxonera: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Lorente, Rufo: No conflict of intereset||Dr. Rodríguez-Lago, Iago: No conflict of intereset||Dr. Forés-Bosch, Ana: No conflict of intereset||Dr. Bernardos, Esther: No conflict of intereset||Dr. Ramos, Laura: No conflict of intereset||Dr. Delgado, Pedro: No conflict of intereset||Dr. Hernández, Alejandro: No conflict of intereset||Dr. Van Domselaar, Manuel: No conflict of intereset||Dr. Hervás, David: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset

P538

Geldhof, Anja:|:|Salaried employee to Janssen. ||Dr. Volger, Sheri:|:|Salaried employee to Janssen. ||Dr. Lin, Connie B:|:|Salaried employee for Janssen.||Dr. O'Brien, Christopher:|:|Salaried employee for Janssen. ||Dr. Tikhonov, Ilia:|:|Salaried employee for Janssen.

Page 96 of 135

P539

Lichtenstein, Gary R:|:|Personal fees: AbbVie, American Regent, Celgene, Cellceutix, Eli Lily, Endo, Ferring, Gilead, Janssen Biotech, Merck, Morphic Therapeutic, Pfizer Inc, Prometheus Laboratories, Romark, Salix/Valeant, Shire Pharmaceuticals, Takeda, UCB|Other: Associate Editor (Honorarium): American Journal of Gastroenterology; Editor (Honorarium): Gastroenterology and Hepatology (Gastro-Hep Communications); Editor (Honorarium): Springer Science and Business Media; Honorarium (CME Program): American Regent; Honorarium (CME Program): Merck; Honorarium (CME Program): Romark; Author (Honorarium): Up-To-Date; Funding to University of PA (IBD Fellow Education): Janssen Orthobiotech; Funding to University of PA (IBD Fellow Education): Pfizer In; Funding to University of PA (IBD Fellow Education): Takeda; Book royalty: SLACK||Bressler, Brian:|:|Grants: AbbVie, Alvine, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Genentech, GSK, Janssen, Merck, Qu Biologic, RedHill Biopharm|Personal fees: AbbVie, Actavis, Allergan, Amgen, Celgene, Celltrion, Ferring, Genentech, Janssen, Merck, Microbiome Insights, Pendopharm, Pfizer Inc, Protagonist, Robarts Clinical Trials, Shire, Takeda, Qu Biologic||Vermeire, Séverine:|:|Grants: AbbVie, Johnson & Johnson, MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Abivax, Celgene, Dr. Falk Pharma, Ferring, Galapagos, Genentech, GSK, Hospira, Janssen, MSD, Mundipharma, Pfizer Inc, ProDigest, Progenity, Second Genome, Shire, Takeda, Tillotts||Francisconi, Carlos:|:|Personal fees: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Shi, Hongjiong:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Judd, Donna:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Loftus Jr, Edward V:|:|Grants: AbbVie, Amgen, Celgene, Genentech, Gilead, Janssen, Pfizer Inc, Robarts Clinical Trials, Takeda, UCB|Personal fees: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Eli Lilly, Exact Sciences, Genentech, Gilead, Janssen, Pfizer Inc, Takeda, UCB

P540

Dr. Levesque, Barrett: No conflict of intereset||Dr. Taylor Meadows, Kristen:|:|Employment and shares, Gossamer Bio, Inc.||Dr. Buch, Akshay:|:|Employment, Aerpio Pharmaceuticals, Inc.||Mr. Flynn, Michael:|:|Employment, Aerpio Pharmaceuticals, Inc.||Dr. Peters, Kevin:|:|Employment, Aerpio Pharmaceuticals, Inc.||Dr. Olson, Allan:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Shen, Jinshan:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Slee, Debbie:|:|Employment and stock, Gossamer Bio, Inc.|||Van Biene, Courtney:|:|Employment and stock, Gossamer Bio, Inc.||Dr. Aranda, Richard:|:|Employment and stock, Gossamer Bio, Inc.|||Dr. Vande Casteele, Niels: No conflict of intereset||Dr. Opiteck, Gregory:|:|Employment and stock, Gossamer Bio, Inc.

P541

Geldof, Jeroen: No conflict of intereset||Dr. LeBlanc, Jean-Frédéric: No conflict of intereset||Dr. Lucaciu, Laura: No conflict of intereset||Dr. Segal, Jonathan P: No conflict of intereset||Dr. Lees, Charlie W: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset

P542

Ms. Kantasiripitak, Wannee: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Dr. Lobatón, Triana: No conflict of intereset||Dr. Thomas, Debby: No conflict of intereset||Prof. Gils, Ann:|:|Ann Gils: served as a speaker for Merck Sharp & Dohme, Janssen Biologicals, Pfizer, Takeda, Novartis, and AbbVie, and received Investigator-Initiated Research Grants from Pfizer and a national grant from Takeda. KU Leuven licensed antibodies for the infliximab, adalimumab, vedolizumab, golimumab, and ustekinumab ELISA to apDia and infliximab and adalimumab lateral flow assays to R-Biopharm.||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Dr. Dreesen, Erwin:|:|Erwin Dreesen: is a postdoctoral research fellow of the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) |and received consultancy fees from argenx and Janssen (all honoraria/fees paid to the department).

P543

Dr. Arkteg, Christian: No conflict of intereset||Dr. Goll, Rasmus: No conflict of intereset||Dr. Dixon Gundersen, Mona: No conflict of intereset||Mr. Anderssen, Endre: No conflict of intereset||Mr. Fenton, Christopher Graham: No conflict of intereset||Prof. Dr. Florholmen, Jon: No conflict of intereset

Page 97 of 135

P544

Dr. Torres-Rodriguez, Paola: No conflict of intereset||Dr. Cañete, Fiorella: No conflict of intereset||Dr. Calafat, Margalida: No conflict of intereset||Dr. Sánchez-Aldehuelo, Rubén: No conflict of intereset||Rivero, Montserrat: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Dr. González-Vivo, María: No conflict of intereset||Dr. Vera, Isabel: No conflict of intereset||Dr. de Castro, Luisa: No conflict of intereset||Bujanda, Luis: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset||Dr. Calvet, Xavier: No conflict of intereset||Dr. Benítez, José Manuel: No conflict of intereset||Dr. Llorente, Mónica: No conflict of intereset||Dr. Surís, Gerard: No conflict of intereset||Dr. Arias-García, Lara: No conflict of intereset||Dr. David, Monfort: No conflict of intereset||Dr. Castaño-García, Andrés: No conflict of intereset||Dr. Garcia-Alonso, Francisco Javier: No conflict of intereset||Dr. Rufo, Lorente: No conflict of intereset||Dr. Ferrer, Juan Angel: No conflict of intereset||Dr. Camo, Patricia: No conflict of intereset||Dr. P. Gisbert, Javier: No conflict of intereset||Dr. Huguet, José Manuel: No conflict of intereset||Dr. Pajares, Ramón: No conflict of intereset||Dr. Morales, Víctor: No conflict of intereset||Dr. Llaó, Jordina: No conflict of intereset||Dr. Rodríguez, Andrés: No conflict of intereset||Dr. Rodríguez, Cristina: No conflict of intereset||Dr. Navarro, Mercè: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Dr. Carrillo-Palau, Marta: No conflict of intereset||Dr. Sesé, Eva: No conflict of intereset||Dr. Almela, Pedro: No conflict of intereset||Dr. Ramírez de la Piscina, Patricia: No conflict of intereset||Dr. Rodríguez-Lago, Iago: No conflict of intereset||Dr. Papo, Michel: No conflict of intereset||Dr. Vela, Milagros: No conflict of intereset||Dr. Mañosa, Míriam: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset

P545

Dr. Calvo Moya, Marta Isabel: No conflict of intereset||Dr. Omella Usieto, Ignacio: No conflict of intereset||Dr. González Lama, Yago: No conflict of intereset||Dr. Matallana Royo, Virginia: No conflict of intereset||Dr. González Partida, Irene: No conflict of intereset||Dr. Menchen Viso, Belén: No conflict of intereset||Mrs. De Lucas Téllez de Meneses, Rocío: No conflict of intereset||Mrs. González Rodriguez , Macarena: No conflict of intereset||Mr. Bella del Castillo, Pablo: No conflict of intereset||Dr. Vera Mendoza, Maria Isabel: No conflict of intereset

P546

Dr. Narula, Neeraj: No conflict of intereset||Ms. Wong, Emily: No conflict of intereset||Dr. Achuthan, Aruljothy: No conflict of intereset||Dr. Dulai, Parambir: No conflict of intereset||Dr. Colombel, Jean-Frederic: No conflict of intereset||Dr. Marshall, John K.: No conflict of intereset||Dr. Ferrante, Marc: No conflict of intereset||Dr. Reinisch, Walter: No conflict of intereset

P547

Dr. Wall, Catherine: No conflict of intereset||Dr. MacFarlane, Kirsty: No conflict of intereset||Dr. Carr, Anitra: No conflict of intereset||Prof. Day, Andrew: No conflict of intereset||Prof. Gearry, Richard: No conflict of intereset

P548

Dr. Fischer, Sarah: No conflict of intereset||Ms. Mesfin, Sarah: No conflict of intereset||Dr. Klenske, Entcho: No conflict of intereset||Dr. Schmitt, Heike: No conflict of intereset||Dr. Vitali, Francesco: No conflict of intereset||Dr. Hirschmann, Simon: No conflict of intereset||Prof. Ramming, Andreas: No conflict of intereset||Dr. Zundler, Sebastian: No conflict of intereset||Prof. Rath, Timo: No conflict of intereset||Dr. Krebs, Sabine: No conflict of intereset||Prof. Dr. Dörje, Frank: No conflict of intereset||Prof. Dr. Uter, Wolfgang: No conflict of intereset||Dr. Nagore, Daniel: No conflict of intereset||Dr. Meyer, Sebastian: No conflict of intereset||Prof. Dr. Neurath, Markus F.: No conflict of intereset||Prof. Dr. Atreya, Raja: No conflict of intereset

P549

Dr. Srinivasan, Ashish: No conflict of intereset||Dr. van Langenberg, Daniel R:|:|DvL has received educational grants or research support from Pfizer, Takeda, Ferring, Shire and has received consultancy and/or speaker’s fees from Pfizer, Janssen, Abbvie, Ferring, Vifor and Emerge Health. ||Dr. Little, Robert: No conflict of intereset||Dr. Sparrow, Miles P:|:|MS has received educational grants or research support from Ferring and Orphan; has received speaker fees from Janssen, Abbvie, Ferring, Takeda, Pfizer, Celgene, MSD and Shire; and has served on advisory boards for Janssen, Takeda, Pfizer, Celgene, Abbvie, MSD.||Dr. De Cruz, Peter:|:|PDC is on advisory boards for Janssen, Celgene, Takeda, Ferring, Shire and Baxter. ||Dr. Ward, Mark G:|:|MW has received educational grants or research support from AbbVie and the Ferring GESA IBD Clinical Project Award and received speaker fees from Janssen, AbbVie, Ferring, Takeda, MSD and Shire.

Page 98 of 135

P550

Dr. Rodríguez-Lago, Iago:|:|IR-L has received financial support for travelling and educational activities from or has served as an advisory board member for MSD, Pfizer, Abbvie, Takeda, Janssen, Tillotts Pharma, Shire Pharmaceuticals, Ferring, Dr. Falk Pharma and Otsuka Pharmaceutical.||Dr. Del Hoyo, Javier: No conflict of intereset||Dr. Casanova, María José: No conflict of intereset||Dr. Fernández-Clotet, Agnès: No conflict of intereset||Dr. García, María José: No conflict of intereset||Dr. Ferreiro-Iglesias, Rocío: No conflict of intereset||Dr. Piqueras, Marta: No conflict of intereset||Dr. Suárez, Cristina: No conflict of intereset||Dr. López-García, Alicia: No conflict of intereset||Dr. Arroyo, Maite: No conflict of intereset||Dr. Sierra, Mónica: No conflict of intereset||Dr. Delgado-Guillena, Pedro: No conflict of intereset||Dr. Guerra, Iván: No conflict of intereset||Dr. Merino, Olga: No conflict of intereset||Dr. Arranz, Laura: No conflict of intereset||Dr. Llaó, Jordina: No conflict of intereset||Dr. Plaza, Rocío: No conflict of intereset||Mrs. Molina, Gema: No conflict of intereset||Dr. Torres, Paola: No conflict of intereset||Dr. Pérez-Galindo, Pablo: No conflict of intereset||Dr. Herrera-deGuise, Claudia: No conflict of intereset||Dr. Armesto, Edisa: No conflict of intereset||Dr. Mesonero, Francisco: No conflict of intereset||Mr. Aguirre, Urko: No conflict of intereset||Dr. P. Gisbert, Javier: No conflict of intereset

P551

Dr. Arieira, Catia: No conflict of intereset||Dias de Castro, Francisca: No conflict of intereset||Cúrdia Gonçalves, Tiago: No conflict of intereset||Moreira, Maria João: No conflict of intereset||Cotter, José: No conflict of intereset

P552

Mr. Chandrakumar, Abin: No conflict of intereset||Dr. Carroll, Matthew: No conflict of intereset||Dr. deBruyn, Jennifer: No conflict of intereset||Dr. Jacobson, Kevan: No conflict of intereset||Dr. Huynh, Hien: No conflict of intereset||Dr. Wine, Eytan: No conflict of intereset||Dr. Lawrence, Sally: No conflict of intereset||Dr. El-Matary, Wael: No conflict of intereset

P553

Dr. Moens, Annick: No conflict of intereset||Ms. Ballet, Vera: No conflict of intereset||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda

P554Dr. Crooks, Benjamin: No conflict of intereset||Prof. McLaughlin, John: No conflict of intereset||Prof. Limdi, Jimmy K: No conflict of intereset

P555

Dr. Gordon, Hannah: No conflict of intereset||Dr. Murray, Jennifer: No conflict of intereset||Dr. Tailor, Falguni: No conflict of intereset||Mr. Goh, Sean Ariff: No conflict of intereset||Prof. Lindsay, James O:|:|Served as consultant and an advisory board participant: AbbVie, Alergan (Warner Chilcott), Atlantic Healthcare, Celgene, Celtrion, Ferring, Gilead, GSK, Janssen, Lilly, MSD, Napp, Pfizer, Shire, Takeda and Vifor Pharma|Received speaker fees and sponsorship for academic meetings: from AbbVie, Alergan (Warner Chilcott), Ferring, Janssen, MSD, Napp, Pfizer, Shire, Tillott’s, Takeda|Received investigator led research grants from Abbvie, Gilead, Pfizer, Shire and Takeda

P556

Dr. Luque Carmona, Ana María: No conflict of intereset||Dr. García Ortíz, José Manuel: No conflict of intereset||Dr. NUÑEZ ORTIZ, Andrea: No conflict of intereset||Dr. De la Cruz Ramírez, María Dolores: No conflict of intereset||Dr. Herrera Justiniano, José Manuel: No conflict of intereset||Dr. Leo Carnerero, Eduardo: No conflict of intereset

P557Prof. Iesalnieks, Igors: No conflict of intereset||Dr. Marek, Filip: No conflict of intereset||Prof. Kala, Zdenek: No conflict of intereset||Dr. Kunovsky, Lumir: No conflict of intereset

P558

Mr. FERGUSON, Angus: No conflict of intereset||Dr. Ding, Nik: No conflict of intereset||Dr. Connell, William: No conflict of intereset||Mr. Williams, James: No conflict of intereset||Dr. Wright, Emily: No conflict of intereset||Prof. Kamm, Michael: No conflict of intereset||Prof. Thompson, Alex: No conflict of intereset||Dr. Lust, Mark: No conflict of intereset||Dr. Flanagan, Emily: No conflict of intereset||Dr. Basnayake, Chamara: No conflict of intereset

P559

Dr. Britschu, Océane: No conflict of intereset||Dr. Meyer, Alain: No conflict of intereset||Prof. Gottenberg, Jacques-Eric: No conflict of intereset||Prof. Reimund, Jean-Marie: No conflict of intereset||Dr. Caron, Benedicte: No conflict of intereset

Page 99 of 135

P560

RUIZ-RAMIREZ, Maria Angeles: No conflict of intereset||Rodríguez-Merlos, Pablo: No conflict of intereset||Suarez, Cristina: No conflict of intereset||Plasencia-Rodríguez, Chamaida: No conflict of intereset||Navarro-Compán, Victoria: No conflict of intereset||Poza, Joaquin: No conflict of intereset||Martin-Arranz, Eduardo: No conflict of intereset||Sanchez-Azofra, Maria: No conflict of intereset||Rueda-Garcia, Jose Luis: No conflict of intereset||Garcia-Ramirez, Laura: No conflict of intereset||Franco, Karen: No conflict of intereset||Bonilla, Gema: No conflict of intereset||Peiteado, Diana: No conflict of intereset||Balsa, Alejandro: No conflict of intereset||Martin-Arranz, Maria Dolores: No conflict of intereset

P561 Dr. BATCHELOR, Suzi: No conflict of intereset||Dr. Speight, Ally: No conflict of intereset

P562

Dr. Arieira, Catia: No conflict of intereset||Dias de Castro, Francisca: No conflict of intereset||Cúrdia Gonçalves, Tiago: No conflict of intereset||Moreira, Maria João: No conflict of intereset||Cotter, José: No conflict of intereset

P563

Dr. Williams, Astrid-Jane: No conflict of intereset||Dr. Leung, Yvette: No conflict of intereset||Ms. O'Connor, Katie: No conflict of intereset||Huang, Vivian: No conflict of intereset

P564

Ms. Hirano, Yuri: No conflict of intereset||Dr. Itabashi, Michio: No conflict of intereset||Dr. Saito, Takeshi: No conflict of intereset||Dr. Uchida, Keiichi: No conflict of intereset||Dr. Inoue, Mikihiro: No conflict of intereset||Dr. Katsuhiro, Arai: No conflict of intereset||Dr. Atsuhiro, Hirayama: No conflict of intereset||Dr. Araki , Kentaro: No conflict of intereset||Ms. Nishikawa, Yurika: No conflict of intereset||Ms. Tatsuno, Mizuki: No conflict of intereset||Dr. Hideaki, Kimura: No conflict of intereset||Dr. Reiko, Kunisaki: No conflict of intereset

P565

Dr. Sands, Bruce E.:|:|Investigator and Advisor for Janssen||Dr. Abreu, Maria T.:|:|Investigator and Advisor for Janssen||Dr. Leong, Rupert W.L.:|:|Investigator and Advisor for Janssen||Dr. Marano, Colleen:|:|Salaried employee for Janssen||Dr. O'Brien, Christopher D.:|:|Salaried employee for Janssen||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen||Dr. Zhou, Yiying:|:|Salaried employee for Janssen||Dr. Johanns, Jewel:|:|Salaried employee for Janssen||Dr. Rowbotham, David:|:|Investigator and Advisor for Janssen||Dr. Hisamatsu, Tadakazu:|:|Investigator and Advisor for Janssen||Dr. Arasaradnam, Ramesh P.:|:|Investigator and Advisor for Janssen||Dr. Scherl, Ellen:|:|Investigator and Advisor for Janssen||Dr. Danese, Silvio:|:|Investigator and Advisor for Janssen||Dr. Peyrin-Biroulet, Laurent:|:|Investigator and Advisor for Janssen

P566

Dr. Cassinotti, Andrea: No conflict of intereset||Dr. Mezzina, Nicolò: No conflict of intereset||Dr. Di Paolo, Dhanai: No conflict of intereset||Dr. Lenti, Marco Vincenzo: No conflict of intereset||Dr. Bezzio, Cristina: No conflict of intereset||Dr. Stradella, Davide: No conflict of intereset||Dr. Mauri, Martina: No conflict of intereset||Dr. Zadro, Valentina: No conflict of intereset||Dr. Cortellezzi, Claudio: No conflict of intereset||Dr. Ricci, Chiara: No conflict of intereset||Dr. Casini, Valentina: No conflict of intereset||Dr. Radice, Elisa: No conflict of intereset||Dr. Massari, Alessandro: No conflict of intereset||Prof. Ardizzone, Sandro: No conflict of intereset||Dr. Pastorelli, Luca: No conflict of intereset||Prof. Di Sabatino, Antonio: No conflict of intereset||Dr. Manes, Giampiero: No conflict of intereset||Prof. Caprioli, Flavio: No conflict of intereset||Prof. Vecchi, Maurizio: No conflict of intereset||Dr. Tari, Roberto: No conflict of intereset||Dr. Occhipinti, Pietro: No conflict of intereset||Dr. Fichera, Maria: No conflict of intereset||Prof. Invernizzi, Pietro: No conflict of intereset||Dr. Parravicini, Marco: No conflict of intereset||Dr. Segato, Sergio: No conflict of intereset||Dr. Pace, Fabio: No conflict of intereset||Prof. Testoni, Pier Alberto: No conflict of intereset||Dr. Tinelli, Carmine: No conflict of intereset||Dr. De Silvestri, Annalisa: No conflict of intereset

P567

Howaldt, Stefanie: No conflict of intereset||Jacob, Ian:|:|Ian Jacob is an employee of Health Economics and Outcomes Research Ltd. and received funding from Norgine Ltd. to undertake the analysis outlined in this study.||Sampson, Mark:|:|Mark Sampson is an employee and stockholder at Shield Therapeutics PLC.||Akriche, Fatma:|:|Fatma Akriche is an employee of Norgine Ltd.

P568

Prof. Reinisch, Walter: No conflict of intereset||Prof. Hébuterne, Xavier: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset||Prof. Dr. Schreiber, Stefan: No conflict of intereset||Prof. Desreumaux, Pierre: No conflict of intereset||Dr. Paillarse, Jean-Michel:|:|Enterome Employee||Dr. Bonny, Christophe:|:|Enterome Employee

P569

Dr. Colombo, Francesco: No conflict of intereset||Dr. Lamperti, Giulia Maria Beatrice: No conflict of intereset||Prof. Antinori, Spinello: No conflict of intereset||Dr. Corbellino, Mario: No conflict of intereset||Prof. Maconi, Gianni: No conflict of intereset||Prof. Ardizzone, Sandro: No conflict of intereset||Prof. Foschi, Diego: No conflict of intereset||Dr. Sampietro, Gianluca: No conflict of intereset

Page 100 of 135

P570

Dr. Singh, Kelita: No conflict of intereset||Dr. Al-Khoury, Alex: No conflict of intereset||Dr. Kurti, Zsuzsanna: No conflict of intereset||Dr. Gonczi, Lorant: No conflict of intereset||Dr. Golovics, Petra: No conflict of intereset||Ms. Kohen, Rita: No conflict of intereset||Dr. Afif, Waqqas: No conflict of intereset||Dr. Wild, Gary: No conflict of intereset||Dr. Seidman, Ernest: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Bessissow, Talat: No conflict of intereset||Dr. Lakatos, Peter: No conflict of intereset

P571

Mesonero Gismero, Francisco:|:|Payment for development of educational presentations by MSD||Dr. Rodriguez-Lago, Iago:|:|Board Membership: Tillotts Pharma, Pfizer, Ferring and Adacyte.|Payments for lectures including service on speakers bureaus: MSD, Abbvie, Takeda, Tillots Pharma, Dr. Falk Pharma and Pfizer.|Payment for development of educational presentations: Otsuka Pharmaceutical.|Travel/ accommodations: MSD, Pfizer, Abbvie, Takeda, Janssen, Tillots Pharma, Shire Pharmaceutical, Dr. Falk Pharma, Otsuka Pharmaceutical and Ferring||Ms. Cañas, Mercedes: No conflict of intereset||Ms. Claudia, Savini: No conflict of intereset||Mr. Saldaña, Roberto: No conflict of intereset||Ms. Feo-Lucas, Lidia:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Ms. Fernandez, Sabela:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Dr. Cea-Calvo, Luis:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain||Dr. Juliá, Berta:|:|Full-time employee of Merck Sharp & Dohme (MSD) Spain

P572

Dr. Song, Joo Hye: No conflict of intereset||Dr. Kong , Sung Min: No conflict of intereset||Dr. Shin, Jongbeom: No conflict of intereset||Dr. Seong, Gyeol: No conflict of intereset||Prof. Kang, Eun Ae: No conflict of intereset||Prof. Park, Soo-Kyung: No conflict of intereset||Prof. Hong, Sung Noh: No conflict of intereset||Prof. Kim, You Sun: No conflict of intereset||Prof. Bang, Ki Bae: No conflict of intereset||Prof. Kim, Kyeong Ok: No conflict of intereset||Prof. Lee, Hong Sub: No conflict of intereset||Prof. Kang, Sang-Bum: No conflict of intereset||Prof. Shin, Seung Yong: No conflict of intereset||Prof. Song, Eun Mi: No conflict of intereset||Prof. Choi, Chang Hwan: No conflict of intereset||Prof. Kim, Tae Jun: No conflict of intereset||Prof. Kim, Eun Ran: No conflict of intereset||Prof. Chang, Dong Kyung: No conflict of intereset||Prof. Kim, Young-Ho: No conflict of intereset

P573

GUBERNA BLANCO, Laura: No conflict of intereset||Dr. Nyssen, Olga P.: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Prof. Dr. Gisbert, Javier P.: No conflict of intereset

P574

Li, Ji: No conflict of intereset||Prof. Dr. Li, Zhanju: No conflict of intereset||Prof. Dr. Hu, Pinjin: No conflict of intereset||Prof. Dr. Wen, Zhonghui: No conflict of intereset||Prof. Dr. Cao, Qian: No conflict of intereset||Prof. Dr. Zou, Xiaoping: No conflict of intereset||Prof. Dr. Chen, Yan: No conflict of intereset||Prof. Dr. Wang, Yingde: No conflict of intereset||Prof. Dr. Zhong, Jie: No conflict of intereset||Prof. Dr. Shen, Xizhong: No conflict of intereset||Mr. Demuth, Dirk:|:|Dirk Demuth is an employee of Takeda Singapore branch||Mrs. Fedeeva, Olga:|:|Olga Fadeeva is an employee of Takeda Singapore branch||Mrs. Xie, Li:|:|Li Xie is an employee of Takeda China branch||Mr. Chen, Jun:|:|Jun Chen is an employee of Takeda China branch||Prof. Dr. Qian, Jiaming: No conflict of intereset

P575

Dr. PLEVRIS, Nikolas: No conflict of intereset||Dr. Robertson, Andrew: No conflict of intereset||Dr. Fulforth, James: No conflict of intereset||Dr. Hall, Rebecca: No conflict of intereset||Dr. Campbell, Iona: No conflict of intereset||Dr. Kane, Claire: No conflict of intereset||Dr. Veryan, Jennifer: No conflict of intereset||Dr. Lam, Wai: No conflict of intereset||Dr. Saunders, Jayne: No conflict of intereset||Mr. Jenkinson, Philip: No conflict of intereset||Dr. Chuah, Cher: No conflict of intereset||Dr. Kelly, Christopher: No conflict of intereset||Dr. Watts, David: No conflict of intereset||Dr. Gaya, Daniel: No conflict of intereset||Dr. Macdonald, Jonathan: No conflict of intereset||Dr. Jafferbhoy, Hasnain: No conflict of intereset||Dr. Seenan, John-Paul: No conflict of intereset||Dr. Mowat, Craig: No conflict of intereset||Dr. Sutherland, Diarmid: No conflict of intereset||Dr. Naismith, Graham: No conflict of intereset||Dr. Bain, Gillian: No conflict of intereset||Dr. Arnott, Ian: No conflict of intereset||Dr. Jones, Gareth: No conflict of intereset||Dr. Lees, Charlie: No conflict of intereset

P576

Dr. Viazis, Nikolaos: No conflict of intereset||Mrs. Tsoukali, Emmanouela: No conflict of intereset||Pontas, Christos: No conflict of intereset||Karampekos, Georgios: No conflict of intereset||Mr. Gkeros, Filippos: No conflict of intereset||Filippidis, George: No conflict of intereset||Vraka, Marina: No conflict of intereset||Koustenis, Kanellos: No conflict of intereset||Mountaki, Katerina: No conflict of intereset||Mitselos, Ioannis: No conflict of intereset||Mela , Maria: No conflict of intereset||Christidou, Angeliki: No conflict of intereset||Archavlis, Emmanouil: No conflict of intereset||Ms. Vienna, Eleni: No conflict of intereset||Christodoulou, Dimitrios: No conflict of intereset||Dr. Mantzaris, Gerasimos: No conflict of intereset

Page 101 of 135

P577

Mr. LOPEZ TOBARUELA, Jose Maria: No conflict of intereset||Mr. Sanchez-Capilla, Antonio Damian: No conflict of intereset||Mrs. Ortega-Suazo, Eva Julissa: No conflict of intereset||Mrs. Fernandez-Cano, Maria Carmen: No conflict of intereset||Mrs. Herrador-Paredes, Maria: No conflict of intereset||Ms. Cabello-Tapia, Maria Jose: No conflict of intereset||Ms. Martin-Rodriguez, Maria Mar: No conflict of intereset

P578

Mr. de Voogd, Floris: No conflict of intereset||Dr. Wilkens, Rune: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset||Dr. Allocca, Mariangela: No conflict of intereset||Dr. Novak, Kerri: No conflict of intereset||Dr. Lu, Cathy: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Prof. Dr. Maaser, Christian: No conflict of intereset

P579

Prof. Rhodes, Jonathan Michael: No conflict of intereset||Dr. Subramanian, Sreedhar: No conflict of intereset||Dr. Flanagan, Paul: No conflict of intereset||Dr. Horgan, Graham: No conflict of intereset||Mrs. Martin, Kate: No conflict of intereset||Dr. Mansfield, John: No conflict of intereset||Dr. Parkes, Miles: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset||Dr. Dallal, Helen: No conflict of intereset||Prof. Iqbal, Tariq: No conflict of intereset||Dr. Butterworth, Jeffrey: No conflict of intereset||Ms. Culshaw, Kate: No conflict of intereset||Prof. Probert, Christopher: No conflict of intereset

P580Sezgin, Orhan: No conflict of intereset||Boztepe, Burcu: No conflict of intereset||Dr. Altintas, Engin: No conflict of intereset||Çelikcan, Didem: No conflict of intereset

P581

Dr. Schreiner, Philipp Oliver: No conflict of intereset||Dr. Biedermann, Luc: No conflict of intereset||Prof. Rogler, Gerhard: No conflict of intereset||Prof. Turina, Matthias: No conflict of intereset||Dr. Cabalzar, Daniela: No conflict of intereset

P582

Dr. Shields, Stephanie: No conflict of intereset||Dr. Seenan, John Paul: No conflict of intereset||Dr. Dunlop, Allan: No conflict of intereset||Dr. Galloway, Peter: No conflict of intereset||Dr. Macdonald, Jonathan: No conflict of intereset

P583

Dr. Bouri, Sonia: No conflict of intereset||Dr. Geldof, Jereon: No conflict of intereset||Dr. Willsmore, James: No conflict of intereset||Dr. Donnelly, Suzanne: No conflict of intereset||Dr. Gabe, Simon: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset

P584

Dr. Hernandez Camba, Alejandro: No conflict of intereset||Dr. Arranz, Laura: No conflict of intereset||Dr. Vera, Isabel: No conflict of intereset||Dr. Carpio, Daniel: No conflict of intereset||Dr. Calafat Sard, Margalida: No conflict of intereset||Dr. Lucendo, Alfredo: No conflict of intereset||Dr. Taxonera, Carlos: No conflict of intereset||Dr. Marín, Sandra: No conflict of intereset||Dr. Garcia, María José: No conflict of intereset||Dr. Suris Marín , Gerard: No conflict of intereset||Dr. Sánchez Rodríguez, Eugenia: No conflict of intereset||Dr. Carbajo, Ana Yaiza: No conflict of intereset||Dr. De Castro, María Luisa: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Dr. Martin-Cardona, Albert: No conflict of intereset||Dr. Rodríguez Lago, Iago: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. Bertoletti, Federico: No conflict of intereset||Dr. Sierra Ausín, Mónica: No conflict of intereset||Dr. Tardillo, Carlos: No conflict of intereset||Dr. Huguet Malaves, Jose: No conflict of intereset||Dr. Bujanda, Luis: No conflict of intereset||Dr. Castaño, Andres: No conflict of intereset||Dr. Merino, Olga: No conflict of intereset||Dr. Domènch, Eugeni: No conflict of intereset||Dr. Ramos, Laura: No conflict of intereset

P585

Aksan, Aysegül:|:|Dr Aksan has received research funding from Immundiagnostik AG, and lecturing fees and congress expenses from Vifor Pharma.||Ms. Işık, Hatice: No conflict of intereset||Dr. Aksan, Sami: No conflict of intereset||Ms. Tuğal, Dilem: No conflict of intereset||Prof. Dr. Dignass, Axel:|:|Consultancy fees; Abbott, MSD, Ferring, UCB, Otsuka, Roche/Genentech, Takeda, Pharmacosmos, Holystone Biotech; Falk Foundation. Lecturing fees; Falk Foundation, Ferring, MSD, Abbott, Otsuka, Vifor, Stiftung Leben mit Krebs, Kompetenznetz CED, Takeda, Pharmacosmos. Manuscript/presentation preparation fees; Falk, Abbott, Pharmacosmos, Falk, Ferring.|||Prof. Dr. Stein, Jürgen Michael:|:|Jürgen Stein has received consultancy fees from Abbvie, Fresenius-Kabi, Immundiagnostik, MSD, Pharmacosmos, Takeda, GI Dynamics and Vifor. Dr. Stein has also received payment for lectures from Abbvie, Falk Foundation, Ferring, Immundiagnostik, MSD, Pharmacosmos, Takeda, Thermofischer, GI Dynamics and Vifor. Additionally, Dr. Stein has received payment for manuscript preparation from Abbvie, Falk Foundation and MSD.

P586

Dr. GU, Bonita: No conflict of intereset||Dr. Venkatesh, Kavya: No conflict of intereset||Dr. Williams, Astrid-Jane: No conflict of intereset||Dr. Ng, Watson: No conflict of intereset||Dr. Corte, Crispin: No conflict of intereset||Dr. Ghaly, Simon: No conflict of intereset||Dr. Xuan, Wei: No conflict of intereset||Dr. Paramsothy, Sudarshan: No conflict of intereset||Prof. Connor, Susan: No conflict of intereset

P587

Dr. Lawrence, Sally: No conflict of intereset||Huynh, Hien: No conflict of intereset||Dr. El-Matary, Wael: No conflict of intereset||Dr. DeBruyn, Jennifer: No conflict of intereset||Dr. Carroll, Matthew: No conflict of intereset||Dr. Wine, Eytan: No conflict of intereset||Mr. Chan, Justin: No conflict of intereset||Dr. Jacobson, Kevan: No conflict of intereset

Page 102 of 135

P588

Dr. Marino, Marco: No conflict of intereset||Dr. Domenis, Rossana: No conflict of intereset||Dr. Biribin, Lara: No conflict of intereset||Dr. Cifù, Adriana: No conflict of intereset||Navarria, Luca: No conflict of intereset||Scardino, Giulia: No conflict of intereset||Fabris, Martina: No conflict of intereset

P589Dr. HODGES, Phoebe: No conflict of intereset||Dr. Saunders, John: No conflict of intereset||Dr. Betteridge, Freddie: No conflict of intereset

P590

Dr. Rowan, Catherine: No conflict of intereset||Dr. O'Donnell, Jennifer: No conflict of intereset||Dr. Cullen, Nicola: No conflict of intereset||Dr. O'Toole, Aoibhlinn: No conflict of intereset||Dr. Boland, Karen: No conflict of intereset

P591

Dr. De Castro Parga, Maria Luisa: No conflict of intereset||Dr. Hernández, Vicent: No conflict of intereset||Sanroman, Luciano: No conflict of intereset||Pineda, Juan R: No conflict of intereset||Figueira, Montserrat: No conflict of intereset||Martinez-Cadilla, Jesús: No conflict of intereset||Pereira, Santos: No conflict of intereset||Dr. Rodriguez-Prada, José Ignacio: No conflict of intereset

P592

Prof. Knyazev, Oleg: No conflict of intereset||Kagramanova, Anna: No conflict of intereset||Lishchinskaya, Albina: No conflict of intereset||Prof. Parfenov, Asfold: No conflict of intereset

P593

Ms. JEMMALI, Chayma: No conflict of intereset||Labidi, Asma: No conflict of intereset||Mr. Jouini, Med Ali: No conflict of intereset||Ms. Hafi, Marwa: No conflict of intereset||Ms. Serghini, Meriem: No conflict of intereset||Ms. Fekih, Monia: No conflict of intereset||Dr. Boubaker, Jalel: No conflict of intereset

P594

Mrs. Laoudi, Effrosyni: No conflict of intereset||Mrs. Papalouka, Dimitra: No conflict of intereset||Mr. Gkizis, Michalis: No conflict of intereset||Mr. Kokkotis, George: No conflict of intereset||Mrs. Perlepe, Nikoleta: No conflict of intereset||Prof. Dr. Vlachogiannakos, Ioannis: No conflict of intereset||Prof. Dr. Papakonstantinou, Ioannis: No conflict of intereset||Prof. Dr. Bamias, Giorgos: No conflict of intereset

P595

Dr. Stidham, Ryan:|:|Disclosures:|RWS has served as a consultant for Abbvie, Janssen, Merck and Takeda||Ms. Yao, Heming: No conflict of intereset||Dr. Bishu, Shrinivas: No conflict of intereset||Dr. Rice, Michael: No conflict of intereset||Dr. Gryak, Jonathan: No conflict of intereset||Dr. Wilkins, H. Jeffrey: No conflict of intereset||Prof. Najarian, Kayvan: No conflict of intereset

P596

Ms. TIMEUS, Susan:|:|The author works for a pharmaceutical company that license products with the active ingredient mesalazine||Dr. Laoun, Raphael:|:|The author works for a pharmaceutical company that license products with the active ingredient mesalazine

P597

Besuyen, Robin:|:|Empoyee of Galapagos and holds warrants in Galapagos||Dr. Walker, David:|:|Lilly, Pfizer, Novartis, Roche||Dr. Winthrop, Kevin:|:|AbbVie Inc.,Bristol-Myers Squibb Company, Gilead Sciences, Inc., Insmed Incorporated, Lilly, Pfizer Inc., Roche, UCB Pharma, Inc. Received grants for clinical research from Bristol-Myers Squibb Company and Insmed Incorporated.||Dr. Genovese, Mark:|:|Gilead Sciences Inc, Galapagos NV, AbbVie Inc, Eli Lilly and Company and Pfizer.||Dr. Combe, Bernard:|:|AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Eli Lilly & Co, MSD, Novartis, Pfizer, Roche-Chugai, Sanofi, and UCB.||Dr. Tanaka, Yoshiya:|:|Gilead Sciences Inc., Galapagos NV, AbbVie Inc. Eli Lilly and Company, Pfizer.||Dr. Kivitz, Alan:|:|AbbVie, Celgene, Horizon, Janssen, Merck, Novartis, Pfizer, UCB, Genzyme,Sanofi, Regeneron, SUN Pharma Advanced Research, Boehringer Ingelheim, Flexion, and Novartis||Dr. Matzkies, Franziska:|:|Employee at Gilead Sciences Inc||Dr. Bartok, Beatrix:|:|Employee at Gilead Sciences USA||Ye, Lei:|:|Employee at Gilead Sciences USA||Guo, Ying:|:|Employee at Gilead Sciences USA||Dr. Tasset, Chantal:|:|Employee at Galapagos NV||Dr. Sundy, John:|:|Employee at Gilead Sciences||Dr. Keystone, Edward:|:|AbbVie, Amgen, AstraZeneca Pharma, Biotest, Bristol-Myers Squibb Canada, Celltrion, Crescendo Bioscience, F. Hoffmann-La Roche Ltd, Genentech Inc, Gilead, Janssen Inc, Lilly Pharmaceuticals, Merck, Pfizer Pharmaceuticals, PuraPharm, Sandoz, Sanofi-Aventis, Sanofi- Genzyme Samsung Bioepsis, and UCB. ||Dr. Westhovens, René:|:|Galapagos NV and Gilead Sciences Inc.||Prof. Rigby, William:|:|Gilead Sciences||Dr. Burmester, Gerd:|:|AbbVie, Gilead, Eli Lilly, and Pfizer

Page 103 of 135

P598

Dr. Sandborn, William J:|:|Grants: AbbVie, Amgen, Atlantic Healthcare Limited, Celgene/Receptos, Eli Lilly, Genentech, Gilead, Janssen, Pfizer Inc, Prometheus Laboratories (now Prometheus Biosciences), Takeda|Personal fees: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Eli Lilly, Ferring, Forbion, Genentech, Gilead, Gossamer Bio, Incyte, Janssen, Kyowa Kakko Kirin Co. Ltd., Landos Biopharma, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Biosciences, Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts, UCB, Ventyx Biosciences, Vimalan Biosciences, Vivelix|Other: Spouse: Consultant, Stock options: Escalier Biosciences, Opthotech, Oppilan Pharma, Progenity, Prometheus Biosciences, Ventyx Biosciences, Vimalan Biosciences||Panés, Julian:|:|Grants: AbbVie, MSD|Personal fees: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, F. Hoffmann-La Roche, Gilead, GoodGut, GSK, Immunic, Janssen, MSD, Nestlé, Oppilan, Pfizer Inc, Progenity, Robarts Clinical Trials, Takeda, Theravance, TiGenix||Sands, Bruce E:|:|Grants: Theravance Biopharma|Personal fees: AbbVie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella BiosScence, Celltrion Healthcare, Eli Lilly, Genentech/F. Hoffmann-La Roche, Ironwood Pharmaceuticals, Janssen, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Laboratories, Salix, Shire, Takeda, TARGET PharmaSolutions, Theravance Biopharma, Vivelix|Non-financial support: Eli Lilly, Janssen, Pfizer Inc, Takeda, TARGET PharmaSolutions|Other: Honoraria for speaking in a CME programme: The Academy for Continued Healthcare Learning, Integritas Communications||Reinisch, Walter:|:|Grants: Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GMbH, Immundiagnostik, MSD|Personal fees: 4SC, Abbott Laboratories, AbbVie, Aesca, Amgen, AM Pharma, AOP Orphan, Aptalis, Arena Pharmaceuticals, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, ChemoCentryx, Covance, Danone, Austria, Elan, Eli Lilly, Ernst & Young, Falk Pharma GMbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, Index, Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, MedAhead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestlé, Novartis, Ocera, Otsuka, Parexel, PDL, Pfizer Inc, Pharmacosmos, Philip Morris Institute, PLS Education, Proctor & Gamble, Prometheus, Laboratories, Protagonist, Provention, Robarts Clinical Trials, Roland, Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics SetPoint Medical Shire Sigmoid Takeda Therakos TiGenix UCB Vifor Yakult

P599

Dr. ESSLINGER, Suzan: No conflict of intereset||Dr. Otero-Lobato, Marijo:|:|Employee of Janssen Biologics BV; shareholder||Mrs. Gabriel, Susan:|:|Employee of Janssen; shareholder||Dr. Clark, Michael:|:|Janssen employee; shareholder||Dr. Sheridan, Pamela:|:|Janssen employee; shareholder||Dr. Geldhof, Anja:|:|Janssen employee; shareholder

P600

Prof. Louis, Edouard:|:|Research Grant: Takeda, Pfizer, Janssen|Educational Grant: Abbvie, MSD, Takeda, Janssen |Speaker Fees: Abbvie, Ferring, MSD, Falk, Takeda, Hospira, Janssen, Pfizer Advisory Board: Abbvie, Ferring, MSD, Takeda, Celgene, Hospira, Janssen, Pfizer|Consultant: Abbvie|||Dr. Muls, Vinciane: No conflict of intereset||Dr. Bossuyt, Peter:|:|Financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan|Lecture fees from AbbVie, Takeda, Pfizer and Janssen|Advisory board fees from Abbvie, BMS, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz and Pentax||Dr. Colard, Arnaud: No conflict of intereset||Dr. Nakad, Antoine: No conflict of intereset||Dr. Baert, Didier: No conflict of intereset||Prof. Mana, Fazia: No conflict of intereset||Prof. Caenepeel, Philip: No conflict of intereset||Dr. Vanden Branden, Stijn: No conflict of intereset||Prof. Vermeire, Severine:|:|Receipt of grants/research supports: MSD, Abbvie, Takeda, Janssen, Pfizer|Receipt of honoraria or consultation fees: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, Gilead, Abivax, GSK, Arena and Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, Galapagos/Gilead, and Tillots||Dr. D’Heygere, Francois: No conflict of intereset||Dr. Strubbe, Beatrijs: No conflict of intereset||Dr. Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie||Dr. Coche, Jean-Charles: No conflict of intereset||Dr. Setakhr, Vida: No conflict of intereset||Dr. Baert, Filip:|:|Receipt of grants/research supports: Abbvie, Amgen, Takeda, Janssen.|Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen||Dr. Vijverman, Anne: No conflict of intereset||Dr. Coenegrachts, Jean-Louis: No conflict of intereset||Dr. Flamme, Frederic: No conflict of intereset||Dr. Hantson, Anke:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Wijnen, Katinka:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Piters, Elke:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Mr. Hantsbarger, Gary:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Dolin, Paul: No conflict of intereset

Page 104 of 135

P601

Ms. Van den Berghe, Nathalie: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Ms. Vandeput, Eline: No conflict of intereset||Ms. Ballet, Vera: No conflict of intereset||Mrs. Gils, Ann:|:|AG served as a speaker for Merck Sharp & Dohme, Janssen Biologicals, Pfizer, Takeda, Novartis, and AbbVie, and received Investigator-Initiated Research Grants from Pfizer and a national grant from Takeda.||KU Leuven licensed antibodies for the infliximab, adalimumab, vedolizumab, golimumab, and ustekinumab ELISA to apDia and infliximab and adalimumab lateral flow assays to R-Biopharm.|||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Mrs. Thomas, Debby: No conflict of intereset

P602

Prof. PARK, Yehyun: No conflict of intereset||Prof. Cheon, Jae Hee: No conflict of intereset||Prof. Park, Young Sook: No conflict of intereset||Prof. Huh, Kyu Chan: No conflict of intereset||Prof. Shin, Jeong Eun: No conflict of intereset||Prof. Cha, Jae Myung: No conflict of intereset||Prof. Kim, You Sun: No conflict of intereset||Eun, Chang Soo: No conflict of intereset||Prof. Yoon, Soon Man: No conflict of intereset||Prof. Park, Young Soo: No conflict of intereset||Prof. Ye, Byong Duk: No conflict of intereset||Ms. Seo, BoJung: No conflict of intereset||Mr. Kim, Youngdoe: No conflict of intereset

P603

Prof. Louis, Edouard:|:|Research Grant: Takeda, Pfizer, Janssen|Educational Grant: Abbvie, MSD, Takeda, Janssen Speaker Fees: Abbvie, Ferring, MSD, Falk, Takeda, Hospira, Janssen, Pfizer Advisory Board: Abbvie, Ferring, MSD, Takeda, Celgene, Hospira, Janssen, Pfizer|Consultant: Abbvie|||Dr. Muls, Vinciane: No conflict of intereset||Dr. Bossuyt, Peter:|:|Financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan|Lecture fees from AbbVie, Takeda, Pfizer and Janssen|Advisory board fees from Abbvie, BMS, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz and Pentax.||Dr. Colard, Arnaud: No conflict of intereset||Dr. Nakad, Antoine: No conflict of intereset||Dr. Baert, Didier: No conflict of intereset||Prof. Mana, Fazia: No conflict of intereset||Prof. Caenepeel, Philip: No conflict of intereset||Dr. Vanden Branden, Stijn: No conflict of intereset||Prof. Vermeire, Severine:|:|Receipt of grants/research supports: MSD, Abbvie, Takeda, Janssen, Pfizer|Receipt of honoraria or consultation fees: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, Gilead, Abivax, GSK, Arena and Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, Galapagos/Gilead, and Tillots||Dr. D’Heygere, Francois: No conflict of intereset||Dr. Strubbe, Beatrijs: No conflict of intereset||Dr. Cremer, Anneline:|:|Consultancy fees: Takeda, Janssen|Speaker fees: Pfizer, Abbvie||Dr. Coche, Jean-Charles: No conflict of intereset||Dr. Setakhr, Vida: No conflict of intereset||Dr. Baert, Filip:|:|Receipt of grants/research supports: Abbvie, Amgen, Takeda, Janssen.|Receipt of honoraria or consultation fees: AbbVie, Arena, MSD, Celgene, Takeda, Ferring, Pfizer, Norgine, Janssen.|Participation in a company sponsored speaker’s bureau: AbbVie, MSD, Takeda, Ferring, Pfizer, Janssen||Dr. Vijverman, Anne: No conflict of intereset||Dr. Coenegrachts, Jean-Louis: No conflict of intereset||Dr. Flamme, Frederic: No conflict of intereset||Dr. Hantson, Anke:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Wijnen, Katinka:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Piters, Elke:|:|Employee of Takeda Pharmaceuticals and holds Takeda share options||Dr. Dolin, Paul: No conflict of intereset

P604

Mrs. REES, Fiona: No conflict of intereset||Mrs. Packham, Angela: No conflict of intereset||Mrs. Blake, Catherine: No conflict of intereset||Ms. Hills, Emma: No conflict of intereset||Dr. Scutt, Greg: No conflict of intereset||Mrs. St Clair-Jones, Anja: No conflict of intereset

P605

Dr. Cassieri, Claudio: No conflict of intereset||Dr. Pica, Roberta: No conflict of intereset||Dr. Avallone, Eleonora Veronica: No conflict of intereset||Prof. Dr. Brandimarte, Giovanni: No conflict of intereset||Dr. Zippi, Maddalena: No conflict of intereset||Dr. Crispino, Pietro: No conflict of intereset||Dr. De Nitto, Daniela: No conflict of intereset||Dr. Lecca, Piera Giuseppina: No conflict of intereset||Prof. Dr. Vernia, Piero: No conflict of intereset||Prof. Dr. Pica, Roberta: No conflict of intereset||Prof. Dr. Corazziari, Enrico Stefano: No conflict of intereset

Page 105 of 135

P606

Dr. Kakkadasam Ramaswamy, Pradeep: No conflict of intereset||Ms. Mutsekwa, Rumbidzai: No conflict of intereset||Ms. Lan, Xiao: No conflict of intereset||Ms. Chen, Yvonne: No conflict of intereset||Ms. Angus, Rebecca: No conflict of intereset||Dr. Moattar, Hadi: No conflict of intereset||Dr. Edwards, John: No conflict of intereset||Dr. Shukla, Dheeraj: No conflict of intereset

P607

Dr. Schultz, Robert:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc||Dr. Diakite, Ibrahim: No conflict of intereset||Mr. Carter, John:|:|Employment at Pharmerit International, which received funding to conduct this study||Dr. Snedecor, Sonya:|:|Employment at Pharmerit International, which received funding to conduct this study||Dr. Turpin, Robin: No conflict of intereset

P608

Dr. Yzet, Clara: No conflict of intereset||Dr. Le Mouel, Jean Philippe: No conflict of intereset||Dr. Hakim, Sami: No conflict of intereset||Dr. Brazier, Franck: No conflict of intereset||Prof. Fumery, Mathurin: No conflict of intereset

P609Dr. Levy, Nimrod: No conflict of intereset||Dr. Matz, Hagit: No conflict of intereset||Dr. Maharshak, Nitsan: No conflict of intereset||Dr. Waizbard, Amir: No conflict of intereset

P610

Dr. REES, James: No conflict of intereset||Dr. Maher, Caitlin: No conflict of intereset||Mrs. Jones, Judith: No conflict of intereset||Mrs. Slater, Jayne: No conflict of intereset||Mrs. Bates, Beth: No conflict of intereset||Dr. Rattehalli, Deepa: No conflict of intereset||Dr. De Silva, Shanika: No conflict of intereset

P611

Ms. Moore, Emma: No conflict of intereset||Ms. Wolloff, Sarah: No conflict of intereset||Dr. Glanville, Tracey: No conflict of intereset||Dr. Selinger, Christian Philipp: No conflict of intereset

P612Dr. Crooks, Benjamin: No conflict of intereset||Prof. McLaughlin, John: No conflict of intereset||Prof. Limdi, Jimmy K: No conflict of intereset

P613

Dr. Ribaldone, Davide Giuseppe: No conflict of intereset||Dr. Vernero, Marta: No conflict of intereset||Dr. Pellicano, Rinaldo: No conflict of intereset||Prof. Morino, Mario: No conflict of intereset||Prof. Saracco, Giorgio Maria: No conflict of intereset||Dr. Astegiano, Marco: No conflict of intereset

P614

Sturiale, Alessandro: No conflict of intereset||Dr. Fabiani, Bernardina: No conflict of intereset||Dr. Cafaro, Danilo: No conflict of intereset||Menconi, Claudia: No conflict of intereset||Celedon Porzio, Felipe: No conflict of intereset||Dr. Franceschi, Matteo: No conflict of intereset||Dr. Naldini, Gabriele: No conflict of intereset

P615

PERUZZI, Giulia: No conflict of intereset||Ms. Calandrini , Lucia: No conflict of intereset||Ms. Privitera Hrustemovic, Hana: No conflict of intereset||Mr. Salice, Marco: No conflict of intereset||Mr. Decorato, Anastasio: No conflict of intereset||Ms. Carbone, Anna: No conflict of intereset||Prof. Rizzello, Fernando: No conflict of intereset||Dr. Belluzzi, Andrea: No conflict of intereset||Ms. Scaioli , Eleonora: No conflict of intereset||Dr. Calabrese, Carlo: No conflict of intereset||Prof. Gionchetti, Paolo: No conflict of intereset

P616

Mr. Young, David: No conflict of intereset||Mr. Freudensprung, Ulrich: No conflict of intereset||Dr. Harris, Clare: No conflict of intereset||Dr. Harris, Richard: No conflict of intereset||Dr. Harvey, Justin: No conflict of intereset||Ms. Addison, Janet: No conflict of intereset||Prof. Latter, Sue: No conflict of intereset||Dr. Cummings, Fraser: No conflict of intereset

P617

Prof. Knyazev, Oleg: No conflict of intereset||Dr. Kagramanova, Anna Valeryevna: No conflict of intereset||Dr. Lishchinskaya , Albina: No conflict of intereset||Prof. Parfenov, Asfold: No conflict of intereset

P618

Dr. Rowan, Catherine: No conflict of intereset||Dr. Janjua, Muhammed: No conflict of intereset||Dr. Foley, Clare: No conflict of intereset||Mr. Burke, John: No conflict of intereset||Dr. Boland, Karen: No conflict of intereset||Dr. O'Toole, Aoibhlinn: No conflict of intereset

P619

Sakurai, Kensuke: No conflict of intereset||Dr. Katsurada, Takehiko: No conflict of intereset||Dr. Otagiri, Shinsuke: No conflict of intereset||Dr. Yamanashi, Kana: No conflict of intereset||Dr. Nagashima, Kazunori: No conflict of intereset||Dr. Onishi, Reizo: No conflict of intereset||Dr. Nishimura, Haruto: No conflict of intereset||Dr. Ito, Takahiro: No conflict of intereset||Dr. Furukawa, Shigeru: No conflict of intereset||Dr. Maemoto, Atsuo: No conflict of intereset||Prof. Dr. Sakamoto, Naoya: No conflict of intereset

P620

Dr. Dragoni, Gabriele: No conflict of intereset||Dr. Pieraccini, Alberto: No conflict of intereset||Dr. Bagnoli, Siro: No conflict of intereset||Dr. Caini, Saverio: No conflict of intereset||Dr. Macrì, Giuseppe: No conflict of intereset||Dr. Rogai, Francesca: No conflict of intereset||Prof. Dr. Milani, Stefano: No conflict of intereset||Prof. Dr. Galli, Andrea: No conflict of intereset||Dr. Milla, Monica: No conflict of intereset

Page 106 of 135

P621

Huynh, Lynn:|:|LH is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study.||Hass, Steve:|:|SH is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study.||Sands, Bruce E:|:|BES has received consultancy fees from Shire, a member of the Takeda group of companies, and consultancy fees and honoraria for lectures from Takeda.||Duh, Mei Sheng:|:|MSD is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study.||Sipsma, Heather:|:|HS is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study.||Cheng, Mu:|:|MC is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study.||Lax, Angie:|:|AL is an employee of Analysis Group, Inc., which received funding from Shire, a member of the Takeda group of companies, for the conduct of the present study||Dr. NAG, Arpita:|:|AN is an employee of Shire, a member of the Takeda group of companies. |This study was funded by Shire, a member of the Takeda group of companies. Medical writing support was provided by Maxine Cox of PharmaGenesis London, London, UK, with funding from Shire International GmbH., a member of the Takeda group of companies.

P622

Prof. Dr. Iakovlev, Alexey Alexandrovich: No conflict of intereset||Dr. Volkov, Alexander: No conflict of intereset||Dr. Shcherbakova, Inna: No conflict of intereset||Leonova, Galina: No conflict of intereset||Mr. Piskovets, Valeryi: No conflict of intereset

P623

Dr. GHRIBI, Marwa: No conflict of intereset||Dr. Mohamed, Ghanem: No conflict of intereset||Dr. Bizid, Sondes: No conflict of intereset||Dr. Ben Sliman, Bahaa: No conflict of intereset||Dr. Boughoula, Khouloud: No conflict of intereset||Prof. Ben Abdallah, Hatem: No conflict of intereset||Prof. Bouali, Riadh: No conflict of intereset||Prof. Abdelli, Mohamed Nabil: No conflict of intereset

P624

Dr. Pujol Muncunill, Gemma: No conflict of intereset||Dr. Pascual-Pérez, Alicia Isabel: No conflict of intereset||Dr. Dominguez-Sánchez, Patricia: No conflict of intereset||Dr. Feo-Ortega, Sara: No conflict of intereset||Dr. Suárez-Galvis, Margarita: No conflict of intereset||Dr. Vila-Miravet, Victor: No conflict of intereset||Dr. Martin de Carpi, Francisco Javier: No conflict of intereset

P625

Dr. Pastaud, Clément: No conflict of intereset||Dr. Hordonneau, Constance: No conflict of intereset||Mrs. Lambert, Céline: No conflict of intereset||Mrs. Vignette, Jeanne: No conflict of intereset||Mr. Pereira, Bruno: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset

P626

Mr. SHARVIT, Gal: No conflict of intereset||Dr. Goren, Idan: No conflict of intereset||Mrs. Godny, Lihi: No conflict of intereset||Mrs. Yadgar, Karin: No conflict of intereset||Mrs. Elial Fatal, Sarine: No conflict of intereset||Mrs. Barkan, Revital: No conflict of intereset||Prof. Dr. Turner, Dan: No conflict of intereset||Prof. Dr. Dotan, Iris: No conflict of intereset||Yanai, Henit: No conflict of intereset

P627

Dr. OLLECH, Jacob: No conflict of intereset||Dr. Avni-Biron, Irit: No conflict of intereset||Dr. Dalal, Sushila: No conflict of intereset||Dr. Glick, Laura: No conflict of intereset||Dr. Schafer, Seth: No conflict of intereset||Dr. Pekow, Joel:|:|received grants from Takeda and Abbvie, and serves as a consultant for Verastem. He was on the advisory board for Pfizer and Janssen||Prof. Cohen, Russell:|:|consultant at Abbvie, Celgene, Janssen, Pfizer, Takeda and UCB Pharma||Prof. Rubin, David:|:|consultant and has received grant support from Abbvie, Merck & Co., Janssen, Takeda and Pfizer||Dr. Sakuraba, Atsushi:|:|has received funding from AbbVie, Celltrion and Takeda

P628

Dr. Narula, Neeraj: No conflict of intereset||Dr. Alshahrani, Abdul-Aziz: No conflict of intereset||Ms. Fadida, Ma'ayan: No conflict of intereset||Dr. Al-Saedi, Mona: No conflict of intereset||Dr. Marshall, John K.: No conflict of intereset||Dr. Rubin, David T.: No conflict of intereset||Dr. Christensen, Britt: No conflict of intereset

Page 107 of 135

P629

P630

Dr. Fukuda, Tomohiro: No conflict of intereset||Dr. Naganuma, Makoto:|:|Makoto Naganuma received commercial research funding from EA Pharma Co., Ltd. and Mochida Pharmaceutical Co., Ltd., outside the submitted work. ||Dr. Takabayashi, Kaoru: No conflict of intereset||Dr. Hagihara, Yuya: No conflict of intereset||Dr. Tanemoto, Shun: No conflict of intereset||Dr. Nomura, Ena: No conflict of intereset||Dr. Yoshimatsu, Yusuke: No conflict of intereset||Dr. Sugimoto, Shinya: No conflict of intereset||Dr. Nanki, Kosaku: No conflict of intereset||Dr. Mizuno, Shinta: No conflict of intereset||Dr. Mikami, Yohei: No conflict of intereset||Dr. Fukuhara, Kayoko: No conflict of intereset||Dr. Suzino, Tomohisa: No conflict of intereset||Dr. Mutaguchi, Makoto: No conflict of intereset||Dr. Inoue

P631

Dr. Ritter, Timothy E.:|:|AbbVie, Inc.: Consultant; Eli Lilly & Company: Grant; Ferring Pharmaceuticals: Consultant; Gilead Sciences, Inc.: Consultant; Janssen: Advisory Board, Speaker; Merck, Sharp & Dohme: Advisory Board; Pfizer: Advisory Board, Speaker; Takeda: Grant, Advisory Board, Speaker; Arena Pharmaceutical: Advisory Board; Genentech: Advisory Board||Dr. Sarles, Harry E.: No conflict of intereset||Dr. Mehta, Samantha A.: No conflict of intereset||Dr. Van Anglen, Lucinda J.: No conflict of intereset

P632

Dr. Varghese, Della:|:|Della Varghese is an employee of Pharmerit International, a paid consultant on the project. ||Dr. Patel, Dipen:|:|Dipen Patel is an employee of Pharmerit International, a paid consultant on the project. ||Mr. Martin, Stephan:|:|Stephan Martin is an employee of Pharmerit International, a paid consultant on the project. ||Dr. Luo, Michelle:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Ursos, Lyann:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Lirio, Richard:|:|Employee of Takeda; holds Takeda stock or stock options||Dr. Wang, Song:|:|Employee of Takeda; holds Takeda stock or stock options

Chaparro, Maria:|:|M Chaparro has served as a speaker, or has received research or education funding from MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Shire Pharmaceuticals, Dr. Falk Pharma, and Tillotts Pharma. ||Ms. Sulleiro, Sara:|:|Janssen employee||Dr. Bastón-Rey, Iria: No conflict of intereset||Dr. Rodríguez , Cristina: No conflict of intereset||Dr. García-Tercero, Iván: No conflict of intereset||Dr. Ramírez, Patricia: No conflict of intereset||Dr. García-López, Santiago: No conflict of intereset||Dr. Rojas-Feria, María: No conflict of intereset||Dr. Gutiérrez, Ana: No conflict of intereset||Dr. Huguet Malavés, José María:|:|Dr. Huguet reports educational activities, research projects, scientific meetings or advisory boards from Takeda, Pzifer, Janssen, Abvvie, MSD, Biogen||Dr. García-Sepulcre, Mariana Fé: No conflict of intereset||Dr. Sicilia, Beatriz: No conflict of intereset||Dr. Bermejo, Fernando: No conflict of intereset||Dr. Rodríguez-Moranta, Francisco: No conflict of intereset||Dr. Argüelles, Federico: No conflict of intereset||Dr. Marín, Ignacio: No conflict of intereset||Dr. Leo, Eduardo:|:|Eduardo Leo has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Pfizer, Abbvie, Takeda, Janssen, Tillotts Pharma, Shire Pharmaceuticals, Ferring, Dr. Falk Pharma y Otsuka Pharmaceutical||Dr. Arroyo, Maite: No conflict of intereset||Dr. García, María josé: No conflict of intereset||Dr. Vázquez, Juan María: No conflict of intereset||Dr. Ginard, Daniel: No conflict of intereset||Dr. Martínez Cadilla, Jesús: No conflict of intereset||Dr. Rubín de Célix, Cristina: No conflict of intereset||Dr. García-Herola, Antonio: No conflict of intereset||Dr. Hernández-Camba, Alejandro: No conflict of intereset||Dr. Martín-Arranz, María Dolores: No conflict of intereset||Dr. Riestra, Sabino: No conflict of intereset||Dr. Varela , Pilar: No conflict of intereset||Dr. Velayos, Benito: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. Dueñas, Carmen: No conflict of intereset||Dr. Fernández-Salgado, Estela: No conflict of intereset||Dr. Martínez-Montiel, Pilar: No conflict of intereset||Dr. Diz-Lois , María Teresa: No conflict of intereset||Prof. Dr. González-Lama, Yago: No conflict of intereset||Dr. Muñagorri, Ana: No conflict of intereset||Dr. Navarro-Llavat, Mercé: No conflict of intereset||Ms. Guisado, Cristina:|:|Janssen employee||Dr. Barreiro-de Acosta*, Manuel:|:|Manuel Barreiro-de Acosta has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Hospira, Takeda, Janssen, Pfizer, Ferring, FaesFarma, ShirePharmaceuticals, Dr. FalkPharma, Chiesi, GebroPharma, OtsukaPharmaceuticals, and TillottsPharma||Dr. P. Gisbert*, Javier:|:|Dr. Gisbert has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Hospira, Pfizer, Kern Pharma, Biogen, Takeda, Janssen, Roche, Sandoz, Celgene, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, Vifor Pharma.

Page 108 of 135

P633

D'Haens, Geert R:|:|advisor for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor||Sands, Bruce E:|:|Research Support - Theravance Biopharma|Consultant - Abbvie, Allergan, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella Bioscience, Celltrion Healthcare, Genentech, Hoffmann-La Roche AG, Janssen, Lilly, Morphic Therapeutic, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Laboratorie, Salix, Shire, Takeda Pharmaceuticals , TARGET PharmaSolutions, Theravance Biopharma, Vivelix Pharmaceuticals|Advisory Committee - Arena Pharmaceuticals, Ironwood Pharmaceuticals||Kobayashi, Taku:|:|Consultancy fees from Abbvie GK, Alfresa Pharma, Covidien, Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, Nippon Kyaku, Pfizer, Takeda Pharmaceutical, Thermo Scientific, lecture fees from Abbvie GK, Ajinomoto Pharma, Asahi Kasei Medical, Astellas, Alfresa Pharma, Celltrion, EA Pharma Co.,Ltd, Kyorin Pharmaceutical Co.,Ltd, Nippon Kyaku, Mochida Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma , ZERIA, Eisai Co.,Ltd, Gilead Sciences, Janssen, JIMRO Co.,Ltd, research funding from Abbvie GK, EA Pharma Co.,Ltd, Otsuka Holdings Co.,Ltd, ZERIA, Kyorin Pharmaceutical Co.,Ltd, Mochida Pharmaceutical, EA Pharma Co.,Ltd, Thermo Fisher Scientific, Alfresa Pharma, Nippon Kyaku, Asahi Kasei medical||Tuttle, Jay L:|:|current employee and shareholder of Eli Lilly and Company||Schmitz, Jochen:|:|current employee and shareholder of Eli Lilly and Company||Higgs, Rchard:|:|current employee and shareholder of Eli Lilly and Company||Ho, Stephen:|:|current employee and shareholder of Eli Lilly and Company||Sissons, Sean E:|:|current employee and shareholder of Eli Lilly and Company||Sandborn, William J:|:|research grants from Atlantic Healthcare Limited, Amgen, Genentech, Gilead Sciences, Abbvie, Janssen, Takeda, Lilly, Celgene/Receptos,Pfizer, Prometheus Laboratories (now Prometheus Biosciences) consulting fees from Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio Incyte Janssen Kyowa Kirin Pharmaceutical Research Landos Biopharma Lilly Oppilan

P634

Ms. Zhao, Mirabella: No conflict of intereset||Prof. Dr. Bendtsen, Flemming:|:|F.B. reports personal fee and grants from Ferring A/S, all of which were unrelated to this study.||Dr. Petersen, Andreas Munk:|:|A.M.P reports travel grants and fees from MSD and Pfizer, all of which were unrelated to this study.||Dr. Larsen, Lone: No conflict of intereset||Prof. Dr. Jess, Tine: No conflict of intereset||Dr. Dige, Anders: No conflict of intereset||Dr. Hvas, Christian:|:|C.H. reports speaker fee from MSD.||Prof. Dr. Seidelin, Jakob:|:|J.S. reports research grant from Takeda unrelated to this study, as well as assigned unpaid national coordinator of clinical trials from AbbVie, Eli Lilly and Roche and unpaid investigator at studies from Arena and Zealand Pharma.||Dr. Burisch, Johan:|:|J.B. reports personal fees from AbbVie, Janssen-Cilag, Celgene, MSD, Pfizer and grants and personal fees from Takeda, all of which were unrelated to this study.

P635

Ms. Matheeuwsen, Mijntje: No conflict of intereset||Mr. Vermeijden, Koen: No conflict of intereset||Dr. Bossuyt, Peter: No conflict of intereset||Dr. Pouillon, Lieven: No conflict of intereset||Dr. Baert, Filip: No conflict of intereset||Dr. de Boer, Nanne: No conflict of intereset||Dr. Duijvestein, Marjolijn: No conflict of intereset||Dr. Löwenberg, Mark: No conflict of intereset||Prof. Dr. Ponsioen, Cyriel: No conflict of intereset||Prof. Dr. Bemelman, Willem: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset

P636

Dr. Guo, Kun: No conflict of intereset||Dr. Gong , Wenbin: No conflict of intereset||Zheng, Tao: No conflict of intereset||Dr. Li , Weijie: No conflict of intereset||Dr. Fang, Miao: No conflict of intereset||Dr. Xie, Haohao: No conflict of intereset||Wang, Gefei: No conflict of intereset||Dr. Gu, Guosheng: No conflict of intereset

P637

Dr. Bouhnik, Yoram:|:|Consultancy and/or speaker fees from: AbbVie, Biogaran, Biogen, Boehringer Ingelheim, CTMA, Ferring, Gilead, Hospira, ICON, Inception IBD, Janssen, Lilly, Mayoly Spindler, Merck, Merck Sharp & Dohme, Norgine, Pfizer, Robarts Clinical Trials, Roche, Sanofi, Shire, Takeda, UCB, Vifor Pharma||Dr. Fautrel, Bruno:|:|Consultancy and/or speaker fees from: AbbVie, Biogen, Boehringer-Ingelheim, BMS, Celgene, Janssen, Lilly, Medac, MSD, NORDIC Pharma, Novartis, Pfizer, Roche, SOBI, UCB||Dr. Desjeux, Guillaume:|:|Employee of E-health Services Sanoïa||Dr. Freudensprung, Ulrich:|:|Employee of and may hold stock in Biogen||Dr. Brigui, Amira:|:|Employee of and may hold stock in Biogen.||Dr. Addison, Janet:|:|Employee of and may hold stock in Biogen.

Page 109 of 135

P638

Dr. EL OUARDI, Walid: No conflict of intereset||Dr. nawal, lagdali: No conflict of intereset||Prof. Dr. imane, benelbarhdadi: No conflict of intereset||Dr. camelia, berhili: No conflict of intereset||Prof. Dr. mohamed, borahma: No conflict of intereset||Prof. Dr. fatima zahra, ajana: No conflict of intereset

P639Dr. Eldridge, Fiona: No conflict of intereset||Ms. Strongili, Konstantina: No conflict of intereset||Dr. Parkes, Miles: No conflict of intereset||Dr. Raine, Tim: No conflict of intereset

P640

Sarbagili Shabat, Chen: No conflict of intereset||Dr. Weiner , Dror: No conflict of intereset||Wardi , Joram: No conflict of intereset||Mrs. Abramas , Lee: No conflict of intereset||Dr. Yaakov, Michal: No conflict of intereset||Prof. Levine , Arie: No conflict of intereset

P641

Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda||Mr. Stylli, Jack:|:|Progenity stock holder||Mr. Rahimian, Pejman:|:|Progenity stock holder.||Ms. Rajulapati, Anuradha:|:|Progenity stock holder||Ms. Ehring, Kayla:|:|Progenity stock holder||Dr. Thomas, Debby: No conflict of intereset||Dr. Sabino, João:|:|Speaker’s fee: Abbvie and Nestle Health Sciences.||Prof. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda||Dr. Singh, Sharat:|:|Progenity stock holder||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer;|Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots

P642

Guardiola Capón, Jordi: No conflict of intereset||Ms. SERRA, Katja: No conflict of intereset||Rodríguez-Alonso, Lorena: No conflict of intereset||Santacana, Eugènia: No conflict of intereset||Padullés, Núria: No conflict of intereset||Ruiz-Cerulla, Alexandra: No conflict of intereset||Arajol, Clàudia: No conflict of intereset||Camps, Blau: No conflict of intereset||Surís, Gerard: No conflict of intereset||Sanchez, Elena: No conflict of intereset||Rodríguez-Moranta, Francisco: No conflict of intereset

P643

Dr. LIVNE MARGOLIN, Moran: No conflict of intereset||Prof. Amitai, Michal: No conflict of intereset||Dr. Klung, Eyal: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Prof. Eliakim, Rami: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Dr. Carter, Dan: No conflict of intereset||Prof. Kopylov, Uri: No conflict of intereset

P644

Dr. BROWNSON, Emily: No conflict of intereset||Dr. Shields, Stephanie: No conflict of intereset||Dr. Derakhshan, Mohammad H: No conflict of intereset||Dr. Macdonald, Jonathan: No conflict of intereset||Mr. Nicholson, Gary: No conflict of intereset||Dr. Seenan, John Paul: No conflict of intereset

P645

Dr. CURRAIS, Pedro: No conflict of intereset||Dr. Fernandes, Samuel: No conflict of intereset||Dr. Bernardo, Sónia: No conflict of intereset||Dr. Correia, Luís: No conflict of intereset||Dr. Gonçalves, Ana Rita: No conflict of intereset||Dr. Baldaia, Cilénia: No conflict of intereset||Dr. Moura Santos, Paula: No conflict of intereset||Dr. Valente, Ana: No conflict of intereset||Prof. Dr. Tato Marinho, Rui: No conflict of intereset

P646 Dr. Duan, Yantao: No conflict of intereset||Prof. Li, Yousheng: No conflict of intereset

P647

Mrs. Panetta, Valentina:|:|Consulting||Simonelli, Ilaria:|:|Consulting||Bacchieri, Antonella:|:|Consulting||Mrs. Papetti, Sara:|:|Consulting||Mrs. De Stefani, Eleonora:|:|Consulting||Dr. Colombo, Stefano:|:|Consulting

P648

Dr. Watanabe, Kenji:|:|Personal Fees; Consulting, Lecture Fees, Support for travel for meetings to support study and Fees participation in review activities: Pfizer Inc.||Dr. Kawai, Mikio: No conflict of intereset||Dr. Koshiba, Ryoji: No conflict of intereset||Dr. Fujimoto, Koji: No conflict of intereset||Dr. Kojima, Kentaro: No conflict of intereset||Dr. Kaku, Kazutoshi: No conflict of intereset||Dr. Kinoshita, Naohiko: No conflict of intereset||Dr. Sato, Toshiyuki: No conflict of intereset||Dr. Kamikozuru, Koji: No conflict of intereset||Dr. Yokoyama, Yoko: No conflict of intereset||Dr. Miyazaki, Takako: No conflict of intereset||Dr. Hida, Nobuyuki:|:|Personal Fees; Lecture Fees: Pfizer Inc.||Prof. Nakamura, Shiro:|:|Personal Fees; Lecture Fees and Support for travel for meetings to support study: Pfizer Inc.

P649

Dr. Ben Mustapha, Nadia: No conflict of intereset||Ben Youssef, Hela: No conflict of intereset||Dr. Labidi, Asma: No conflict of intereset||Dr. Hafi, Marwa: No conflict of intereset||Dr. Fekih, Monia: No conflict of intereset||Dr. Serghini, Meriem: No conflict of intereset||Dr. Boubaker, Jalel: No conflict of intereset

P650

Dr. Sarraj, Riad: No conflict of intereset||Dr. Martinho , Maude: No conflict of intereset||Dr. Bravo, Francisco: No conflict of intereset||Dr. Benz, Eileen: No conflict of intereset||Dr. Juillerat, Pascal: No conflict of intereset

P651Dr. Cauchi, Suzanne: No conflict of intereset||Dr. Schembri, John: No conflict of intereset||Dr. Muscat, Martina: No conflict of intereset||Dr. Ellul, Pierre: No conflict of interesetPage 110 of 135

P652

Vranesic Bender, Darija: No conflict of intereset||Dr. Domislović, Viktor: No conflict of intereset||Brinar, Marko: No conflict of intereset||Ljubas Kelečić, Dina: No conflict of intereset||Karas, Irena: No conflict of intereset||Novosel, Martin: No conflict of intereset||Matašin, Marija: No conflict of intereset||Prof. Krznarić, Željko: No conflict of intereset

P653

Rubin, David T:|:|Grants: AbbVie, Genentech/F. Hoffmann-La Roche, Janssen, Prometheus Laboratories, Takeda|Personal fees: AbbVie, AbGenomics, Allergan, Biomica, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Check-Cap, Dizal Pharmaceuticals, Eli Lilly, GalenPharma/Atlantica, Genentech/F. Hoffmann-La Roche, Gilead, Glenmark, GSK, Janssen, Mahana Therapeutics, Narrow River Mgmt, Pfizer Inc, Prometheus Laboratories, Reistone, Seres Therapeutics, Shire, Takeda, TARGET PharmaSolutions, Techlab|Other: Board of Trustees: American College of Gastroenterology; Co-Founder, CFO: Cornerstones Health (non-profit); Co-Founder: GoDuRn||Dubinsky, Marla C:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Danese, Silvio:|:|Consultancy: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer Inc, Roche, Sandoz, Takeda, TiGenix, UCB, Vifor||Saad-Hossne, Rogeiro:|:|Personal fees: AbbVie, Janssen, Pfizer Inc, Takeda|Other: President of the GEBIID congress||Ponce de Leon, Dario:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Maller, Eric:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kwok, Kenneth:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc

P654

Bastón Rey, Iria: No conflict of intereset||Dr. Costa, Marta: No conflict of intereset||Dr. Calviño-Suarez, Cristina: No conflict of intereset||Dr. Mauriz-Barreiro, Violeta: No conflict of intereset||Dr. De la Iglesia, Daniel: No conflict of intereset||Dr. Gonzalez, Jaime: No conflict of intereset||Dr. Ferreiro-Iglesias, Rocio: No conflict of intereset||Prof. Dr. Dominguez- Munoz, J.Enrique: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset

P655

Adedokun, Omoniyi:|:|employee of Janssen Research and Development, LLC |||Dr. Hyams, Jeffrey:|:|Advisory Board: Janssen, Abbvie; Consultant: Pfizer, Lilly, Boehringer Ingelheim, Roche, Allergan|||Dr. Turner, Dan:|:|received consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Biogen, Neopharm, Uniliver, Atlantic Health, Shire, Celgene, Lilly, Roche|||Dr. Griffiths, Anne:|:|Consultant/advisory board member: Abbvie, Janssen, Lilly; Speaker fees: Abbvie, Janssen, Nestle; Research support (investigator initiated) Abbvie|||Dr. Terry, Natalie:|:|employee of Janssen Research and Development, LLC |||Dr. Padgett, Lakshmi:|:|employee of Janssen Research and Development, LLC |||Dr. Jacobstein, Douglass:|:|former employee of Janssen Research and Development, LLC; current employee of Provention Bio||Dr. O'Brien, Christopher:|:|employee of Janssen Research and Development, LLC |||Dr. Rosh, Joel:|:|Grant/Research Support: Abbvie, Janssen; Consultant/Advisory Boards: Abbvie, Janssen, Lilly, Pfizer

P656

Dr. Sakurai, Toshiharu: No conflict of intereset||Dr. Nezu, Riichiro: No conflict of intereset||Dr. Okada, Akiyoshi: No conflict of intereset||Dr. Komeda, Yoriaki: No conflict of intereset||Dr. Nagai, Tomoyuki: No conflict of intereset||Dr. Masaki, Sho: No conflict of intereset||Dr. Yamada, Mitsunari: No conflict of intereset||Dr. Takashima, Kota: No conflict of intereset||Dr. Kashida, Hiroshi: No conflict of intereset||Dr. Kudo, Masatoshi: No conflict of intereset

P657

Dr. Pillai, Nadia: No conflict of intereset||Prof. Dusheiko, Mark: No conflict of intereset||Dr. Maillard, Michel: No conflict of intereset||Prof. Michetti, Pierre: No conflict of intereset||Dr. Pittet, Valérie: No conflict of intereset

P658

Prof. Dr. Stein, Jürgen Michael:|:|J. Stein ahs received consulting fees or honoraria from: Abbvie, Dr. Schär, Falk, Ferring, Fresenius Kabi, Immundiagnostik, Janssen, Medice, MSD, Pfizerm Pharmacosmos, Shire, Shield, Takeda, ThermoFisher, Vifor Pharma. He is a board member for Abbvie, Dr. Schär, Ferring, Fresenius Kabi, Immundiagnostik, Janssen, MSD, NPS, Pharmacosmos, Shield, Takeda, Vifor Pharma.||Prof. Dr. Schiefke, Ingolf: No conflict of intereset||Göhring, Udo-Michael:|:|Udo-Michael Göhring is an employee of Vifor Pharma.||Fabien, Vincent:|:|Vincent Fabien is an employee of Vifor Pharma.||Prof. Dr. Rosano, Giuseppe: No conflict of intereset

P659

Mr. Roth, René: No conflict of intereset||Prof. Dr. Vavrick, Stephan: No conflict of intereset||Prof. Dr. Scharl, Michael: No conflict of intereset||Dr. Schreiner, Philipp: No conflict of intereset||Dr. Greuter, Thomas: No conflict of intereset||Dr. Zeitz, Jonas: No conflict of intereset||Dr. Safroneeva, Ekaterina: No conflict of intereset||Prof. Dr. Schoepfer, Alain: No conflict of intereset||Barry, Mamadou Pathé: No conflict of intereset||Prof. Dr. Rogler, Gerhard: No conflict of intereset||Dr. Biedermann, Luc: No conflict of intereset

Page 111 of 135

P660

Mrs. Slater, Jayne: No conflict of intereset||Dr. ALGIEDER, Akram: No conflict of intereset||Mrs. Jones, Judith: No conflict of intereset||Ms. Bates, Beth: No conflict of intereset||Dr. De Silva, Shanika: No conflict of intereset

P661

Dr. Aharoni Golan, Maya: No conflict of intereset||Dr. Ollech, Jacob: No conflict of intereset||Dr. Avni Biron, Irit: No conflict of intereset||Dr. Broitman, Yelena: No conflict of intereset||Dr. Snir, Yifat: No conflict of intereset||Dr. Banai Eran, Hagar: No conflict of intereset||Dr. Leibovitzh, Haim: No conflict of intereset||Dr. Goren, Idan: No conflict of intereset||Prof. Wasserberg, Nir: No conflict of intereset||Prof. Dotan, Iris: No conflict of intereset||Dr. Yanai, Henit: No conflict of intereset

P662 Dr. Yoshimura, Naoki: No conflict of intereset

P663

Dr. Rutka, Mariann: No conflict of intereset||Dr. Farkas, Klaudia: No conflict of intereset||Dr. Pigniczki, Daniella: No conflict of intereset||Dr. Szántó, Kata: No conflict of intereset||Dr. Anita, Bálint: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Prof. Nagy, Ferenc: No conflict of intereset||Prof. Molnár, Tamás: No conflict of intereset

P664

Dr. TRUYENS, Marie: No conflict of intereset||Dr. Geldof, Jeroen: No conflict of intereset||Ms. Dewitte, Goedele: No conflict of intereset||Mrs. Glorieus, Elien: No conflict of intereset||Dr. Varkas, Gaëlle: No conflict of intereset||Prof. Dr. Elewaut, Dirk: No conflict of intereset||Dr. Lobaton Ortega, Triana: No conflict of intereset

P665

Dr. Rayer, Cassandra: No conflict of intereset||Prof. Roblin, Xavier: No conflict of intereset||Prof. Laharie, David: No conflict of intereset||Dr. Caron, Benedicte: No conflict of intereset||Dr. Flamant, Mathurin: No conflict of intereset||Dr. Dewitte, Marie: No conflict of intereset||Prof. Fumery, Mathurin: No conflict of intereset||Dr. Viennot, Stephanie: No conflict of intereset||Prof. Bourreille, Arnaud: No conflict of intereset||Prof. Pariente, Benjamin: No conflict of intereset||Prof. Siproudhis, Laurent: No conflict of intereset||Prof. Peyrin-Biroulet, Laurent: No conflict of intereset||Dr. Bouguen, Guillaume: No conflict of intereset

P666

Dr. AlAskar, Dimah: No conflict of intereset||Dr. Mais , AlSardi: No conflict of intereset||Dr. Al Sulais, Eman: No conflict of intereset||Dr. Alameel, Turki:|:|Speaker's fees Abvvie, Takeda and Janssen. Advisory board Takeda and Janssen.

P667

Dr. Surowiecka-Pastewka, Agnieszka: No conflict of intereset||Dr. Łodyga , Michał: No conflict of intereset||Prof. Dr. Durlik, Marek: No conflict of intereset||Prof. Grażyna, Rydzewska: No conflict of intereset

P668

Dr. Barberio, Brigida: No conflict of intereset||Dr. Zingone, Fabiana: No conflict of intereset||Dr. D'Incà, Renata: No conflict of intereset||Dr. Marinelli, Carla: No conflict of intereset||Dr. Maccarone, Maria Chiara: No conflict of intereset||Dr. Gubbiotti, Alessandro: No conflict of intereset||Dr. Cingolani, Linda: No conflict of intereset||Dr. Lorenzon, Greta: No conflict of intereset||Dr. Ghisa, Matteo: No conflict of intereset||Prof. Savarino, Edoardo Vincenzo: No conflict of intereset

P669

Ms. Ramos Lopez, Laura: No conflict of intereset||Mr. Ramos Rodríguez, Javier: No conflict of intereset||Mrs. De La Barreda, Raquel: No conflict of intereset||Dr. Guitierrez, Fernando: No conflict of intereset||Ms. Nazco Casariego, Gloria Julia: No conflict of intereset||Dr. Alonso Abreu, Inmaculada: No conflict of intereset||Dr. Carrillo Palau, Marta: No conflict of intereset||Prof. Quintero, Enrique: No conflict of intereset

P670

Dr. Bąk-Drabik, Katarzyna: No conflict of intereset||Mrs. Duda-Wrońska, Justyna: No conflict of intereset||Mrs. Dąbrowska-Piechota, Dominika: No conflict of intereset||Mr. Adamczyk, Piotr: No conflict of intereset

P671

Dr. Madarame, Akira: No conflict of intereset||Dr. Kinoshita, Hiroto: No conflict of intereset||Dr. Yamaguchi , Tadashi: No conflict of intereset||Dr. Izumi, Yohei: No conflict of intereset||Dr. Nishikawa, Yurika: No conflict of intereset||Dr. Shonai, Shiori: No conflict of intereset||Dr. Tatsuno, Mizuki: No conflict of intereset||Dr. Ishii, Yoshito: No conflict of intereset||Dr. Yaguchi, Katsuki: No conflict of intereset||Dr. Nakamori, Yoshinori: No conflict of intereset||Dr. Ikeda, Aya: No conflict of intereset||Dr. Araki, Kentaro: No conflict of intereset||Dr. Hirayama, Atsuhiro: No conflict of intereset||Dr. Ogashiwa

P672

Dr. Walsh, Alissa Jane: No conflict of intereset||Dr. Matini, Lawrence: No conflict of intereset||Ms. Kantschuster, Ramona: No conflict of intereset||Mrs. Lepetyukh, Marianna: No conflict of intereset||Mr. Simadibrata, Daniel: No conflict of intereset||Prof. Collins, Gary: No conflict of intereset||Mrs. Wilson, Jean: No conflict of intereset||Mr. Hussain, Moheez: No conflict of intereset||Mr. Tarafdar, Adib: No conflict of intereset||Dr. Brain, Oliver: No conflict of intereset||Dr. Palmer, Rebecca: No conflict of intereset||Dr. Ambrose, Timothy: No conflict of intereset||Prof. Satsangi, Jack: No conflict of intereset||Prof. Travis, Simon P L: No conflict of intereset

Page 112 of 135

P673

Dr. AMANO, Takahiro: No conflict of intereset||Dr. Shinzaki, Shinichiro:|:|lecture fees from AbbVie and lecture fees and grant from Mitsubishi-Tanabe||Dr. Tashiro, Taku: No conflict of intereset||Dr. Otake, Yuriko: No conflict of intereset||Dr. Tani, Mizuki: No conflict of intereset||Dr. Yoshihara, Takeo: No conflict of intereset||Dr. Iwatani, Shuko: No conflict of intereset||Dr. Tsujii, Yoshiki: No conflict of intereset||Dr. Inoue, Takahiro: No conflict of intereset||Dr. Hayashi, Yoshito: No conflict of intereset||Dr. Iijima, Hideki:|:|lecture fees from AbbVie and Mitsubishi-Tanabe||Prof. Takehara, Tetsuo:|:|lecture fees and grant from Mitsubishi-Tanabe, AbbVie, and Eisai

P674

Dr. Diz Lois Palomares, Maria Teresa: No conflict of intereset||Ms. Porta Sánchez, Ángeles: No conflict of intereset||Ms. Elberdin Pazos, Laida: No conflict of intereset||Dr. González Conde, Benito: No conflict of intereset||Ms. Outeda Macías, María: No conflict of intereset||Dr. Vázquez Rey, María Teresa: No conflict of intereset||Dr. Guerrero Montañés, Alberto: No conflict of intereset||Dr. Estévez Prieto, Emilio: No conflict of intereset

P675

Bouhnik, Yoram: No conflict of intereset||Prof. Hebuterne, Xavier: No conflict of intereset||Mr. Raith, Mrad: No conflict of intereset||Prof. Amiot, Aurelien: No conflict of intereset||Dr. Tanasa Stefanescu, Carmen: No conflict of intereset||Prof. Laharie, David: No conflict of intereset||Prof. Roblin, Xavier: No conflict of intereset||Prof. Bourreille, Arnaud: No conflict of intereset||Prof. Nancey, Stephane: No conflict of intereset||Mr. Sabbah, Norman: No conflict of intereset||Prof. Peyrin Biroulet, Laurent: No conflict of intereset

P676

Farkas, Klaudia: No conflict of intereset||Dr. Szántó, Kata Judit: No conflict of intereset||Dr. Kata, Diána: No conflict of intereset||Dr. Földesi, Imre: No conflict of intereset||Mr. Ferenci, Tamás: No conflict of intereset||Dr. Rutka, Mariann: No conflict of intereset||Dr. Pigniczki, Daniella: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Prof. Dr. Nagy, Ferenc: No conflict of intereset||Prof. Dr. Molnár, Tamás: No conflict of intereset

P677

Dr. Keightley, Philip: No conflict of intereset||Dr. Prematunga, Rajivi: No conflict of intereset||Dr. Hoffmann, Peta: No conflict of intereset||Subramaniam, Kavitha: No conflict of intereset

P678

Dr. Coronel-Arismendi, María Belen: No conflict of intereset||Dr. Pujol Muncunill, Gemma: No conflict of intereset||Dr. Minguez-Rodríguez, Beatriz: No conflict of intereset||Dr. Feo-Ortego, Sara: No conflict of intereset||Dr. Guevara-Caviedes, Laura Nathalia: No conflict of intereset||Dr. Vila-Miravet, Victor: No conflict of intereset||Dr. Martin De Carpi, Francisco Javier: No conflict of intereset

P679

Mr. CERPA ARENCIBIA, Alberto: No conflict of intereset||Suarez Ferrer, Cristina: No conflict of intereset||Poza Cordón, Joaquín: No conflict of intereset||Martín Arranz, Eduardo: No conflict of intereset||Ramírez, Laura: No conflict of intereset||Martín Arranz, María Dolores: No conflict of intereset

P680 Dr. El-Hussuna, Alaa: No conflict of intereset

P681

Dr. Mañosa Ciria, Miriam: No conflict of intereset||Dr. Hinojosa, Esther: No conflict of intereset||Dr. Carbajo, Ana: No conflict of intereset||Dr. Castro, Jesús: No conflict of intereset||Dr. Manceñido, Noemí: No conflict of intereset||Dr. Calvo, Marta: No conflict of intereset||Dr. Núñez Alonso, Alejandro: No conflict of intereset||Dr. P Gisbert, Javier: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. Guardiola, Jordi: No conflict of intereset||Dr. Sainz, Empar: No conflict of intereset||Dr. Sánchez-Rodríguez, Eugenia: No conflict of intereset||Dr. Cañete, Fiorella: No conflict of intereset||Dr. Calafat, Margalida: No conflict of intereset||Domènech, Eugeni: No conflict of intereset

Page 113 of 135

P682

Yarur, Andres:|:|AY is a consultant to Arena Pharmaceuticals; medical writing assistance was funded by Arena Pharmaceuticals, Inc.||Chiorean, Michael:|:|MC received honoraria or consultation fees from AbbVie, Janssen, Takeda, Arena, UCB, Pfizer, Medtronic, and Prometheus. Medical writing support was funded by Arena Pharmaceuticals.||Zhang, Jinkun:|:|JZ is an employee of Arena Pharmaceuticals, Inc.||Reinisch, Walter:|:|WR has served: as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult; as a consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC; as an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpoint Medical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC; and has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnostik, MSD. Medical writing assistance was funded by Arena Pharmaceuticals, Inc.||Vermeire, Séverine:|:|SV discloses has received grants/research support from MSD, Abbvie, Takeda, Janssen, Pfizer; honoraria or consultation fees from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, Gilead and Janssen; and participated in company sponsored speaker’s bureaus for AbbVie MSD Takeda Ferring Hospira

P683

Dr. Flanagan, Emma: No conflict of intereset||GIbson, Peter R: No conflict of intereset||Ms. Rosella, Ourania: No conflict of intereset||Ms. Ross, Alyson: No conflict of intereset||Bell, Sally J: No conflict of intereset

Page 114 of 135

P684

P685

Howaldt, Stefanie: No conflict of intereset||Jacob, Ian:|:|Ian Jacob is an employee of Health Economics and Outcomes Research Ltd. and received funding from Norgine Ltd. to undertake the analysis outlined in this study.||Sampson, Mark:|:|Mark Sampson is an employee and stockholder at Shield Therapeutics PLC.||Akriche, Fatma:|:|Fatma Akriche is an employee of Norgine Ltd.

P686

Prof. Dr. Petrichuk, Svetlana Valentinovna: No conflict of intereset||Dr. Radygina , Тatiana: No conflict of intereset||Dr. Illarionov, Alexey: No conflict of intereset||Dr. Kuptsova, Darya: No conflict of intereset||Prof. Dr. Potapov, Alexsander: No conflict of intereset

Sands, Bruce E:|:|Grants: Theravance Biopharma|Personal fees: AbbVie, Allergan, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Capella BiosScence, Celltrion Healthcare, Eli Lilly, Genentech/F. Hoffmann-La Roche, Ironwood Pharmaceuticals, Janssen, Oppilan Pharma, Otsuka, Pfizer Inc, Progenity, Prometheus Laboratories, Salix, Shire, Takeda, TARGET PharmaSolutions, Theravance Biopharma, Vivelix|Non-financial support: Eli Lilly, Janssen, Pfizer Inc, Takeda, TARGET PharmaSolutions|Other: Honoraria for speaking in a CME programme: The Academy for Continued Healthcare Learning, Integritas Communications||Taub, Pam R:|:|Personal fees: Amgen, Amarin, Boehringer Ingelheim, Novo Nordisk, Pfizer Inc, Sanofi/Regeneron||Feagan, Brian G:|:|Grants: AbbVie, Amgen, AstraZeneca/MedImmune, Atlantic Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltech, Genentech/F. Hoffmann-La Roche, Gilead Sciences, GSK, Janssen Research & Development, Pfizer Inc, Receptos/Celgene, Sanofi, Santarus, Takeda Development Center Americas, Tillotts, UCB|Personal fees: Abbott/AbbVie, AdMIRx, Akebia Therapeutics, Allergan, Amgen, Applied Molecular Transport, Aptevo Therapeutics, Asta Pharma, AstraZeneca, Atlantic Pharma, Avaxia Biologics, Avir Pharma, Biogen, BioMx Israel, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Calypso Biotech, Celgene, Centocor, Elan/Biogen, Eli Lilly, EnGene, Everest Clinical Research, Ferring Pharmaceuticals, Galapagos, Galen/Atlantica, Genentech/F. Hoffmann-La Roche, GiCare Pharma, Gilead, Gossamer Pharma, GSK, Inception IBD, Intact Therapeutics, Janssen/Johnson & Johnson, Kyowa Kakko Kirin Co. Ltd., Lexicon, Lycera BioTech, Merck, Mesoblast Pharma, Millennium, Nestlé, Nextbiotix, Novo Nordisk, Novartis, ParImmune, Parvus Therapeutics, Pfizer Inc, Progenity, Prometheus Therapeutics and Diagnostics, Protagonist, Qu Biologics, Rebiotix, Receptos, Salix, Shire, Sienna Biologics, Sigmoid Pharma, Sterna Biologicals, Synergy, Takeda, Teva Pharmaceuticals, TiGenix, Tillotts, UCB, Vertex, Vivelix Pharmaceuticals, VHsquared, Zyngenia|Other: Senior Scientific Officer: Robarts Clinical Trials||Armuzzi, Alessandro:|:|Grants: MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Chiesi, Eli Lilly, Ferring, Hospira, Janssen, Mitsubishi-Tanabe, Mylan, MSD, Mundipharma, Nikkiso, Otsuka, Pfizer Inc, Roche, Samsung Bioepis, Sandoz, Sofar, Takeda, TiGenix, Zambon||Damião, Adérson OMC:|:|Personal fees: Takeda, Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Solano, Gastón:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kwok, Kenneth:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Woolcott, John:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc

Page 115 of 135

P687

D'Haens, Geert R.:|:|advisor for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill; Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor||Hibi, Toshifumi:|:|• Grants ：　Abbvie, EA Pharma, JIMRO, Otuska Holdings, and Zeria Pharmaceuticals|• Personal Fees|o Consulting : Aspen Japan K.K, Abbvie GK , Ferring,GileadSciences, Janssen, JIMRO, Kissei Pharmaceutical, Mitsubishi-TanabePharma,|Mochida Pharmaceutical, NipponKayaku Pfizer, Takeda Pharmaceutical,Zeria Pharmaceutical Advisory/consultancy fees from Abbvie, Bristol-Myaers Squibb, Celltrion, EA Pharma, Eli Lilly, Gilead Sciences, Janssen,Kyorin,Mitsubishi-TanabePharma.,Nichi-IkoPharmaceutical, Pfizer,Takeda Pharmaceutical, Zeria Pharmaceutical |o Support for travel for meetings to support study : Aspen Japan K.K,Ferring,Janssen, JIMRO,Mitsubishi-Tanabe Pharma,Takeda Pharmaceutical,Zeria Pharmaceutical,EA Pharma,Pfizer|||Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, Lilly, MSD, Pfizer, Sandoz, Takeda|Speakers fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Bhandari, Bal R.:|:|personal fees from Delta Research Partners||Berliba, Elina:|:|other - paid investigator||Tuttle, Jay L.:|:|current employee and shareholder of Eli Lilly and Company||Lissoos, Trevor:|:|current employee and shareholder of Eli Lilly and Company||Krueger, Kathryn:|:|current employee and shareholder of Eli Lilly and Company||Morris, Nathan:|:|current employee and shareholder of Eli Lilly and Company||Arora, Vipin:|:|current employee and shareholder of Eli Lilly and Company||Naegeli, April N.:|:|current employee and shareholder of Eli Lilly and Company||Feagan , Brian G.:|:|Grant/Research Support - AbbVie Inc., Amgen Inc., AstraZeneca/MedImmune Ltd., Atlantic Pharmaceuticals Ltd., Boehringer-Ingelheim, Celgene Corporation, Celltech, Genentech Inc/Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline (GSK), Janssen Research & Development LLC., Pfizer Inc., Receptos Inc. / Celgene International, Sanofi, Santarus Inc., Takeda Development Center Americas Inc., Tillotts Pharma AG, UCB| Consultant - Abbott/AbbVie, AdMIRx Inc., Akebia Therapeutics, Allergan, Amgen, Applied Molecular Transport Inc., Aptevo Therapeutics, Asta Pharma, Astra Zeneca, Atlantic Pharma, Avir Pharma, Biogen Idec, BioMx Israel, Boehringer-Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Calypso Biotech, Celgene, Elan/Biogen, EnGene, Everest Clinical Research Corp., Ferring Pharma, Roche/Genentech, Galapagos, Galen/Atlantica, GiCare Pharma, Gilead, Gossamer Pharma, GSK, Inception IBD Inc, Intact Therapeutics, JnJ/Janssen, Japan Tobacco Company, Kyowa Kakko Kirin Co Ltd., Lexicon, Lilly, Lycera BioTech, Merck, Mesoblast Pharma, Millennium, Nestles, Nextbiotix, Novonordisk, Pandion Therapeutics, ParImmune, Parvus Therapeutics Inc., Pfizer, Prometheus Therapeutics and Diagnostics, Progenity, Protagonist, Qu Biologics, Rebiotix, Receptos, Salix Pharma, Shire, Sienna Biologics, Sigmoid Pharma, Sterna Biologicals, Synergy Pharma Inc., Takeda, Teva Pharma, TiGenix, Tillotts, UCB Pharma, Vertex Pharma, Vivelix Pharma, VHsquared Ltd., Zyngenia|Speakers Bureau - Abbott/AbbVie, JnJ/Janssen, Lilly, Takeda, Tillotts, UCB Pharma|Member, Scientific Advisory Board - Abbott/AbbVie, Allergan, Amgen, Astra Zeneca, Atlantic Pharma, Avaxia Biologics Inc., Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Centocor Inc., Elan/Biogen, Galapagos, Genentech/Roche, JnJ/Janssen, Merck, Nestles, Novartis, Novonordisk, Pfizer, Prometheus Laboratories, Protagonist, Salix Pharma, Sterna Biologicals, Takeda, Teva, TiGenix, Tillotts Pharma AG, UCB Pharma|Member, Board of Directors - Senior Scientific Officer – Robarts Clinical Trials Inc, London

Page 116 of 135

P688

Johansson, Tony:|:|TJ is an employee of MSD and holds stock/stock options in the company||Weinstein, Cindy:|:|CW is an employee of Merck & Co., Inc. and holds stock/stock options in the company.||Dr. MEEHAN, Alan:|:|AM is an employee of Merck & Co., Inc. and holds stock/stock options in the company.||Tzontcheva, Anjela:|:|AT is an employee of Merck & Co., Inc. and may hold stock/stock options in the company.||Xu, Ping:|:|PX is an employee of Merck & Co., Inc. and may own stock/stock options in the company.||Marano, Colleen:|:|CM is an employee of Janssen Research & Development, LLC and may hold stock/stock options in the company.||de Hertogh, Gert:|:|GDH collaborates with Merck & Co., Inc. and Janssen Research on the golimumab study.

P689

Prof. Dr. Maaser, Christian: No conflict of intereset||Prof. Dr. Helwig, Ulf:|:|U. Helwig has received lecture and consulting fees from AbbVie.||Dr. Fischer, Imma:|:|I. Fischer has received consulting fees from AbbVie. ||Mr. Rath, Stefan:|:|S. Rath is AbbVie employee, and may own AbbVie stock or options.||Dr. Kolterer, Stefanie:|:|. S. Kolterer is AbbVie employee, and may own AbbVie stock or options. ||Prof. Dr. Kucharzik, Torsten:|:|T. Kucharzik has received lecture and consulting fees from AbbVie.

P690

Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as an advisory board member and/or received lecture grants from AbbVie, Biogen, MSD, and Takeda Pharmaceuticals||Dr. Ventimiglia, Marco: No conflict of intereset||Prof. Fries, Walter: No conflict of intereset||Dr. Viola, Anna: No conflict of intereset||Dr. Cappello, Maria:|:|Maria Cappello served as an advisory board member for AbbVie, MSD, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Chiesi, and Takeda Pharmaceuticals||Dr. Scrivo, Barbara: No conflict of intereset||Dr. Magnano, Antonio: No conflict of intereset||Dr. Pluchino, Dario: No conflict of intereset||Dr. Camilleri, Salvatore: No conflict of intereset||Dr. Garufi, Serena: No conflict of intereset||Dr. Di Mitri, Roberto: No conflict of intereset||Dr. Mocciaro, Filippo:|:|Filippo Mocciaro served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, MSD and Takeda Pharmaceuticals||Dr. Magrì, Giovanni: No conflict of intereset||Dr. Ferracane, Concetta: No conflict of intereset||Dr. Citrano, Michele: No conflict of intereset||Dr. Graziano, Francesco: No conflict of intereset||Dr. Bertolami, Carmelo: No conflict of intereset||Dr. Renna, Sara:|:|Sara Renna served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, MSD and Takeda Pharmaceuticals ||Dr. Orlando, Rosalba: No conflict of intereset||Dr. Rizzuto, Giulia: No conflict of intereset||Prof. Cottone, Mario: No conflict of intereset||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals.

P691

Prof. Kim, Duk Hwan: No conflict of intereset||Prof. Park, Dong Il: No conflict of intereset||Prof. Kobayashi, Taku: No conflict of intereset||Prof. Ahuja, Vineet: No conflict of intereset||Prof. Jang, Byung Ik: No conflict of intereset||Prof. Cao, Qian: No conflict of intereset||Prof. Lee, Yoo Jin: No conflict of intereset||Prof. Ran, Zhihua: No conflict of intereset

P692

Dr. RAMAN, Maitreyi: No conflict of intereset||Dr. Taylor, Lorian: No conflict of intereset||Dr. Schick, Alana: No conflict of intereset||Dr. Ohland, Christine: No conflict of intereset||Dr. McCoy, Kathy: No conflict of intereset||Ms. Kaur, Sandeep: No conflict of intereset||Dr. Panaccione, Remo: No conflict of intereset||Dr. Reimer, Raylene: No conflict of intereset

P693

Mr. Noguier, Guillaume: No conflict of intereset||Mr. Montaillier, Christophe: No conflict of intereset||Mr. Daviere, Simon: No conflict of intereset||Mr. Colombeau, Lilian: No conflict of intereset||Mr. Parussini, Ermis: No conflict of intereset

P694

Mr. Berghmans, Raf:|:|Employee of apDia||Mr. Naudts, Jürgen:|:|Employee of apDia||Mrs. Ferkinghoff, Bianca:|:|Employee of R-Biopharm||Mrs. Gören, Hannah:|:|Employee of R-Biopharm||Ms. Henke, Marie-Luise:|:|Employee of R-Biopharm||Dr. Lennerz, Andrea:|:|Employee of R-Biopharm||Dr. Van Stappen, Thomas:|:|Employee of R-Biopharm

P695

Dr. Gutiérrez Casbas, Ana: No conflict of intereset||Dr. Sempere Robles, Laura: No conflict of intereset||Mrs. Muñoz Pérez, Roser: No conflict of intereset||Mr. Rodríguez Angulo, Andrés: No conflict of intereset||Mrs. Climent, Seira: No conflict of intereset||Mr. Cameo Lorenzo, Jose Ignacio: No conflict of intereset||Mr. Díaz, Marcos: No conflict of intereset||Mrs. Boada, Pepa: No conflict of intereset||Dr. Más-Serrano, Patricio: No conflict of intereset

P696

Ms. KUBOTA (KAJIWARA), Mariko: No conflict of intereset||Mr. Uchiyama, Kazuhiko: No conflict of intereset||Ms. Azuma, Yuka: No conflict of intereset||Mr. Yasuda, Ritsu: No conflict of intereset||Mr. Takayama, Syun: No conflict of intereset||Mr. Takagi, Tomohisa: No conflict of intereset||Mr. Naitoh, Yuji: No conflict of intereset

P697

Dr. Kakkadasam Ramaswamy, Pradeep: No conflict of intereset||Dr. Moattar, Hadi: No conflict of intereset||Ms. Sawyer, Elise: No conflict of intereset||Dr. Edwards, John: No conflict of intereset||Dr. Shukla, Dheeraj: No conflict of intereset

Page 117 of 135

P698

Dr. Bezzio, Cristina: No conflict of intereset||Dr. Andreozzi, Paolo: No conflict of intereset||Dr. Schettino, Mario: No conflict of intereset||Dr. Arena, Ilaria: No conflict of intereset||Dr. Della Corte, Cristina: No conflict of intereset||Dr. Devani, Massimo: No conflict of intereset||Dr. Manes, Gianpiero: No conflict of intereset||Dr. Omazzi, Barbara: No conflict of intereset||Dr. Saibeni, Simone: No conflict of intereset

P699

Dubinsky, Marla C:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Bushmakin, Andrew G:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Cappelleri, Joseph C:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Woolcott, John:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Sharma, Puza:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Maller, Eric:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Armuzzi, Alessandro:|:|Grants: MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Chiesi, Eli Lilly, Ferring, Hospira, Janssen, Mitsubishi-Tanabe, Mylan, MSD, Mundipharma, Nikkiso, Otsuka, Pfizer Inc, Roche, Samsung Bioepis, Sandoz, Sofar, Takeda, TiGenix, Zambon

P700

Dr. Guzman, Yuli: No conflict of intereset||Mr. Samson, Ondrej: No conflict of intereset||Dr. Segal, Jonathan P.: No conflict of intereset||Dr. Limdi, Jimmy K.: No conflict of intereset||Dr. Hayee, Bu': No conflict of intereset

P701

Ms. Tetley, Alice M: No conflict of intereset||Dr. Lobaton, Triana: No conflict of intereset||Dr. Truyens, Marie: No conflict of intereset||Prof. Katsanos, Konstantinos H: No conflict of intereset||Dr. de Boer, K.h.n: No conflict of intereset||Ms. Pattinson, Alison: No conflict of intereset||Dr. Molnar, Tamas: No conflict of intereset||Dr. Filip, Rafal: No conflict of intereset||Dr. Michalopoulos, Georgios: No conflict of intereset||Prof. Sebastian, Shaji: No conflict of intereset

P702

Ms. Waars, Sanne: No conflict of intereset||Ms. Asscher, Vera: No conflict of intereset||Dr. Pieterse, Arwen: No conflict of intereset||Dr. van der Meulen-de Jong, Andrea:|:|Dr. van der Meulen - de Jong has served on advisory boards, or as speaker or consultant for Takeda, Tramedico, AbbVie, and has received grants from Takeda.||Dr. Mooijaart, Simon: No conflict of intereset||Dr. Maljaars, Jeroen:|:|Dr. Maljaars has served as a speaker and an advisory board member for Abbvie, Takeda and Janssen-Cilag.

P703

Prof. Paul, stephane:|:|Theradiag||Dr. Williet, nicolas: No conflict of intereset||Prof. Nancey, stephane:|:|MSD, Abbvie, Janssen, Takeda||Dr. Veyrard, Pauline: No conflict of intereset||Prof. Boschetti, gilles: No conflict of intereset||Dr. Berger, anne emmanuelle: No conflict of intereset||Prof. Flourie, bernard: No conflict of intereset||Prof. Peyrin Biroulet, Laurent: No conflict of intereset||Prof. Dr. Roblin, Xavier:|:|MSD, Abbvie, Theradiag

P704

Liatsos, Christos: No conflict of intereset||Dr. Papaefthymiou, Apostolis: No conflict of intereset||Dr. Kyriakos, Nikolaos: No conflict of intereset||Dr. Giakoumis, Marios: No conflict of intereset||Dr. Tzouvala, Maria: No conflict of intereset||Dr. Doulberis, Michael: No conflict of intereset||Prof. Mavrogiannis, Christos: No conflict of intereset||Prof. Dr. Kountouras, Jannis: No conflict of intereset

P705Dr. Crooks, Benjamin: No conflict of intereset||Prof. McLaughlin, John: No conflict of intereset||Prof. Limdi, Jimmy K: No conflict of intereset

P706

Dr. Swaine, Adrian: No conflict of intereset||Dr. Reynolds, Rebecca: No conflict of intereset||Dr. Roblin, Xavier: No conflict of intereset||Dr. Gibson, David: No conflict of intereset||Dr. Martin, Catherine: No conflict of intereset||Dr. Irving, Peter: No conflict of intereset||Prof. Sparrow, Miles: No conflict of intereset||Dr. Ward, Mark: No conflict of intereset

P707

Dr. Filip, Rafal: No conflict of intereset||Mrs. Jarmakiewicz - Czaja, Sara: No conflict of intereset||Dr. Piątek, Dominika: No conflict of intereset||Mrs. Sztembis, Joanna: No conflict of intereset||Mrs. Pękala, Anna: No conflict of intereset

P708

Mrs. Paulides, Emma: No conflict of intereset||Ms. Boukema, Inge: No conflict of intereset||Prof. Dr. van der Woude, Christien Janneke: No conflict of intereset||Dr. de Boer, Nanne K H: No conflict of intereset

P709

Dr. Martínez Ibeas, María Angeles: No conflict of intereset||Dr. Bacelo Ruano, Irene: No conflict of intereset||Dr. Rodríguez Manchón, Silvia: No conflict of intereset||Velasco Rodríguez-Belvís, Marta: No conflict of intereset||Dr. Viada Bris, Javier Francisco: No conflict of intereset||Dr. Domínguez Ortega, Gloria: No conflict of intereset||Dr. Muñoz Codoceo, Rosa Ana: No conflict of intereset

Page 118 of 135

P710

Dr. YASUDA, Ritsu: No conflict of intereset||Dr. Uchiyama, Kazuhiko: No conflict of intereset||Dr. Takagi, Tomohisa: No conflict of intereset||Dr. Kubota, Mariko: No conflict of intereset||Dr. Sugino, Satoshi: No conflict of intereset||Dr. Azuma, Yuka: No conflict of intereset||Dr. Kitae, Hiroaki: No conflict of intereset||Dr. Torii, Takashi: No conflict of intereset||Dr. Takayama, Shun: No conflict of intereset||Dr. Inoue, Ken: No conflict of intereset||Dr. Katada, Kazuhiro: No conflict of intereset||Dr. Kamada, Kazuhiro: No conflict of intereset||Dr. Ishikawa, Takeshi: No conflict of intereset||Dr. Konishi, Hideyuki: No conflict of intereset||Dr. Naito, Yuji: No conflict of intereset||Dr. Itoh, Yoshito: No conflict of intereset

P711

Guardiola Capón, Jordi: No conflict of intereset||Ms. SERRA, Katja: No conflict of intereset||Ms. Rodríguez-Alonso, Lorena: No conflict of intereset||Santacana, Eugenia: No conflict of intereset||Padró, Ariadna: No conflict of intereset||Dr. Padullés, Núria: No conflict of intereset||Ruiz-Cerulla, Alexandra: No conflict of intereset||Arajol, Clàudia: No conflict of intereset||Camps, Blau: No conflict of intereset||Surís, Gerard: No conflict of intereset||Orobitg, Judit: No conflict of intereset||Dr. Rodríguez-Moranta, Francisco: No conflict of intereset

P712

Dr. Li, Katherine:|:|Salaried employee for Janssen||Dr. Yang, Feifei:|:|Salaried employee for Janssen||Dr. Marano, Colleen:|:|Salaried employee for Janssen||Dr. Zhang, Hongyan:|:|Salaried employee for Janssen||Dr. Sandborn, William J.:|:|Investigator and Advisor for Janssen||Dr. Sands, Bruce E.:|:|Investigator and Advisor for Janssen||Dr. Feagan, Brian G.:|:|Investigator and Advisor for Janssen||Dr. Rubin, David T.:|:|Investigator and Advisor for Janssen||Dr. Peyrin-Biroulet, Laurent:|:|Investigator and Advisor for Janssen||Dr. Friendman, Joshua R.:|:|Salaried employee for Janssen||Dr. De Hertogh, Gert:|:|Investigator and Advisor for Janssen

P713

Dr. Parkes, Gareth:|:|GP: Personal payments/honoraria/fees: AbbVie, Allergan, Ferring, Janssen, Napp, Takeda, Tillotts; Travel grant or fellowship - AbbVie, Janssen, Takeda, Tillotts; Is a Director and Shareholder in Ampersand Health|||Dr. Akbar, Ayesha:|:|AA: Speaker fees/advisory board fees - Janssen and Dr Falk; Speaker fees - Kyowo Kirin, Abbvie, Biogen, Almirall|||Dr. Beales, Ian: No conflict of intereset||Dr. Buckley, Martin: No conflict of intereset||Dr. Creed, Tom:|:|TC: Advisory board fee - Takeda||Dr. Din, Said: No conflict of intereset||Mrs. Fraser, Aileen:|:|AF: Fees from Abbvie, Actavis, Allergan, Dr Falk, Ferring, Janssen, Pharmacosmos, Shield, Takeda, Tillots||Dr. Plevris, Nikolas:|:|NP: Consultancy fees from Takeda and speaker fees and travel support from AbbVie, Takeda, Norgine and Janssen.||Dr. Meadowcroft, Simon:|:|SM: Employee of Takeda UK Ltd||Dr. Owen, Glynn:|:|GO: Employee of Takeda UK Ltd||Ms. Heggs, Nicola:|:|NH: Employee of Takeda UK Ltd

P714

Mr. ERIKSSON, Carl: No conflict of intereset||Dr. Rundquist, Sara: No conflict of intereset||Dr. Lykiardopoulos, Vyron: No conflict of intereset||Ms. Udumyan, Ruzan: No conflict of intereset||Dr. Karlén, Per:|:|Lecture fee(s): AbbVie, Takeda and Otsuka / Consultancy: AbbVie, MSD, Takeda, Otsuka|||Dr. Grip, Olof:|:|has received consulting fees from AbbVie, Ferring, Janssen, Pfizer, Takeda and Vifor Pharma||Dr. Söderman, Charlotte.:|:|has received consultant fees from Janssen and Takeda.||Dr. Almer, Sven:|:|research grants from AbbVie and consultancy fees from Takeda, Janssen and Hospira||Dr. Hertervig, Erik:|:|has received consultant fees from Abbvie, MSD, Janssen and Takeda||Dr. Gunnarsson, Jenny: No conflict of intereset||Ms. Malmgren, Carolina:|:|works as a medical advisor at Takeda, Sweden||Dr. Delin, Jenny: No conflict of intereset||Dr. Strid, Hans:|:|has received lecture fee and has been an advisory board member for Takeda||Dr. Sjöberg, Mats: No conflict of intereset||Dr. Öberg, David: No conflict of intereset||Dr. Bergemalm, Daniel:|:|Has received speakers fee from Pfizer and Ferring||Dr. Hjortswang, Henrik:|:|Hjortswang, H. Financial support for research: AbbVie, Ferring, and Tillotts Pharma / Lecture fee(s): AbbVie, Falk pharma, Takeda, and Tillotts Pharma Consultancy: AbbVie, Fresenius Kabi, Hospira, Janssen, Phizer, Takeda, and Vifor Pharma||Dr. Halfvarson, Jonas:|:|JH has served as speaker and/or advisory board member for AbbVie, Celgene, Celltrion, Ferring, Hospira, Janssen, MEDA, Medivir, MSD, Olink Proteomics, Pfizer, Prometheus Laboratories, Sandoz/Novartis, Shire, Takeda, Thermo Fisher Scientific, Tillotts Pharma, Vifor Pharma, and UCB. He also has received grant support from Janssen, MSD, and Takeda.

P715

Pettersson, Nina: No conflict of intereset||Dr. Kragsbjerg, Fredrik: No conflict of intereset||Dr. Hamrin, Arvid: No conflict of intereset||Prof. Dr. Forsblad-D´elia, Helena: No conflict of intereset||Dr. Karling, Pontus: No conflict of intereset

P716

Dr. Shin, Jongbeom: No conflict of intereset||Dr. Seong, Gyeol: No conflict of intereset||Dr. Song, Joo Hye: No conflict of intereset||Dr. Kong, Sung Min: No conflict of intereset||Prof. Dr. Kim, Tea Jun: No conflict of intereset||Prof. Dr. Kim, Ean Ran: No conflict of intereset||Prof. Dr. Hong, Sung Noh: No conflict of intereset||Prof. Dr. Chang, Dong Kyung: No conflict of intereset||Prof. Dr. Kim, Young-ho: No conflict of intereset

Page 119 of 135

P717

Dr. Viola, Anna: No conflict of intereset||Dr. Fiocco, Gabriele: No conflict of intereset||Alibrandi, Angela: No conflict of intereset||Dr. Macaluso, Fabio Salvatore: No conflict of intereset||Cappello, Maria: No conflict of intereset||Dr. Privitera, Antonio Carlo: No conflict of intereset||Dr. Magrì, Giovanni: No conflict of intereset||Dr. Garufi, Serena: No conflict of intereset||Dr. Centritto, Andrea: No conflict of intereset||Dr. Ventimiglia, Marco: No conflict of intereset||Dr. Giuffrida, Enrica: No conflict of intereset||Dr. Ferracane, Concetta: No conflict of intereset||Dr. Costantino, Giuseppe: No conflict of intereset||Dr. Renna, Sara: No conflict of intereset||Dr. Orlando, Ambrogio: No conflict of intereset||Prof. Fries, Walter: No conflict of intereset

P718

Dr. Matar, Manar: No conflict of intereset||Prof. Dr. Shamir, Raanan:|:|Research grants: Abbvie||Prof. Dr. Turner, Dan:|:|Consultation fees, research grants, royalties or honorarium from Janssen, Pfizer, Ferring, Abbvie, Takeda, Biogen, Neopharm, Uniliver, Atlantic Health, Shire, Celgene, Lilly, Roche. ||Prof. Dr. Broide, Efrat: No conflict of intereset||Dr. Weiss, Batia:|:|Consultation fees from Janssen, lectures fees from Abbvie||Dr. Ledder, Oren: No conflict of intereset||Dr. Guz-Mark, Anat: No conflict of intereset||Dr. Rinawi, Firas: No conflict of intereset||Dr. Cohen, Shlomi: No conflict of intereset||Dr. Topf Olivestone, Chani: No conflict of intereset||Prof. Dr. Shaul, Ron:|:|Consultation and lecture fees from Abbvie and Janssen, research grant from Janssen||Prof. Dr. Ben-Horin, Shomron:|:|Consultancy fees and/or research support from Janssen, Abbvie, Celltrion, Takeda, Pfizer and GSK||Prof. Dr. Assa, Amit:|:|Lectures and consult fee: Abbvie|Rerearch grants: Abbvie, Janssen

P719

Amiot, Aurelien: No conflict of intereset||Vered, Abitbol: No conflict of intereset||Filippi, Jerome: No conflict of intereset||Cadiot, Guillaume: No conflict of intereset||Laharie, David: No conflict of intereset||Melanie, Serrero: No conflict of intereset||Altwegg, Romain: No conflict of intereset||Bouhnik, Yoram: No conflict of intereset||Peyrin-biroulet, Laurent: No conflict of intereset||Gilletta, Cyrielle: No conflict of intereset||Roblin, Xavier: No conflict of intereset||Pineton de chambrun , Guillaume: No conflict of intereset||Vuitton, Lucine: No conflict of intereset||Bourrier, Anne: No conflict of intereset||Nancey, Stéphane: No conflict of intereset||Gornet, Jean-marc: No conflict of intereset||Nahon, Stephane: No conflict of intereset||Bouguen, Guillaume: No conflict of intereset||Viennot, Stephanie: No conflict of intereset||Benjamin, Pariente: No conflict of intereset||Dr. Fumery, Mathurin: No conflict of intereset

P720

Frontali, Alice: No conflict of intereset||Dr. Rottoli, Matteo: No conflict of intereset||Dr. Chierici, Andrea: No conflict of intereset||Prof. Poggioli, Gilberto: No conflict of intereset||Prof. Dr. Panis, Yves: No conflict of intereset

P721

Dr. O'Connell, Jim: No conflict of intereset||Dr. Corcoran, Roisin: No conflict of intereset||Ms. Argue, Ruth: No conflict of intereset||Dr. McDonagh, Padraic: No conflict of intereset||Ismail, M Syafiq: No conflict of intereset||Cullen, Garret: No conflict of intereset||Dr. Doherty, Glen: No conflict of intereset||Dr. Hartery, Karen: No conflict of intereset||Dr. Healy, Martin: No conflict of intereset||McCormack, Margaret: No conflict of intereset||Dr. MacCarthy, Finbar: No conflict of intereset||Prof. McKiernan, Susan: No conflict of intereset||O'Connor, Anthony: No conflict of intereset||Dr. McNamara, Deirdre: No conflict of intereset||Ryan, Barbara: No conflict of intereset||Dr. Kevans, David: No conflict of intereset

P722

Prof. Dr. D'Haens, Geert:|:|Received consulting and/or lecture fees from AbbVie, ActoGeniX, AIM, Boehringer Ingelheim GmbH, Centocor, ChemoCentryx, Cosmo Technologies, Elan Pharmaceuticals, enGene, Dr Falk Pharma, Ferring, Galapagos, Giuliani SpA, Given Imaging, GlaxoSmithKline, Janssen Biologics, MSD, Neovacs, NovoNordisk, Otsuka, PDL BioPharma, Pfizer, Receptos, Salix, SetPoint, Shire Pharmaceuticals, Schering-Plough, Takeda, Tillotts Pharma, UCB Pharma, Versant, and Vifor Pharma; research grants from AbbVie, Janssen, Given Imaging, MSD, Dr Falk Pharma, and PhotoPill; and speaking honoraria from AbbVie, Tillotts, Tramedico, Ferring, MSD, UCB Pharma, Norgine, and Shire.||Dr. Hebuterne, Xavier:|:|Received financial support for research from AbbVie, Abivax, Alfasigma, Celgene, Gilead, Eli Lilly, Enterome, Janssen, InDex Pharmaceuticals, Pfizer, Roche, Salix, Takeda, and Theravance; advisory boards: AbbVie, Abivax, Arkopharma, Astellas, Janssen, Nutricia, Pfizer, and Takeda; and lecture fees from AbbVie, ARARD, Arkopharma, Baxter, Bristol-Myers Squibb, Ferring Pharmaceuticals, Janssen, MSD, Nutricia, Pfizer, Sanofi-Aventis, Takeda, and Tillotts.||Dr. Higgins, Peter D.R.:|:|Received consulting fees from AbbVie, Takeda, Pfizer, Genentech, and Amgen.||Dr. Loftus, Jr., Edward V.:|:|Received consulting fees from AbbVie, UCB, Janssen, Takeda, Eli Lilly, Pfizer, Amgen, Celgene, Celltrion Healthcare, Allergan, Bristol-Myers Squibb, Gilead, and Genentech; and research support from AbbVie, UCB, Genentech, Janssen, Amgen, Pfizer, Takeda, Robarts Clinical Trials, Gilead, Receptos, and Celgene.||Dr. Zhou, Wen:|:|AbbVie employee and may own AbbVie stock and/or options.

Page 120 of 135

P723

Dr. Samaan, Mark:|:|Served as a speaker, a consultant and/or an advisory board member for Janssen, Takeda, MSD, Falk, Sandoz||Dr. Cunningham, Georgina: No conflict of intereset||Dr. Tamilarasan, Gokul: No conflict of intereset||Mrs. Rawstron, Krystal: No conflict of intereset||Mr. Hawash, Karim: No conflict of intereset||Mrs. Beltran, Luisa: No conflict of intereset||Dr. Ray, Shuvra: No conflict of intereset||Dr. Mawdsley, Joel: No conflict of intereset||Dr. Anderson, Simon: No conflict of intereset||Prof. Dr. Sanderson, Jeremy: No conflict of intereset||Ms. Arkir, Zehra: No conflict of intereset||Dr. Irving, Peter:|:|Served as a speaker, a consultant and/or an advisory board member for Abbvie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, and has received research funding from MSD, Takeda

P724

Ungar, Bella:|:|BU has received research grants / lectures fees from Janssen, Takeda, Abbvie and Neopharm. ||Mr. Ben-Shatach, Zohar: No conflict of intereset||Dr. Ziv-Baran, Tomer: No conflict of intereset||Dr. Fudim, Ella: No conflict of intereset||Ms. Yavzori, Miri: No conflict of intereset||Dr. Picard, Orit: No conflict of intereset||Dr. Selinger, Limor: No conflict of intereset||Dr. Weiss, Batia: No conflict of intereset||Prof. Dr. Kopylov, Uri:|:|UK received research support from Jannsen, Takeda, and Medtronic and Lecture/advisory fees from Abbvie, Jannsen, Takeda, MSD and Medtronic||Prof. Dr. Eliakim, Rami:|:|RE received consultant and speaker fees from Jannsen Abbvie Medtronic and Takeda||Prof. Dr. Ben-Horin, Shomron:|:|SBH received consulting and advisory board fees and/or research support from AbbVie, MSD, Janssen, Takeda and CellTrion. All other authors have nothing to declare.

P725

Dr. CHOPRA, Deepti: No conflict of intereset||Dr. Kennedy, Erin: No conflict of intereset||Dr. Weizman, Adam V: No conflict of intereset||Ms. Tennakoon, Aruni: No conflict of intereset||Dr. Targownik, Laura E: No conflict of intereset

P726

Dr. Bokemeyer, Bernd:||Disclosures: PD Dr. B. Bokemeyer|Consulting Fee:|Abbvie, MSD, Shire, Ferring, UCB, Hospira,|Takeda, Movetis, Shield Therapeutics, Pfizer,|Biogen, Janssen, Hexal, Cellgene, Boehringer,|Allergan, Celltrion||Speaking and Teaching:|Abbvie, Ferring, MSD, Merckle, Falk, HLR,|UCB, Shield Therapeutics, Pfizer, Celltrion,|Takeda, Janssen, Mundipharma||Grant/Research:|Abbvie, Ferring, UCB, Given Imaging, Janssen,|Takeda, Pfizer||Dr. Plachta-Danielzik, Sandra: No conflict of intereset||Dr. Sobotzki, Christina: No conflict of intereset||Dr. Mohl, Wolfgang: No conflict of intereset||Dr. Hoffstadt, Martin: No conflict of intereset||Dr. Krause, Thomas: No conflict of intereset||Prof. Dr. Atreya, Raja: No conflict of intereset||Dr. von der Ohe, Manfred: No conflict of intereset||Dr. Graefe, Ulrich: No conflict of intereset||Dr. Trentmann, Leo: No conflict of intereset||Dr. Eisold, Marc: No conflict of intereset||Dr. Linde, Astrid: No conflict of intereset||Mrs. Franzenburg, Sina: No conflict of intereset||Mrs. Moser, Maren: No conflict of intereset||Mrs. Hartmann, Petra: No conflict of intereset||Prof. Dr. Schreiber, Stefan: No conflict of intereset

P727

Dr. Gómez, Estanislao Jesús: No conflict of intereset||Gonzalez, Raquel Analia: No conflict of intereset||Dr. Pereyra, Lisandro: No conflict of intereset||Dr. Mella, José M: No conflict of intereset||Dr. Panigadi, Guillermo N: No conflict of intereset||Dr. Fischer, Carolina: No conflict of intereset||Dr. Roel, Mariela: No conflict of intereset||Dr. Cimmino, Daniel G.: No conflict of intereset||Dr. Pedreira, Silvia: No conflict of intereset||Dr. Boerr, Luis Alberto: No conflict of intereset

P728

Dr. Malandris, Konstantinos: No conflict of intereset||Dr. Paschos, Paschalis: No conflict of intereset||Dr. Koukoufiki, Argyro: No conflict of intereset||Dr. Katsoula, Anastasia: No conflict of intereset||Dr. Manolopoulos, Apostolos: No conflict of intereset||Prof. Tsapas, Apostolos: No conflict of intereset||Dr. Bekiari, Eleni: No conflict of intereset

P729

Dr. Axelrad, Jordan: No conflict of intereset||Dr. Colombel, Jean-Frederic: No conflict of intereset||Dr. Scherl, Ellen: No conflict of intereset||Dr. Lukin, Dana: No conflict of intereset||Dr. Chang, Shannon: No conflict of intereset||Dr. Chen, LeaAnn: No conflict of intereset||Dr. Kwah, Joann: No conflict of intereset||Dr. Swaminath, Arun: No conflict of intereset||Dr. Sultan, Keith: No conflict of intereset||Dr. Lawlor, Garrett: No conflict of intereset||Mrs. Villagra, Cristina: No conflict of intereset||Dr. Galanko, Joseph: No conflict of intereset||Ms. Sharpless, Virginia: No conflict of intereset||Dr. Itzkowitz, Steven: No conflict of intereset

Page 121 of 135

P730

Dr. TILMANT, Marion: No conflict of intereset||Dr. serrero, melanie: No conflict of intereset||Dr. Poullenot, Florian: No conflict of intereset||Prof. Bouguen, Guillaume: No conflict of intereset||Dr. Pariente, Benjamin: No conflict of intereset||Dr. Altwegg, Romain: No conflict of intereset||Dr. Basile, Paul: No conflict of intereset||Dr. Filippi, Jerome: No conflict of intereset||Dr. Vanelslander, Pierre: No conflict of intereset||Dr. Buisson, Anthony: No conflict of intereset||Dr. Vuitton, Lucine: No conflict of intereset||Dr. Desjeux, Ariane: No conflict of intereset||Prof. Laharie, David: No conflict of intereset||Dr. Le Balch, Eric: No conflict of intereset||Dr. Nachury, Maria: No conflict of intereset||Mrs. Boivineau, Lucile: No conflict of intereset||Prof. Savoye, Guillaume: No conflict of intereset||Dr. Hebuterne, Xavier: No conflict of intereset||Dr. Poincloux, Laurent: No conflict of intereset||Mr. Lamrani, Adnane: No conflict of intereset||Prof. Fumery, Mathurin: No conflict of intereset

P731

Dr. Alexakis, Christopher: No conflict of intereset||Mrs. Robinson, Jenna: No conflict of intereset||Mrs. Yeates, Rebecca: No conflict of intereset||Mrs. Ho-Yen, Nicola: No conflict of intereset||Dr. Mathew, Sanju: No conflict of intereset||Dr. Gallagher, Michelle: No conflict of intereset||Dr. Banks, Charmian: No conflict of intereset||Dr. Alexandropoulou, Kalliopi: No conflict of intereset

P732

Dr. MATSUNO, Yuichi: No conflict of intereset||Dr. Hirano, Atsushi: No conflict of intereset||Dr. Torisu, Takehiro: No conflict of intereset||Dr. Fuyuno, Yuta: No conflict of intereset||Dr. Okamoto, Yasuharu: No conflict of intereset||Dr. Shin, Fujioka: No conflict of intereset||Dr. Tomohiko, Moriyama: No conflict of intereset||Dr. Umeno, Junji: No conflict of intereset||Dr. Hirakawa, Yoichiro: No conflict of intereset||Dr. Esaki, Motohiro: No conflict of intereset||Prof. Dr. Kitazono, Takanari: No conflict of intereset

P733

Prof. Dr. Yuksel, Ilhami: No conflict of intereset||Dr. Kilincalp, Serta: No conflict of intereset||Dr. Coskun, Yusuf: No conflict of intereset||Dr. Akinci, Hakan: No conflict of intereset||Dr. Hamamci, Mevlut: No conflict of intereset

P734

Dr. Arieira, Catia: No conflict of intereset||Dias de Castro, Francisca: No conflict of intereset||Cúrdia Gonçalves, Tiago: No conflict of intereset||Moreira, Maria João: No conflict of intereset||Cotter, José: No conflict of intereset

P735

Dr. Paschos, Paschalis: No conflict of intereset||Katsoula, Anastasia: No conflict of intereset||Malandris, Konstantinos: No conflict of intereset||Sarigianni , Maria: No conflict of intereset||Athanasiadou, Eleni: No conflict of intereset||Koukoufiki, Argyro: No conflict of intereset||Prof. Dr. Giouleme, Olga: No conflict of intereset||Prof. Dr. Tsapas, Apostolos: No conflict of intereset

P736

Dr. Carrillo Palau, Marta: No conflict of intereset||Dr. Alonso-Abreu, Inmaculada: No conflict of intereset||Mrs. Ramos-Lopez, Laura: No conflict of intereset||Dr. Fernando, Gutierrez-Nicolas: No conflict of intereset||Dr. Hernandez Alvarez-Buylla, Noemi: No conflict of intereset||Mrs. Hernandez-Perez, Anjara: No conflict of intereset||Mr. Medina-Chico, Sergio: No conflict of intereset||Prof. Dr. Quintero, Enrique: No conflict of intereset

P737Ms. SÁNCHEZ RODRÍGUEZ, Eugenia: No conflict of intereset||Dr. Mesonero Gismero, Francisco: No conflict of intereset||Dr. López sanroman, Antonio: No conflict of intereset

P738

Dr. Chatzinikolaou, Matina-Lydia: No conflict of intereset||Dr. O'Shea, Nuala: No conflict of intereset||Dr. Erian, Gamal: No conflict of intereset||Dr. Koutsoumpas, Andreas: No conflict of intereset||Dr. Ryan, Jennifer: No conflict of intereset||Dr. Hamilton, Mark: No conflict of intereset||Dr. Murray, Charles: No conflict of intereset

P739

Dr. Bouri, Sonia: No conflict of intereset||Dr. Willsmore, James: No conflict of intereset||Dr. Geldof, Jereon: No conflict of intereset||Dr. Gabe, Simon: No conflict of intereset||Dr. Donnelly, Suzanne: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset

P740

Prof. Dr. Halfvarson, Jonas:|:|JH has served as speaker, advisory board member and/or consultant for AbbVie, Celgene, Celltrion, Ferring, Hospira, Janssen, MEDA, Medivir, MSD, Olink Proteomics, Pfizer, Prometheus Laboratories, Sandoz/Novartis, Shire, Takeda, Thermo Fischer Scientific, Tillotts Pharma, Vifor Pharma, and UCB, and received grant support from Janssen, MSD, and Takeda.||Prof. Dr. Ludvigsson, Jonas:|:|JFL coordinates a study unrelated to the present study on behalf of the Swedish IBD Quality Register (SWIBREG), which has received funding from Janssen.||Mr. Sachs, Michael: No conflict of intereset||Prof. Dr. Askling, Johan:|:|JA reports grants from AbbVie, Bristol-Myers Squibb, Lilly, Merck, Pfizer, Roche, Samsung Bioepis, and UCB, mainly in the context of a national safety monitoring programme for immunomoduators in rheumatology.||Dr. Olén, Ola:|:|OO has been a principal investigator on projects at Karolinska Institutet partly financed by investigator-initiated grants from Janssen and Ferring; and reports a grant from Pfizer in the context of a national safety monitoring programme; none of those studies have any relation to the present study. Karolinska Institutet has received fees for lectures by OO and participation by OO on advisory boards from Janssen, Ferring, Takeda, and Pfizer regarding topics not related to the present study.

P741 Dr. De Castro Parga, Maria Luisa: No conflict of intereset

Page 122 of 135

P742

Dr. Burgess, Christopher:|:|This work was supported by an Edinburgh Children’s Hospital Charity Research Fellowship award [to C.J.B] and by funding from Crohn’s and Colitis UK (Edinburgh branch).||Dr. Schnier, Christian: No conflict of intereset||Dr. Chalmers, Iain: No conflict of intereset||Prof. Russell, Richard K:|:|RKR is supported by an NHS Research Scotland Senior Research Fellowship. RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson,|Nutricia & 4D Pharma.||Dr. Hansen, Richard:|:|RH is supported by an NHS Research Scotland Senior Research Fellowship. RH has received speaker’s fees, travel support, and/or participated in medical board meetings with MSD Immunology, Dr Falk, Nutricia & 4D Pharma.||Dr. Henderson, Paul: No conflict of intereset||Dr. Wood, Rachael: No conflict of intereset||Prof. Wilson, David C:|:|DCW has received speaker’s fees, travel support, and/or participated in medical board meetings with AbbVie, Takeda, Roche, Ferring, Predictimmune, Dr Falk, Napp, and 4D Pharma.

P743

Mr. Brunet, Eduard: No conflict of intereset||Dr. Melcarne, Luigi:|:|Luigi Melcarne has received fees from Sandoz. ||Ms. Vela, Emili: No conflict of intereset||Ms. Clèries, Montserrat: No conflict of intereset||Dr. Pontes, Caridad: No conflict of intereset||Ms. García-Iglesias, Pilar: No conflict of intereset||Dr. Gallach, Marta: No conflict of intereset||Ms. Hernández, Leticia: No conflict of intereset||Ms. Soria, Anna: No conflict of intereset||Mr. Jordi, Vives: No conflict of intereset||Ms. Pedregal, Patricia: No conflict of intereset||Mr. Grau, Gerard: No conflict of intereset||Ms. Garcia-Sagué, Belén: No conflict of intereset||Mr. Frisancho, Luís Enrique: No conflict of intereset||Dr. Villòria, Albert:|:|Albert Villoria has served as a speaker and consultant for MSD and Abbvie||Dr. Vergara, Mercedes:|:|Mercedes Vergara has given lectures for MSD, Abbott, Gilead, and Intercept, and has received fees from Intercept for advisory services.||Prof. Dr. Calvet, Xavier:|:|Xavier Calvet has received grants for research from Abbott, MSD, and Vifor, and fees for advisory services form Abbott, MSD, Takeda and Vifor. He has also given lectures for Abbott, MSD, Takeda, Shire and Allergan.

P744

Chaparro, Maria: No conflict of intereset||Dr. Barreiro-de Acosta, Manuel: No conflict of intereset||Dr. Benítez, José Manuel: No conflict of intereset||Dr. Cabriada, José Luis: No conflict of intereset||Dr. Casanova, María José: No conflict of intereset||Dr. Ceballos, Daniel: No conflict of intereset||Dr. Esteve, María: No conflict of intereset||Dr. Fernández, Hipólito: No conflict of intereset||Dr. Ginard, Daniel: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Dr. Lorente, Rufo: No conflict of intereset||Dr. Nos, Pilar: No conflict of intereset||Dr. Riestra, Sabino: No conflict of intereset||Dr. Rivero, Montserrat: No conflict of intereset||Dr. Robledo, Pilar: No conflict of intereset||Dr. Rodríguez, Cristina: No conflict of intereset||Dr. Sicilia, Beatriz: No conflict of intereset||Dr. Torrella, Emilio: No conflict of intereset||Mrs. Garre, Ana: No conflict of intereset||Dr. Rodríguez-Artalejo, Fernando: No conflict of intereset||Dr. García-Esquinas, Esther: No conflict of intereset||Dr. Gisbert, Javier P: No conflict of intereset

P745

Dr. ATIA, Ohad: No conflict of intereset||Ms. Asayag, Noa: No conflict of intereset||Ms. Focht, Gili: No conflict of intereset||Dr. Cahan, Amos: No conflict of intereset||Prof. Dotan, Iris:|:|Received last 3 years consultation fee, research grant, or honorarium from Janssen, Pfizer, Abbvie, Takeda, Genentech/Roche, Neopharm, Ferring, Rafa Laboratories, Falk Pharma, Nestle, Given Imaging/Medtronic, Gilead, Celgene, Arena, Sublimity, Celltrion, Altman Research||Prof. Balicer, Ran: No conflict of intereset||Dr. Gavish, Matan: No conflict of intereset||Dr. Feldman, Becca: No conflict of intereset||Dr. Brufman, Ilan: No conflict of intereset||Dr. Haklai, Ziona: No conflict of intereset||Prof. Dr. Turner, Dan:|:|received last 3 years consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Biogen, Neopharm, Uniliver, Atlantic Health, Shire, Celgene, Lilly, Roche

P746

Dr. Masnou, Helena: No conflict of intereset||Dr. Mañosa, Míriam: No conflict of intereset||Dr. Menchén, Luis: No conflict of intereset||Dr. Mesonero, Francisco: No conflict of intereset||Dr. Bujanda, Luis: No conflict of intereset||Dr. Castro, Jesús: No conflict of intereset||Dr. Gonzalez-Partida, Irene: No conflict of intereset||Dr. De Francisco, Ruth: No conflict of intereset||Dr. García-Alonso, Francisco J: No conflict of intereset||Dr. García, María-José: No conflict of intereset||Dr. González-Muñoza, Carlos: No conflict of intereset||Dr. Huguet, José M: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Mrs. Cano-Sanz, Noelia: No conflict of intereset||Dr. Domènech Moral, Eugeni: No conflict of intereset

P747

PARIGI, Tommaso Lorenzo: No conflict of intereset||Dr. Roda, Giulia: No conflict of intereset||Dr. Allocca, Mariangela: No conflict of intereset||Dr. Furfaro, Federica: No conflict of intereset||Dr. Loy, Laura: No conflict of intereset||Dr. Zilli, Alessandra: No conflict of intereset||Dr. Bonovas, Stefanos: No conflict of intereset||Danese, Silvio: No conflict of intereset||Dr. Fiorino, Gionata: No conflict of intereset

Page 123 of 135

P748

Dr. Szántó, Kata Judit: No conflict of intereset||Dr. Bálint, Anita: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Milassin, Ágnes: No conflict of intereset||Dr. Rutka, Mariann: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Dr. Vass, Noémi: No conflict of intereset||Prof. Dr. Molnár, Tamás: No conflict of intereset||Dr. Farkas, Klaudia: No conflict of intereset

P749

Prof. Dr. Yamamoto-Furusho, Jesús Kazuo: No conflict of intereset||Dr. Parra-Holguín , Norma N: No conflict of intereset||Mr. Grupo-Colombiano , Eii: No conflict of intereset||Dr. Bosques-Padilla, Francisco: No conflict of intereset||Dr. Veitia-Velásquez , Guillermo: No conflict of intereset||Dr. Torres, Esther: No conflict of intereset||Dr. Piñol-Jiménez , Felipe: No conflict of intereset||Bautista, Socrates: No conflict of intereset||Dr. Frías-Santana , Aleydi: No conflict of intereset||Dr. Villa-Ovalles , Keyla: No conflict of intereset||Dr. Otoya-Moreno , Guillermo: No conflict of intereset||Dr. Iadé-Vergara , Beatriz: No conflict of intereset

P750Dr. Han, Yoo Min: No conflict of intereset||Dr. Lee, Jooyoung: No conflict of intereset||Dr. Im, Jong Pil: No conflict of intereset||Dr. Kim, Joo Sung: No conflict of intereset

P751Dr. Hoffmann, Peter: No conflict of intereset||Mrs. Jung, Victoria: No conflict of intereset||Mr. Behnisch, Rouven: No conflict of intereset||Dr. Gauss, Annika: No conflict of intereset

P752

Dr. Umeno, Junji: No conflict of intereset||Dr. Fuyuno, Yuta: No conflict of intereset||Dr. Torisu, Takehiro: No conflict of intereset||Dr. Hirano, Atsushi: No conflict of intereset||Dr. Esaki, Motohiro: No conflict of intereset||Dr. Yanai, Shunichi: No conflict of intereset||Prof. Ohmiya, Naoki: No conflict of intereset||Prof. Dr. Hisamatsu, Tadakazu:|:|Grant support: Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Astellas Pharma Inc., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd.|Consulting: EA pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd.|Lecture fee: Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd.||Dr. Watanabe, Kenji: No conflict of intereset||Dr. Hosoe, Naoki: No conflict of intereset||Prof. Ogata, Haruhiko: No conflict of intereset||Prof. Hirai, Fumihito: No conflict of intereset||Dr. Hisabe, Takashi: No conflict of intereset||Dr. Matsui, Toshiyuki: No conflict of intereset||Dr. Yao, Tsuneyoshi: No conflict of intereset||Prof. Kitazono, Takanari: No conflict of intereset||Prof. Matsumoto, Takayuki: No conflict of intereset

P753

Dr. ATIA, Ohad: No conflict of intereset||Turner, Dan:|:|received last 3 years consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Biogen, Neopharm, Uniliver, Atlantic Health, Shire, Celgene, Lilly, Roche||Ms. Mendelovici, Adi: No conflict of intereset||Prof. Assa, Amit: No conflict of intereset||Ms. Mozer-Glassberg, Yael: No conflict of intereset||Dr. Cahan, Amos: No conflict of intereset||Dr. Lederman, Natan: No conflict of intereset||Dr. Matz, Eran: No conflict of intereset||Prof. Dotan, Iris:|:|Received last 3 years consultation fee, research grant, or honorarium from Janssen, Pfizer, Abbvie, Takeda, Genentech/Roche, Neopharm, Ferring, Rafa Laboratories, Falk Pharma, Nestle, Given Imaging/Medtronic, Gilead, Celgene, Arena, Sublimity, Celltrion, Altman Research||Dr. Shteyer , Eyal: No conflict of intereset

P754

Dr. SANCHEZ, Maria Belen: No conflict of intereset||Dr. Cepeda , Jesica: No conflict of intereset||Dr. Etchevers, Maria Josefina: No conflict of intereset||Dr. Sobrero, Maria Josefina: No conflict of intereset||Dr. Gonzalez Sueyro, Ramiro: No conflict of intereset||Dr. Arguero, Maria Julieta: No conflict of intereset||Dr. De Paula, Juan Andres: No conflict of intereset||Dr. Marcolongo, Mariano Martin: No conflict of intereset

P755

Dr. Norsa, Lorenzo: No conflict of intereset||Prof. Berni Canani, Roberto: No conflict of intereset||Dr. Duclaux- Loras , Remi: No conflict of intereset||Dr. Bequet , Emeline: No conflict of intereset||Dr. Koeglmeier, Jutta: No conflict of intereset||Prof. Russell , Richard K: No conflict of intereset||Prof. Ulhig , Holm: No conflict of intereset||Prof. Koletzko , Sibylle: No conflict of intereset||Dr. Rodrigues, Astor: No conflict of intereset||Dr. Deflandre, Jaques: No conflict of intereset||Dr. Dembinski, Lukasz: No conflict of intereset||Dr. Castaldo, Giuseppe: No conflict of intereset||Dr. Grimaldi, Giusi: No conflict of intereset||Dr. Shah, Neil: No conflict of intereset||Dr. Heinz- Erian, Peter: No conflict of intereset||Prof. Janecke, Andreas: No conflict of intereset||Dr. Leskinen, Saara: No conflict of intereset||Dr. Wedenoja, Satu: No conflict of intereset||Prof. Lachaux , Alain: No conflict of intereset||Prof. Kolho , Kaja-Lena: No conflict of intereset||Prof. Ruemmele , Frank: No conflict of intereset

P756

Dr. Pillay, Lushen: No conflict of intereset||Dr. Piggott, Raymond Simon: No conflict of intereset||Dr. Ganter, Niamh: No conflict of intereset||Dr. McCormack, Geraldine: No conflict of intereset

Page 124 of 135

P757

Ms. Heisler, Courtney Grace: No conflict of intereset||Dr. Mirza, Raza: No conflict of intereset||Ms. Kits, Olga: No conflict of intereset||Ms. Zelinsky, Sandra: No conflict of intereset||Dr. Veldhuyzen van Zanten , Sander: No conflict of intereset||Dr. Nguyen, Geoffrey: No conflict of intereset||Dr. McCurdy, Jeffrey: No conflict of intereset||Dr. MacMillan, Mark: No conflict of intereset||Dr. Lakatos, Peter L.: No conflict of intereset||Dr. Targownik, Laura: No conflict of intereset||Dr. Fowler, Sharyle: No conflict of intereset||Dr. Rioux, Kevin: No conflict of intereset||Dr. Jones, Jennifer: No conflict of intereset

P758

Dr. De Buck Van Overstraeten, Anthony: No conflict of intereset||Dr. Brar, Mantaj: No conflict of intereset||Dr. Khorasani , Sepehr: No conflict of intereset||Dr. Dossa, Fahima: No conflict of intereset||Dr. Myrelid, Pär: No conflict of intereset

P759

Dr. Domislović, Viktor: No conflict of intereset||Dr. Brinar, Marko: No conflict of intereset||Mr. Vujičić, Lovro: No conflict of intereset||Mr. Novosel, Martin: No conflict of intereset||Dr. Grgić, Dora: No conflict of intereset||Prof. Krznarić, Željko: No conflict of intereset

P760

Prof. Dr. Fossmark, Reidar:|:|The study was financially supported by Takeda||Dr. Olaisen, Maya: No conflict of intereset||Dr. Martinsen, Tom Christian: No conflict of intereset||Prof. Melberg, Hans Olav:|:|The study was financially supported by Takeda

P761

Mosli, Mahmoud Hisham Ahmed: No conflict of intereset||Dr. Saeedi , Asalh: No conflict of intereset||Dr. ALNEFAIE, Majed: No conflict of intereset||Dr. Bawahab , Noor: No conflict of intereset||Dr. Abdu, Lujain: No conflict of intereset||Ms. Shobai , Seigah: No conflict of intereset

P762

Mr. RODRIGUES BOARINI, Lucas: No conflict of intereset||Prof. Dr. Sobrado Jr, Carlos Walter: No conflict of intereset||Ms. Guzela, Vivian Regina: No conflict of intereset||Pozzebon Gonçalves, Aline: No conflict of intereset||Prof. Dr. Lina Villa, Luisa: No conflict of intereset||Prof. Dr. Nadal, Sidney Roberto: No conflict of intereset||Mr. Da Costa Lino Costa, Anderson: No conflict of intereset||Prof. Dr. Nahas, Sergio Carlos: No conflict of intereset

P763

Dr. Feo-Ortega, Sara: No conflict of intereset||Dr. Pujol Muncunill, Gemma: No conflict of intereset||Dr. Minguez-Rodríguez, Beatriz: No conflict of intereset||Ms. Álvarez-Carnero, Laura: No conflict of intereset||Dr. Guevara-Caviedes, Laura Nathalia: No conflict of intereset||Dr. Coronel-Arismendi, Maria Belén: No conflict of intereset||Dr. Vila-Miravet, Victor: No conflict of intereset||Dr. Martin De Carpi, Francisco Javier: No conflict of intereset

P764

Dr. Páez Cancelado, Cristian Camilo: No conflict of intereset||Dr. García Duperly , Rafael: No conflict of intereset||Mr. Park , John: No conflict of intereset||Dr. López Panqueva, Rocio: No conflict of intereset||Dr. Londoño Schimmer, Eduardo Emilio: No conflict of intereset||Dr. Rey Rubiano, Adriana Margarita: No conflict of intereset||Dr. Padrón Mercado, Jorge Enrique: No conflict of intereset||Dr. Mejía Arango, Marcela: No conflict of intereset||Dr. Vallejo Madroñero, Roberto Javier: No conflict of intereset||Dr. MENDOZA DE MOLANO, Belen: No conflict of intereset

P765

Dr. ĆAĆIĆ, Petra: No conflict of intereset||Dr. Tomašić, Vedran: No conflict of intereset||Dr. Kralj, Dominik: No conflict of intereset||Dr. Bišćanin, Alen: No conflict of intereset||Dr. Dorosulić, Zdravko: No conflict of intereset||Dr. Lerotić, Ivan: No conflict of intereset||Dr. Ogresta, Doris: No conflict of intereset||Dr. Forgač, Jelena: No conflict of intereset||Dr. Hrabar, Davor: No conflict of intereset

P766

Dr. Lai, Hsiang-Chun: No conflict of intereset||Dr. Chou, Jen-Wei: No conflict of intereset||Dr. Cheng, Ken-Sheng: No conflict of intereset||Dr. Wu, Yi-Hua: No conflict of intereset||Dr. Tsai, Yuan-Yao: No conflict of intereset||Dr. Chen, Tsung-Wei: No conflict of intereset

P767

Dr. Peña-Sánchez, Juan-Nicolás: No conflict of intereset||Dr. Jennings, Derek: No conflict of intereset||Osei, Jessica A.: No conflict of intereset||Mr. Andkhoie, Mustafa: No conflict of intereset||Mr. Brass, Colten: No conflict of intereset||Dr. Bukassa Kazadi, Germain: No conflict of intereset||Dr. Fowler, Sharyle: No conflict of intereset||Dr. Johnson-Jennings, Michelle: No conflict of intereset||Mr. Lu, Xinya: No conflict of intereset||Mr. Marques Santos, Jose Diego: No conflict of intereset||Ms. Porter, Linda: No conflict of intereset||Mr. Porter, Rob: No conflict of intereset||Ms. Quintin, Carol-Lynne: No conflict of intereset||Ms. Sanderson, Rhonda: No conflict of intereset||Dr. Teucher, Ulrich: No conflict of intereset

Page 125 of 135

P768

Prof. Dr. Ye, Byong Duk:|:|Research grant: CELLTRION, Inc., Pfizer Korea|Consulting fees: Abbvie Korea, Chong Kun Dang Pharm., Daewoong Pharma, Ferring Korea, Janssen Korea, Kangstem Biotech, Kuhnil Pharm., Medtronic Korea, Shire Korea, Takeda Korea, IQVIA, Cornerstones Health, Robarts Clinical Trials Inc., Takeda|Speaking fees: Abbvie Korea, CELLTRION, Inc. Ferring Korea, Janssen Korea, Pfizer Korea, Shire Korea, Takeda Korea, IQVIA|However, all of these are not relevant to this study. ||Dr. Park, Hyunju: No conflict of intereset||Dr. Kim, Sung Hoon: No conflict of intereset||Prof. Dr. Hong, Sung Noh: No conflict of intereset||Prof. Dr. Yoon, Hyuk: No conflict of intereset||Ms. Kim, Ye-Jee: No conflict of intereset||Prof. Dr. Seo, Seung In: No conflict of intereset||Dr. Rhee, Kyoung Hoon: No conflict of intereset||Prof. Dr. Kim, Young-Ho: No conflict of intereset||Prof. Dr. Kim, Kyung Ho: No conflict of intereset||Prof. Dr. Cha, Jae Myung: No conflict of intereset||Dr. Park, Sun Yong: No conflict of intereset||Dr. Jeong, Seung Kyu: No conflict of intereset||Prof. Dr. Kim, Joo Sung: No conflict of intereset||Prof. Dr. Im, Jong Pil: No conflict of intereset||Dr. Jang, Jisun: No conflict of intereset||Prof. Dr. Kim, Jeong Hwan: No conflict of intereset||Dr. Suh, Seong O: No conflict of intereset||Dr. Kim, Young Kyun: No conflict of intereset||Prof. Dr. Park, Sang Hyoung: No conflict of intereset||Prof. Dr. Yang, Suk-Kyun:|:|This work was partially supported by a Korean Health Technology R&D Project grant from the Korea Health Industry Development Institute to Suk-Kyun Yang (A120176), funded by the Ministry of Health & Welfare; and by a research grant from Janssen Korea

P769

Dr. Blackwell, Jonathan: No conflict of intereset||Prof. Saxena, Sonia: No conflict of intereset||Dr. Jayasooriya, Nishani: No conflict of intereset||Prof. Petersen, Irene: No conflict of intereset||Prof. Hotopf, Matthew: No conflict of intereset||Prof. Bottle, Alex: No conflict of intereset||Dr. Pollok, Richard: No conflict of intereset

P770

Jantchou, Prevost: No conflict of intereset||Mrs. Conus, Florence: No conflict of intereset||Mr. Richard, Hugues: No conflict of intereset||Prof. Rousseau, Marie-Claude: No conflict of intereset

P771

Ms. Osei, Jessica A.: No conflict of intereset||Dr. Peña-Sánchez, Juan Nicolás: No conflict of intereset||Dr. Fowler, Sharyle A: No conflict of intereset||Dr. Muhajarine , Nazeem: No conflict of intereset||Dr. Kaplan, Gilaad: No conflict of intereset||Dr. Lix, Lisa M: No conflict of intereset

P772

Dr. Moon, Jung Min: No conflict of intereset||Prof. Dr. Kang, Eun Ae: No conflict of intereset||Dr. Han, Kyungdo: No conflict of intereset||Dr. Hong, Seung Wook: No conflict of intereset||Dr. Soh, Hosim: No conflict of intereset||Dr. Park, Seona: No conflict of intereset||Prof. Dr. Lee, Jooyoung: No conflict of intereset||Prof. Dr. Lee, Hyun Jung: No conflict of intereset||Prof. Dr. Im, Jong Pil: No conflict of intereset||Prof. Dr. Kim, Joo Sung: No conflict of intereset

P773

Dr. Golovics, Petra: No conflict of intereset||Dr. Gonczi, Lorant: No conflict of intereset||Dr. Reinglass, Jason: No conflict of intereset||Dr. Verdon, Christine: No conflict of intereset||Dr. Afif, Waqqas: No conflict of intereset||Dr. Wild, Gary: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Seidman, Ernest: No conflict of intereset||Dr. Bessissow, Talat: No conflict of intereset||Prof. Dr. Lakatos, Péter Laszlo: No conflict of intereset

Page 126 of 135

P774

Dr. Zabana Abdo, Yamile: No conflict of intereset||Dr. de Francisco, Ruth: No conflict of intereset||Dr. Rodríguez-Lago, Iago: No conflict of intereset||Dr. Chaparro, María: No conflict of intereset||Dr. Gomollón, Fernando: No conflict of intereset||Dr. Piqueras, Marta: No conflict of intereset||Dr. Llaó, Jordina: No conflict of intereset||Dr. Sicilia, Beatriz: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. García-Bosch, Orlando: No conflict of intereset||Dr. de Castro, Luisa: No conflict of intereset||Dr. Calvet, Xavier: No conflict of intereset||Dr. Morales, Víctor: No conflict of intereset||Dr. Rivero, Montserrat: No conflict of intereset||Dr. Lucendo, Alfredo J: No conflict of intereset||Dr. Navarro, Pablo: No conflict of intereset||Dr. Márquez, Lucía: No conflict of intereset||Dr. Busquets, David: No conflict of intereset||Dr. Guardiola, Jordi: No conflict of intereset||Dr. Gordillo, Jordi: No conflict of intereset||Dr. Iglesias, Eva: No conflict of intereset||Dr. Beltrán, Belén: No conflict of intereset||Dr. Sesé, Eva: No conflict of intereset||Dr. Ferreiro-Iglesias, Rocío: No conflict of intereset||Dr. Francisco, Mesonero: No conflict of intereset||Dr. Pajares, Ramón: No conflict of intereset||Dr. Algaba, Alicia: No conflict of intereset||Dr. Vicente, Raquel: No conflict of intereset||Mrs. Benítez, Olga: No conflict of intereset||Dr. Aceituno, Montserrat: No conflict of intereset||Dr. Riestra, Sabino: No conflict of intereset||Mrs. Rodríguez-Pescador, Ainhoa: No conflict of intereset||Dr. Gisbert, Javiert P: No conflict of intereset||Dr. Arroyo, María Teresa: No conflict of intereset||Mrs. Mena, Raquel: No conflict of intereset||Dr. Sáinz, Empar: No conflict of intereset||Dr. Arias-García, Lara: No conflict of intereset||Dr. Mañosa, Míriam: No conflict of intereset||Dr. Navarro, Mercé: No conflict of intereset||Mr. Sanromán, Luciano: No conflict of intereset||Dr. Villória, Albert: No conflict of intereset||Dr. Delgado-Villena, Pedro: No conflict of intereset||Dr. García, María José: No conflict of intereset||Dr. Angueira, Teresa: No conflict of intereset||Dr. Mínguez, Miguel: No conflict of intereset||Mrs. Murciano, Francisca: No conflict of intereset||Dr. Arajol, Clàudia: No conflict of intereset||Dr. Esteve, Maria: No conflict of intereset

P775

Dr. Barash, Yiftach: No conflict of intereset||Dr. Klan, Eyal: No conflict of intereset||Dr. Tau, Noam: No conflict of intereset||Prof. Ben-Horin, Shomron: No conflict of intereset||Dr. LEVARTOVSKY, Asaf: No conflict of intereset||Dr. Arebi, Naila: No conflict of intereset||Dr. Soffer, Shelly: No conflict of intereset||Prof. Kopylov, Uri: No conflict of intereset

P776

Dr. Fromson, Renate: No conflict of intereset||Dr. Johnson, Emma: No conflict of intereset||Dr. Routledge, Emma: No conflict of intereset||Dr. Jameie-Oskooei, Sina: No conflict of intereset||Dr. Blad, Will: No conflict of intereset||Dr. Patel, Rajan: No conflict of intereset||Dr. Wong, Voishim: No conflict of intereset

P777Dr. El-Matary, Wael: No conflict of intereset||Mr. Chandrakumar, Abin: No conflict of intereset||Mr. Zohni, Hussein: No conflict of intereset

P778

Mrs. Borren, Nynke: No conflict of intereset||Dr. Long, Millie: No conflict of intereset||Prof. Dr. van der Woude, Janneke:|:|C.J. van der Woude received grant support from Falk Benelux and Pfizer; received speaker fees from AbbVie, Takeda, Ferring, Dr. Falk Pharma, Hospira, Pfizer; and served as a consultant for AbbVie, MSD, Takeda, Celgene, Mundipharma and Janssen.||Prof. Dr. Sandler, Robert: No conflict of intereset||Dr. Ananthakrishnan, Ashwin:|:|Dr. Ananthakrishnan has served on advisory boards for Abbvie, Takeda, and Merck. He is supported by research funding from the Crohn’s and Colitis Foundation, National Institutes of Health, Chleck Family Foundation, and Pfizer

P779Dr. Shinozaki, Masaru:|:|Grants from Mitsubishi Tanabe Pharma Co.Ltd.||Dr. Takahashi, Ryo: No conflict of intereset

P780

Prof. Dr. Kim, Joo Sung: No conflict of intereset||Dr. Park, Seona: No conflict of intereset||Dr. Lee, Hyun Jung: No conflict of intereset||Dr. Soh, Hosim: No conflict of intereset||Dr. Moon, Jung Min: No conflict of intereset||Dr. Hong, Seung Wook: No conflict of intereset||Dr. Kang, Eun Ae: No conflict of intereset||Dr. Im, Jong Pil: No conflict of intereset

P781

Dr. García García, María José: No conflict of intereset||Dr. Rodriguez-Duque, Juan Carlos: No conflict of intereset||Prof. Arias Loste, Maria Teresa: No conflict of intereset||Dr. Castro Senosiain, Beatriz: No conflict of intereset||Prof. Crespo , Javier: No conflict of intereset||Prof. Rivero , Montserrat: No conflict of intereset

P782

Dr. HONG, Hee Seung: No conflict of intereset||Dr. Jung, Jiwon: No conflict of intereset||Dr. Park, Sang Hyoung: No conflict of intereset||Dr. Noh, Soo Min: No conflict of intereset||Dr. Oh, Eun Hye: No conflict of intereset||Dr. Kim, Jin Yong: No conflict of intereset||Dr. Kim, Jeongseok: No conflict of intereset||Dr. Hwang, Sung Wook: No conflict of intereset||Dr. Yang, Dong-Hoon: No conflict of intereset||Dr. Byeon, Jeong-Sik: No conflict of intereset||Dr. Myung, Seung-Jae: No conflict of intereset||Dr. Yang, Suk-Kyun: No conflict of intereset||Dr. Ye, Byong Duk: No conflict of intereset

P783 Prof. Dr. Demir, Mehmet: No conflict of intereset

P784

Dr. Zerboni, Giulia: No conflict of intereset||Dr. Barello, Serena: No conflict of intereset||Dr. Festa, Stefano: No conflict of intereset||Dr. Aratari, Annalisa: No conflict of intereset||Prof. Graffigna, Guendalina: No conflict of intereset||Dr. Papi, Claudio: No conflict of intereset

Page 127 of 135

P785

Dr. Ukashi, Offir: No conflict of intereset||Dr. Barash, Yifatch: No conflict of intereset||Dr. J. Segel, Michael: No conflict of intereset||Dr. Ungar, Bella: No conflict of intereset||Dr. Soffer, Shelly: No conflict of intereset||Prof. Dr. Ben-Horin, Shomron: No conflict of intereset||Dr. Klang, Eyal: No conflict of intereset||Prof. Kopylov, Uri: No conflict of intereset

P786

Dr. Almohannadi, Muneera: No conflict of intereset||Dr. Chandra , Prem: No conflict of intereset||Dr. Varughese, Betsy: No conflict of intereset||Dr. Darweesh, Adham: No conflict of intereset||Dr. Hamid, Abdulwahab: No conflict of intereset||Dr. Badi , Ahmed: No conflict of intereset||Dr. Kaabi , Saad Al: No conflict of intereset||Dr. Yakoob, Rafie: No conflict of intereset||Dr. Al-Ejji , Khalid: No conflict of intereset||Dr. Sultan , Khaleel: No conflict of intereset||Ms. Abunahia , Nevin: No conflict of intereset||Dr. Ameer Hamza Shah , Mohammed: No conflict of intereset||Prof. Dr. Derbala , Moutaz: No conflict of intereset

P787

Dr. Mocci, Giammarco: No conflict of intereset||Dr. Demurtas, Mauro: No conflict of intereset||Dr. Onidi, Francesca Maria: No conflict of intereset||Dr. Picchio, Marcello: No conflict of intereset||Dr. Elisei, Walter: No conflict of intereset||Dr. Manca, Roberto: No conflict of intereset||Dr. Miculan, Federica: No conflict of intereset||Dr. Mais, Claudia: No conflict of intereset||Prof. Usai, Paolo: No conflict of intereset||Dr. Chicco, Fabio: No conflict of intereset||Dr. Lai, Maria Antonia: No conflict of intereset||Dr. Magrì, Salvatore: No conflict of intereset||Dr. Binaghi, Laura: No conflict of intereset||Dr. Dore, Maria Francesca: No conflict of intereset||Prof. Dore, Maria Pina: No conflict of intereset||Dr. Colosso, Bianca Quarta: No conflict of intereset||Dr. Cugia, Luigi: No conflict of intereset||Dr. Carta, Monica: No conflict of intereset||Dr. Pisanu, Roberta: No conflict of intereset||Dr. Marzo, Manuela: No conflict of intereset||Dr. Porcedda, Maria Laura: No conflict of intereset||Dr. Argiolas, Mariangela: No conflict of intereset||Dr. Cabras, Francesco: No conflict of intereset||Prof. Armuzzi, Alessandro: No conflict of intereset

P788

Mrs. Sarbagili Shabat, Chen: No conflict of intereset||Prof. Zelber-Sagi , Shira: No conflict of intereset||Dr. Fliss Isakov, Naomi: No conflict of intereset||Dr. Ron, Yulia: No conflict of intereset||Hirsch, Ayal: No conflict of intereset||Dr. Maharshak , Nitsan: No conflict of intereset

P789 Dr. Filip, Rafal: No conflict of intereset||Dr. Gruszecka, Jolanta: No conflict of intereset

P790

Dr. Piątek, Dominika: No conflict of intereset||Mrs. Jarmakiewicz-Czaja, Sara: No conflict of intereset||Dr. Korona-Głowniak, Izabela: No conflict of intereset||Prof. Malm, Anna: No conflict of intereset||Dr. Sztembis, Joanna: No conflict of intereset||Dr. Filip, Rafał: No conflict of intereset

P791

Prof. Dr. Choe, Byung-Ho: No conflict of intereset||Prof. Dr. Kang, Ben: No conflict of intereset||Dr. Suh, Hyo Rim: No conflict of intereset||Dr. Kim, Eun Sil: No conflict of intereset||Dr. Park, Ji Hyung: No conflict of intereset||Prof. Dr. Kim, Mi Jin: No conflict of intereset||Prof. Dr. Choe, Yon Ho: No conflict of intereset||Dr. Kim, Seung: No conflict of intereset||Prof. Dr. Koh, Hong: No conflict of intereset||Prof. Dr. Lee, Yeoun Joo: No conflict of intereset||Prof. Dr. Park, Jae Hong: No conflict of intereset||Prof. Dr. Ryoo, Eell: No conflict of intereset

P792 Dr. CHARRO CALVILLO, Mara: No conflict of intereset

P793

Dr. Argyriou, Konstantinos: No conflict of intereset||Dr. Karantanos, Panagiotis: No conflict of intereset||Dr. Vasilakis, Nikolaos: No conflict of intereset||Prof. Kapsoritakis, Andreas: No conflict of intereset||Dr. Lalla, Efi: No conflict of intereset||Dr. Varytimiadis, Konstantinos: No conflict of intereset||Dr. Mpetsios, George: No conflict of intereset||Dr. Tsakiridou, Eirini: No conflict of intereset||Prof. Dr. Potamianos, Spyridon: No conflict of intereset

P794

Ms. Peters, Vera: No conflict of intereset||Dr. Alizadeh, Behrooz: No conflict of intereset||Dr. de Vries, Jeanne: No conflict of intereset||Prof. Dr. Dijkstra, Gerard: No conflict of intereset||Dr. Campmans-Kuijpers, Marjo: No conflict of intereset

P795

Dr. WARD, Daniel: No conflict of intereset||Ms. Gørtz, Sanne: No conflict of intereset||Dr. Nyboe Andersen, Nynne: No conflict of intereset||Dr. Kirchgesner, Julien: No conflict of intereset||Prof. Jess, Tine: No conflict of intereset

P796

Jung, Sung Hoon: No conflict of intereset||Prof. Dr. Kim, Tae-Oh: No conflict of intereset||Prof. Dr. Baek, Dong Hoon: No conflict of intereset||Prof. Dr. Kim, Dae Bum: No conflict of intereset||Prof. Dr. Song, Geun Am: No conflict of intereset||Prof. Dr. Kang, Ho Suk: No conflict of intereset||Prof. Dr. Goong, Hyeon Jeong: No conflict of intereset||Prof. Dr. Bae, Jung Ho: No conflict of intereset||Prof. Dr. Hye Kyung, Song: No conflict of intereset||Prof. Dr. Lee, Hong Sub: No conflict of intereset

Page 128 of 135

P797

Dr. Burgess, Christopher:|:|This work was supported by an Edinburgh Children’s Hospital Charity Research Fellowship award [to C.J.B] and by funding from Crohn’s and Colitis UK (Edinburgh branch).||Dr. Jackson, Rebecca: No conflict of intereset||Dr. Chalmers, Iain: No conflict of intereset||Prof. Russell, Richard K:|:|RKR is supported by an NHS Research Scotland Senior Research Fellowship. RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson,|Nutricia & 4D Pharma.||Dr. Hansen, Richard:|:|RH is supported by an NHS Research Scotland Senior Research Fellowship. RH has received speaker’s fees, travel support, and/or participated in medical board meetings with MSD Immunology, Dr Falk, Nutricia & 4D Pharma.||Dr. Henderson, Paul: No conflict of intereset||Prof. Wilson, David C:|:|DCW has received speaker’s fees, travel support, and/or participated in medical board meetings with AbbVie, Takeda, Roche, Ferring, Predictimmune, Dr Falk, Napp, and 4D Pharma.

P798

Ms. ALULIS, Sarah: No conflict of intereset||Mr. Vadstrup, Kasper:|:|K Vadstrup is an employee of Jansse-Cilag||Mr. Borsi, Andras:|:|A Borsi is an employee of Janssen-Cilag||Ms. Elkjær Stallknecht, Sandra:|:|Data collection was carried out by Incentive, and S Elkjær Stallknecht is an employee of Incentive||Mr. Olsen, Jens:|:|Data collection was carried out by Incentive and J Olsen is an employee of Incentive||Mrs. Rikke Jørgensen, Tine:|:|At the time of the study, T Rikke Jørgensen was an employee of Janssen-Cilag.||Ms. Wennerström, Christina:|:|C Wennerström is an employee of Janssen-Cilag||Dr. Qvist, Niels: No conflict of intereset||Dr. Munkholm, Pia: No conflict of intereset

P799

Prof. Dr. Kim, Hee Man: No conflict of intereset||Prof. Kim, Su Young: No conflict of intereset||Prof. Kim, Hyun-soo: No conflict of intereset||Mr. Lee, Jung Kuk: No conflict of intereset||Ms. Park, So Hyun: No conflict of intereset||Ms. Moon, Jin Sil: No conflict of intereset||Ms. Cho, Yeon Seo: No conflict of intereset||Prof. Kang, Dae Ryong: No conflict of intereset

P800

Ms. ALULIS, Sarah:|:|S Alulis is an employee of Janssen-Cilag||Vadstrup, Kasper:|:|K Vadstrup is an employee of Janssen-Cilag||Mr. Borsi, Andras:|:|A Borsi is an employee of Janssen-Cilag||Ms. Nielsen, Agnete:|:|Data collection was carried out by Incentive and at the time of the study, A Nielsen was employed by Incentive.||Mrs. Rikke Jørgensen, Tine:|:|At the time of the study, T Rikke Jørgensen was employed by Janssen-Cilag||Dr. Qvist, Niels: No conflict of intereset||Dr. Munkholm, Pia: No conflict of intereset

P801

Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Siproudhis, Laurent:|:|•

P802

Dr. Dulai, Parambir:|:|Steering committee Takeda; Consulting Takeda, Janssen; Honorarium for speaker events Takeda; Travel support Takeda, Janssen; Grant support Takeda, Pfizer||Dr. Wan, Yaping:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Huang, Zhongwen:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options||Dr. Luo, Michelle:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; have stock or stock options

P803

Dr. Kim, Ye-Jee: No conflict of intereset||Dr. Ahn, Hyung Jin: No conflict of intereset||Dr. Noh, Soomin: No conflict of intereset||Dr. Park, Jae Cheol: No conflict of intereset||Dr. Kim, Jin Yong: No conflict of intereset||Dr. Kim, Jeongseok: No conflict of intereset||Dr. Ham, Nam Seok: No conflict of intereset||Dr. Oh, Eun Hye: No conflict of intereset||Prof. Dr. Hwang, Sung Wook: No conflict of intereset||Prof. Dr. Yang, Dong-Hoon: No conflict of intereset||Prof. Dr. Ye, Byong Duk: No conflict of intereset||Prof. Dr. Byeon, Jeong-Sik: No conflict of intereset||Prof. Dr. Myung, Seung-Jae: No conflict of intereset||Prof. Dr. Yang, Suk-Kyun: No conflict of intereset||Prof. Dr. Park, Sang Hyoung: No conflict of intereset

P804

Dr. Kim, Seohee: No conflict of intereset||Ms. Kwak, GyuRie: No conflict of intereset||Ms. Park, Yujin: No conflict of intereset||Prof. Dr. Oh, SeakHee: No conflict of intereset||Prof. Dr. Kim, KyungMo: No conflict of intereset||Prof. Dr. Yoon, HyungJin: No conflict of intereset||Prof. Dr. Lee, JuYeon: No conflict of intereset

P805

Dr. Chiorean, Michael: No conflict of intereset||Dr. Jiang, Jeanne:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; has stock or stock options||Dr. Candela, Ninfa:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; has stock or stock options||Dr. Chen, Grace:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; has stock or stock options||Dr. Romdhani, Hela:|:|Employee of Analysis Group, Inc., a consulting company which received funding from Takeda Pharmaceuticals USA, Inc.||Mr. Latremouille-Viau, Dominick:|:|Employee of Analysis Group, Inc., a consulting company which received funding from Takeda Pharmaceuticals USA, Inc.||Ms. Shi, Sherry:|:|Employee of Analysis Group, Inc., a consulting company which received funding from Takeda Pharmaceuticals USA, Inc.||Ms. Bungay, Rebecca:|:|Employee of Analysis Group, Inc., a consulting company which received funding from Takeda Pharmaceuticals USA, Inc.||Dr. Fan, Tao:|:|Employee of Takeda Pharmaceuticals U.S.A., Inc; has stock or stock options

Page 129 of 135

P806Dr. Maye, Hugo: No conflict of intereset||Dr. Ekaterina, Safroneeva: No conflict of intereset||Prof. Schoepfer, Alain: No conflict of intereset

P807

Golovics, Petra Anna: No conflict of intereset||Dr. Gonczi, Lorant: No conflict of intereset||Dr. Reinglass, Jason: No conflict of intereset||Dr. Verdon, Christine: No conflict of intereset||Dr. Afif, Waqqas: No conflict of intereset||Dr. Wild, Gary: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Seidman, Ernest: No conflict of intereset||Dr. Bessissow, Talat: No conflict of intereset||Prof. Dr. Lakatos, Péter Laszlo: No conflict of intereset

P808

Ms. CALOZ, Emilie: No conflict of intereset||Ms. Vullièmoz, Marianne: No conflict of intereset||Dr. Haba Rubio, Jose: No conflict of intereset||Ms. Pittet , Valérie: No conflict of intereset||Mr. Mamadou Barry, Pathé: No conflict of intereset||Prof. Dr. Michetti, Pierre: No conflict of intereset||Prof. Dr. Heinzer, Raphël: No conflict of intereset||Dr. Maillard, Michel H.: No conflict of intereset

P809

Prof. Dr. Choi, Seong Ji: No conflict of intereset||Kim, Eun Sun: No conflict of intereset||Prof. Dr. Lee, Jae Min: No conflict of intereset||Prof. Dr. Choi, Hyuk Soon: No conflict of intereset||Prof. Dr. Keum, Bora: No conflict of intereset||Prof. Dr. Jeen, Yoon Tae: No conflict of intereset||Prof. Dr. Chun, Hoon Jai: No conflict of intereset

P810

Ms. Asscher, Vera: No conflict of intereset||Ms. Waars, Sanne: No conflict of intereset||Dr. van der Meulen-de Jong, Andrea:|:|Dr. van der Meulen - de Jong has served on advisory boards, or as speaker or consultant for Takeda, Tramedico, AbbVie, and has received grants from Takeda.||Dr. Stuyt, Rogier: No conflict of intereset||Ms. Brouwer, Samantha: No conflict of intereset||Dr. van der Marel, Sander: No conflict of intereset||Dr. Haans, Jeoffrey:|:|Dr. Haans reports personal fees from advisory boards for Takeda Nederland B.V., personal fees from advisory boards for Lamepro B.V.||Ms. van Deudekom, Floor: No conflict of intereset||Dr. Mooijaart, Simon: No conflict of intereset||Dr. Maljaars, Jeroen:|:|Dr. Maljaars has served as a speaker and an advisory board member for Abbvie, Takeda and Janssen-Cilag.

P811

Dr. YASSIN, Sharif: No conflict of intereset||Dr. Fliss-Isakov, Naomi: No conflict of intereset||Dr. Ron, Yulia: No conflict of intereset||Dr. Hirsch, Ayal: No conflict of intereset||Dr. Cohen, Nathaniel Aviv: No conflict of intereset||Dr. Maharshak, Nitsan: No conflict of intereset

P812

Dr. SANCHEZ, Maria Belen: No conflict of intereset||Dr. Etchevers, Maria Josefina: No conflict of intereset||Dr. De Paula, Juan Andres: No conflict of intereset||Dr. Gonzalez Sueyro, Ramiro: No conflict of intereset||Dr. Daffra, Pamela: No conflict of intereset||Dr. Ramirez Medinacelli, Jesica: No conflict of intereset||Dr. Sobrero, Maria Josefina: No conflict of intereset||Dr. Marcolongo, Mariano Martin: No conflict of intereset

P813

Ms. Diaz Alcazar, Maria Mar: No conflict of intereset||Ms. Martinez Tirado, Pilar: No conflict of intereset||Ms. Vidal Vilchez, Begoña: No conflict of intereset||Ms. Zuñiga de Mora Figueroa, Beatriz: No conflict of intereset

P814

Dr. KOKKOTIS, Georgios: No conflict of intereset||Ms. Bekiari, Despoina: No conflict of intereset||Ms. Bletsa, Maria: No conflict of intereset||Dr. Gizis, Mihail: No conflict of intereset||Dr. Perlepe, Nikoleta: No conflict of intereset||Dr. Athanasiou, Vasiliki: No conflict of intereset||Dr. Kounadis, Georgios: No conflict of intereset||Dr. Koutsounas, Ioannis: No conflict of intereset||Prof. Dr. Kolios, Georgios: No conflict of intereset||Prof. Dr. Bamias, Georgios: No conflict of intereset

P815 Dr. Filip, Rafal: No conflict of intereset||Dr. Gruszecka, Jolanta: No conflict of intereset

P816

Baek, Donghoon: No conflict of intereset||Prof. Dr. Lee, Hong Sub: No conflict of intereset||Prof. Dr. Park, Su Bum: No conflict of intereset||Prof. Dr. Song, Hye Kyung: No conflict of intereset||Prof. Dr. Jang, Byung Ik: No conflict of intereset||Prof. Dr. Bae, Jung Ho: No conflict of intereset||Prof. Dr. goong, Hyeon Jeong: No conflict of intereset||Prof. Dr. Kang, Ho Seok: No conflict of intereset||Prof. Dr. Jung, Sung Hoon: No conflict of intereset||Prof. Dr. Kim, Tae Oh: No conflict of intereset||Prof. Dr. Song, Geun Am: No conflict of intereset||Prof. Dr. Park, Eun Young: No conflict of intereset

P817

Molnár, Tamás: No conflict of intereset||Dr. Miheller, Pál: No conflict of intereset||Dr. Sarlós, Patrícia: No conflict of intereset||Ms. Sánta, Anett: No conflict of intereset||Ms. Juhász, Anita: No conflict of intereset||Dr. Hamvas, Edina: No conflict of intereset||Dr. Nyári, Tibor: No conflict of intereset||Dr. Szántó, Kata Judit: No conflict of intereset||Dr. Bor, Renáta: No conflict of intereset||Dr. Fábián, Anna: No conflict of intereset||Dr. Bálint, Anita: No conflict of intereset||Dr. Milassin, Ágnes: No conflict of intereset||Dr. Rutka, Mariann: No conflict of intereset||Dr. Szepes, Zoltán: No conflict of intereset||Dr. Farkas, Klaudia: No conflict of intereset

P818

Dr. Khoury, Tawfik: No conflict of intereset||Dr. Shafrir, Asher: No conflict of intereset||Dr. Kalisky, Itai: No conflict of intereset||Dr. Safadi, Mohammad: No conflict of intereset||Dr. Mari, Amir: No conflict of intereset||Dr. Mahamid, Mahmud: No conflict of intereset||Dr. H Katz, Lior: No conflict of intereset||Dr. Kadah, Anas: No conflict of intereset||Dr. Sbeit, Wisam: No conflict of intereset

P819 Prof. Dulger, Ahmet Cumhur: No conflict of interesetPage 130 of 135

P820

Ms. Verstockt, Sare: No conflict of intereset||Dr. Hannes, Laurens: No conflict of intereset||Mrs. Deman, Stephanie: No conflict of intereset||Mr. Wollants, Willem-Jan: No conflict of intereset||Mrs. Souche, Erika: No conflict of intereset||Dr. Verstockt, Bram:|:|Research grant: Pfizer|Consultancy: Janssen and Sandoz|Speaker’s fee: Abbvie, Ferring Pharmaceuticals, Janssen, R-biopharm and Takeda|||Mrs. van der Werf, Ilse: No conflict of intereset||Mr. Hoischen, Alexander: No conflict of intereset||Prof. Dr. Ferrante, Marc:|:|Research grant: Amgen, Biogen, Janssen, Pfizer, Takeda|Consultancy: Abbvie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, Takeda|Speaker’s fee: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Takeda|||Prof. Dr. Vermeire, Séverine:|:|Research grant: MSD, Abbvie, Takeda, Janssen, Pfizer; |Consultancy: AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, Progenity, Lilly, Arena, GSK, Amgen, Ferring, Gilead and Janssen|Speaker’s fee: AbbVie, MSD, Takeda, Ferring, Hospira, Pfizer, Janssen, and Tillots|||Prof. Cleynen, Isabelle: No conflict of intereset

P821

Dr. Wilson, Aze: No conflict of intereset||Wang, Qian: No conflict of intereset||Dr. Gregor, Jamie: No conflict of intereset||Dr. Chande, Nilesh: No conflict of intereset||Dr. Beaton, Melanie: No conflict of intereset||Dr. Ponich, Terry: No conflict of intereset||Dr. Sey, Michael: No conflict of intereset||Dr. Yan, Brian: No conflict of intereset||Dr. Kim, Richard: No conflict of intereset

P822

Dr. OKAMOTO, Daisuke: No conflict of intereset||Dr. Kakuta, Yoichi: No conflict of intereset||Dr. Takeo, Naito: No conflict of intereset||Dr. Moroi, Rintaro: No conflict of intereset||Dr. Kuroha, Masatake: No conflict of intereset||Dr. Kanazawa, Yoshitake: No conflict of intereset||Dr. Hisashi, Shiga: No conflict of intereset||Dr. Fuyuno , Yuta: No conflict of intereset||Dr. Umeno, Junji: No conflict of intereset||Dr. Hirano, Atsushi: No conflict of intereset||Dr. Torisu, Takehiro: No conflict of intereset||Dr. Nakamura, Minoru: No conflict of intereset||Prof. Esaki, Motohiro: No conflict of intereset||Prof. Matsumoto, Takayuki: No conflict of intereset||Prof. Kinouchi, Yoshitaka: No conflict of intereset||Prof. Masamune, Atsushi: No conflict of intereset

P823

Mr. Joustra, Vincent: No conflict of intereset||Ms. Hageman, Ishtu: No conflict of intereset||Mr. Li Yim, Andrew: No conflict of intereset||Dr. Gecse, Krisztina: No conflict of intereset||Dr. Lowenberg, Mark: No conflict of intereset||Dr. te Velde, Anje: No conflict of intereset||Prof. Dr. Satsangi, Jack: No conflict of intereset||Prof. Dr. de Jonge, Wouter: No conflict of intereset||Dr. Henneman, Peter: No conflict of intereset||Prof. Dr. D'Haens, Geert: No conflict of intereset

P824

Mr. WALCZAK, Michal: No conflict of intereset||Dr. Lykowska-Szuber, Liliana: No conflict of intereset||Ms. Plucinska, Marianna: No conflict of intereset||Dr. Michalak, Michal: No conflict of intereset||Dr. Krela-Kazmierczak, Iwona: No conflict of intereset||Dr. Zakerska-Banaszak, Oliwia: No conflict of intereset||Dr. Stawczyk-Eder, Kamila: No conflict of intereset||Dr. Eder, Piotr: No conflict of intereset||Prof. Dr. Dobrowolska, Agnieszka: No conflict of intereset||Prof. Dr. Slomski, Ryszard: No conflict of intereset||Dr. Skrzypczak-Zielinska, Marzena: No conflict of intereset

P825

Dr. Biedermann, Luc: No conflict of intereset||Ms. Denoth, Luisa: No conflict of intereset||Rossel, Jean-Benoit: No conflict of intereset||Mr. Butter, Matthias: No conflict of intereset||Prof. Dr. Vavricka, Stephan: No conflict of intereset||Prof. Dr. Misselwitz, Benjamin: No conflict of intereset||Dr. Greuter, Thomas: No conflict of intereset||Dr. Schreiner, Philipp: No conflict of intereset||Prof. Dr. Cleynen, Isabelle: No conflict of intereset||Prof. Dr. Rogler, Gerhard: No conflict of intereset||Prof. Dr. Scharl, Michael: No conflict of intereset

P826

Ms. Kulmala, Katja: No conflict of intereset||Mr. Diaz, Oscar E.: No conflict of intereset||Dr. Huber, Samuel: No conflict of intereset||Dr. Hedin, Charlotte: No conflict of intereset||Prof. Villablanca, Eduardo J.: No conflict of intereset

P827

Dr. Roda, Giulia: No conflict of intereset||Dr. Piovani, Daniele: No conflict of intereset||Dr. Prantesh, Jain: No conflict of intereset||Dr. Gordon, Ilyssa: No conflict of intereset||Dr. Asselta, Rosanna: No conflict of intereset||Dr. Duga, Stefano: No conflict of intereset||Dr. Vetrano, Stefania: No conflict of intereset||Dr. Bonovas, Stefanos: No conflict of intereset||Prof. Harpaz, Noam: No conflict of intereset||Prof. Danese, Silvio: No conflict of intereset||Dr. Peter, Inga: No conflict of intereset||Prof. Colombel, Jean-Frederic: No conflict of intereset||Dr. Rieder, Florian: No conflict of intereset

P828

Kim, Tae Oh: No conflict of intereset||Prof. Dr. Yi, JooMi: No conflict of intereset||Prof. Dr. Jung, Sung Hoon: No conflict of intereset||Prof. Dr. Baek, Dong Hoon: No conflict of intereset||Prof. Dr. Lee, Hong Sub: No conflict of intereset

Page 131 of 135

P829

Prof. Dr. da Luz Rosa, Isadora Alexandra:|:|Isadora Rosa reports grants, personal fees or non-financial support from ABBVIE, FERRING, MSD, TAKEDA, PHARMAKERN, JANSSEN, and DR FALK PHARMA, outside the submitted work.||Silva, Patrícia: No conflict of intereset||Dr. Mata, Sara: No conflict of intereset||Prof. Dr. Magro, Fernando: No conflict of intereset||Prof. Dr. Carneiro, Fátima: No conflict of intereset||Dr. Peixoto, Armando: No conflict of intereset||Dr. Silva, Marco: No conflict of intereset||Dr. Sousa, Helena:|:|Helena Tavares de Sousa reports personal fees or non-financial support from ABBVIE, FERRING, MSD, TAKEDA, PHARMAKERN, JANSSEN, PFIZER and DR FALK PHARMA.||Dr. Roseira, Joana:|:|Joana Roseira reports personal fees or non-financial support from ABBVIE, FERRING, MSD, TAKEDA, PHARMAKERN, JANSSEN, PFIZER and DR FALK PHARMA||Dr. Parra, José: No conflict of intereset||Dr. Barosa, Rita: No conflict of intereset||Dr. Vieira, Ana: No conflict of intereset||Dr. Brito, M José: No conflict of intereset||Dr. Lago, Paula: No conflict of intereset||Dr. Coelho, André: No conflict of intereset||Dr. Moleiro, Joana: No conflict of intereset||Dr. Silva, João: No conflict of intereset||Dr. Fonseca, Ricardo: No conflict of intereset||Albuquerque, Cristina: No conflict of intereset||Prof. Dr. Pereira, A Dias: No conflict of intereset

P830

Dr. Chang, Ji Young: No conflict of intereset||Prof. Park1, Soo Jung: No conflict of intereset||Dr. Jung , Eun Suk: No conflict of intereset||Prof. Jung , Sung-Ae: No conflict of intereset||Prof. Moon, Chang Mo: No conflict of intereset||Prof. Chun, Jaeyoung: No conflict of intereset||Prof. Park , Jae Jun: No conflict of intereset||Prof. Kim , Eun Sun: No conflict of intereset||Prof. Park, Yehyun: No conflict of intereset||Prof. Kim, Tae-Il: No conflict of intereset||Kim, Won Ho: No conflict of intereset||Prof. Cheon, Jae Hee: No conflict of intereset

P831 Mrs. FAQERAH, Nojoud: No conflict of intereset

P832

Dr. Axelrad, Jordan:|:|BioFire Diagnostics- Consulting, research support.||Ms. Hine, Ashley: No conflict of intereset||Mr. Devlin, Joseph: No conflict of intereset||Dr. Loke, P'ng: No conflict of intereset||Dr. Cadwell, Ken: No conflict of intereset

P833

Dr. Olaisen, Maya: No conflict of intereset||Mr. Flatberg, Arnar: No conflict of intereset||Mr. van Beelen Granlund, Atle: No conflict of intereset||Dr. Røyset, Elin Synnøve: No conflict of intereset||Dr. Martinsen, Tom Christian: No conflict of intereset||Prof. Dr. Sandvik, Arne Kristian: No conflict of intereset||Prof. Dr. Fossmark, Reidar: No conflict of intereset

P834

Prof. Dr. Eun, Chang Soo: No conflict of intereset||Prof. Dr. Han, Dong Soo: No conflict of intereset||Dr. Lee, Jae Gon: No conflict of intereset||Prof. Dr. Park, Chan Hyuk: No conflict of intereset

P835

Mr. Amoedo Cibeira, Joan: No conflict of intereset||Dr. Ramió-Pujol, Sara: No conflict of intereset||Dr. Serra-Pagès, Mariona: No conflict of intereset||Dr. Bahí, Anna: No conflict of intereset||Ms. Puig-Amiel, Carlota: No conflict of intereset||Mrs. Oliver, Lia: No conflict of intereset||Mr. Gilabert, Pau: No conflict of intereset||Dr. Clos, Ariadna: No conflict of intereset||Dr. Mañosa, Míriam: No conflict of intereset||Dr. Cañete, Fiorella: No conflict of intereset||Mr. Miquel-Cusachs, Josep Oriol: No conflict of intereset||Mrs. Torrealba, Leyanira: No conflict of intereset||Mr. Busquets, David: No conflict of intereset||Dr. Sàbat, Míriam: No conflict of intereset||Dr. Domènech, Eugeni: No conflict of intereset||Dr. Guardiola, Jordi: No conflict of intereset||Prof. Dr. Garcia-Gil, Jesús: No conflict of intereset||Dr. Aldeguer, Xavier: No conflict of intereset

P836

Dr. Sanchis, Laura: No conflict of intereset||Mr. Manresa, Sergio: No conflict of intereset||Prof. Dr. Martínez, Juan Francisco: No conflict of intereset||Dr. Valls, Marina: No conflict of intereset||Dr. Iborra, Marisa: No conflict of intereset||Dr. Paredes, Jose María: No conflict of intereset||Dr. Boscá, Maia: No conflict of intereset||Dr. Huguet, Jose María: No conflict of intereset||Dr. Gil, Rafael: No conflict of intereset||Dr. Maroto, Nuria: No conflict of intereset||Mrs. Rodriguez, Josefa: No conflict of intereset||Dr. Cortés, Xavier: No conflict of intereset

P837

Dr. Seong, Gyeol: No conflict of intereset||Dr. Song, Joo Hye: No conflict of intereset||Dr. Shin, Jongbeom: No conflict of intereset||Dr. Kong, sung min: No conflict of intereset||Dr. Kim, Eun Ran: No conflict of intereset||Dr. Chang, Dong Kyung: No conflict of intereset||Dr. Hong, Sung Noh: No conflict of intereset||Dr. Kim, Young-Ho: No conflict of intereset

P838Dr. Hirano, Atsushi: No conflict of intereset||Dr. Umeno, Junji: No conflict of intereset||Dr. Torisu, Takehiro: No conflict of intereset

P839

Dr. Fukushima, Shinya: No conflict of intereset||Prof. Shiotani, Akiko: No conflict of intereset||Dr. Matsumoto, Hiroshi: No conflict of intereset||Dr. Inoue, Ryo: No conflict of intereset||Prof. Naito, Yuji: No conflict of intereset

P840 Mrs. Mayorgas, Aida: No conflict of intereset

Page 132 of 135

P841

Dr. COCCIOLILLO, Sila:|:|Research grant award from FIRE (Fondazione Italiana per la Ricerca in Epatologia) onlus.||Dr. De Palma, Giada: No conflict of intereset||Dr. Chen, Tianyan: No conflict of intereset||Dr. Ghali, Maged Peter: No conflict of intereset||Dr. Deschenes, Marc:|:|Ad board Gilead and Eisai||Dr. Wong, Philip: No conflict of intereset||Dr. Wild, Gary: No conflict of intereset||Dr. Afif, Waqqas:|:|Janssen, Abbvie, Takeda, Pfizer, Merck, Ferring, Novartis, Arena, Prometheus, Theradiag||Dr. Lakatos, Peter L: No conflict of intereset||Dr. Bitton, Alain: No conflict of intereset||Dr. Sebastiani, Giada: No conflict of intereset||Dr. Bercik, Premysl: No conflict of intereset||Dr. Bessissow, Talat:|:|Speaker and consultant: Janssen, Abbvie, Takeda, Pfizer, Shire, Ferring, pendopharm, Merck. Research grants: Abbvie, Jansse

P842Ms. ZENG, Li: No conflict of intereset||Mrs. Wang, Yufang: No conflict of intereset||Mrs. Zhuo, Ma: No conflict of intereset

P843

Dr. Barberio, Brigida: No conflict of intereset||Dr. Bertazzo, Elena: No conflict of intereset||Dr. Marinelli, Carla: No conflict of intereset||Dr. Massimi, Davide: No conflict of intereset||Dr. Ghisa, Matteo: No conflict of intereset||Dr. Gubbiotti, Alessandro: No conflict of intereset||Dr. Casadei, Cesare: No conflict of intereset||Dr. Lorenzon, Greta: No conflict of intereset||Dr. Zingone, Fabiana: No conflict of intereset||Dr. D'Incà, Renata: No conflict of intereset||Prof. Savarino, Edoardo Vincenzo: No conflict of intereset

P844

Dr. Segal, Jonathan: No conflict of intereset||Dr. Mullish, Benjamin: No conflict of intereset||Prof. Clark, Susan: No conflict of intereset||Prof. Marchesi, Julian: No conflict of intereset||Prof. Hart, Ailsa: No conflict of intereset

P845

Mrs. Gros Alcalde, Beatriz: No conflict of intereset||Ms. Soto Escribano, Pilar: No conflict of intereset||Ms. Iglesias-Flores, Eva: No conflict of intereset||Ms. Marín Pedrosa, Sandra: No conflict of intereset||Ms. García-Sánchez, Valle: No conflict of intereset||Mr. Benítez, Jose Manuel: No conflict of intereset

P846

Mr. Amoedo Cibeira, Joan: No conflict of intereset||Dr. Ramió-Pujol, Sara: No conflict of intereset||Dr. Serra-Pagès, Mariona: No conflict of intereset||Mrs. Oliver, Lia: No conflict of intereset||Dr. Bahí, Anna: No conflict of intereset||Mr. Miquel-Cusachs, Josep Oriol: No conflict of intereset||Mr. Busquets, David: No conflict of intereset||Prof. Dr. Garcia-Gil, Jesús: No conflict of intereset||Dr. Aldeguer, Xavier: No conflict of intereset

P847

Dr. Herrera De Guise, Claudia Maria: No conflict of intereset||Dr. Varela, Encarna: No conflict of intereset||Ms. Ibarz, Arantxa: No conflict of intereset||Dr. Burgos, Rosa: No conflict of intereset||Cardenas, Guillermo: No conflict of intereset||Dr. Luis Fernando, Mayorga: No conflict of intereset||Dr. Robles, Virginia: No conflict of intereset||Dr. Borruel, Natalia: No conflict of intereset||Dr. Guarner Aguilar, Francisco: No conflict of intereset||Dr. Casellas, Francesc: No conflict of intereset

P848

Mrs. OLIVER, Lia: No conflict of intereset||Dr. Ramió-Pujol, Sara: No conflict of intereset||Mr. Amoedo, Joan: No conflict of intereset||Ms. Malagón, Marta: No conflict of intereset||Dr. Serrano, Marta: No conflict of intereset||Dr. Bahí, Anna: No conflict of intereset||Mr. Lluansí, Aleix: No conflict of intereset||Mr. Busquets, David: No conflict of intereset||Mrs. Leyanira, Torrealba: No conflict of intereset||Dr. Serra-Pagès, Mariona: No conflict of intereset||Dr. Aldeguer, Xavier: No conflict of intereset||Prof. Dr. Jesús, Garcia-Gil: No conflict of intereset

P849 Dr. Filip, Rafal: No conflict of intereset||Dr. Gruszecka, Jolanta: No conflict of intereset

P850

Prof. Dr. Lee, Hong Sub: No conflict of intereset||Prof. Dr. Kim, Tae Oh: No conflict of intereset||Prof. Dr. Jung, Sung Hoon: No conflict of intereset||Prof. Dr. Baek, Dong Hoon: No conflict of intereset

P851

Dr. León F, Moisés: No conflict of intereset||Dr. Nieto, Carlos Alfonso: No conflict of intereset||Dr. Corredor, Zayda: No conflict of intereset||Dr. Flórez-Sarmiento, Cristian: No conflict of intereset||Dr. Parra - Izquierdo, Viviana: No conflict of intereset||Dr. ROMERO-SANCHEZ, Consuelo: No conflict of intereset

P852

Mrs. O'MEARA, Diane: No conflict of intereset||Dr. Tufail, Qamar: No conflict of intereset||Dr. Lim, Felicia: No conflict of intereset||Dr. Richards, Cathy: No conflict of intereset||Dr. Thi, Aye Aye: No conflict of intereset

P853

TUFAIL, Qamar: No conflict of intereset||Ms. O’Meara, Diane: No conflict of intereset||Dr. Thi , AyeAye: No conflict of intereset||Dr. Lim, Felicia: No conflict of intereset||Dr. Richards, Cathy: No conflict of intereset

Page 133 of 135

N01 Ms. Cañas, Mercedes: No conflict of intereset||Dr. Mesonero, Francisco:|:|Payment for development of educational presentations: MSD||Dr. Rodriguez-Lago, Iago:|:|Board membership: Tillots Pharma, Pfizer, Ferring and Adacyte|Payment for lectures including service on speakers bureaus: MSD, Abbie, Takeda, Tillots Pharma, Dr. Falk Pharma and Pfizer|Payment for development os educational presentatios: Otsuka Pharmaceutical|Travel/ accomodations meeting expenses: MSD, Pfizer, Abbie, Takeda, Janssen, Tillotts Pharma, Shire Pharmaceutical, Dr. Falk Pharma, Otsuka Pharmaceutical, Ferring.||Ms. Savini, Claudia: No conflict of intereset||Mr. Saldaña, Roberto: No conflict of intereset||Ms. Feo-Luca, Lidia:|:|Full time employee of Merck Sharp and Dohme Spain||Ms. FERNANDEZ, Sabela:|:|Full time employee of Merck Sharp & Dohme Spain||Dr. Cea-Calvo, Luis:|:|Full time employee of Merck Sharp & Dohme Spain||Dr. Juliá, Berta:|:|Ful time employee of Merck Sharp & Dohme Spain

N02 Dr. Windgassen, Sula: No conflict of intereset||Dr. Artom, Micol: No conflict of intereset||Prof. Norton, Christine:|:|CN has received lecture fees from Tillotts Pharma, Abbvie and Ferring Pharmaceuticals.||Ms. Sweeney, Louise:|:|LS received funding from the BRC for sample analyses.||Prof. Moss-Morris, Rona:|:|RMM received funding from the BRC for sample analyses. RMM reports personal fees from training in irritable bowel syndrome intervention for Central and North|West London NHS Foundation Trust and University of East Anglia, outside the submitted work. She has received payment for consultancy to Mahana Therapeutics and a private company has signed a licence agreement with King’s College London with the view to bringing the Regul8 website product to the NHS and other international markets.

N03 Ms. Takahashi, Miho: No conflict of intereset||Dr. Aoyama, Nobuo: No conflict of intereset||Ms. Nunotani, Maya: No conflict of intereset

N04 Dr. Khan, Fiza: No conflict of intereset||Dr. Czuber-Dochan, Wladzia: No conflict of intereset||Prof. Norton, Christine: No conflict of intereset

N05 Ms. Avery, Pearl:|:|Educational grant received from Bühlmann 2017||Ms. Blackmore, Kelly: No conflict of intereset||Ms. Angel, Caroline: No conflict of intereset

N06 Ms. NI DHALAIGH, Doireann: No conflict of intereset||Dr. Anna Marie , Greaney: No conflict of intereset||Dr. Farrell, Dawn: No conflict of intereset

N07 Ms. Avery, Pearl: No conflict of intereset||Ms. Blackmore, Kelly: No conflict of intereset||Mrs. Angel, Caroline: No conflict of intereset

N08 Dr. Jäghult, Susanna: No conflict of interesetN09 Ms. Sweeney, Louise:|:|LS received funding from the BRC for sample analyses||Prof. Moss-Morris,

Rona:|:|RMM received funding from the BRC for sample analyses. RMM reports personal fees from training in irritable bowel syndrome intervention for Central and North|West London NHS Foundation Trust and University of East Anglia, outside the submitted work. She has received payment for consultancy to Mahana Therapeutics and a private company has signed a licence agreement with King’s College London with the view to bringing the Regul8 website product to the NHS and other international markets. ||Dr. Czuber-Dochan, Wladysawa:|:|WCD has received lecture fees from Dr Falk Pharma and EGIS Pharmaceuticals. ||Prof. Norton, Christine:|:|CN has received lecture fees from Tillotts Pharma, Abbvie and Ferring Pharmaceuticals.

N10 Dr. Rivera Sequeiros, Adriana: No conflict of intereset||Mrs. Torres Dominguez, Yolanda: No conflict of intereset||Mrs. Izquierdo Macías, María Ángeles: No conflict of intereset||Dr. Ruiz Romero, María Victoria: No conflict of intereset

N11 Ms. BAILEY, Yvonne: No conflict of interesetN12 Ms. Sugrue, Kathleen: No conflict of intereset||Ms. Gleeson, Sarah: No conflict of intereset||Dr.

McCarthy, Jane: No conflict of intereset||Dr. Buckley, Martin: No conflict of intereset

N13 withdrawnN14 Fawson, Sophie: No conflict of intereset||Dr. Dibley, Lesley:|:|Speaker fees from Janssen and AbbVie;

consultancy fees from GL Assessments and Crohn’s & Colitis UK ||Smith, Kaylee: No conflict of intereset||Batista, Joanna: No conflict of intereset||Dr. Artom, Micol: No conflict of intereset||Windgassen, Sula: No conflict of intereset||Syred, Jonathan: No conflict of intereset||Prof. Moss-Morris, Rona: No conflict of intereset||Prof. Norton, Christine:|:|Speaker fees from Ferring, Takeda, and Tillots Pharma

N15 Kearns, Jacqueline:|:|Ferring Pharmaceuticals Limited supported this study through the loan of a laptop for data entry.||Scullion, Louise:|:|Ferring Pharmaceuticals Limited supported this study through the loan of a laptop for data entry.||Masterson, Caroline:|:|Ferring Pharmaceuticals Limited supported this study through the loan of a laptop for data entry.||Kennedy, Noreen:|:|Ferring Pharmaceuticals Limited supported this study through the loan of a laptop for data entry.||Butcher, Catherine:|:|Ferring Pharmaceuticals Limited supported this study through the loan of a laptop for data entry.

N16 Ms. Keogh, Aine M.: No conflict of intereset||Dr. Farrell , Dawn: No conflict of interesetPage 134 of 135

N17 Ms. Barros, Jaqueline: No conflict of intereset||Herrerias, Giedre: No conflict of intereset||Oliveira, Leticia: No conflict of intereset||Baima, Julio: No conflict of intereset||Alencar, Rubia: No conflict of intereset||Saad-Hossne, Rogerio: No conflict of intereset||Prof. Dr. Sassaki, Ligia: No conflict of intereset

N18 Dr. MUKHERJEE, Suzanne: No conflict of intereset||Prof. Beresford, Bryony: No conflict of intereset

N19 Mrs. Younge, Lisa: No conflict of intereset||Ms. Medcalf, Lucy: No conflict of intereset||Mrs. Hall, Alex: No conflict of intereset||Mrs. Shaw, Claire: No conflict of intereset

N20 Ms. Radford, Shellie: No conflict of intereset||Dr. Moran, Gordon W.: No conflict of intereset||Dr. Czuber-Dochan, Wladyslawa: No conflict of intereset

N21 Ms. Forry, Mary: No conflict of intereset||Dr. Milewska, Malgorzata: No conflict of intereset||Ms. Lardner, Caroline: No conflict of intereset||Ms. Lukose, Tincy: No conflict of intereset||Ms. Godwin, Nuala: No conflict of intereset||Dr. Boland, Karen: No conflict of intereset||Prof. Patchett, Stephen: No conflict of intereset||Dr. O'Toole, Aoibhlinn: No conflict of intereset

N22 Ms. Gleeson, Sarah: No conflict of intereset||Ms. Sugrue, Kathleen: No conflict of intereset||Dr. Buckley, Martin: No conflict of intereset||Dr. McCarthy, Jane: No conflict of intereset

N23 Mr. MOHSENIZADEH, Seyed Mostafa: No conflict of intereset||Dr. Manzari, Zahra Sadat: No conflict of intereset||Dr. vosoghinia, Hasan: No conflict of intereset||Dr. Ebrahimipour, Hossein: No conflict of intereset

N24 Prof. Dr. Rohatinsky, Noelle: No conflict of intereset||Prof. Dr. Risling, Tracie: No conflict of intereset||Ms. Kumaran, Maha: No conflict of intereset||Prof. Dr. Hellsten, Laurie-ann: No conflict of intereset

N25 Ms. Windak, Halina: No conflict of intereset||Ms. Cairnes, Vida: No conflict of intereset||Mr. Chanchlani , Neil: No conflict of intereset||Mr. Desmond, Chee: No conflict of intereset||Mr. Hamilton, Ben: No conflict of intereset||Heerasing , Neil: No conflict of intereset||Hendy, Peter: No conflict of intereset||Simeng , Lin: No conflict of intereset||Kennedy, Nicholas A: No conflict of intereset||Goodhand, James: No conflict of intereset||Mr. Ahmad, Tariq: No conflict of intereset||Ms. Gordon, Claire: No conflict of intereset

N26 Mrs. Toivonen, Tanja Tiitta Inkeri: No conflict of intereset||Mrs. Helin, Kaisa: No conflict of intereset||Nikkola, Riitta: No conflict of intereset

N27 Mrs. Fourie, Simona: No conflict of intereset||Dr. Czuber-Dochan, Wladyslawa: No conflict of intereset||Prof. Norton, Christine: No conflict of intereset

N28 Mrs. Clarke, Michelle: No conflict of intereset||Mr. Goodhand, James: No conflict of intereset||Mr. Ahmad, Tariq: No conflict of intereset||Ms. Cairnes, Vida: No conflict of intereset||Ms. Kennedy, Nick A: No conflict of intereset

N29 Mrs. Mateos Hernandez, Maria Isabel: No conflict of interesetN30 Dr. Czuber-Dochan, Wladyslawa: No conflict of interesetN31 Ms. Roberts, Danniella: No conflict of intereset||Ms. Liu, Qianyu: No conflict of intereset||Dr. Czuber-

Dochan, Wladyslawa: No conflict of intereset||Dr. Smith, Philip: No conflict of intereset||Prof. Norton, Christine: No conflict of intereset

Page 135 of 135